CN101541832B - 能中和流感病毒h5n1的人结合分子及其应用 - Google Patents
能中和流感病毒h5n1的人结合分子及其应用 Download PDFInfo
- Publication number
- CN101541832B CN101541832B CN200780041285.1A CN200780041285A CN101541832B CN 101541832 B CN101541832 B CN 101541832B CN 200780041285 A CN200780041285 A CN 200780041285A CN 101541832 B CN101541832 B CN 101541832B
- Authority
- CN
- China
- Prior art keywords
- seq
- ser
- val
- binding molecule
- gly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000027455 binding Effects 0.000 title claims abstract description 386
- 241000282414 Homo sapiens Species 0.000 title claims abstract description 177
- 241000712461 unidentified influenza virus Species 0.000 title claims abstract description 143
- 230000003472 neutralizing effect Effects 0.000 title abstract description 5
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 48
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 48
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 48
- 206010022000 influenza Diseases 0.000 claims abstract description 17
- 238000003745 diagnosis Methods 0.000 claims abstract description 13
- 101710154606 Hemagglutinin Proteins 0.000 claims description 128
- 101710093908 Outer capsid protein VP4 Proteins 0.000 claims description 128
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims description 128
- 101710176177 Protein A56 Proteins 0.000 claims description 128
- 150000001413 amino acids Chemical class 0.000 claims description 31
- 238000006386 neutralization reaction Methods 0.000 claims description 31
- 239000003814 drug Substances 0.000 claims description 30
- 230000000694 effects Effects 0.000 claims description 29
- 239000008194 pharmaceutical composition Substances 0.000 claims description 19
- 238000002360 preparation method Methods 0.000 claims description 15
- 238000000926 separation method Methods 0.000 claims description 10
- 238000000034 method Methods 0.000 abstract description 83
- 208000015181 infectious disease Diseases 0.000 abstract description 53
- 239000000203 mixture Substances 0.000 abstract description 52
- 238000011282 treatment Methods 0.000 abstract description 32
- 230000004224 protection Effects 0.000 abstract description 12
- 238000001727 in vivo Methods 0.000 abstract description 9
- 238000011321 prophylaxis Methods 0.000 abstract description 4
- 125000003275 alpha amino acid group Chemical group 0.000 description 187
- 210000004027 cell Anatomy 0.000 description 147
- 239000000185 hemagglutinin Substances 0.000 description 127
- 241000699666 Mus <mouse, genus> Species 0.000 description 79
- 239000012634 fragment Substances 0.000 description 69
- 241001465754 Metazoa Species 0.000 description 63
- 241000880493 Leptailurus serval Species 0.000 description 58
- 241000700605 Viruses Species 0.000 description 53
- 108090000623 proteins and genes Proteins 0.000 description 44
- 125000003729 nucleotide group Chemical group 0.000 description 43
- 239000002773 nucleotide Chemical group 0.000 description 41
- 108010052670 arginyl-glutamyl-glutamic acid Proteins 0.000 description 39
- 235000018102 proteins Nutrition 0.000 description 39
- 102000004169 proteins and genes Human genes 0.000 description 39
- 230000009870 specific binding Effects 0.000 description 38
- 208000024891 symptom Diseases 0.000 description 38
- 229940127121 immunoconjugate Drugs 0.000 description 36
- IHCXPSYCHXFXKT-DCAQKATOSA-N Pro-Arg-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O IHCXPSYCHXFXKT-DCAQKATOSA-N 0.000 description 35
- 108090000765 processed proteins & peptides Proteins 0.000 description 35
- 239000000427 antigen Substances 0.000 description 34
- ZYRXTRTUCAVNBQ-GVXVVHGQSA-N Glu-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N ZYRXTRTUCAVNBQ-GVXVVHGQSA-N 0.000 description 33
- UQFYNFTYDHUIMI-WHFBIAKZSA-N Ser-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CO UQFYNFTYDHUIMI-WHFBIAKZSA-N 0.000 description 33
- 102000036639 antigens Human genes 0.000 description 33
- 108091007433 antigens Proteins 0.000 description 33
- 235000001014 amino acid Nutrition 0.000 description 31
- 229940024606 amino acid Drugs 0.000 description 30
- 239000000523 sample Substances 0.000 description 30
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 29
- 108010031719 prolyl-serine Proteins 0.000 description 29
- 108010017391 lysylvaline Proteins 0.000 description 27
- CGBYDGAJHSOGFQ-LPEHRKFASA-N Pro-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 CGBYDGAJHSOGFQ-LPEHRKFASA-N 0.000 description 26
- 241000894006 Bacteria Species 0.000 description 25
- 108010060199 cysteinylproline Proteins 0.000 description 24
- 102000004196 processed proteins & peptides Human genes 0.000 description 24
- 230000008859 change Effects 0.000 description 23
- 238000011160 research Methods 0.000 description 23
- MNQMTYSEKZHIDF-GCJQMDKQSA-N Asp-Thr-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O MNQMTYSEKZHIDF-GCJQMDKQSA-N 0.000 description 22
- PDIDTSZKKFEDMB-UWVGGRQHSA-N Lys-Pro-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O PDIDTSZKKFEDMB-UWVGGRQHSA-N 0.000 description 22
- 239000000463 material Substances 0.000 description 22
- OYTPNWYZORARHL-XHNCKOQMSA-N Gln-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)N)N OYTPNWYZORARHL-XHNCKOQMSA-N 0.000 description 21
- BYYNJRSNDARRBX-YFKPBYRVSA-N Gly-Gln-Gly Chemical compound NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O BYYNJRSNDARRBX-YFKPBYRVSA-N 0.000 description 21
- 108060003951 Immunoglobulin Proteins 0.000 description 21
- LGIMRDKGABDMBN-DCAQKATOSA-N Ser-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N LGIMRDKGABDMBN-DCAQKATOSA-N 0.000 description 21
- MBLJBGZWLHTJBH-SZMVWBNQSA-N Trp-Val-Arg Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)=CNC2=C1 MBLJBGZWLHTJBH-SZMVWBNQSA-N 0.000 description 21
- 108010069020 alanyl-prolyl-glycine Proteins 0.000 description 21
- 108010000434 glycyl-alanyl-leucine Proteins 0.000 description 21
- 108010050475 glycyl-leucyl-tyrosine Proteins 0.000 description 21
- 102000018358 immunoglobulin Human genes 0.000 description 21
- 108010073472 leucyl-prolyl-proline Proteins 0.000 description 21
- 238000012360 testing method Methods 0.000 description 21
- 108010052774 valyl-lysyl-glycyl-phenylalanyl-tyrosine Proteins 0.000 description 21
- 238000005406 washing Methods 0.000 description 21
- 108020004414 DNA Proteins 0.000 description 20
- HAOUOFNNJJLVNS-BQBZGAKWSA-N Gly-Pro-Ser Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O HAOUOFNNJJLVNS-BQBZGAKWSA-N 0.000 description 20
- AIQWYVFNBNNOLU-RHYQMDGZSA-N Leu-Thr-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O AIQWYVFNBNNOLU-RHYQMDGZSA-N 0.000 description 20
- JDMKQHSHKJHAHR-UHFFFAOYSA-N Phe-Phe-Leu-Tyr Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)CC1=CC=CC=C1 JDMKQHSHKJHAHR-UHFFFAOYSA-N 0.000 description 20
- JQTYTBPCSOAZHI-FXQIFTODSA-N Val-Ser-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N JQTYTBPCSOAZHI-FXQIFTODSA-N 0.000 description 20
- 108010086434 alanyl-seryl-glycine Proteins 0.000 description 20
- 230000037396 body weight Effects 0.000 description 20
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 20
- 230000014509 gene expression Effects 0.000 description 20
- 108010048397 seryl-lysyl-leucine Proteins 0.000 description 20
- SNDBKTFJWVEVPO-WHFBIAKZSA-N Asp-Gly-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(O)=O SNDBKTFJWVEVPO-WHFBIAKZSA-N 0.000 description 19
- DHNWZLGBTPUTQQ-QEJZJMRPSA-N Gln-Asp-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)N)N DHNWZLGBTPUTQQ-QEJZJMRPSA-N 0.000 description 19
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 19
- OIARJGNVARWKFP-YUMQZZPRSA-N Leu-Asn-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O OIARJGNVARWKFP-YUMQZZPRSA-N 0.000 description 19
- PVMPDMIKUVNOBD-CIUDSAMLSA-N Leu-Asp-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O PVMPDMIKUVNOBD-CIUDSAMLSA-N 0.000 description 19
- YQFZRHYZLARWDY-IHRRRGAJSA-N Leu-Val-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN YQFZRHYZLARWDY-IHRRRGAJSA-N 0.000 description 19
- UAYHMOIGIQZLFR-NHCYSSNCSA-N Pro-Gln-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O UAYHMOIGIQZLFR-NHCYSSNCSA-N 0.000 description 19
- BMKNXTJLHFIAAH-CIUDSAMLSA-N Ser-Ser-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O BMKNXTJLHFIAAH-CIUDSAMLSA-N 0.000 description 19
- NHOVZGFNTGMYMI-KKUMJFAQSA-N Tyr-Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NHOVZGFNTGMYMI-KKUMJFAQSA-N 0.000 description 19
- SYSWVVCYSXBVJG-RHYQMDGZSA-N Val-Leu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)N)O SYSWVVCYSXBVJG-RHYQMDGZSA-N 0.000 description 19
- HTONZBWRYUKUKC-RCWTZXSCSA-N Val-Thr-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O HTONZBWRYUKUKC-RCWTZXSCSA-N 0.000 description 19
- LLJLBRRXKZTTRD-GUBZILKMSA-N Val-Val-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)O)N LLJLBRRXKZTTRD-GUBZILKMSA-N 0.000 description 19
- 108010008355 arginyl-glutamine Proteins 0.000 description 19
- 239000003795 chemical substances by application Substances 0.000 description 19
- 239000000243 solution Substances 0.000 description 19
- 230000001225 therapeutic effect Effects 0.000 description 19
- 108010080629 tryptophan-leucine Proteins 0.000 description 19
- ISJWBVIYRBAXEB-CIUDSAMLSA-N Arg-Ser-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O ISJWBVIYRBAXEB-CIUDSAMLSA-N 0.000 description 18
- 238000002965 ELISA Methods 0.000 description 18
- IKFZXRLDMYWNBU-YUMQZZPRSA-N Gln-Gly-Arg Chemical compound NC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N IKFZXRLDMYWNBU-YUMQZZPRSA-N 0.000 description 18
- XMPXVJIDADUOQB-RCOVLWMOSA-N Gly-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C([O-])=O)NC(=O)CNC(=O)C[NH3+] XMPXVJIDADUOQB-RCOVLWMOSA-N 0.000 description 18
- UWKNTTJNVSYXPC-CIUDSAMLSA-N Lys-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN UWKNTTJNVSYXPC-CIUDSAMLSA-N 0.000 description 18
- QPVFUAUFEBPIPT-CDMKHQONSA-N Phe-Gly-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O QPVFUAUFEBPIPT-CDMKHQONSA-N 0.000 description 18
- XTDDIVQWDXMRJL-IHRRRGAJSA-N Val-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](C(C)C)N XTDDIVQWDXMRJL-IHRRRGAJSA-N 0.000 description 18
- ZLNYBMWGPOKSLW-LSJOCFKGSA-N Val-Val-Asp Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O ZLNYBMWGPOKSLW-LSJOCFKGSA-N 0.000 description 18
- 108010024654 phenylalanyl-prolyl-alanine Proteins 0.000 description 18
- 229920001184 polypeptide Polymers 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- 108010071097 threonyl-lysyl-proline Proteins 0.000 description 18
- 108010073969 valyllysine Proteins 0.000 description 18
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 17
- UQJNXZSSGQIPIQ-FBCQKBJTSA-N Gly-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)CN UQJNXZSSGQIPIQ-FBCQKBJTSA-N 0.000 description 17
- SRSPTFBENMJHMR-WHFBIAKZSA-N Ser-Ser-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SRSPTFBENMJHMR-WHFBIAKZSA-N 0.000 description 17
- KRAHMIJVUPUOTQ-DCAQKATOSA-N Val-Ser-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N KRAHMIJVUPUOTQ-DCAQKATOSA-N 0.000 description 17
- 108010038320 lysylphenylalanine Proteins 0.000 description 17
- 210000002966 serum Anatomy 0.000 description 17
- 239000000126 substance Substances 0.000 description 17
- OHLLDUNVMPPUMD-DCAQKATOSA-N Cys-Leu-Val Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CS)N OHLLDUNVMPPUMD-DCAQKATOSA-N 0.000 description 16
- HUFCEIHAFNVSNR-IHRRRGAJSA-N Glu-Gln-Tyr Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 HUFCEIHAFNVSNR-IHRRRGAJSA-N 0.000 description 16
- SJDQOYTYNGZZJX-SRVKXCTJSA-N Met-Glu-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O SJDQOYTYNGZZJX-SRVKXCTJSA-N 0.000 description 16
- MKGIILKDUGDRRO-FXQIFTODSA-N Pro-Ser-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1 MKGIILKDUGDRRO-FXQIFTODSA-N 0.000 description 16
- NJEMRSFGDNECGF-GCJQMDKQSA-N Thr-Ala-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O NJEMRSFGDNECGF-GCJQMDKQSA-N 0.000 description 16
- WUFHZIRMAZZWRS-OSUNSFLBSA-N Val-Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C(C)C)N WUFHZIRMAZZWRS-OSUNSFLBSA-N 0.000 description 16
- 108010015792 glycyllysine Proteins 0.000 description 16
- 239000013642 negative control Substances 0.000 description 16
- 108010051110 tyrosyl-lysine Proteins 0.000 description 16
- VNYMOTCMNHJGTG-JBDRJPRFSA-N Ala-Ile-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O VNYMOTCMNHJGTG-JBDRJPRFSA-N 0.000 description 15
- MNZHHDPWDWQJCQ-YUMQZZPRSA-N Ala-Leu-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O MNZHHDPWDWQJCQ-YUMQZZPRSA-N 0.000 description 15
- HNXWVVHIGTZTBO-LKXGYXEUSA-N Asn-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O HNXWVVHIGTZTBO-LKXGYXEUSA-N 0.000 description 15
- BRTVHXHCUSXYRI-CIUDSAMLSA-N Leu-Ser-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O BRTVHXHCUSXYRI-CIUDSAMLSA-N 0.000 description 15
- VUBIPAHVHMZHCM-KKUMJFAQSA-N Leu-Tyr-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CC1=CC=C(O)C=C1 VUBIPAHVHMZHCM-KKUMJFAQSA-N 0.000 description 15
- SJRQWEDYTKYHHL-SLFFLAALSA-N Phe-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC3=CC=CC=C3)N)C(=O)O SJRQWEDYTKYHHL-SLFFLAALSA-N 0.000 description 15
- BMGOFDMKDVVGJG-NHCYSSNCSA-N Val-Asp-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N BMGOFDMKDVVGJG-NHCYSSNCSA-N 0.000 description 15
- HGJRMXOWUWVUOA-GVXVVHGQSA-N Val-Leu-Gln Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N HGJRMXOWUWVUOA-GVXVVHGQSA-N 0.000 description 15
- JVGDAEKKZKKZFO-RCWTZXSCSA-N Val-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N)O JVGDAEKKZKKZFO-RCWTZXSCSA-N 0.000 description 15
- 108010013768 glutamyl-aspartyl-proline Proteins 0.000 description 15
- 108010057821 leucylproline Proteins 0.000 description 15
- YQPFCZVKMUVZIN-AUTRQRHGSA-N Glu-Val-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O YQPFCZVKMUVZIN-AUTRQRHGSA-N 0.000 description 14
- AIMGJYMCTAABEN-GVXVVHGQSA-N Leu-Val-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O AIMGJYMCTAABEN-GVXVVHGQSA-N 0.000 description 14
- KCXUCYYZNZFGLL-SRVKXCTJSA-N Lys-Ala-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O KCXUCYYZNZFGLL-SRVKXCTJSA-N 0.000 description 14
- NTBFKPBULZGXQL-KKUMJFAQSA-N Lys-Asp-Tyr Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NTBFKPBULZGXQL-KKUMJFAQSA-N 0.000 description 14
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 14
- ZJPGOXWRFNKIQL-JYJNAYRXSA-N Phe-Pro-Pro Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=CC=C1 ZJPGOXWRFNKIQL-JYJNAYRXSA-N 0.000 description 14
- QPFJSHSJFIYDJZ-GHCJXIJMSA-N Ser-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CO QPFJSHSJFIYDJZ-GHCJXIJMSA-N 0.000 description 14
- SQUMHUZLJDUROQ-YDHLFZDLSA-N Tyr-Val-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O SQUMHUZLJDUROQ-YDHLFZDLSA-N 0.000 description 14
- HJSLDXZAZGFPDK-ULQDDVLXSA-N Val-Phe-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N HJSLDXZAZGFPDK-ULQDDVLXSA-N 0.000 description 14
- 108010050848 glycylleucine Proteins 0.000 description 14
- 238000004806 packaging method and process Methods 0.000 description 14
- 230000009182 swimming Effects 0.000 description 14
- WQKAQKZRDIZYNV-VZFHVOOUSA-N Ala-Ser-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WQKAQKZRDIZYNV-VZFHVOOUSA-N 0.000 description 13
- YJHKTAMKPGFJCT-NRPADANISA-N Ala-Val-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O YJHKTAMKPGFJCT-NRPADANISA-N 0.000 description 13
- ULBHWNVWSCJLCO-NHCYSSNCSA-N Arg-Val-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCN=C(N)N ULBHWNVWSCJLCO-NHCYSSNCSA-N 0.000 description 13
- DONWIPDSZZJHHK-HJGDQZAQSA-N Asp-Lys-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)N)O DONWIPDSZZJHHK-HJGDQZAQSA-N 0.000 description 13
- JSNWZMFSLIWAHS-HJGDQZAQSA-N Asp-Thr-Leu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O JSNWZMFSLIWAHS-HJGDQZAQSA-N 0.000 description 13
- CKOFNWCLWRYUHK-XHNCKOQMSA-N Glu-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)N)C(=O)O CKOFNWCLWRYUHK-XHNCKOQMSA-N 0.000 description 13
- QDMVXRNLOPTPIE-WDCWCFNPSA-N Glu-Lys-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QDMVXRNLOPTPIE-WDCWCFNPSA-N 0.000 description 13
- BUEFQXUHTUZXHR-LURJTMIESA-N Gly-Gly-Pro zwitterion Chemical compound NCC(=O)NCC(=O)N1CCC[C@H]1C(O)=O BUEFQXUHTUZXHR-LURJTMIESA-N 0.000 description 13
- SYOJVRNQCXYEOV-XVKPBYJWSA-N Gly-Val-Glu Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SYOJVRNQCXYEOV-XVKPBYJWSA-N 0.000 description 13
- MAABHGXCIBEYQR-XVYDVKMFSA-N His-Asn-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CN=CN1)N MAABHGXCIBEYQR-XVYDVKMFSA-N 0.000 description 13
- HIAHVKLTHNOENC-HGNGGELXSA-N His-Glu-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O HIAHVKLTHNOENC-HGNGGELXSA-N 0.000 description 13
- CSTDQOOBZBAJKE-BWAGICSOSA-N His-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC2=CN=CN2)N)O CSTDQOOBZBAJKE-BWAGICSOSA-N 0.000 description 13
- VGSPNSSCMOHRRR-BJDJZHNGSA-N Ile-Ser-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N VGSPNSSCMOHRRR-BJDJZHNGSA-N 0.000 description 13
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 13
- TYYLDKGBCJGJGW-UHFFFAOYSA-N L-tryptophan-L-tyrosine Natural products C=1NC2=CC=CC=C2C=1CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 TYYLDKGBCJGJGW-UHFFFAOYSA-N 0.000 description 13
- LINKCQUOMUDLKN-KATARQTJSA-N Leu-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(C)C)N)O LINKCQUOMUDLKN-KATARQTJSA-N 0.000 description 13
- ILDSIMPXNFWKLH-KATARQTJSA-N Leu-Thr-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O ILDSIMPXNFWKLH-KATARQTJSA-N 0.000 description 13
- MWVUEPNEPWMFBD-SRVKXCTJSA-N Lys-Cys-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(O)=O)CCCCN MWVUEPNEPWMFBD-SRVKXCTJSA-N 0.000 description 13
- ODUQLUADRKMHOZ-JYJNAYRXSA-N Lys-Glu-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)N)O ODUQLUADRKMHOZ-JYJNAYRXSA-N 0.000 description 13
- RFQATBGBLDAKGI-VHSXEESVSA-N Lys-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CCCCN)N)C(=O)O RFQATBGBLDAKGI-VHSXEESVSA-N 0.000 description 13
- CANPXOLVTMKURR-WEDXCCLWSA-N Lys-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN CANPXOLVTMKURR-WEDXCCLWSA-N 0.000 description 13
- LUTDBHBIHHREDC-IHRRRGAJSA-N Lys-Pro-Lys Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O LUTDBHBIHHREDC-IHRRRGAJSA-N 0.000 description 13
- YTJFXEDRUOQGSP-DCAQKATOSA-N Lys-Pro-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O YTJFXEDRUOQGSP-DCAQKATOSA-N 0.000 description 13
- YKBSXQFZWFXFIB-VOAKCMCISA-N Lys-Thr-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCCN)C(O)=O YKBSXQFZWFXFIB-VOAKCMCISA-N 0.000 description 13
- BCRQJDMZQUHQSV-STQMWFEESA-N Met-Gly-Tyr Chemical compound [H]N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O BCRQJDMZQUHQSV-STQMWFEESA-N 0.000 description 13
- QARPMYDMYVLFMW-KKUMJFAQSA-N Phe-Pro-Glu Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C1=CC=CC=C1 QARPMYDMYVLFMW-KKUMJFAQSA-N 0.000 description 13
- UIMCLYYSUCIUJM-UWVGGRQHSA-N Pro-Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 UIMCLYYSUCIUJM-UWVGGRQHSA-N 0.000 description 13
- MHHQQZIFLWFZGR-DCAQKATOSA-N Pro-Lys-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O MHHQQZIFLWFZGR-DCAQKATOSA-N 0.000 description 13
- YDTUEBLEAVANFH-RCWTZXSCSA-N Pro-Val-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 YDTUEBLEAVANFH-RCWTZXSCSA-N 0.000 description 13
- XNCUYZKGQOCOQH-YUMQZZPRSA-N Ser-Leu-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O XNCUYZKGQOCOQH-YUMQZZPRSA-N 0.000 description 13
- JMBRNXUOLJFURW-BEAPCOKYSA-N Thr-Phe-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N2CCC[C@@H]2C(=O)O)N)O JMBRNXUOLJFURW-BEAPCOKYSA-N 0.000 description 13
- SGAOHNPSEPVAFP-ZDLURKLDSA-N Thr-Ser-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SGAOHNPSEPVAFP-ZDLURKLDSA-N 0.000 description 13
- KZTLZZQTJMCGIP-ZJDVBMNYSA-N Thr-Val-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KZTLZZQTJMCGIP-ZJDVBMNYSA-N 0.000 description 13
- PWKMJDQXKCENMF-MEYUZBJRSA-N Tyr-Thr-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O PWKMJDQXKCENMF-MEYUZBJRSA-N 0.000 description 13
- PZTZYZUTCPZWJH-FXQIFTODSA-N Val-Ser-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PZTZYZUTCPZWJH-FXQIFTODSA-N 0.000 description 13
- 108010047857 aspartylglycine Proteins 0.000 description 13
- 108010054812 diprotin A Proteins 0.000 description 13
- 108010003700 lysyl aspartic acid Proteins 0.000 description 13
- 108010077112 prolyl-proline Proteins 0.000 description 13
- 230000004083 survival effect Effects 0.000 description 13
- 108010044292 tryptophyltyrosine Proteins 0.000 description 13
- JNTMAZFVYNDPLB-PEDHHIEDSA-N (2S,3S)-2-[[[(2S)-1-[(2S,3S)-2-amino-3-methyl-1-oxopentyl]-2-pyrrolidinyl]-oxomethyl]amino]-3-methylpentanoic acid Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JNTMAZFVYNDPLB-PEDHHIEDSA-N 0.000 description 12
- SUHLZMHFRALVSY-YUMQZZPRSA-N Ala-Lys-Gly Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)NCC(O)=O SUHLZMHFRALVSY-YUMQZZPRSA-N 0.000 description 12
- OQWQTGBOFPJOIF-DLOVCJGASA-N Ala-Lys-His Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N OQWQTGBOFPJOIF-DLOVCJGASA-N 0.000 description 12
- PNQWAUXQDBIJDY-GUBZILKMSA-N Arg-Glu-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PNQWAUXQDBIJDY-GUBZILKMSA-N 0.000 description 12
- ZUVMUOOHJYNJPP-XIRDDKMYSA-N Arg-Trp-Gln Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZUVMUOOHJYNJPP-XIRDDKMYSA-N 0.000 description 12
- PUUPMDXIHCOPJU-HJGDQZAQSA-N Asn-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O PUUPMDXIHCOPJU-HJGDQZAQSA-N 0.000 description 12
- DPNWSMBUYCLEDG-CIUDSAMLSA-N Asp-Lys-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O DPNWSMBUYCLEDG-CIUDSAMLSA-N 0.000 description 12
- NDNZRWUDUMTITL-FXQIFTODSA-N Cys-Ser-Val Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O NDNZRWUDUMTITL-FXQIFTODSA-N 0.000 description 12
- XKBASPWPBXNVLQ-WDSKDSINSA-N Gln-Gly-Asn Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O XKBASPWPBXNVLQ-WDSKDSINSA-N 0.000 description 12
- OACPJRQRAHMQEQ-NHCYSSNCSA-N Gln-Val-Arg Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O OACPJRQRAHMQEQ-NHCYSSNCSA-N 0.000 description 12
- MWMJCGBSIORNCD-AVGNSLFASA-N Glu-Leu-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O MWMJCGBSIORNCD-AVGNSLFASA-N 0.000 description 12
- FULZDMOZUZKGQU-ONGXEEELSA-N Gly-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)CN FULZDMOZUZKGQU-ONGXEEELSA-N 0.000 description 12
- HZWWOGWOBQBETJ-CUJWVEQBSA-N His-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N)O HZWWOGWOBQBETJ-CUJWVEQBSA-N 0.000 description 12
- BTNXKBVLWJBTNR-SRVKXCTJSA-N Leu-His-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(O)=O BTNXKBVLWJBTNR-SRVKXCTJSA-N 0.000 description 12
- GHQFLTYXGUETFD-UFYCRDLUSA-N Met-Tyr-Tyr Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N GHQFLTYXGUETFD-UFYCRDLUSA-N 0.000 description 12
- JEGFCFLCRSJCMA-IHRRRGAJSA-N Phe-Arg-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)O)N JEGFCFLCRSJCMA-IHRRRGAJSA-N 0.000 description 12
- JOXIIFVCSATTDH-IHPCNDPISA-N Phe-Asn-Trp Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)O)N JOXIIFVCSATTDH-IHPCNDPISA-N 0.000 description 12
- HWLKHNDRXWTFTN-GUBZILKMSA-N Pro-Pro-Cys Chemical compound C1C[C@H](NC1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CS)C(=O)O HWLKHNDRXWTFTN-GUBZILKMSA-N 0.000 description 12
- FDMKYQQYJKYCLV-GUBZILKMSA-N Pro-Pro-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 FDMKYQQYJKYCLV-GUBZILKMSA-N 0.000 description 12
- KGKWKSSSQGGYAU-SUSMZKCASA-N Thr-Gln-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N)O KGKWKSSSQGGYAU-SUSMZKCASA-N 0.000 description 12
- KKPOGALELPLJTL-MEYUZBJRSA-N Thr-Lys-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 KKPOGALELPLJTL-MEYUZBJRSA-N 0.000 description 12
- JJNXZIPLIXIGBX-HJPIBITLSA-N Tyr-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N JJNXZIPLIXIGBX-HJPIBITLSA-N 0.000 description 12
- VCIYTVOBLZHFSC-XHSDSOJGSA-N Val-Phe-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N2CCC[C@@H]2C(=O)O)N VCIYTVOBLZHFSC-XHSDSOJGSA-N 0.000 description 12
- KISFXYYRKKNLOP-IHRRRGAJSA-N Val-Phe-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)O)N KISFXYYRKKNLOP-IHRRRGAJSA-N 0.000 description 12
- KSFXWENSJABBFI-ZKWXMUAHSA-N Val-Ser-Asn Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O KSFXWENSJABBFI-ZKWXMUAHSA-N 0.000 description 12
- 108010013835 arginine glutamate Proteins 0.000 description 12
- 238000013016 damping Methods 0.000 description 12
- 239000012530 fluid Substances 0.000 description 12
- 238000011081 inoculation Methods 0.000 description 12
- 108010090894 prolylleucine Proteins 0.000 description 12
- 238000007789 sealing Methods 0.000 description 12
- BTRULDJUUVGRNE-DCAQKATOSA-N Ala-Pro-Lys Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O BTRULDJUUVGRNE-DCAQKATOSA-N 0.000 description 11
- WONGRTVAMHFGBE-WDSKDSINSA-N Asn-Gly-Gln Chemical compound C(CC(=O)N)[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)N WONGRTVAMHFGBE-WDSKDSINSA-N 0.000 description 11
- QNNBHTFDFFFHGC-KKUMJFAQSA-N Asn-Tyr-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O QNNBHTFDFFFHGC-KKUMJFAQSA-N 0.000 description 11
- GYNUXDMCDILYIQ-QRTARXTBSA-N Asp-Val-Trp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC(=O)O)N GYNUXDMCDILYIQ-QRTARXTBSA-N 0.000 description 11
- ZEEPYMXTJWIMSN-GUBZILKMSA-N Gln-Lys-Ser Chemical compound NCCCC[C@@H](C(=O)N[C@@H](CO)C(O)=O)NC(=O)[C@@H](N)CCC(N)=O ZEEPYMXTJWIMSN-GUBZILKMSA-N 0.000 description 11
- ZGXGVBYEJGVJMV-HJGDQZAQSA-N Glu-Thr-Met Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O ZGXGVBYEJGVJMV-HJGDQZAQSA-N 0.000 description 11
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 11
- JHNJNTMTZHEDLJ-NAKRPEOUSA-N Ile-Ser-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O JHNJNTMTZHEDLJ-NAKRPEOUSA-N 0.000 description 11
- 241001500351 Influenzavirus A Species 0.000 description 11
- WSGXUIQTEZDVHJ-GARJFASQSA-N Leu-Ala-Pro Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@@H]1C(O)=O WSGXUIQTEZDVHJ-GARJFASQSA-N 0.000 description 11
- XOWMDXHFSBCAKQ-SRVKXCTJSA-N Leu-Ser-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C XOWMDXHFSBCAKQ-SRVKXCTJSA-N 0.000 description 11
- 241000124008 Mammalia Species 0.000 description 11
- ZTVCLZLGHZXLOT-ULQDDVLXSA-N Pro-Glu-Trp Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)O ZTVCLZLGHZXLOT-ULQDDVLXSA-N 0.000 description 11
- OZPDGESCTGGNAD-CIUDSAMLSA-N Ser-Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CO OZPDGESCTGGNAD-CIUDSAMLSA-N 0.000 description 11
- SNXUIBACCONSOH-BWBBJGPYSA-N Ser-Thr-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CO)C(O)=O SNXUIBACCONSOH-BWBBJGPYSA-N 0.000 description 11
- AXKJPUBALUNJEO-UBHSHLNASA-N Ser-Trp-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(N)=O)C(O)=O AXKJPUBALUNJEO-UBHSHLNASA-N 0.000 description 11
- XKWABWFMQXMUMT-HJGDQZAQSA-N Thr-Pro-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O XKWABWFMQXMUMT-HJGDQZAQSA-N 0.000 description 11
- ZESGVALRVJIVLZ-VFCFLDTKSA-N Thr-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@@H]1C(=O)O)N)O ZESGVALRVJIVLZ-VFCFLDTKSA-N 0.000 description 11
- UDCHKDYNMRJYMI-QEJZJMRPSA-N Trp-Glu-Ser Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O UDCHKDYNMRJYMI-QEJZJMRPSA-N 0.000 description 11
- BZDGLJPROOOUOZ-XGEHTFHBSA-N Val-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](C(C)C)N)O BZDGLJPROOOUOZ-XGEHTFHBSA-N 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 10
- GYWQGGUCMDCUJE-DLOVCJGASA-N Asp-Phe-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(O)=O GYWQGGUCMDCUJE-DLOVCJGASA-N 0.000 description 10
- CUVBTVWFVIIDOC-YEPSODPASA-N Gly-Thr-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)CN CUVBTVWFVIIDOC-YEPSODPASA-N 0.000 description 10
- IHRFZLQEQVHXFA-RHYQMDGZSA-N Met-Thr-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCCCN IHRFZLQEQVHXFA-RHYQMDGZSA-N 0.000 description 10
- KIPIKSXPPLABPN-CIUDSAMLSA-N Pro-Glu-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1 KIPIKSXPPLABPN-CIUDSAMLSA-N 0.000 description 10
- VPEVBAUSTBWQHN-NHCYSSNCSA-N Pro-Glu-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O VPEVBAUSTBWQHN-NHCYSSNCSA-N 0.000 description 10
- YUJLIIRMIAGMCQ-CIUDSAMLSA-N Ser-Leu-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YUJLIIRMIAGMCQ-CIUDSAMLSA-N 0.000 description 10
- 108010047495 alanylglycine Proteins 0.000 description 10
- 230000003321 amplification Effects 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 230000004048 modification Effects 0.000 description 10
- 238000012986 modification Methods 0.000 description 10
- 238000003199 nucleic acid amplification method Methods 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- SRUUBQBAVNQZGJ-LAEOZQHASA-N Asn-Gln-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)N)N SRUUBQBAVNQZGJ-LAEOZQHASA-N 0.000 description 9
- MJIJBEYEHBKTIM-BYULHYEWSA-N Asn-Val-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N MJIJBEYEHBKTIM-BYULHYEWSA-N 0.000 description 9
- FITIQFSXXBKFFM-NRPADANISA-N Gln-Val-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O FITIQFSXXBKFFM-NRPADANISA-N 0.000 description 9
- FEHQLKKBVJHSEC-SZMVWBNQSA-N Leu-Glu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(C)C)C(O)=O)=CNC2=C1 FEHQLKKBVJHSEC-SZMVWBNQSA-N 0.000 description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 125000000539 amino acid group Chemical group 0.000 description 9
- 238000010790 dilution Methods 0.000 description 9
- 239000012895 dilution Substances 0.000 description 9
- 238000002347 injection Methods 0.000 description 9
- 239000007924 injection Substances 0.000 description 9
- 238000009413 insulation Methods 0.000 description 9
- 231100000636 lethal dose Toxicity 0.000 description 9
- 238000002823 phage display Methods 0.000 description 9
- 238000001556 precipitation Methods 0.000 description 9
- 230000002265 prevention Effects 0.000 description 9
- 238000012545 processing Methods 0.000 description 9
- 108010070643 prolylglutamic acid Proteins 0.000 description 9
- 108010053725 prolylvaline Proteins 0.000 description 9
- -1 radical amino acid Chemical class 0.000 description 9
- 238000001890 transfection Methods 0.000 description 9
- 239000003981 vehicle Substances 0.000 description 9
- 230000003612 virological effect Effects 0.000 description 9
- ZFBBMCKQSNJZSN-AUTRQRHGSA-N Gln-Val-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZFBBMCKQSNJZSN-AUTRQRHGSA-N 0.000 description 8
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 8
- IOQWIOPSKJOEKI-SRVKXCTJSA-N Lys-Ser-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O IOQWIOPSKJOEKI-SRVKXCTJSA-N 0.000 description 8
- 229920001213 Polysorbate 20 Polymers 0.000 description 8
- LGSANCBHSMDFDY-GARJFASQSA-N Pro-Glu-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCC[C@@H]2C(=O)O LGSANCBHSMDFDY-GARJFASQSA-N 0.000 description 8
- 206010038687 Respiratory distress Diseases 0.000 description 8
- OYEDZGNMSBZCIM-XGEHTFHBSA-N Ser-Arg-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OYEDZGNMSBZCIM-XGEHTFHBSA-N 0.000 description 8
- FPCGZYMRFFIYIH-CIUDSAMLSA-N Ser-Lys-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O FPCGZYMRFFIYIH-CIUDSAMLSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- DSLHSTIUAPKERR-XGEHTFHBSA-N Thr-Cys-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(O)=O DSLHSTIUAPKERR-XGEHTFHBSA-N 0.000 description 8
- BDGBHYCAZJPLHX-HJGDQZAQSA-N Thr-Lys-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O BDGBHYCAZJPLHX-HJGDQZAQSA-N 0.000 description 8
- OWFGFHQMSBTKLX-UFYCRDLUSA-N Val-Tyr-Tyr Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N OWFGFHQMSBTKLX-UFYCRDLUSA-N 0.000 description 8
- 108010087924 alanylproline Proteins 0.000 description 8
- 206010064097 avian influenza Diseases 0.000 description 8
- 239000007853 buffer solution Substances 0.000 description 8
- 230000000295 complement effect Effects 0.000 description 8
- 230000034994 death Effects 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- 230000003203 everyday effect Effects 0.000 description 8
- 230000036541 health Effects 0.000 description 8
- 230000002779 inactivation Effects 0.000 description 8
- 108010064235 lysylglycine Proteins 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 8
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 8
- 230000009261 transgenic effect Effects 0.000 description 8
- IORKCNUBHNIMKY-CIUDSAMLSA-N Ala-Pro-Glu Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O IORKCNUBHNIMKY-CIUDSAMLSA-N 0.000 description 7
- XWFWAXPOLRTDFZ-FXQIFTODSA-N Ala-Pro-Ser Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O XWFWAXPOLRTDFZ-FXQIFTODSA-N 0.000 description 7
- SQIARYGNVQWOSB-BZSNNMDCSA-N Asp-Tyr-Phe Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SQIARYGNVQWOSB-BZSNNMDCSA-N 0.000 description 7
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- GLWXKFRTOHKGIT-ACZMJKKPSA-N Glu-Asn-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O GLWXKFRTOHKGIT-ACZMJKKPSA-N 0.000 description 7
- KASDBWKLWJKTLJ-GUBZILKMSA-N Glu-Glu-Met Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(O)=O KASDBWKLWJKTLJ-GUBZILKMSA-N 0.000 description 7
- ALMBZBOCGSVSAI-ACZMJKKPSA-N Glu-Ser-Asn Chemical compound C(CC(=O)O)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)O)N ALMBZBOCGSVSAI-ACZMJKKPSA-N 0.000 description 7
- PABFFPWEJMEVEC-JGVFFNPUSA-N Gly-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)CN)C(=O)O PABFFPWEJMEVEC-JGVFFNPUSA-N 0.000 description 7
- FFJQHWKSGAWSTJ-BFHQHQDPSA-N Gly-Thr-Ala Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O FFJQHWKSGAWSTJ-BFHQHQDPSA-N 0.000 description 7
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 7
- 108010065920 Insulin Lispro Proteins 0.000 description 7
- XNKDCYABMBBEKN-IUCAKERBSA-N Lys-Gly-Gln Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O XNKDCYABMBBEKN-IUCAKERBSA-N 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 7
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 7
- WWPAHTZOWURIMR-ULQDDVLXSA-N Phe-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC1=CC=CC=C1 WWPAHTZOWURIMR-ULQDDVLXSA-N 0.000 description 7
- TUYWCHPXKQTISF-LPEHRKFASA-N Pro-Cys-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CS)C(=O)N2CCC[C@@H]2C(=O)O TUYWCHPXKQTISF-LPEHRKFASA-N 0.000 description 7
- ZLXKLMHAMDENIO-DCAQKATOSA-N Pro-Lys-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O ZLXKLMHAMDENIO-DCAQKATOSA-N 0.000 description 7
- GOMUXSCOIWIJFP-GUBZILKMSA-N Pro-Ser-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GOMUXSCOIWIJFP-GUBZILKMSA-N 0.000 description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 7
- XQJCEKXQUJQNNK-ZLUOBGJFSA-N Ser-Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O XQJCEKXQUJQNNK-ZLUOBGJFSA-N 0.000 description 7
- JVTHIXKSVYEWNI-JRQIVUDYSA-N Thr-Asn-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JVTHIXKSVYEWNI-JRQIVUDYSA-N 0.000 description 7
- KWQBJOUOSNJDRR-XAVMHZPKSA-N Thr-Cys-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)O)N)O KWQBJOUOSNJDRR-XAVMHZPKSA-N 0.000 description 7
- FIFDDJFLNVAVMS-RHYQMDGZSA-N Thr-Leu-Met Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(O)=O FIFDDJFLNVAVMS-RHYQMDGZSA-N 0.000 description 7
- MROIJTGJGIDEEJ-RCWTZXSCSA-N Thr-Pro-Pro Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 MROIJTGJGIDEEJ-RCWTZXSCSA-N 0.000 description 7
- SINRIKQYQJRGDQ-MEYUZBJRSA-N Tyr-Lys-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 SINRIKQYQJRGDQ-MEYUZBJRSA-N 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 7
- 238000003556 assay Methods 0.000 description 7
- 210000003719 b-lymphocyte Anatomy 0.000 description 7
- 229940098773 bovine serum albumin Drugs 0.000 description 7
- 230000009137 competitive binding Effects 0.000 description 7
- 230000000120 cytopathologic effect Effects 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 230000004927 fusion Effects 0.000 description 7
- 108010078144 glutaminyl-glycine Proteins 0.000 description 7
- 108010037850 glycylvaline Proteins 0.000 description 7
- 210000002829 igm memory b cell Anatomy 0.000 description 7
- 238000003119 immunoblot Methods 0.000 description 7
- 238000012216 screening Methods 0.000 description 7
- 229960005486 vaccine Drugs 0.000 description 7
- DIBLBAURNYJYBF-XLXZRNDBSA-N (2s)-2-[[(2s)-2-[[2-[[(2s)-6-amino-2-[[(2s)-2-amino-3-methylbutanoyl]amino]hexanoyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid Chemical compound C([C@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 DIBLBAURNYJYBF-XLXZRNDBSA-N 0.000 description 6
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 6
- JBGSZRYCXBPWGX-BQBZGAKWSA-N Ala-Arg-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N JBGSZRYCXBPWGX-BQBZGAKWSA-N 0.000 description 6
- OYJCVIGKMXUVKB-GARJFASQSA-N Ala-Leu-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N OYJCVIGKMXUVKB-GARJFASQSA-N 0.000 description 6
- WQLDNOCHHRISMS-NAKRPEOUSA-N Ala-Pro-Ile Chemical compound [H]N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WQLDNOCHHRISMS-NAKRPEOUSA-N 0.000 description 6
- SLKLLQWZQHXYSV-CIUDSAMLSA-N Asn-Ala-Lys Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O SLKLLQWZQHXYSV-CIUDSAMLSA-N 0.000 description 6
- MKJBPDLENBUHQU-CIUDSAMLSA-N Asn-Ser-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O MKJBPDLENBUHQU-CIUDSAMLSA-N 0.000 description 6
- JPPLRQVZMZFOSX-UWJYBYFXSA-N Asn-Tyr-Ala Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=C(O)C=C1 JPPLRQVZMZFOSX-UWJYBYFXSA-N 0.000 description 6
- AHWRSSLYSGLBGD-CIUDSAMLSA-N Asp-Pro-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O AHWRSSLYSGLBGD-CIUDSAMLSA-N 0.000 description 6
- ZXCAQANTQWBICD-DCAQKATOSA-N Cys-Lys-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)N ZXCAQANTQWBICD-DCAQKATOSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 241000282326 Felis catus Species 0.000 description 6
- XKPACHRGOWQHFH-IRIUXVKKSA-N Gln-Thr-Tyr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O XKPACHRGOWQHFH-IRIUXVKKSA-N 0.000 description 6
- ITYRYNUZHPNCIK-GUBZILKMSA-N Glu-Ala-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O ITYRYNUZHPNCIK-GUBZILKMSA-N 0.000 description 6
- MFYLRRCYBBJYPI-JYJNAYRXSA-N Glu-Tyr-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O MFYLRRCYBBJYPI-JYJNAYRXSA-N 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- VSVZIEVNUYDAFR-YUMQZZPRSA-N Gly-Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN VSVZIEVNUYDAFR-YUMQZZPRSA-N 0.000 description 6
- GRIRDMVMJJDZKV-RCOVLWMOSA-N Gly-Asn-Val Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O GRIRDMVMJJDZKV-RCOVLWMOSA-N 0.000 description 6
- IKAIKUBBJHFNBZ-LURJTMIESA-N Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CN IKAIKUBBJHFNBZ-LURJTMIESA-N 0.000 description 6
- TVTZEOHWHUVYCG-KYNKHSRBSA-N Gly-Thr-Thr Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O TVTZEOHWHUVYCG-KYNKHSRBSA-N 0.000 description 6
- 241000238631 Hexapoda Species 0.000 description 6
- MKWSZEHGHSLNPF-NAKRPEOUSA-N Ile-Ala-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O)N MKWSZEHGHSLNPF-NAKRPEOUSA-N 0.000 description 6
- FADXGVVLSPPEQY-GHCJXIJMSA-N Ile-Cys-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)O)N FADXGVVLSPPEQY-GHCJXIJMSA-N 0.000 description 6
- HGCNKOLVKRAVHD-UHFFFAOYSA-N L-Met-L-Phe Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 HGCNKOLVKRAVHD-UHFFFAOYSA-N 0.000 description 6
- GPICTNQYKHHHTH-GUBZILKMSA-N Leu-Gln-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O GPICTNQYKHHHTH-GUBZILKMSA-N 0.000 description 6
- QJUWBDPGGYVRHY-YUMQZZPRSA-N Leu-Gly-Cys Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)O)N QJUWBDPGGYVRHY-YUMQZZPRSA-N 0.000 description 6
- HYMLKESRWLZDBR-WEDXCCLWSA-N Leu-Gly-Thr Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O HYMLKESRWLZDBR-WEDXCCLWSA-N 0.000 description 6
- YOKVEHGYYQEQOP-QWRGUYRKSA-N Leu-Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YOKVEHGYYQEQOP-QWRGUYRKSA-N 0.000 description 6
- MVJRBCJCRYGCKV-GVXVVHGQSA-N Leu-Val-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O MVJRBCJCRYGCKV-GVXVVHGQSA-N 0.000 description 6
- WQDKIVRHTQYJSN-DCAQKATOSA-N Lys-Ser-Arg Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N WQDKIVRHTQYJSN-DCAQKATOSA-N 0.000 description 6
- IEVXCWPVBYCJRZ-IXOXFDKPSA-N Lys-Thr-His Chemical compound NCCCC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 IEVXCWPVBYCJRZ-IXOXFDKPSA-N 0.000 description 6
- DLCAXBGXGOVUCD-PPCPHDFISA-N Lys-Thr-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O DLCAXBGXGOVUCD-PPCPHDFISA-N 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 6
- MSHZERMPZKCODG-ACRUOGEOSA-N Phe-Leu-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 MSHZERMPZKCODG-ACRUOGEOSA-N 0.000 description 6
- JLLJTMHNXQTMCK-UBHSHLNASA-N Phe-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC1=CC=CC=C1 JLLJTMHNXQTMCK-UBHSHLNASA-N 0.000 description 6
- IIEOLPMQYRBZCN-SRVKXCTJSA-N Phe-Ser-Cys Chemical compound N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O IIEOLPMQYRBZCN-SRVKXCTJSA-N 0.000 description 6
- MCIXMYKSPQUMJG-SRVKXCTJSA-N Phe-Ser-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MCIXMYKSPQUMJG-SRVKXCTJSA-N 0.000 description 6
- PCWLNNZTBJTZRN-AVGNSLFASA-N Pro-Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 PCWLNNZTBJTZRN-AVGNSLFASA-N 0.000 description 6
- OWQXAJQZLWHPBH-FXQIFTODSA-N Pro-Ser-Asn Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O OWQXAJQZLWHPBH-FXQIFTODSA-N 0.000 description 6
- GMJDSFYVTAMIBF-FXQIFTODSA-N Pro-Ser-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O GMJDSFYVTAMIBF-FXQIFTODSA-N 0.000 description 6
- PRKWBYCXBBSLSK-GUBZILKMSA-N Pro-Ser-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O PRKWBYCXBBSLSK-GUBZILKMSA-N 0.000 description 6
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 6
- VGNYHOBZJKWRGI-CIUDSAMLSA-N Ser-Asn-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO VGNYHOBZJKWRGI-CIUDSAMLSA-N 0.000 description 6
- GZFAWAQTEYDKII-YUMQZZPRSA-N Ser-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO GZFAWAQTEYDKII-YUMQZZPRSA-N 0.000 description 6
- GZSZPKSBVAOGIE-CIUDSAMLSA-N Ser-Lys-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O GZSZPKSBVAOGIE-CIUDSAMLSA-N 0.000 description 6
- HHJFMHQYEAAOBM-ZLUOBGJFSA-N Ser-Ser-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O HHJFMHQYEAAOBM-ZLUOBGJFSA-N 0.000 description 6
- VGQVAVQWKJLIRM-FXQIFTODSA-N Ser-Ser-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O VGQVAVQWKJLIRM-FXQIFTODSA-N 0.000 description 6
- PCJLFYBAQZQOFE-KATARQTJSA-N Ser-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N)O PCJLFYBAQZQOFE-KATARQTJSA-N 0.000 description 6
- RCOUFINCYASMDN-GUBZILKMSA-N Ser-Val-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCSC)C(O)=O RCOUFINCYASMDN-GUBZILKMSA-N 0.000 description 6
- ASJDFGOPDCVXTG-KATARQTJSA-N Thr-Cys-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(O)=O ASJDFGOPDCVXTG-KATARQTJSA-N 0.000 description 6
- NCXVJIQMWSGRHY-KXNHARMFSA-N Thr-Leu-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N)O NCXVJIQMWSGRHY-KXNHARMFSA-N 0.000 description 6
- DXPURPNJDFCKKO-RHYQMDGZSA-N Thr-Lys-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)[C@@H](C)O)C(O)=O DXPURPNJDFCKKO-RHYQMDGZSA-N 0.000 description 6
- UKINEYBQXPMOJO-UBHSHLNASA-N Trp-Asn-Ser Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N UKINEYBQXPMOJO-UBHSHLNASA-N 0.000 description 6
- DQDXHYIEITXNJY-BPUTZDHNSA-N Trp-Gln-Gln Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N DQDXHYIEITXNJY-BPUTZDHNSA-N 0.000 description 6
- MQGGXGKQSVEQHR-KKUMJFAQSA-N Tyr-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 MQGGXGKQSVEQHR-KKUMJFAQSA-N 0.000 description 6
- RIVVDNTUSRVTQT-IRIUXVKKSA-N Tyr-Thr-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)O RIVVDNTUSRVTQT-IRIUXVKKSA-N 0.000 description 6
- GNWUWQAVVJQREM-NHCYSSNCSA-N Val-Asn-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N GNWUWQAVVJQREM-NHCYSSNCSA-N 0.000 description 6
- ZIGZPYJXIWLQFC-QTKMDUPCSA-N Val-His-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](C(C)C)N)O ZIGZPYJXIWLQFC-QTKMDUPCSA-N 0.000 description 6
- HPANGHISDXDUQY-ULQDDVLXSA-N Val-Lys-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N HPANGHISDXDUQY-ULQDDVLXSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 108010044940 alanylglutamine Proteins 0.000 description 6
- 108010050025 alpha-glutamyltryptophan Proteins 0.000 description 6
- 230000000890 antigenic effect Effects 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000002299 complementary DNA Substances 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 239000013604 expression vector Substances 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Chemical compound NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 6
- 108010089804 glycyl-threonine Proteins 0.000 description 6
- 230000008676 import Effects 0.000 description 6
- 239000002054 inoculum Substances 0.000 description 6
- 230000003993 interaction Effects 0.000 description 6
- 231100000518 lethal Toxicity 0.000 description 6
- 230000001665 lethal effect Effects 0.000 description 6
- 108010044311 leucyl-glycyl-glycine Proteins 0.000 description 6
- 108010068488 methionylphenylalanine Proteins 0.000 description 6
- 108091033319 polynucleotide Proteins 0.000 description 6
- 102000040430 polynucleotide Human genes 0.000 description 6
- 239000002157 polynucleotide Substances 0.000 description 6
- 230000003449 preventive effect Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000003127 radioimmunoassay Methods 0.000 description 6
- 241000894007 species Species 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000004580 weight loss Effects 0.000 description 6
- 108010027345 wheylin-1 peptide Proteins 0.000 description 6
- AWAXZRDKUHOPBO-GUBZILKMSA-N Ala-Gln-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O AWAXZRDKUHOPBO-GUBZILKMSA-N 0.000 description 5
- LGCVSPFCFXWUEY-IHPCNDPISA-N Asn-Trp-Tyr Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N LGCVSPFCFXWUEY-IHPCNDPISA-N 0.000 description 5
- UZFHNLYQWMGUHU-DCAQKATOSA-N Asp-Lys-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O UZFHNLYQWMGUHU-DCAQKATOSA-N 0.000 description 5
- 206010015548 Euthanasia Diseases 0.000 description 5
- ILKYYKRAULNYMS-JYJNAYRXSA-N Gln-Lys-Phe Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ILKYYKRAULNYMS-JYJNAYRXSA-N 0.000 description 5
- WMKXFMUJRCEGRP-SRVKXCTJSA-N His-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N WMKXFMUJRCEGRP-SRVKXCTJSA-N 0.000 description 5
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 5
- SBANPBVRHYIMRR-UHFFFAOYSA-N Leu-Ser-Pro Natural products CC(C)CC(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O SBANPBVRHYIMRR-UHFFFAOYSA-N 0.000 description 5
- CTJUSALVKAWFFU-CIUDSAMLSA-N Lys-Ser-Cys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N CTJUSALVKAWFFU-CIUDSAMLSA-N 0.000 description 5
- 102000005348 Neuraminidase Human genes 0.000 description 5
- 108010006232 Neuraminidase Proteins 0.000 description 5
- YMTLKLXDFCSCNX-BYPYZUCNSA-N Ser-Gly-Gly Chemical compound OC[C@H](N)C(=O)NCC(=O)NCC(O)=O YMTLKLXDFCSCNX-BYPYZUCNSA-N 0.000 description 5
- QHDXUYOYTPWCSK-RCOVLWMOSA-N Val-Asp-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)O)N QHDXUYOYTPWCSK-RCOVLWMOSA-N 0.000 description 5
- WDIGUPHXPBMODF-UMNHJUIQSA-N Val-Glu-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N WDIGUPHXPBMODF-UMNHJUIQSA-N 0.000 description 5
- UEHRGZCNLSWGHK-DLOVCJGASA-N Val-Glu-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O UEHRGZCNLSWGHK-DLOVCJGASA-N 0.000 description 5
- 238000004043 dyeing Methods 0.000 description 5
- 238000004520 electroporation Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 108010067216 glycyl-glycyl-glycine Proteins 0.000 description 5
- 230000001900 immune effect Effects 0.000 description 5
- 230000003053 immunization Effects 0.000 description 5
- 238000002649 immunization Methods 0.000 description 5
- 238000003780 insertion Methods 0.000 description 5
- 230000037431 insertion Effects 0.000 description 5
- 210000004698 lymphocyte Anatomy 0.000 description 5
- 210000001806 memory b lymphocyte Anatomy 0.000 description 5
- 238000012544 monitoring process Methods 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 238000001262 western blot Methods 0.000 description 5
- TTXMOJWKNRJWQJ-FXQIFTODSA-N Ala-Arg-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N TTXMOJWKNRJWQJ-FXQIFTODSA-N 0.000 description 4
- OINVDEKBKBCPLX-JXUBOQSCSA-N Ala-Lys-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OINVDEKBKBCPLX-JXUBOQSCSA-N 0.000 description 4
- MGSVBZIBCCKGCY-ZLUOBGJFSA-N Asp-Ser-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MGSVBZIBCCKGCY-ZLUOBGJFSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- JWNZHMSRZXXGTM-XKBZYTNZSA-N Glu-Ser-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JWNZHMSRZXXGTM-XKBZYTNZSA-N 0.000 description 4
- AAHSHTLISQUZJL-QSFUFRPTSA-N Gly-Ile-Ile Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O AAHSHTLISQUZJL-QSFUFRPTSA-N 0.000 description 4
- ZZWUYQXMIFTIIY-WEDXCCLWSA-N Gly-Thr-Leu Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O ZZWUYQXMIFTIIY-WEDXCCLWSA-N 0.000 description 4
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 4
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 4
- OOSPRDCGTLQLBP-NHCYSSNCSA-N Met-Glu-Val Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O OOSPRDCGTLQLBP-NHCYSSNCSA-N 0.000 description 4
- 108700022034 Opsonin Proteins Proteins 0.000 description 4
- UIGMAMGZOJVTDN-WHFBIAKZSA-N Ser-Gly-Ser Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O UIGMAMGZOJVTDN-WHFBIAKZSA-N 0.000 description 4
- OQPNSDWGAMFJNU-QWRGUYRKSA-N Ser-Gly-Tyr Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 OQPNSDWGAMFJNU-QWRGUYRKSA-N 0.000 description 4
- XJDMUQCLVSCRSJ-VZFHVOOUSA-N Ser-Thr-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O XJDMUQCLVSCRSJ-VZFHVOOUSA-N 0.000 description 4
- ZKOKTQPHFMRSJP-YJRXYDGGSA-N Ser-Thr-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZKOKTQPHFMRSJP-YJRXYDGGSA-N 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 239000003443 antiviral agent Substances 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 108010038633 aspartylglutamate Proteins 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000009260 cross reactivity Effects 0.000 description 4
- 230000008034 disappearance Effects 0.000 description 4
- 238000000684 flow cytometry Methods 0.000 description 4
- 238000005755 formation reaction Methods 0.000 description 4
- 210000004602 germ cell Anatomy 0.000 description 4
- 210000004408 hybridoma Anatomy 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000000069 prophylactic effect Effects 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 238000010561 standard procedure Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 230000014616 translation Effects 0.000 description 4
- 108010003137 tyrosyltyrosine Proteins 0.000 description 4
- 241000701447 unidentified baculovirus Species 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
- IESDGNYHXIOKRW-YXMSTPNBSA-N (2s)-2-[[(2s)-1-[(2s)-6-amino-2-[[(2s,3r)-2-amino-3-hydroxybutanoyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O IESDGNYHXIOKRW-YXMSTPNBSA-N 0.000 description 3
- NWXMGUDVXFXRIG-WESIUVDSSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O NWXMGUDVXFXRIG-WESIUVDSSA-N 0.000 description 3
- UBCHPRBFMUDMNC-UHFFFAOYSA-N 1-(1-adamantyl)ethanamine Chemical compound C1C(C2)CC3CC2CC1(C(N)C)C3 UBCHPRBFMUDMNC-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- BVLIJXXSXBUGEC-SRVKXCTJSA-N Asn-Asn-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O BVLIJXXSXBUGEC-SRVKXCTJSA-N 0.000 description 3
- KBQOUDLMWYWXNP-YDHLFZDLSA-N Asn-Val-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CC(=O)N)N KBQOUDLMWYWXNP-YDHLFZDLSA-N 0.000 description 3
- WSGVTKZFVJSJOG-RCOVLWMOSA-N Asp-Gly-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O WSGVTKZFVJSJOG-RCOVLWMOSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 102100027207 CD27 antigen Human genes 0.000 description 3
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- XOKGKOQWADCLFQ-GARJFASQSA-N Gln-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)N)N)C(=O)O XOKGKOQWADCLFQ-GARJFASQSA-N 0.000 description 3
- NVEASDQHBRZPSU-BQBZGAKWSA-N Gln-Gln-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O NVEASDQHBRZPSU-BQBZGAKWSA-N 0.000 description 3
- HMIXCETWRYDVMO-GUBZILKMSA-N Gln-Pro-Glu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O HMIXCETWRYDVMO-GUBZILKMSA-N 0.000 description 3
- HNVFSTLPVJWIDV-CIUDSAMLSA-N Glu-Glu-Gln Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O HNVFSTLPVJWIDV-CIUDSAMLSA-N 0.000 description 3
- YHOJJFFTSMWVGR-HJGDQZAQSA-N Glu-Met-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O YHOJJFFTSMWVGR-HJGDQZAQSA-N 0.000 description 3
- BFEZQZKEPRKKHV-SRVKXCTJSA-N Glu-Pro-Lys Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CCC(=O)O)N)C(=O)N[C@@H](CCCCN)C(=O)O BFEZQZKEPRKKHV-SRVKXCTJSA-N 0.000 description 3
- HAXARWKYFIIHKD-ZKWXMUAHSA-N Gly-Ile-Ser Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O HAXARWKYFIIHKD-ZKWXMUAHSA-N 0.000 description 3
- QGDOOCIPHSSADO-STQMWFEESA-N Gly-Met-Phe Chemical compound [H]NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O QGDOOCIPHSSADO-STQMWFEESA-N 0.000 description 3
- 101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 3
- 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 description 3
- NTSPQIONFJUMJV-AVGNSLFASA-N Lys-Arg-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O NTSPQIONFJUMJV-AVGNSLFASA-N 0.000 description 3
- YKIRNDPUWONXQN-GUBZILKMSA-N Lys-Asn-Gln Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N YKIRNDPUWONXQN-GUBZILKMSA-N 0.000 description 3
- MIFFFXHMAHFACR-KATARQTJSA-N Lys-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN MIFFFXHMAHFACR-KATARQTJSA-N 0.000 description 3
- CAVRAQIDHUPECU-UVOCVTCTSA-N Lys-Thr-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CAVRAQIDHUPECU-UVOCVTCTSA-N 0.000 description 3
- GILLQRYAWOMHED-DCAQKATOSA-N Lys-Val-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN GILLQRYAWOMHED-DCAQKATOSA-N 0.000 description 3
- 108010090054 Membrane Glycoproteins Proteins 0.000 description 3
- 102000012750 Membrane Glycoproteins Human genes 0.000 description 3
- FVKRQMQQFGBXHV-QXEWZRGKSA-N Met-Asp-Val Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O FVKRQMQQFGBXHV-QXEWZRGKSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000282341 Mustela putorius furo Species 0.000 description 3
- 102000003992 Peroxidases Human genes 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- VAUMZJHYZQXZBQ-WHFBIAKZSA-N Ser-Asn-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O VAUMZJHYZQXZBQ-WHFBIAKZSA-N 0.000 description 3
- MOVJSUIKUNCVMG-ZLUOBGJFSA-N Ser-Cys-Ser Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)O)N)O MOVJSUIKUNCVMG-ZLUOBGJFSA-N 0.000 description 3
- WLJPJRGQRNCIQS-ZLUOBGJFSA-N Ser-Ser-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O WLJPJRGQRNCIQS-ZLUOBGJFSA-N 0.000 description 3
- JURQXQBJKUHGJS-UHFFFAOYSA-N Ser-Ser-Ser-Ser Chemical compound OCC(N)C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(CO)C(O)=O JURQXQBJKUHGJS-UHFFFAOYSA-N 0.000 description 3
- OLKICIBQRVSQMA-SRVKXCTJSA-N Ser-Ser-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O OLKICIBQRVSQMA-SRVKXCTJSA-N 0.000 description 3
- 102100038081 Signal transducer CD24 Human genes 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- XSLXHSYIVPGEER-KZVJFYERSA-N Thr-Ala-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O XSLXHSYIVPGEER-KZVJFYERSA-N 0.000 description 3
- BEZTUFWTPVOROW-KJEVXHAQSA-N Thr-Tyr-Arg Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N)O BEZTUFWTPVOROW-KJEVXHAQSA-N 0.000 description 3
- RPECVQBNONKZAT-WZLNRYEVSA-N Thr-Tyr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H]([C@@H](C)O)N RPECVQBNONKZAT-WZLNRYEVSA-N 0.000 description 3
- SSSDKJMQMZTMJP-BVSLBCMMSA-N Trp-Tyr-Val Chemical compound C([C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CC=C(O)C=C1 SSSDKJMQMZTMJP-BVSLBCMMSA-N 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- 230000010530 Virus Neutralization Effects 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 108010070783 alanyltyrosine Proteins 0.000 description 3
- KLOHDWPABZXLGI-YWUHCJSESA-M ampicillin sodium Chemical compound [Na+].C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C([O-])=O)(C)C)=CC=CC=C1 KLOHDWPABZXLGI-YWUHCJSESA-M 0.000 description 3
- 108010092854 aspartyllysine Proteins 0.000 description 3
- 108010068265 aspartyltyrosine Proteins 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 230000000975 bioactive effect Effects 0.000 description 3
- 239000007767 bonding agent Substances 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000002860 competitive effect Effects 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005336 cracking Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 231100000673 dose–response relationship Toxicity 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 229960002989 glutamic acid Drugs 0.000 description 3
- 108010010147 glycylglutamine Proteins 0.000 description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 3
- 238000011532 immunohistochemical staining Methods 0.000 description 3
- 230000001524 infective effect Effects 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 108010027338 isoleucylcysteine Proteins 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 238000002703 mutagenesis Methods 0.000 description 3
- 231100000350 mutagenesis Toxicity 0.000 description 3
- VSZGPKBBMSAYNT-RRFJBIMHSA-N oseltamivir Chemical compound CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1 VSZGPKBBMSAYNT-RRFJBIMHSA-N 0.000 description 3
- 229960003752 oseltamivir Drugs 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 108040007629 peroxidase activity proteins Proteins 0.000 description 3
- 108010051242 phenylalanylserine Proteins 0.000 description 3
- 210000004180 plasmocyte Anatomy 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 230000004481 post-translational protein modification Effects 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 238000004445 quantitative analysis Methods 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- 229960000888 rimantadine Drugs 0.000 description 3
- 238000005096 rolling process Methods 0.000 description 3
- 238000007790 scraping Methods 0.000 description 3
- 235000020183 skimmed milk Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 238000002255 vaccination Methods 0.000 description 3
- 230000009385 viral infection Effects 0.000 description 3
- ARAIBEBZBOPLMB-UFGQHTETSA-N zanamivir Chemical compound CC(=O)N[C@@H]1[C@@H](N=C(N)N)C=C(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO ARAIBEBZBOPLMB-UFGQHTETSA-N 0.000 description 3
- 229960001028 zanamivir Drugs 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- YYSWCHMLFJLLBJ-ZLUOBGJFSA-N Ala-Ala-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YYSWCHMLFJLLBJ-ZLUOBGJFSA-N 0.000 description 2
- CSAHOYQKNHGDHX-ACZMJKKPSA-N Ala-Gln-Asn Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O CSAHOYQKNHGDHX-ACZMJKKPSA-N 0.000 description 2
- DPNZTBKGAUAZQU-DLOVCJGASA-N Ala-Leu-His Chemical compound C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N DPNZTBKGAUAZQU-DLOVCJGASA-N 0.000 description 2
- MEFILNJXAVSUTO-JXUBOQSCSA-N Ala-Leu-Thr Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MEFILNJXAVSUTO-JXUBOQSCSA-N 0.000 description 2
- LTTLSZVJTDSACD-OWLDWWDNSA-N Ala-Thr-Trp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O LTTLSZVJTDSACD-OWLDWWDNSA-N 0.000 description 2
- 108010032595 Antibody Binding Sites Proteins 0.000 description 2
- VKKYFICVTYKFIO-CIUDSAMLSA-N Arg-Ala-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N VKKYFICVTYKFIO-CIUDSAMLSA-N 0.000 description 2
- GIVATXIGCXFQQA-FXQIFTODSA-N Arg-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N GIVATXIGCXFQQA-FXQIFTODSA-N 0.000 description 2
- OVVUNXXROOFSIM-SDDRHHMPSA-N Arg-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O OVVUNXXROOFSIM-SDDRHHMPSA-N 0.000 description 2
- KMFPQTITXUKJOV-DCAQKATOSA-N Arg-Ser-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O KMFPQTITXUKJOV-DCAQKATOSA-N 0.000 description 2
- PJOPLXOCKACMLK-KKUMJFAQSA-N Arg-Tyr-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O PJOPLXOCKACMLK-KKUMJFAQSA-N 0.000 description 2
- JJGRJMKUOYXZRA-LPEHRKFASA-N Asn-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)N)N)C(=O)O JJGRJMKUOYXZRA-LPEHRKFASA-N 0.000 description 2
- WQLJRNRLHWJIRW-KKUMJFAQSA-N Asn-His-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC(=O)N)N)O WQLJRNRLHWJIRW-KKUMJFAQSA-N 0.000 description 2
- HPBNLFLSSQDFQW-WHFBIAKZSA-N Asn-Ser-Gly Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O HPBNLFLSSQDFQW-WHFBIAKZSA-N 0.000 description 2
- UXHYOWXTJLBEPG-GSSVUCPTSA-N Asn-Thr-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O UXHYOWXTJLBEPG-GSSVUCPTSA-N 0.000 description 2
- LBOVBQONZJRWPV-YUMQZZPRSA-N Asp-Lys-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O LBOVBQONZJRWPV-YUMQZZPRSA-N 0.000 description 2
- JSHWXQIZOCVWIA-ZKWXMUAHSA-N Asp-Ser-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O JSHWXQIZOCVWIA-ZKWXMUAHSA-N 0.000 description 2
- LTARLVHGOGBRHN-AAEUAGOBSA-N Asp-Trp-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(O)=O LTARLVHGOGBRHN-AAEUAGOBSA-N 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108091035707 Consensus sequence Proteins 0.000 description 2
- NDUSUIGBMZCOIL-ZKWXMUAHSA-N Cys-Asn-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CS)N NDUSUIGBMZCOIL-ZKWXMUAHSA-N 0.000 description 2
- YMBAVNPKBWHDAW-CIUDSAMLSA-N Cys-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)N YMBAVNPKBWHDAW-CIUDSAMLSA-N 0.000 description 2
- SMEYEQDCCBHTEF-FXQIFTODSA-N Cys-Pro-Ala Chemical compound [H]N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O SMEYEQDCCBHTEF-FXQIFTODSA-N 0.000 description 2
- KSMSFCBQBQPFAD-GUBZILKMSA-N Cys-Pro-Pro Chemical compound SC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 KSMSFCBQBQPFAD-GUBZILKMSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000206602 Eukaryota Species 0.000 description 2
- 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 2
- LOJYQMFIIJVETK-WDSKDSINSA-N Gln-Gln Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(O)=O LOJYQMFIIJVETK-WDSKDSINSA-N 0.000 description 2
- BYKZWDGMJLNFJY-XKBZYTNZSA-N Gln-Ser-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N)N)O BYKZWDGMJLNFJY-XKBZYTNZSA-N 0.000 description 2
- WPJDPEOQUIXXOY-AVGNSLFASA-N Gln-Tyr-Asn Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O WPJDPEOQUIXXOY-AVGNSLFASA-N 0.000 description 2
- FTMLQFPULNGION-ZVZYQTTQSA-N Gln-Val-Trp Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O FTMLQFPULNGION-ZVZYQTTQSA-N 0.000 description 2
- ITVBKCZZLJUUHI-HTUGSXCWSA-N Glu-Phe-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ITVBKCZZLJUUHI-HTUGSXCWSA-N 0.000 description 2
- AAJHGGDRKHYSDH-GUBZILKMSA-N Glu-Pro-Gln Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CCC(=O)O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O AAJHGGDRKHYSDH-GUBZILKMSA-N 0.000 description 2
- BPCLDCNZBUYGOD-BPUTZDHNSA-N Glu-Trp-Glu Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)N)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CNC2=C1 BPCLDCNZBUYGOD-BPUTZDHNSA-N 0.000 description 2
- XBWMTPAIUQIWKA-BYULHYEWSA-N Gly-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CN XBWMTPAIUQIWKA-BYULHYEWSA-N 0.000 description 2
- YWAQATDNEKZFFK-BYPYZUCNSA-N Gly-Gly-Ser Chemical compound NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O YWAQATDNEKZFFK-BYPYZUCNSA-N 0.000 description 2
- MIIVFRCYJABHTQ-ONGXEEELSA-N Gly-Leu-Val Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O MIIVFRCYJABHTQ-ONGXEEELSA-N 0.000 description 2
- GMTXWRIDLGTVFC-IUCAKERBSA-N Gly-Lys-Glu Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O GMTXWRIDLGTVFC-IUCAKERBSA-N 0.000 description 2
- PDUHNKAFQXQNLH-ZETCQYMHSA-N Gly-Lys-Gly Chemical compound NCCCC[C@H](NC(=O)CN)C(=O)NCC(O)=O PDUHNKAFQXQNLH-ZETCQYMHSA-N 0.000 description 2
- WNZOCXUOGVYYBJ-CDMKHQONSA-N Gly-Phe-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CN)O WNZOCXUOGVYYBJ-CDMKHQONSA-N 0.000 description 2
- CQMFNTVQVLQRLT-JHEQGTHGSA-N Gly-Thr-Gln Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O CQMFNTVQVLQRLT-JHEQGTHGSA-N 0.000 description 2
- ZVXMEWXHFBYJPI-LSJOCFKGSA-N Gly-Val-Ile Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ZVXMEWXHFBYJPI-LSJOCFKGSA-N 0.000 description 2
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 2
- 101150039660 HA gene Proteins 0.000 description 2
- SDTPKSOWFXBACN-GUBZILKMSA-N His-Glu-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O SDTPKSOWFXBACN-GUBZILKMSA-N 0.000 description 2
- TTYKEFZRLKQTHH-MELADBBJSA-N His-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CN=CN2)N)C(=O)O TTYKEFZRLKQTHH-MELADBBJSA-N 0.000 description 2
- ALPXXNRQBMRCPZ-MEYUZBJRSA-N His-Thr-Phe Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ALPXXNRQBMRCPZ-MEYUZBJRSA-N 0.000 description 2
- JVEKQAYXFGIISZ-HOCLYGCPSA-N His-Trp-Gly Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(O)=O)C1=CN=CN1 JVEKQAYXFGIISZ-HOCLYGCPSA-N 0.000 description 2
- DFJJAVZIHDFOGQ-MNXVOIDGSA-N Ile-Glu-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N DFJJAVZIHDFOGQ-MNXVOIDGSA-N 0.000 description 2
- LWWILHPVAKKLQS-QXEWZRGKSA-N Ile-Gly-Met Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CCSC)C(=O)O)N LWWILHPVAKKLQS-QXEWZRGKSA-N 0.000 description 2
- LBRCLQMZAHRTLV-ZKWXMUAHSA-N Ile-Gly-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O LBRCLQMZAHRTLV-ZKWXMUAHSA-N 0.000 description 2
- CZWANIQKACCEKW-CYDGBPFRSA-N Ile-Pro-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)O)N CZWANIQKACCEKW-CYDGBPFRSA-N 0.000 description 2
- 108700005091 Immunoglobulin Genes Proteins 0.000 description 2
- 208000002979 Influenza in Birds Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241000235058 Komagataella pastoris Species 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- LZDNBBYBDGBADK-UHFFFAOYSA-N L-valyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C(C)C)C(O)=O)=CNC2=C1 LZDNBBYBDGBADK-UHFFFAOYSA-N 0.000 description 2
- KAFOIVJDVSZUMD-DCAQKATOSA-N Leu-Gln-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O KAFOIVJDVSZUMD-DCAQKATOSA-N 0.000 description 2
- KAFOIVJDVSZUMD-UHFFFAOYSA-N Leu-Gln-Gln Natural products CC(C)CC(N)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(N)=O)C(O)=O KAFOIVJDVSZUMD-UHFFFAOYSA-N 0.000 description 2
- AXZGZMGRBDQTEY-SRVKXCTJSA-N Leu-Gln-Met Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(O)=O AXZGZMGRBDQTEY-SRVKXCTJSA-N 0.000 description 2
- DPURXCQCHSQPAN-AVGNSLFASA-N Leu-Pro-Pro Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DPURXCQCHSQPAN-AVGNSLFASA-N 0.000 description 2
- KIZIOFNVSOSKJI-CIUDSAMLSA-N Leu-Ser-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N KIZIOFNVSOSKJI-CIUDSAMLSA-N 0.000 description 2
- LJBVRCDPWOJOEK-PPCPHDFISA-N Leu-Thr-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LJBVRCDPWOJOEK-PPCPHDFISA-N 0.000 description 2
- WSXTWLJHTLRFLW-SRVKXCTJSA-N Lys-Ala-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O WSXTWLJHTLRFLW-SRVKXCTJSA-N 0.000 description 2
- GQZMPWBZQALKJO-UWVGGRQHSA-N Lys-Gly-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O GQZMPWBZQALKJO-UWVGGRQHSA-N 0.000 description 2
- ODTZHNZPINULEU-KKUMJFAQSA-N Lys-Phe-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCCN)N ODTZHNZPINULEU-KKUMJFAQSA-N 0.000 description 2
- SUZVLFWOCKHWET-CQDKDKBSSA-N Lys-Tyr-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O SUZVLFWOCKHWET-CQDKDKBSSA-N 0.000 description 2
- QLFAPXUXEBAWEK-NHCYSSNCSA-N Lys-Val-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O QLFAPXUXEBAWEK-NHCYSSNCSA-N 0.000 description 2
- UZVKFARGHHMQGX-IUCAKERBSA-N Met-Gly-Met Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCSC UZVKFARGHHMQGX-IUCAKERBSA-N 0.000 description 2
- RKIIYGUHIQJCBW-SRVKXCTJSA-N Met-His-Glu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O RKIIYGUHIQJCBW-SRVKXCTJSA-N 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- 108010066427 N-valyltryptophan Proteins 0.000 description 2
- 108091007491 NSP3 Papain-like protease domains Proteins 0.000 description 2
- 229940123424 Neuraminidase inhibitor Drugs 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 102000011931 Nucleoproteins Human genes 0.000 description 2
- 108010061100 Nucleoproteins Proteins 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- CUMXHKAOHNWRFQ-BZSNNMDCSA-N Phe-Asp-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 CUMXHKAOHNWRFQ-BZSNNMDCSA-N 0.000 description 2
- BIYWZVCPZIFGPY-QWRGUYRKSA-N Phe-Gly-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CO)C(O)=O BIYWZVCPZIFGPY-QWRGUYRKSA-N 0.000 description 2
- BPCLGWHVPVTTFM-QWRGUYRKSA-N Phe-Ser-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)NCC(O)=O BPCLGWHVPVTTFM-QWRGUYRKSA-N 0.000 description 2
- GLJZDMZJHFXJQG-BZSNNMDCSA-N Phe-Ser-Phe Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O GLJZDMZJHFXJQG-BZSNNMDCSA-N 0.000 description 2
- FGWUALWGCZJQDJ-URLPEUOOSA-N Phe-Thr-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FGWUALWGCZJQDJ-URLPEUOOSA-N 0.000 description 2
- NXEYSLRNNPWCRN-SRVKXCTJSA-N Pro-Glu-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NXEYSLRNNPWCRN-SRVKXCTJSA-N 0.000 description 2
- FMLRRBDLBJLJIK-DCAQKATOSA-N Pro-Leu-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1 FMLRRBDLBJLJIK-DCAQKATOSA-N 0.000 description 2
- SMFQZMGHCODUPQ-ULQDDVLXSA-N Pro-Lys-Phe Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SMFQZMGHCODUPQ-ULQDDVLXSA-N 0.000 description 2
- WCNVGGZRTNHOOS-ULQDDVLXSA-N Pro-Lys-Tyr Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O WCNVGGZRTNHOOS-ULQDDVLXSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- UEJYSALTSUZXFV-SRVKXCTJSA-N Rigin Chemical compound NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O UEJYSALTSUZXFV-SRVKXCTJSA-N 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- ZUGXSSFMTXKHJS-ZLUOBGJFSA-N Ser-Ala-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O ZUGXSSFMTXKHJS-ZLUOBGJFSA-N 0.000 description 2
- YQHZVYJAGWMHES-ZLUOBGJFSA-N Ser-Ala-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YQHZVYJAGWMHES-ZLUOBGJFSA-N 0.000 description 2
- QEDMOZUJTGEIBF-FXQIFTODSA-N Ser-Arg-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O QEDMOZUJTGEIBF-FXQIFTODSA-N 0.000 description 2
- YUSRGTQIPCJNHQ-CIUDSAMLSA-N Ser-Arg-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O YUSRGTQIPCJNHQ-CIUDSAMLSA-N 0.000 description 2
- HZWAHWQZPSXNCB-BPUTZDHNSA-N Ser-Arg-Trp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O HZWAHWQZPSXNCB-BPUTZDHNSA-N 0.000 description 2
- UGJRQLURDVGULT-LKXGYXEUSA-N Ser-Asn-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O UGJRQLURDVGULT-LKXGYXEUSA-N 0.000 description 2
- SFZKGGOGCNQPJY-CIUDSAMLSA-N Ser-Asp-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)N SFZKGGOGCNQPJY-CIUDSAMLSA-N 0.000 description 2
- XXXAXOWMBOKTRN-XPUUQOCRSA-N Ser-Gly-Val Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O XXXAXOWMBOKTRN-XPUUQOCRSA-N 0.000 description 2
- QYSFWUIXDFJUDW-DCAQKATOSA-N Ser-Leu-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QYSFWUIXDFJUDW-DCAQKATOSA-N 0.000 description 2
- MUJQWSAWLLRJCE-KATARQTJSA-N Ser-Leu-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MUJQWSAWLLRJCE-KATARQTJSA-N 0.000 description 2
- AMRRYKHCILPAKD-FXQIFTODSA-N Ser-Met-Asn Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CO)N AMRRYKHCILPAKD-FXQIFTODSA-N 0.000 description 2
- VIIJCAQMJBHSJH-FXQIFTODSA-N Ser-Met-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(O)=O VIIJCAQMJBHSJH-FXQIFTODSA-N 0.000 description 2
- RHAPJNVNWDBFQI-BQBZGAKWSA-N Ser-Pro-Gly Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O RHAPJNVNWDBFQI-BQBZGAKWSA-N 0.000 description 2
- FKYWFUYPVKLJLP-DCAQKATOSA-N Ser-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO FKYWFUYPVKLJLP-DCAQKATOSA-N 0.000 description 2
- JCLAFVNDBJMLBC-JBDRJPRFSA-N Ser-Ser-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JCLAFVNDBJMLBC-JBDRJPRFSA-N 0.000 description 2
- UQGAAZXSCGWMFU-UBHSHLNASA-N Ser-Trp-Asp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CO)N UQGAAZXSCGWMFU-UBHSHLNASA-N 0.000 description 2
- FHXGMDRKJHKLKW-QWRGUYRKSA-N Ser-Tyr-Gly Chemical compound OC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 FHXGMDRKJHKLKW-QWRGUYRKSA-N 0.000 description 2
- UBTNVMGPMYDYIU-HJPIBITLSA-N Ser-Tyr-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O UBTNVMGPMYDYIU-HJPIBITLSA-N 0.000 description 2
- HNDMFDBQXYZSRM-IHRRRGAJSA-N Ser-Val-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HNDMFDBQXYZSRM-IHRRRGAJSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- LAFLAXHTDVNVEL-WDCWCFNPSA-N Thr-Gln-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N)O LAFLAXHTDVNVEL-WDCWCFNPSA-N 0.000 description 2
- SXAGUVRFGJSFKC-ZEILLAHLSA-N Thr-His-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SXAGUVRFGJSFKC-ZEILLAHLSA-N 0.000 description 2
- FQPDRTDDEZXCEC-SVSWQMSJSA-N Thr-Ile-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O FQPDRTDDEZXCEC-SVSWQMSJSA-N 0.000 description 2
- KZSYAEWQMJEGRZ-RHYQMDGZSA-N Thr-Leu-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O KZSYAEWQMJEGRZ-RHYQMDGZSA-N 0.000 description 2
- JLNMFGCJODTXDH-WEDXCCLWSA-N Thr-Lys-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O JLNMFGCJODTXDH-WEDXCCLWSA-N 0.000 description 2
- WPSKTVVMQCXPRO-BWBBJGPYSA-N Thr-Ser-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WPSKTVVMQCXPRO-BWBBJGPYSA-N 0.000 description 2
- MNYNCKZAEIAONY-XGEHTFHBSA-N Thr-Val-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O MNYNCKZAEIAONY-XGEHTFHBSA-N 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 241000218636 Thuja Species 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- 239000006035 Tryptophane Substances 0.000 description 2
- SCCKSNREWHMKOJ-SRVKXCTJSA-N Tyr-Asn-Ser Chemical compound N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O SCCKSNREWHMKOJ-SRVKXCTJSA-N 0.000 description 2
- HVHJYXDXRIWELT-RYUDHWBXSA-N Tyr-Glu-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O HVHJYXDXRIWELT-RYUDHWBXSA-N 0.000 description 2
- CNLKDWSAORJEMW-KWQFWETISA-N Tyr-Gly-Ala Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](C)C(O)=O CNLKDWSAORJEMW-KWQFWETISA-N 0.000 description 2
- ARJASMXQBRNAGI-YESZJQIVSA-N Tyr-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N ARJASMXQBRNAGI-YESZJQIVSA-N 0.000 description 2
- GZUIDWDVMWZSMI-KKUMJFAQSA-N Tyr-Lys-Cys Chemical compound NCCCC[C@@H](C(=O)N[C@@H](CS)C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 GZUIDWDVMWZSMI-KKUMJFAQSA-N 0.000 description 2
- YSGAPESOXHFTQY-IHRRRGAJSA-N Tyr-Met-Asp Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N YSGAPESOXHFTQY-IHRRRGAJSA-N 0.000 description 2
- FDKDGFGTHGJKNV-FHWLQOOXSA-N Tyr-Phe-Gln Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N FDKDGFGTHGJKNV-FHWLQOOXSA-N 0.000 description 2
- CDBXVDXSLPLFMD-BPNCWPANSA-N Tyr-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC1=CC=C(O)C=C1 CDBXVDXSLPLFMD-BPNCWPANSA-N 0.000 description 2
- QKXAEWMHAAVVGS-KKUMJFAQSA-N Tyr-Pro-Glu Chemical compound N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O QKXAEWMHAAVVGS-KKUMJFAQSA-N 0.000 description 2
- QFXVAFIHVWXXBJ-AVGNSLFASA-N Tyr-Ser-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O QFXVAFIHVWXXBJ-AVGNSLFASA-N 0.000 description 2
- KHPLUFDSWGDRHD-SLFFLAALSA-N Tyr-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)N)C(=O)O KHPLUFDSWGDRHD-SLFFLAALSA-N 0.000 description 2
- UUJHRSTVQCFDPA-UFYCRDLUSA-N Tyr-Tyr-Val Chemical compound C([C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 UUJHRSTVQCFDPA-UFYCRDLUSA-N 0.000 description 2
- OACSGBOREVRSME-NHCYSSNCSA-N Val-His-Asn Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(N)=O)C(O)=O OACSGBOREVRSME-NHCYSSNCSA-N 0.000 description 2
- SSYBNWFXCFNRFN-GUBZILKMSA-N Val-Pro-Ser Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O SSYBNWFXCFNRFN-GUBZILKMSA-N 0.000 description 2
- SDHZOOIGIUEPDY-JYJNAYRXSA-N Val-Ser-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)C(C)C)C(O)=O)=CNC2=C1 SDHZOOIGIUEPDY-JYJNAYRXSA-N 0.000 description 2
- QHSSPPHOHJSTML-HOCLYGCPSA-N Val-Trp-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)NCC(=O)O)N QHSSPPHOHJSTML-HOCLYGCPSA-N 0.000 description 2
- PGBMPFKFKXYROZ-UFYCRDLUSA-N Val-Tyr-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)N PGBMPFKFKXYROZ-UFYCRDLUSA-N 0.000 description 2
- BGTDGENDNWGMDQ-KJEVXHAQSA-N Val-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)N)O BGTDGENDNWGMDQ-KJEVXHAQSA-N 0.000 description 2
- 101710097943 Viral-enhancing factor Proteins 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- 108010008685 alanyl-glutamyl-aspartic acid Proteins 0.000 description 2
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 2
- 229960003805 amantadine Drugs 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 230000002924 anti-infective effect Effects 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 108010072041 arginyl-glycyl-aspartic acid Proteins 0.000 description 2
- 108010091092 arginyl-glycyl-proline Proteins 0.000 description 2
- 210000004436 artificial bacterial chromosome Anatomy 0.000 description 2
- 210000001106 artificial yeast chromosome Anatomy 0.000 description 2
- 108010029566 avian influenza A virus hemagglutinin Proteins 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 239000013599 cloning vector Substances 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000012502 diagnostic product Substances 0.000 description 2
- 238000012631 diagnostic technique Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 108010049041 glutamylalanine Proteins 0.000 description 2
- 230000013595 glycosylation Effects 0.000 description 2
- 238000006206 glycosylation reaction Methods 0.000 description 2
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 2
- 108010081551 glycylphenylalanine Proteins 0.000 description 2
- 108010087823 glycyltyrosine Proteins 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 238000012151 immunohistochemical method Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 108010044374 isoleucyl-tyrosine Proteins 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 238000011330 nucleic acid test Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 108010020755 prolyl-glycyl-glycine Proteins 0.000 description 2
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000013207 serial dilution Methods 0.000 description 2
- 108010071207 serylmethionine Proteins 0.000 description 2
- 239000002911 sialidase inhibitor Substances 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 238000002741 site-directed mutagenesis Methods 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 229960004799 tryptophan Drugs 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 108010035534 tyrosyl-leucyl-alanine Proteins 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- 239000005723 virus inoculator Substances 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- CVOFKRWYWCSDMA-UHFFFAOYSA-N 2-chloro-n-(2,6-diethylphenyl)-n-(methoxymethyl)acetamide;2,6-dinitro-n,n-dipropyl-4-(trifluoromethyl)aniline Chemical compound CCC1=CC=CC(CC)=C1N(COC)C(=O)CCl.CCCN(CCC)C1=C([N+]([O-])=O)C=C(C(F)(F)F)C=C1[N+]([O-])=O CVOFKRWYWCSDMA-UHFFFAOYSA-N 0.000 description 1
- 102100039358 3-hydroxyacyl-CoA dehydrogenase type-2 Human genes 0.000 description 1
- 206010069754 Acquired gene mutation Diseases 0.000 description 1
- KQFRUSHJPKXBMB-BHDSKKPTSA-N Ala-Ala-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)C)C(O)=O)=CNC2=C1 KQFRUSHJPKXBMB-BHDSKKPTSA-N 0.000 description 1
- WXERCAHAIKMTKX-ZLUOBGJFSA-N Ala-Asp-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O WXERCAHAIKMTKX-ZLUOBGJFSA-N 0.000 description 1
- QCTFKEJEIMPOLW-JURCDPSOSA-N Ala-Ile-Phe Chemical compound C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 QCTFKEJEIMPOLW-JURCDPSOSA-N 0.000 description 1
- BGGAIXWIZCIFSG-XDTLVQLUSA-N Ala-Tyr-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O BGGAIXWIZCIFSG-XDTLVQLUSA-N 0.000 description 1
- ZJLORAAXDAJLDC-CQDKDKBSSA-N Ala-Tyr-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O ZJLORAAXDAJLDC-CQDKDKBSSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 241000272813 Anser indicus Species 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- KMSHNDWHPWXPEC-BQBZGAKWSA-N Arg-Asp-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O KMSHNDWHPWXPEC-BQBZGAKWSA-N 0.000 description 1
- FEZJJKXNPSEYEV-CIUDSAMLSA-N Arg-Gln-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O FEZJJKXNPSEYEV-CIUDSAMLSA-N 0.000 description 1
- NXDXECQFKHXHAM-HJGDQZAQSA-N Arg-Glu-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NXDXECQFKHXHAM-HJGDQZAQSA-N 0.000 description 1
- AMIQZQAAYGYKOP-FXQIFTODSA-N Arg-Ser-Asn Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O AMIQZQAAYGYKOP-FXQIFTODSA-N 0.000 description 1
- ZJBUILVYSXQNSW-YTWAJWBKSA-N Arg-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O ZJBUILVYSXQNSW-YTWAJWBKSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- QEYJFBMTSMLPKZ-ZKWXMUAHSA-N Asn-Ala-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O QEYJFBMTSMLPKZ-ZKWXMUAHSA-N 0.000 description 1
- FFMIYIMKQIMDPK-BQBZGAKWSA-N Asn-His Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 FFMIYIMKQIMDPK-BQBZGAKWSA-N 0.000 description 1
- NVWJMQNYLYWVNQ-BYULHYEWSA-N Asn-Ile-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O NVWJMQNYLYWVNQ-BYULHYEWSA-N 0.000 description 1
- RCFGLXMZDYNRSC-CIUDSAMLSA-N Asn-Lys-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O RCFGLXMZDYNRSC-CIUDSAMLSA-N 0.000 description 1
- COWITDLVHMZSIW-CIUDSAMLSA-N Asn-Lys-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O COWITDLVHMZSIW-CIUDSAMLSA-N 0.000 description 1
- XTMZYFMTYJNABC-ZLUOBGJFSA-N Asn-Ser-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)N XTMZYFMTYJNABC-ZLUOBGJFSA-N 0.000 description 1
- NCXTYSVDWLAQGZ-ZKWXMUAHSA-N Asn-Ser-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O NCXTYSVDWLAQGZ-ZKWXMUAHSA-N 0.000 description 1
- DPSUVAPLRQDWAO-YDHLFZDLSA-N Asn-Tyr-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)N)N DPSUVAPLRQDWAO-YDHLFZDLSA-N 0.000 description 1
- JZLFYAAGGYMRIK-BYULHYEWSA-N Asn-Val-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O JZLFYAAGGYMRIK-BYULHYEWSA-N 0.000 description 1
- DBWYWXNMZZYIRY-LPEHRKFASA-N Asp-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N)C(=O)O DBWYWXNMZZYIRY-LPEHRKFASA-N 0.000 description 1
- UQBGYPFHWFZMCD-ZLUOBGJFSA-N Asp-Asn-Asn Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O UQBGYPFHWFZMCD-ZLUOBGJFSA-N 0.000 description 1
- QOVWVLLHMMCFFY-ZLUOBGJFSA-N Asp-Asp-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O QOVWVLLHMMCFFY-ZLUOBGJFSA-N 0.000 description 1
- TVVYVAUGRHNTGT-UGYAYLCHSA-N Asp-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O TVVYVAUGRHNTGT-UGYAYLCHSA-N 0.000 description 1
- QXHVOUSPVAWEMX-ZLUOBGJFSA-N Asp-Asp-Ser Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O QXHVOUSPVAWEMX-ZLUOBGJFSA-N 0.000 description 1
- NHSDEZURHWEZPN-SXTJYALSSA-N Asp-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H](CC(=O)O)N NHSDEZURHWEZPN-SXTJYALSSA-N 0.000 description 1
- RXBGWGRSWXOBGK-KKUMJFAQSA-N Asp-Lys-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O RXBGWGRSWXOBGK-KKUMJFAQSA-N 0.000 description 1
- CUQDCPXNZPDYFQ-ZLUOBGJFSA-N Asp-Ser-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O CUQDCPXNZPDYFQ-ZLUOBGJFSA-N 0.000 description 1
- NAAAPCLFJPURAM-HJGDQZAQSA-N Asp-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O NAAAPCLFJPURAM-HJGDQZAQSA-N 0.000 description 1
- YUELDQUPTAYEGM-XIRDDKMYSA-N Asp-Trp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC(=O)O)N YUELDQUPTAYEGM-XIRDDKMYSA-N 0.000 description 1
- BYLPQJAWXJWUCJ-YDHLFZDLSA-N Asp-Tyr-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O BYLPQJAWXJWUCJ-YDHLFZDLSA-N 0.000 description 1
- QOJJMJKTMKNFEF-ZKWXMUAHSA-N Asp-Val-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC(O)=O QOJJMJKTMKNFEF-ZKWXMUAHSA-N 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- WXKWQSDHEXKKNC-ZKWXMUAHSA-N Cys-Asp-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)N WXKWQSDHEXKKNC-ZKWXMUAHSA-N 0.000 description 1
- ALTQTAKGRFLRLR-GUBZILKMSA-N Cys-Val-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CS)N ALTQTAKGRFLRLR-GUBZILKMSA-N 0.000 description 1
- 101150074155 DHFR gene Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 102100027280 Fanconi anemia group A protein Human genes 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- OVQXQLWWJSNYFV-XEGUGMAKSA-N Gln-Ala-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(N)=O)C)C(O)=O)=CNC2=C1 OVQXQLWWJSNYFV-XEGUGMAKSA-N 0.000 description 1
- MQANCSUBSBJNLU-KKUMJFAQSA-N Gln-Arg-Tyr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O MQANCSUBSBJNLU-KKUMJFAQSA-N 0.000 description 1
- PONUFVLSGMQFAI-AVGNSLFASA-N Gln-Asn-Phe Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PONUFVLSGMQFAI-AVGNSLFASA-N 0.000 description 1
- QYTKAVBFRUGYAU-ACZMJKKPSA-N Gln-Asp-Asn Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O QYTKAVBFRUGYAU-ACZMJKKPSA-N 0.000 description 1
- GNMQDOGFWYWPNM-LAEOZQHASA-N Gln-Gly-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)CCC(N)=O)C(O)=O GNMQDOGFWYWPNM-LAEOZQHASA-N 0.000 description 1
- OTQSTOXRUBVWAP-NRPADANISA-N Gln-Ser-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O OTQSTOXRUBVWAP-NRPADANISA-N 0.000 description 1
- KOSRFJWDECSPRO-WDSKDSINSA-N Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O KOSRFJWDECSPRO-WDSKDSINSA-N 0.000 description 1
- QEJKKJNDDDPSMU-KKUMJFAQSA-N Glu-Tyr-Met Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCSC)C(O)=O QEJKKJNDDDPSMU-KKUMJFAQSA-N 0.000 description 1
- PMSDOVISAARGAV-FHWLQOOXSA-N Glu-Tyr-Phe Chemical compound C([C@H](NC(=O)[C@H](CCC(O)=O)N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 PMSDOVISAARGAV-FHWLQOOXSA-N 0.000 description 1
- ZALGPUWUVHOGAE-GVXVVHGQSA-N Glu-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCC(=O)O)N ZALGPUWUVHOGAE-GVXVVHGQSA-N 0.000 description 1
- QXUPRMQJDWJDFR-NRPADANISA-N Glu-Val-Ser Chemical compound CC(C)[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O QXUPRMQJDWJDFR-NRPADANISA-N 0.000 description 1
- WGYHAAXZWPEBDQ-IFFSRLJSSA-N Glu-Val-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WGYHAAXZWPEBDQ-IFFSRLJSSA-N 0.000 description 1
- 102000005720 Glutathione transferase Human genes 0.000 description 1
- 108010070675 Glutathione transferase Proteins 0.000 description 1
- LJPIRKICOISLKN-WHFBIAKZSA-N Gly-Ala-Ser Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O LJPIRKICOISLKN-WHFBIAKZSA-N 0.000 description 1
- WKJKBELXHCTHIJ-WPRPVWTQSA-N Gly-Arg-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N WKJKBELXHCTHIJ-WPRPVWTQSA-N 0.000 description 1
- XCLCVBYNGXEVDU-WHFBIAKZSA-N Gly-Asn-Ser Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O XCLCVBYNGXEVDU-WHFBIAKZSA-N 0.000 description 1
- LURCIJSJAKFCRO-QWRGUYRKSA-N Gly-Asn-Tyr Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LURCIJSJAKFCRO-QWRGUYRKSA-N 0.000 description 1
- MHHUEAIBJZWDBH-YUMQZZPRSA-N Gly-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CN MHHUEAIBJZWDBH-YUMQZZPRSA-N 0.000 description 1
- KMSGYZQRXPUKGI-BYPYZUCNSA-N Gly-Gly-Asn Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC(N)=O KMSGYZQRXPUKGI-BYPYZUCNSA-N 0.000 description 1
- ZOTGXWMKUFSKEU-QXEWZRGKSA-N Gly-Ile-Met Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(O)=O ZOTGXWMKUFSKEU-QXEWZRGKSA-N 0.000 description 1
- XVYKMNXXJXQKME-XEGUGMAKSA-N Gly-Ile-Tyr Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 XVYKMNXXJXQKME-XEGUGMAKSA-N 0.000 description 1
- GAFKBWKVXNERFA-QWRGUYRKSA-N Gly-Phe-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 GAFKBWKVXNERFA-QWRGUYRKSA-N 0.000 description 1
- JJGBXTYGTKWGAT-YUMQZZPRSA-N Gly-Pro-Glu Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O JJGBXTYGTKWGAT-YUMQZZPRSA-N 0.000 description 1
- GAAHQHNCMIAYEX-UWVGGRQHSA-N Gly-Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN GAAHQHNCMIAYEX-UWVGGRQHSA-N 0.000 description 1
- IRJWAYCXIYUHQE-WHFBIAKZSA-N Gly-Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CN IRJWAYCXIYUHQE-WHFBIAKZSA-N 0.000 description 1
- SOEGEPHNZOISMT-BYPYZUCNSA-N Gly-Ser-Gly Chemical compound NCC(=O)N[C@@H](CO)C(=O)NCC(O)=O SOEGEPHNZOISMT-BYPYZUCNSA-N 0.000 description 1
- JSLVAHYTAJJEQH-QWRGUYRKSA-N Gly-Ser-Phe Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 JSLVAHYTAJJEQH-QWRGUYRKSA-N 0.000 description 1
- LCRDMSSAKLTKBU-ZDLURKLDSA-N Gly-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN LCRDMSSAKLTKBU-ZDLURKLDSA-N 0.000 description 1
- MYXNLWDWWOTERK-BHNWBGBOSA-N Gly-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN)O MYXNLWDWWOTERK-BHNWBGBOSA-N 0.000 description 1
- WSWWTQYHFCBKBT-DVJZZOLTSA-N Gly-Thr-Trp Chemical compound C[C@@H](O)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O WSWWTQYHFCBKBT-DVJZZOLTSA-N 0.000 description 1
- GNNJKUYDWFIBTK-QWRGUYRKSA-N Gly-Tyr-Asp Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O GNNJKUYDWFIBTK-QWRGUYRKSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 206010069767 H1N1 influenza Diseases 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- YJBMLTVVVRJNOK-SRVKXCTJSA-N His-Asp-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N YJBMLTVVVRJNOK-SRVKXCTJSA-N 0.000 description 1
- 101001035740 Homo sapiens 3-hydroxyacyl-CoA dehydrogenase type-2 Proteins 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- 101000914673 Homo sapiens Fanconi anemia group A protein Proteins 0.000 description 1
- NZOCIWKZUVUNDW-ZKWXMUAHSA-N Ile-Gly-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(O)=O NZOCIWKZUVUNDW-ZKWXMUAHSA-N 0.000 description 1
- SLQVFYWBGNNOTK-BYULHYEWSA-N Ile-Gly-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)O)N SLQVFYWBGNNOTK-BYULHYEWSA-N 0.000 description 1
- BJECXJHLUJXPJQ-PYJNHQTQSA-N Ile-Pro-His Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N BJECXJHLUJXPJQ-PYJNHQTQSA-N 0.000 description 1
- NXRNRBOKDBIVKQ-CXTHYWKRSA-N Ile-Tyr-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N NXRNRBOKDBIVKQ-CXTHYWKRSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- 229940124873 Influenza virus vaccine Drugs 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- TWQIYNGNYNJUFM-NHCYSSNCSA-N Leu-Asn-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O TWQIYNGNYNJUFM-NHCYSSNCSA-N 0.000 description 1
- YWYQSLOTVIRCFE-SRVKXCTJSA-N Leu-His-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(O)=O YWYQSLOTVIRCFE-SRVKXCTJSA-N 0.000 description 1
- BKTXKJMNTSMJDQ-AVGNSLFASA-N Leu-His-Gln Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N BKTXKJMNTSMJDQ-AVGNSLFASA-N 0.000 description 1
- UHNQRAFSEBGZFZ-YESZJQIVSA-N Leu-Phe-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N2CCC[C@@H]2C(=O)O)N UHNQRAFSEBGZFZ-YESZJQIVSA-N 0.000 description 1
- WMIOEVKKYIMVKI-DCAQKATOSA-N Leu-Pro-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O WMIOEVKKYIMVKI-DCAQKATOSA-N 0.000 description 1
- IRMLZWSRWSGTOP-CIUDSAMLSA-N Leu-Ser-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O IRMLZWSRWSGTOP-CIUDSAMLSA-N 0.000 description 1
- RGUXWMDNCPMQFB-YUMQZZPRSA-N Leu-Ser-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RGUXWMDNCPMQFB-YUMQZZPRSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 206010025327 Lymphopenia Diseases 0.000 description 1
- FUKDBQGFSJUXGX-RWMBFGLXSA-N Lys-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)N)C(=O)O FUKDBQGFSJUXGX-RWMBFGLXSA-N 0.000 description 1
- QUCDKEKDPYISNX-HJGDQZAQSA-N Lys-Asn-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QUCDKEKDPYISNX-HJGDQZAQSA-N 0.000 description 1
- KWUKZRFFKPLUPE-HJGDQZAQSA-N Lys-Asp-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KWUKZRFFKPLUPE-HJGDQZAQSA-N 0.000 description 1
- VMTYLUGCXIEDMV-QWRGUYRKSA-N Lys-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN VMTYLUGCXIEDMV-QWRGUYRKSA-N 0.000 description 1
- 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 1
- FWAHLGXNBLWIKB-NAKRPEOUSA-N Met-Ile-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCSC FWAHLGXNBLWIKB-NAKRPEOUSA-N 0.000 description 1
- 241000699660 Mus musculus Species 0.000 description 1
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- 108091061960 Naked DNA Proteins 0.000 description 1
- 241000158526 Nasalis Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000320412 Ogataea angusta Species 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108010067902 Peptide Library Proteins 0.000 description 1
- FPTXMUIBLMGTQH-ONGXEEELSA-N Phe-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 FPTXMUIBLMGTQH-ONGXEEELSA-N 0.000 description 1
- QPQDWBAJWOGAMJ-IHPCNDPISA-N Phe-Asp-Trp Chemical compound C([C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CC=CC=C1 QPQDWBAJWOGAMJ-IHPCNDPISA-N 0.000 description 1
- APMXLWHMIVWLLR-BZSNNMDCSA-N Phe-Tyr-Ser Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(O)=O)C1=CC=CC=C1 APMXLWHMIVWLLR-BZSNNMDCSA-N 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 229920001710 Polyorthoester Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- JMVQDLDPDBXAAX-YUMQZZPRSA-N Pro-Gly-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 JMVQDLDPDBXAAX-YUMQZZPRSA-N 0.000 description 1
- BCNRNJWSRFDPTQ-HJWJTTGWSA-N Pro-Ile-Phe Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O BCNRNJWSRFDPTQ-HJWJTTGWSA-N 0.000 description 1
- DRKAXLDECUGLFE-ULQDDVLXSA-N Pro-Leu-Phe Chemical compound CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O DRKAXLDECUGLFE-ULQDDVLXSA-N 0.000 description 1
- ULWBBFKQBDNGOY-RWMBFGLXSA-N Pro-Lys-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@@H]2C(=O)O ULWBBFKQBDNGOY-RWMBFGLXSA-N 0.000 description 1
- APIAILHCTSBGLU-JYJNAYRXSA-N Pro-Met-Phe Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@@H]2CCCN2 APIAILHCTSBGLU-JYJNAYRXSA-N 0.000 description 1
- DWPXHLIBFQLKLK-CYDGBPFRSA-N Pro-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 DWPXHLIBFQLKLK-CYDGBPFRSA-N 0.000 description 1
- KHRLUIPIMIQFGT-AVGNSLFASA-N Pro-Val-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O KHRLUIPIMIQFGT-AVGNSLFASA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 241000190932 Rhodopseudomonas Species 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
- 241000315672 SARS coronavirus Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- GXXTUIUYTWGPMV-FXQIFTODSA-N Ser-Arg-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O GXXTUIUYTWGPMV-FXQIFTODSA-N 0.000 description 1
- OOKCGAYXSNJBGQ-ZLUOBGJFSA-N Ser-Asn-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O OOKCGAYXSNJBGQ-ZLUOBGJFSA-N 0.000 description 1
- KNCJWSPMTFFJII-ZLUOBGJFSA-N Ser-Cys-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(O)=O)C(O)=O KNCJWSPMTFFJII-ZLUOBGJFSA-N 0.000 description 1
- IXCHOHLPHNGFTJ-YUMQZZPRSA-N Ser-Gly-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CO)N IXCHOHLPHNGFTJ-YUMQZZPRSA-N 0.000 description 1
- UIPXCLNLUUAMJU-JBDRJPRFSA-N Ser-Ile-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O UIPXCLNLUUAMJU-JBDRJPRFSA-N 0.000 description 1
- XUDRHBPSPAPDJP-SRVKXCTJSA-N Ser-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO XUDRHBPSPAPDJP-SRVKXCTJSA-N 0.000 description 1
- NUEHQDHDLDXCRU-GUBZILKMSA-N Ser-Pro-Arg Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O NUEHQDHDLDXCRU-GUBZILKMSA-N 0.000 description 1
- PPCZVWHJWJFTFN-ZLUOBGJFSA-N Ser-Ser-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPCZVWHJWJFTFN-ZLUOBGJFSA-N 0.000 description 1
- NADLKBTYNKUJEP-KATARQTJSA-N Ser-Thr-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O NADLKBTYNKUJEP-KATARQTJSA-N 0.000 description 1
- HAUVENOGHPECML-BPUTZDHNSA-N Ser-Trp-Val Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@@H](N)CO)=CNC2=C1 HAUVENOGHPECML-BPUTZDHNSA-N 0.000 description 1
- PIQRHJQWEPWFJG-UWJYBYFXSA-N Ser-Tyr-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O PIQRHJQWEPWFJG-UWJYBYFXSA-N 0.000 description 1
- ZVBCMFDJIMUELU-BZSNNMDCSA-N Ser-Tyr-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)N ZVBCMFDJIMUELU-BZSNNMDCSA-N 0.000 description 1
- VVKVHAOOUGNDPJ-SRVKXCTJSA-N Ser-Tyr-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(O)=O VVKVHAOOUGNDPJ-SRVKXCTJSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical class [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- IGROJMCBGRFRGI-YTLHQDLWSA-N Thr-Ala-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O IGROJMCBGRFRGI-YTLHQDLWSA-N 0.000 description 1
- DGDCHPCRMWEOJR-FQPOAREZSA-N Thr-Ala-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 DGDCHPCRMWEOJR-FQPOAREZSA-N 0.000 description 1
- DJDSEDOKJTZBAR-ZDLURKLDSA-N Thr-Gly-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O DJDSEDOKJTZBAR-ZDLURKLDSA-N 0.000 description 1
- KBBRNEDOYWMIJP-KYNKHSRBSA-N Thr-Gly-Thr Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)O)N)O KBBRNEDOYWMIJP-KYNKHSRBSA-N 0.000 description 1
- GXUWHVZYDAHFSV-FLBSBUHZSA-N Thr-Ile-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GXUWHVZYDAHFSV-FLBSBUHZSA-N 0.000 description 1
- WFAUDCSNCWJJAA-KXNHARMFSA-N Thr-Lys-Pro Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@@H]1C(O)=O WFAUDCSNCWJJAA-KXNHARMFSA-N 0.000 description 1
- KZURUCDWKDEAFZ-XVSYOHENSA-N Thr-Phe-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O KZURUCDWKDEAFZ-XVSYOHENSA-N 0.000 description 1
- DEGCBBCMYWNJNA-RHYQMDGZSA-N Thr-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O DEGCBBCMYWNJNA-RHYQMDGZSA-N 0.000 description 1
- BPGDJSUFQKWUBK-KJEVXHAQSA-N Thr-Val-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 BPGDJSUFQKWUBK-KJEVXHAQSA-N 0.000 description 1
- 108010022394 Threonine synthase Proteins 0.000 description 1
- 108020004440 Thymidine kinase Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- XLMDWQNAOKLKCP-XDTLVQLUSA-N Tyr-Ala-Gln Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N XLMDWQNAOKLKCP-XDTLVQLUSA-N 0.000 description 1
- QYSBJAUCUKHSLU-JYJNAYRXSA-N Tyr-Arg-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O QYSBJAUCUKHSLU-JYJNAYRXSA-N 0.000 description 1
- XMNDQSYABVWZRK-BZSNNMDCSA-N Tyr-Asn-Phe Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O XMNDQSYABVWZRK-BZSNNMDCSA-N 0.000 description 1
- NSTPFWRAIDTNGH-BZSNNMDCSA-N Tyr-Asn-Tyr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O NSTPFWRAIDTNGH-BZSNNMDCSA-N 0.000 description 1
- PMDWYLVWHRTJIW-STQMWFEESA-N Tyr-Gly-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 PMDWYLVWHRTJIW-STQMWFEESA-N 0.000 description 1
- AZGZDDNKFFUDEH-QWRGUYRKSA-N Tyr-Gly-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AZGZDDNKFFUDEH-QWRGUYRKSA-N 0.000 description 1
- YMUQBRQQCPQEQN-CXTHYWKRSA-N Tyr-Ile-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N YMUQBRQQCPQEQN-CXTHYWKRSA-N 0.000 description 1
- GULIUBBXCYPDJU-CQDKDKBSSA-N Tyr-Leu-Ala Chemical compound [O-]C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CC1=CC=C(O)C=C1 GULIUBBXCYPDJU-CQDKDKBSSA-N 0.000 description 1
- JQOMHZMWQHXALX-FHWLQOOXSA-N Tyr-Tyr-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O JQOMHZMWQHXALX-FHWLQOOXSA-N 0.000 description 1
- BUPRFDPUIJNOLS-UFYCRDLUSA-N Tyr-Tyr-Met Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCSC)C(O)=O BUPRFDPUIJNOLS-UFYCRDLUSA-N 0.000 description 1
- AGDDLOQMXUQPDY-BZSNNMDCSA-N Tyr-Tyr-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(O)=O AGDDLOQMXUQPDY-BZSNNMDCSA-N 0.000 description 1
- RMRFSFXLFWWAJZ-HJOGWXRNSA-N Tyr-Tyr-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 RMRFSFXLFWWAJZ-HJOGWXRNSA-N 0.000 description 1
- 101150117115 V gene Proteins 0.000 description 1
- SCBITHMBEJNRHC-LSJOCFKGSA-N Val-Asp-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)O)N SCBITHMBEJNRHC-LSJOCFKGSA-N 0.000 description 1
- DJEVQCWNMQOABE-RCOVLWMOSA-N Val-Gly-Asp Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)N DJEVQCWNMQOABE-RCOVLWMOSA-N 0.000 description 1
- PIFJAFRUVWZRKR-QMMMGPOBSA-N Val-Gly-Gly Chemical compound CC(C)[C@H]([NH3+])C(=O)NCC(=O)NCC([O-])=O PIFJAFRUVWZRKR-QMMMGPOBSA-N 0.000 description 1
- BTWMICVCQLKKNR-DCAQKATOSA-N Val-Leu-Ser Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C([O-])=O BTWMICVCQLKKNR-DCAQKATOSA-N 0.000 description 1
- NZYNRRGJJVSSTJ-GUBZILKMSA-N Val-Ser-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O NZYNRRGJJVSSTJ-GUBZILKMSA-N 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 108010084455 Zeocin Proteins 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 230000009824 affinity maturation Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000002986 anti-lethal effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000012875 competitive assay Methods 0.000 description 1
- 230000006957 competitive inhibition Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000004163 cytometry Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 239000007933 dermal patch Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- NAGJZTKCGNOGPW-UHFFFAOYSA-K dioxido-sulfanylidene-sulfido-$l^{5}-phosphane Chemical compound [O-]P([O-])([S-])=S NAGJZTKCGNOGPW-UHFFFAOYSA-K 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- 108010051307 glycyl-glycyl-proline Proteins 0.000 description 1
- 108010010096 glycyl-glycyl-tyrosine Proteins 0.000 description 1
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 description 1
- 108010082286 glycyl-seryl-alanine Proteins 0.000 description 1
- 108010077515 glycylproline Proteins 0.000 description 1
- 239000003979 granulating agent Substances 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 108010040030 histidinoalanine Proteins 0.000 description 1
- 102000057593 human F8 Human genes 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- YQYJSBFKSSDGFO-FWAVGLHBSA-N hygromycin A Chemical compound O[C@H]1[C@H](O)[C@H](C(=O)C)O[C@@H]1Oc1ccc(\C=C(/C)C(=O)N[C@@H]2[C@@H]([C@H]3OCO[C@H]3[C@@H](O)[C@@H]2O)O)cc1O YQYJSBFKSSDGFO-FWAVGLHBSA-N 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 239000003701 inert diluent Substances 0.000 description 1
- 208000037797 influenza A Diseases 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 150000002484 inorganic compounds Chemical group 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000000138 intercalating agent Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 231100001023 lymphopenia Toxicity 0.000 description 1
- 230000005291 magnetic effect Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 210000003071 memory t lymphocyte Anatomy 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 108010005942 methionylglycine Proteins 0.000 description 1
- YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000036438 mutation frequency Effects 0.000 description 1
- 230000036963 noncompetitive effect Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000012053 oil suspension Substances 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 150000002894 organic compounds Chemical group 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000006320 pegylation Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 210000005105 peripheral blood lymphocyte Anatomy 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 108010073101 phenylalanylleucine Proteins 0.000 description 1
- CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 229920002704 polyhistidine Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 210000002729 polyribosome Anatomy 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 108010029020 prolylglycine Proteins 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 239000012857 radioactive material Substances 0.000 description 1
- 239000000941 radioactive substance Substances 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229940047431 recombinate Drugs 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 238000009774 resonance method Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 108010091078 rigin Proteins 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 239000012146 running buffer Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 108010048818 seryl-histidine Proteins 0.000 description 1
- 108010026333 seryl-proline Proteins 0.000 description 1
- 150000003384 small molecules Chemical group 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000011091 sodium acetates Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 230000037439 somatic mutation Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 201000010740 swine influenza Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000008866 synergistic binding Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000013077 target material Substances 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011830 transgenic mouse model Methods 0.000 description 1
- 230000010474 transient expression Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1018—Orthomyxoviridae, e.g. influenza virus
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
本发明涉及结合流感病毒H5N1且对于流感病毒H5N1具有中和活性的结合分子如人单克隆抗体。本发明提供了编码所述抗体的核酸分子、其序列和包含所述抗体的组合物以及鉴别和产生所述抗体的方法。所述抗体可用于流感病毒H5N1感染的诊断、预防和/或治疗中。在一个优选的实施方案中,所述抗体提供了在体内的交叉亚型保护作用,由此可以预防和/或治疗基于H5、H2、H6、H9和H1的流感病毒亚型的感染。
Description
发明领域
本发明涉及医学。特别地,本发明涉及流感病毒H5N1感染的诊断、预防和/或治疗。
发明背景
流感病毒由三个类型组成:A、B和C。流感病毒A感染多种鸟类和哺乳动物,包括人、马、海洋哺乳动物、猪、雪貂和鸡。在动物中,大多数流感病毒A导致呼吸道和肠道的轻微局部感染。然而,高致病性流感A毒株如H5N1导致家禽全身性感染,死亡率可达到100%。感染了流感病毒A的动物通常作为流感病毒库(reservoir)并且一些亚型已经示出越过物种屏障而感染人。
流感病毒A基于编码表面糖蛋白的两个基因的抗原性区域中的等位基因变异而可以分成亚型,所述表面糖蛋白即血凝素(HA)和神经氨酸酶(NA),其为病毒附着和细胞释放所必需。其它主要的病毒蛋白包括核蛋白、核壳结构蛋白、膜蛋白(M1和M2)、聚合酶(PA、PB和PB2)以及非结构蛋白(NS1和NS2)。
目前已知流感病毒A的16个HA亚型(H1-H16)和9个NA(N1-N9)抗原性变体。先前已知仅三个亚型在人体内循环(H1N1、H1N2和H3N2)。然而,近年来已经报道了禽流感病毒A的致病性H5N1亚型越过物种屏障并且感染人,导致一些患者的死亡,如1997和2003年在香港的文献记录。
在人体内,禽流感病毒感染呼吸道以及肠道、肝、脾、肾及其它器官的细胞。禽流感的症状包括发热、呼吸困难(包括气短和咳嗽)、淋巴细胞减少、腹泻以及血糖水平调节困难。与季节性流感相反,最处于风险中的人群是构成人群主体的健康成人。由于某些禽流感病毒A亚型特别是H5N1的高致病性以及经证实的其越过物种屏障感染人体的能力,因此存在与这些病毒株相关的重大经济和公众健康风险,包括严重的流行性和爆发性威胁。这种威胁的规模如1918年的流感大爆发,导致超过五千万人死亡。
目前还没有H5N1感染的有效疫苗,因此用免疫球蛋白进行的被动免疫治疗可能是一种替代策略。据报道在1918年期间被动免疫的应用使得死亡率减半。鉴于它们对于人体的治疗益处,因此需要能中和H5N1的结合分子优选人结合分子。本发明提供了这些结合分子并且揭示了它们可用于医学中,特别是用于诊断、预防和/或治疗H5N1感染中。
附图描述
图1示出了使用抗体CR6307(左侧部分)、CR6323(中间部分)和CR5111(右侧部分)对不同的血凝素(HA)进行的免疫印迹分析。将重组HA进行还原性SDS-PAGE分析和免疫印迹分析。泳道1示出H5N1TV的sHA,泳道2示出重组HA、亚型H5(A/Vietnam/1203/2004(H5N1)),泳道3示出重组HA、亚型H3(A/Wyoming/3/2003(H3N2)),泳道4示出重组HA、亚型H1(A/New Caledonia/20/99(H1N1))。图中还标出了可以发现HA0、HA1和HA2的位置。
图2示出一项研究中(实施例12)每组小鼠的平均临床评分,其中在用流感病毒H5N1感染前一天,用三种人H5N1单克隆抗体CR6261,CR6323,和CR6325以不同剂量预防性治疗小鼠。
图3示出在感染后21天期间用抗H5N1抗体预防性治疗小鼠期间的体重变化(实施例12)。
图4示出在图2和3的研究(实施例12)中不同组中存活小鼠的数目。
图5示出在图2-4的研究(实施例12)中死亡率与给予的抗-H5N1抗体剂量之间的关系。
图6示出在一项研究中(实施例13)每组小鼠的平均临床评分,其中用致死剂量的流感病毒H5N1感染小鼠并且在感染后的不同时间点(4小时、1天、2天和3天)用CR6261抗-H5N1单克隆抗体或者不相关的抗体CR2006(在感染后第1天给予)治疗。
图7示出图6所述研究中每组小鼠的存活数目。第1-4组的所有动物(除了第1组中的1只动物之外)在整个研究期间均存活直至感染后第21天。第5组的所有动物在第9天全部死亡。
图8示出图6所述的研究期间每组小鼠的平均体重。在第9天停止测量第5组小鼠体重,因为该组的所有小鼠此时已经死亡。尽管每组动物康复的快慢依赖于治疗时间,但是第1-4组中存活的小鼠在感染后第21天均达到正常体重水平。
图9示出一项研究的每组动物中存活动物的百分比,其中用致死剂量的H1N1流感病毒感染小鼠并且在不同时间点(感染前1天,感染后1、2和3天)用CR6261抗-H5N1单克隆抗体或者不相关的抗体CR57(在感染后第1天给予)治疗。
图10示出图9所述研究期间每组小鼠的平均体重。在第9天停止测量第5组小鼠体重,因为该组的所有小鼠此时已经死亡。尽管每组动物康复的快慢依赖于治疗时间,但是第1-4组中存活的小鼠在感染后第21天均达到正常体重水平。
发明描述
下文阐述了本发明使用的一些术语的定义。
如本文所用,术语“结合分子”是指完整的免疫球蛋白,包括单克隆抗体,如嵌合抗体、人源化抗体或人单克隆抗体,或者是指抗原结合和/或可变结构域,其包含与所述完整的免疫球蛋白竞争特异性结合所述免疫球蛋白的结合配偶体例如H5N1的免疫球蛋白片段。无论结构如何,所述抗原结合片段结合由所述完整的免疫球蛋白识别的相同抗原。抗原结合片段可包含具有这样的氨基酸序列的肽或多肽,所述氨基酸序列为所述结合分子的氨基酸序列的至少2、5、10、15、20、25、30、35、40、50、60、70、80、90、100、125、150、175、200或者250个连续氨基酸残基。
如本文所用,术语“结合分子”包括本领域已知的所有免疫球蛋白类别和亚类。根据其重链恒定结构域的氨基酸序列,结合分子可以被分为五种主要类别的完整抗体:IgA、IgD、IgE、IgG和IgM,并且其中一些类别可进一步分成亚类(同种型),例如IgA1、IgA2、IgG1、IgG2、IgG3和IgG4。
抗原结合片段包括Fab、F(ab′)、F(ab′)2、Fv、dAb、Fd、互补决定区(CDR)片段、单链抗体(scFv)、二价单链抗体、单链噬菌体抗体、双特异双链抗体(diabody)、三链抗体(triabody)、四链抗体(tetrabody)、含有至少足以赋予与(多)肽特异性抗原结合的免疫球蛋白片段的(多)肽等。上述片段可以合成产生或者通过酶或化学裂解完整的免疫球蛋白而产生或者可以通过重组DNA技术遗传工程化。所述产生方法为本领域所熟知,例如并入本文作参考的由E.Harlow and D,Lane(1988)编辑的Antibodies:A LaboratoryManual,Cold Spring Harbor Labotatory,Cold Spring Harbor,New York。结合分子或者其抗原结合片段可以具有一或多个结合位点。如果存在一个以上的结合位点,则所述结合位点可以彼此相同或不同。
结合分子可以是裸的或者未缀合的结合分子,但是也可以是免疫缀合物的一部分。裸的或者未缀合的结合分子是指这样的结合分子,其未与效应部分或标记缀合、可操纵地连接或者另外物理或功能性关联,所述效应部分或者标记例如是毒性物质、放射性物质、脂质体、酶。裸的或者未缀合的结合分子不排除已经稳定化的、多聚体化的、人源化或者以任何其它方式操作的(除了效应成分或者标记的附着之外)结合分子。因此,所有翻译后修饰的裸的和未缀合的结合分子均包含在其中,包括其中是在产生天然结合分子的细胞环境中通过产生重组结合分子的细胞而产生修饰以及在最初的结合分子制备后通过人工导入修饰。当然,术语裸的或者未缀合的结合分子不排除在给予机体后所述结合分子与效应细胞和/或分子形成功能联系的能力,因为一些这样的相互作用是发挥生物学作用所必需的。相关联的效应基团或者标记的缺少因此用于定义在体外而不是在体内的裸的或者未缀合的结合分子。
如本文所用,术语“生物学样品”涵盖了多种样品类型,包括生物学来源的血液及其它体液样品,实体组织样品如活检组织样品或者组织培养物,或者衍生自其中的细胞或者其后代。该术语还包括在获得后已经通过任何方式处理的样品,例如用试剂处理、溶解、或者富集某些成分如蛋白质或者多核苷酸。该术语涵盖了得自任何物种的各种临床样品,也包括培养的细胞、细胞上清和细胞溶解产物。
如本文所用,术语“互补决定区(CDR)”是指结合分子如免疫球蛋白的可变区中的序列,其通常很大程度上构成抗原结合位点,在形态和电荷分布方面与在抗原上识别的表位互补。CDR区可以特异于蛋白质或者蛋白质片段的线性表位、不连续表位或者构象表位,这些表位以其天然构象存在于蛋白质上,或者在一些情况中以变性形式(例如通过在SDS中溶解)存在于蛋白质上。表位也可以由蛋白质的翻译后修饰物组成。
如本文所用,术语“缺失”是指与通常是天然发生的亲代分子相比,氨基酸序列或者核苷酸序列中分别缺少一或多个氨基酸或者核苷酸残基的改变。
如本文所用,术语“调节表达的核酸序列”是指可操纵地连接的编码序列在特定宿主生物体中表达所必需的和/或影响所述编码序列表达的多核苷酸序列。调节表达的核酸序列可以是在选择的宿主生物体中具有活性的任何核酸序列且可以衍生自编码与宿主生物体同源或异源的蛋白质的基因,所述序列例如是合适的转录起始序列、终止序列、启动子序列、增强子序列;阻抑物或者激活物序列;有效的RNA加工信号如剪接和聚腺苷酸化信号;稳定细胞质mRNA的序列;增强翻译效率的序列(例如核糖体结合位点);增强蛋白质稳定性的序列;以及当需要时增强蛋白质分泌的序列。调节表达的序列的鉴别与应用为本领域技术人员所熟知。
如本文所用,术语“功能变体”是指这样的结合分子,其与亲代结合分子的核苷酸序列和/或氨基酸序列相比包含一或多个核苷酸和/或氨基酸被改变的核苷酸和/或氨基酸序列,而与亲代结合分子相比仍能竞争结合所述结合配偶体例如H5N1。换句话说,亲代结合分子的氨基酸和/或核苷酸序列中的修饰不显著影响或改变由所述核苷酸序列编码的或者含有所述氨基酸序列的所述结合分子的结合特性,即所述结合分子仍能识别并结合其靶位。所述功能变体可以具有保守序列修饰,包括核苷酸和氨基酸取代、添加和缺失。这些修饰可以通过本领域已知的标准技术导入,例如定向诱变和随机PCR介导的诱变,并且可包含天然以及非天然核苷酸和氨基酸。
保守氨基酸取代包括其中氨基酸残基由具有相似结构或者化学性质的另一氨基酸残基置换的取代。具有相似侧链的氨基酸残基的家族已经在本领域中限定。这些家族包括具有碱性侧链的氨基酸(例如赖氨酸、精氨酸、组氨酸)、酸性侧链氨基酸(例如天冬氨酸、谷氨酸)、无电荷极性侧链氨基酸(例如天冬酰胺、谷氨酰胺、丝氨酸、苏氨酸、酪氨酸、半胱氨酸、色氨酸)、非极性侧链氨基酸(例如甘氨酸、丙氨酸、缬氨酸、亮氨酸、异亮氨酸、脯氨酸、苯丙氨酸、甲硫氨酸)、β-分支侧链氨基酸(例如苏氨酸、缬氨酸、异亮氨酸)以及芳香侧链氨基酸(例如酪氨酸、苯丙氨酸、色氨酸)。本领域技术人员明白也可以使用除了上述家族之外的其它氨基酸残基家族分类方式。另外,变体可具有非保守的氨基酸取代,例如氨基酸由具有不同结构或者化学性质的另一氨基酸残基置换。相似的小变异也可包括氨基酸缺失或者插入,或者这二者。使用本领域熟知的计算机程序可以发现确定哪些氨基酸残基可以被取代、插入或者缺失而不消除免疫学活性的指导。
核苷酸序列中的突变可以是在一个基因座的单一改变(点突变),例如转换或颠换突变,或者可以在一个基因座插入、缺失或者改变多个核苷酸。另外,可以在核苷酸序列中的任何数目的基因座中产生一或多个改变。所述突变可以通过本领域已知的任何合适方法进行。
如本文所用,术语“宿主”是指其中已经导入载体的生物体或者细胞,所述载体例如是克隆载体或者表达载体。所述生物体或者细胞可以是原核或真核生物体或细胞。应理解该术语不仅是指特定对象生物体或细胞,而且可以是这种生物体或细胞的后代。由于突变或者环境影响而导致某些修饰可以在随后的世代中出现,因此事实上这种后代也许与所述亲代生物体或细胞不相同,但是其仍包含在如本文所用术语“宿主”的范围内。
术语“人”当用于描述本文所述结合分子时是指直接衍生自人或者基于人序列的分子。当结合分子衍生自或者基于人序列以及随后被修饰时,在本说明书中仍认为其是人分子。换句话说,术语“人”当用于描述结合分子时包括具有这样的可变区和恒定区的结合分子,所述可变区和恒定区衍生自人种系免疫球蛋白序列或者基于在人或人淋巴细胞中出现的且以一些形式修饰的可变区或恒定区。因此,人结合分子可包括不是由人种系免疫球蛋白序列编码的氨基酸残基,包含取代和/或缺失(例如通过体外随机或位点特异性诱变方法或者通过体内体细胞突变方法导入的突变)。如本文所用,“基于”是指这样的情形,即核酸序列可以精确地从模板中拷贝,或者例如通过易错PCR方法而具有小突变,或者经合成制备而与所述模板精确匹配或者具有小修饰。基于人序列的半合成分子在本文中也被认为是人分子。
术语“插入”也被称作“添加”,是指与亲代序列相比分别导致添加一或多个氨基酸或者核苷酸残基的氨基酸或核苷酸序列中的变化。
术语“分离的”当用于描述本文所述结合分子时是指这样的结合分子,其基本上不含其它蛋白质或多肽、特别是不含具有不同抗原特异性的其它结合分子,而且也基本上不含其它细胞材料和/或化学物。例如,当所述结合分子是重组产生的时,其优选基本上不含培养基;当所述结合分子是通过化学合成方法产生的时,其优选基本上不含化学物前体或者其它化学物,即其与参与蛋白质合成的化学物前体或者其它化学物是分开的。术语“分离的”当用于描述编码本文所述结合分子的核酸分子时是指其中编码所述结合分子的核苷酸序列不含其它核苷酸序列、特别是编码结合除了H5N1之外的结合配偶体的结合分子的核苷酸序列的核酸分子。此外,术语“分离的”是指与其它细胞成分基本上分开的核酸分子,所述其它细胞成分是与天然核酸分子在其天然宿主中天然相伴随的细胞成分,例如核糖体、聚合酶或者与其天然相关联的基因组序列。此外,“分离的”核酸分子如cDNA分子当通过重组技术产生时可以基本上不含其它细胞材料或者培养基,当通过化学合成时基本上不含化学物前体或者其它化学物。
如本文所用,术语“单克隆抗体”是指单一分子组成的抗体分子的制备物。单克隆抗体对于特定表位展示单一的结合特异性和亲和性。因此,术语“人单克隆抗体”是指展示单一结合特异性的抗体,其具有衍生自或者基于人种系免疫球蛋白序列或者衍生自完全合成的序列的可变区和恒定区。制备单克隆抗体的方法是无关的。
如本文所用,术语“天然发生的”用于描述一个对象时,是指可以在自然界中发现该对象的事实。例如,存在于可分离自自然届来源且未经在实验室中人工有意修饰的生物体中的多肽或者多核苷酸序列是天然发生的。
如本发明所用,术语“核酸分子”是指核苷酸的聚合形式,包括RNA、cDNA、基因组DNA的有义和反义链以及上述分子的合成形式和混合的聚合物。核苷酸是指核糖核苷酸、脱氧核糖核苷酸或者任一类型核苷酸的修饰形式。该术语还包括单链和双链形式的DNA。另外,多核苷酸可包括通过天然发生的和/或非天然发生的核苷酸键连接在一起的天然发生的核苷酸和修饰的核苷酸任一或这二者。所述核酸分子可以经化学或者生物化学方法修饰或者可含有非天然的或者衍生的核苷酸碱基,这一点本领域技术人员很容易意识到。这种修饰包括例如标记,甲基化,一或多个天然发生的核苷酸由类似物取代,核苷酸间修饰如无电荷键(例如甲基膦酸酯、磷酸三酯、氨基磷酸酯、氨基甲酸酯等)、带电荷键(例如硫代磷酸酯、二硫代磷酸酯等),悬垂部分(pendent moiety)(例如多肽),嵌入剂(例如吖啶、补骨脂素等),螯合剂,烷化剂,以及修饰的键(例如α异头核酸等)。该术语还包括任何拓扑构象,包括单链、双链、部分双螺旋、三螺旋、发夹、环形和扣锁构象。该术语也包括合成的分子,其模拟多核苷酸通过氢键及其它化学相互作用而结合指定序列的能力。这种分子为本领域所已知,包括例如其中用肽键取代分子主链中的磷酸键的那些分子。除非特别指出,提及核酸序列时包含其互补体。因此,具有特定序列的核酸分子应理解为包含其互补链以及其互补序列。所述互补链也可用于例如反义治疗、杂交探针和PCR引物。
术语“可操纵地连接”是指两或多个核酸序列元件通常是物理连接的,而且彼此功能相关联。例如,如果启动子能起始或者调节编码序列的转录或表达,则该启动子与所述编码序列是可操纵地连接的,在这种情况中应理解所述编码序列是在所述启动子的“控制下”。
“药物可接受的赋形剂”是指任何惰性物质,其与活性分子如药物、药剂或者结合分子组合以制备合适或常规的剂型。“药物可接受的赋形剂”是在所用剂量和浓度对于受体无毒性的赋形剂,而且与包含所述药物、药剂或结合分子的配制品的其它成分相容。药物可接受的赋形剂在本领域中广泛应用。
如本文所用,术语“特异性结合”当用于描述结合分子例如抗体与其结合配偶体例如抗原之间的相互作用时意味着该相互作用依赖于所述结合配偶体上特定结构例如抗原决定簇或者表位的存在。换句话说,抗体优先结合或者识别结合配偶体,即使当所述结合配偶体存在于其它分子或生物体的混合物中时也如此。结合可以由共价或非共价相互作用或者这二者的组合介导。再换句话说,术语“特异性结合”是指与抗原或其片段的免疫特异性结合,而与其它抗原不是免疫特异性结合。与抗原免疫特异性结合的结合分子与其它肽或多肽可以较低亲和性结合,例如通过放射性免疫测定(RIA)、酶联免疫吸附测定(ELISA)、BIACORE、或者本领域已知的其它测定方法确定。与抗原免疫特异性结合的结合分子或其片段可以与相关抗原交叉反应。优选地,与抗原免疫特异性结合的结合分子或其片段与其它抗原不交叉反应。
如本文所用,“取代”是指一或多个氨基酸或核苷酸分别由不同的氨基酸或核苷酸置换。
术语“治疗有效量”是指本文所述结合分子有效预防、改善和/或治疗得自H5N1感染的病症的量。
术语“治疗”是指治疗性治疗以及预防(prophylactic)或保护(preventative)措施以治愈疾病或者使疾病停止进展或者至少延迟疾病进展。需要治疗的那些对象包括已经患有H5N1感染所致病症的对象以及其中H5N1感染待被预防的那些对象。部分或者完全自H5N1感染中复原的对象或许也需要治疗。预防包含抑制或降低的H5N1传播或者抑制或降低与H5N1感染相关的一或多种症状的发生、发展或进展。
术语“载体”是指这样的核酸分子,向其中可以插入另一种核酸分子以导入宿主中,在宿主中其将被复制,以及在一些情况中被表达。换句话说,载体能转运与其连接的核酸分子。克隆载体以及表达载体包含在本文所用术语“载体”范围中。载体包括但不限于质粒、粘粒、细菌人工染色体(BAC)和酵母人工染色体(YAC)以及衍生自噬菌体或者植物或动物(包括人)病毒的载体。载体包含由提议的宿主识别的复制起点,在表达载体的情况中还包含启动子及由所述宿主识别的其它调节区。含有另一个核酸分子的载体通过转化、转染或者通过使用病毒进入机制被导入细胞中。某些载体能在其被导入的宿主中自主复制(例如具有细菌复制起点的载体可以在细菌中复制)。其它载体在导入宿主中时可以被整合进宿主基因组中,从而与宿主基因组一起复制。
发明概述
本发明提供了能特异性结合流感病毒H5N1并且呈现针对H5N1中和活性的人结合分子。本发明还提供了结合流感病毒亚型之间共有的血凝素蛋白中的表位的结合分子,并因此涉及在基于H5-、H1-、H2-、H6-和H9-流感病毒的亚型如H5N1、H1N1和含有具有这些特定表位的HA蛋白的其它流感病毒毒株之间交叉反应的结合分子。本发明还涉及编码至少所述人结合分子的结合区的核酸分子。本发明进一步提供了本发明的人结合分子在预防和/或治疗患有H5N1感染或者处于H5N1感染风险的对象中的应用。除此之外,本发明还涉及本发明的人结合分子在诊断/检测H5N1中的应用。
详细描述
第一方面,本发明涉及能特异性结合流感病毒A、特别是流感病毒A亚型H5N1的结合分子。优选地,所述结合分子是人结合分子。优选地,本发明的结合分子呈现对于流感病毒A亚型H5N1的中和活性。另一方面,本发明的结合分子能特异性结合不同的流感病毒H5N1毒株和/或对其具有中和活性。这些毒株可以是流感病毒H5N1毒株的进化枝1、进化枝2或者进化枝3的成员。对来自2004年和2005年爆发的H5N1的HA基因进行的系统发生学分析揭示了HA基因的两个不同谱系(lineage),称作进化枝1和进化枝2。这些进化枝的每一个中的病毒分布于亚洲的不相重叠的地理区域。来自印度支那半岛的H5N1病毒在进化枝1中紧密群集,而来自一些周围国家的H5N1分离株与进化枝1分离物不同,属于更发散的进化枝2。进化枝1 H5N1病毒分离自越南、泰国和柬埔寨的人和禽类,但是在老挝和马来西亚仅分离自禽类。进化枝2病毒在只是从中国、印度尼西亚、日本和韩国的禽类中分离的病毒中发现。2003年和1997年在香港从禽类和人中分离的病毒分别组成进化枝1’(也被分类为进化枝1中)和进化枝3(见WHOGlobal Influenza Program Surveillance Network,2005)。所述进化枝的血凝素的氨基酸序列不同。进化枝1毒株的例子包括但不限于A/Hong Kong/213/03,A/Vietnam/1194/04,A/Vietnam/1203/04和A/Thailand/1(KAN-1)/2004。进化枝2毒株的例子包括但不限于A/Indonesia/5/05,A/bar headedgoose/Qinghai/1A/05,A/turkey/Turkey/1/05和A/Anhui/1/05。进化枝3毒株的例子包括但不限于A/Hong Kong/156/97和A/goose/Guangdong/1/96。其它毒株可见于例如WHO Global Influenza Program Surveillance Network,2005以及http://www.who.int/csr/disease/avian_influenza/guidelines/recommendation vaccine.pdf。优选地,本发明的结合分子能特异性结合进化枝1、进化枝2和进化枝3毒株并且对其具有中和活性。本发明的结合分子能特异性结合存活的、活的和/或感染性或者失活/减毒形式的流感病毒H5N1。使流感病毒H5N1失活/减毒的方法为本领域所熟知,包括但不限于用甲醛、β-丙酸内酯(BPL)、硫柳汞和/或紫外线处理。
本发明的结合分子也可以特异性结合流感病毒H5N1的一或多个片段,如衍生自亚型H5N1的一或多种蛋白质和/或(多)肽或者一或多种重组产生的H5N1蛋白质和/或多肽的制备物。对于治疗和/或预防H5N1感染的方法而言,所述结合分子优选能特异性结合H5N1的表面可及蛋白质如为病毒附着和细胞释放所必需的表面糖蛋白血凝素(HA)和神经氨酸酶(NA)或者膜蛋白(M1和M2)。在特定的实施方案中,本发明的结合分子能特异性结合H5N1毒株的HA分子。它们也许能特异性结合HA分子的HA1和/或HA2亚基。它们也许能特异性结合HA分子的HA1和/或HA2亚基上的线性或结构和/或构象表位。所述HA分子可以在使用之前纯化自病毒或者重组产生以及任选地分离。或者,HA可以在细胞的表面上表达。
为了诊断目的,结合分子也能特异性结合H5N1表面上不存在的蛋白质,包括核蛋白、核壳结构蛋白、聚合酶(PA、PB和PB2)以及非结构蛋白(NS1和NS2)。各种H5N1毒株的核苷酸序列和/或蛋白质的氨基酸序列可见于GenBank-数据库、NCBI流感病毒序列数据库、流感病毒序列数据库(ISD)、EMBL-数据库和/或其它数据库。本领域技术人员易于在各自的数据库中发现这种序列。
在另一个实施方案中,本发明的结合分子能特异性结合上述蛋白质和/或多肽的片段,其中所述片段至少包含由本发明的结合分子识别的抗原决定簇。如本文所用,“抗原决定簇”是能以足够高的亲和性结合本发明的结合分子以形成可检测的抗原-结合分子复合物的部分。本发明的结合分子可以或者不能特异性结合HA的胞外部分(在本文也称作可溶HA(sHA))。
本发明的结合分子可以是完整的免疫球蛋白分子例如多克隆或单克隆抗体或者所述结合分子可以是抗原结合片段,包括但不限于Fab、F(ab′)、F(ab′)2、Fv、dAb、Fd、互补决定区(CDR)片段、单链抗体(scFv)、二价单链抗体、单链噬菌体抗体、双特异双链抗体、三链抗体、四链抗体以及至少含有足以赋予与流感病毒H5N1毒株的特异性抗原结合的免疫球蛋白的片段的(多)肽或其片段。在优选实施方案中,本发明的结合分子是人单克隆抗体。
本发明的结合分子可以以未分离的或者分离的形式使用。此外,本发明的结合分子可以单独应用或者于包含至少一种本发明的结合分子(或其变体或片段)的混合物中应用。换句话说,所述结合分子可以组合应用,例如作为包含两或更多种本发明的结合分子、其变体或片段的药物组合物。例如,具有不同但互补活性的结合分子可以组合在一个治疗方案中以达到希望的预防、治疗或诊断作用,但是或者也可以将具有相同活性的结合分子组合在一个治疗方案中以达到希望的预防、治疗或诊断作用。任选地,所述混合物进一步包含至少一种其它治疗剂。优选地,所述治疗剂如M2抑制剂(例如amantidine、金刚乙胺(rimantadine))和/或神经氨酸酶抑制剂(例如扎那米韦(zanamivir)、奥司他韦(oseltamivir))可用于预防和/或治疗流感病毒H5N1感染。
典型地,本发明的结合分子可结合其结合配偶体,即流感病毒H5N1或其片段,亲和常数(Kd值)低于0.2×10-4M、1.0×10-5M、1.0×10-6M、1.0×10-7M,优选地低于1.0×10-8M,更优选低于1.0×10-9M,更优选低于1.0×10-10M,甚至更优选低于1.0×10-11M,特别优选低于1.0×10-12M。所述亲和常数根据抗体类型而可以有所不同。例如,IgM同种型的亲和性结合是指至少大约1.0×10-7M的结合亲和性。亲和性常数可例如通过使用表面等离子共振技术测量,例如使用BIACORE系统(Pharmacia Biosensor AB,Uppsala,Sweden)。
本发明的结合分子可以结合可溶形式例如于样品中或悬浮液中的流感病毒H5N1或其片段或者可以结合与载体或基材结合或附着例如与微滴定平板、膜和珠结合或附着的流感病毒H5N1或其片段。载体或基材可以由玻璃、塑料(例如聚苯乙烯)、多糖、尼龙、硝化纤维素或Teflon等制成。这种支持物的表面可以是固相或者多孔的以及可以是任何便利的形状。此外,所述结合分子可以结合纯化/分离或者非纯化/非分离形式的流感病毒H5N1。
本发明的结合分子呈现中和活性。中和活性可例如如本文所述测量。另一种测量中和活性的测定方法例如在WHO Manual on Animal InfluenzaDiagnosis and Surveillance,Geneva:World Health Organisation,2005,version2002.5中描述。本发明涉及分离的人结合分子,其能识别并结合流感血凝素蛋白(HA)的HA2亚基中的表位,特征在于所述结合分子具有针对包含H5亚型的HA的流感病毒的中和活性。含有这种H5亚型的HA且是具有流行性威胁的重要毒株的流感病毒毒株的例子是H5N1、H5N2、H5N8和H5N9。特别优选的是至少中和H5N1流感病毒毒株的结合分子。优选地,本发明的所述结合分子与所述HA蛋白的结合不依赖于HA蛋白的HA1亚基中的表位。现有技术领域中描述的也结合HA2结构域中相同表位的已知鼠抗体(C179)也依赖于与HA蛋白的HA1结构域中表位的结合。这是不利的,因为其增加了不再由所述抗体识别的逃逸突变体(escape mutant)的可能性。此外,许多本发明抗体(如CR6307和CR6323)不依赖于构象表位,甚至可识别还原形式的HA2表位(当用于蛋白质印迹中时)。这优于现有技术的抗体,因为当由于在蛋白质的另一部分中无论何样的突变而在HA蛋白中导入构象改变时,这种构象改变不太可能阻碍本发明的抗体与HA2表位的结合;而当这种突变发生时,依赖于构象的抗体非常可能不能结合。
在另一个优选的实施方案中,本发明的结合分子对于包含H1亚型的HA的流感病毒也具有中和活性,优选其中所述结合分子对于包含H2、H6和/或H9亚型的HA的流感病毒也具有中和活性。本文揭示了本发明的结合分子与H5、H1、H2、H6和H9亚型中存在的HA2表位中存在的一个表位相互作用,并且揭示了本发明的结合分子由于这种表位共享而在流感病毒亚型之间具有交叉中和性。推断依赖于与HA2结构域中的特定部分结合(且不与HA1中具有突变倾向的另一表位结合)的本发明的结合分子在流感病毒亚型之间具有交叉中和性,因为看起来其不依赖于与HA1中的由于抗原性漂移而被明显改变的结构域的结合。本领域技术人员基于本文所描述内容可以确定抗体与不同亚型的HA蛋白是否确实交叉反应,且也可以确定它们是否能在体内中和不同亚型的流感病毒。
在本发明的另一优选方面,本发明的结合分子结合HA2亚基中的表位,所述表位选自如下氨基酸序列组成的一组中:GVTNKVNSIIDK(SEQ IDNO:368)、GVTNKVNSIINK(SEQ ID NO:369)、GVTNKENSIIDK(SEQ IDNO:370)、GVTNKVNRIIDK(SEQ ID NO:371)、GITNKVNSVIEK(SEQ IDNO:372)、GITNKENSVIEK(SEQ ID NO:373)、GITNKVNSIIDK(SEQ IDNO:374)和KITSKVNNIVDK(SEQ ID NO:375)。从表13中示出的数据中可以推断本发明的某些结合分子CR6261、CR6325和CR6329与H5N1中存在的GVTNKVNSIIDK(SEQ ID NO:368)表位相互作用,且不受HA1中的TGLRN表位中突变的妨碍,该突变影响C179的结合。此外,一些结合分子如CR6307和CR6323甚至不受逃逸突变体的妨碍,如Okuno et al.(1993)所述在第6位缬氨酸突变为谷氨酸(GVTNKENSIIDK(SEQ ID NO:370))。这个表位是HA2区中延伸的α螺旋的一部分。预测这个推定表位中最暴露于溶剂的残基是粗体下划线处的残基:GVTNKENSIIDK(SEQ ID NO:370)。这些氨基酸最易接近结合分子,并因此形成表位最重要的区域。与这个观点一致,高亮的氨基酸在所有呈现的序列中在相同性和位置方面是绝对保守的。这方面的知识可用于预测流感病毒亚型中不具有上述相同序列的结合表位(即H3、H7和B毒株)。
优选本发明的结合分子选自如下一组:
a)包含SEQ ID NO:1所示重链CDR1区、SEQ ID NO:2所示重链CDR2区和SEQ ID NO:3所示重链CDR3区的结合分子,
b)包含SEQ ID NO:16所示重链CDR1区、SEQ ID NO:17所示重链CDR2区和SEQ ID NO:18所示重链CDR3区的结合分子,
c)包含SEQ ID NO:1所示重链CDR1区、SEQ ID NO:22所示重链CDR2区和SEQ ID NO:23所示重链CDR3区的结合分子,
d)包含SEQ ID NO:27所示重链CDR1区、SEQ ID NO:28所示重链CDR2区和SEQ ID NO:29所示重链CDR3区的结合分子,
e)包含SEQ ID NO:39所示重链CDR1区、SEQ ID NO:40所示重链CDR2区和SEQ ID NO:41所示重链CDR3区的结合分子,
f)包含SEQ ID NO:45所示重链CDR1区、SEQ ID NO:46所示重链CDR2区和SEQ ID NO:47所示重链CDR3区的结合分子,
g)包含SEQ ID NO:1所示重链CDR1区、SEQ ID NO:49所示重链CDR2区和SEQ ID NO:50所示重链CDR3区的结合分子,
h)包含SEQ ID NO:52所示重链CDR1区、SEQ ID NO:53所示重链CDR2区和SEQ ID NO:54所示重链CDR3区的结合分子,
i)包含SEQ ID NO:262所示重链CDR1区、SEQ ID NO:263所示重链CDR2区和SEQ ID NO:264所示重链CDR3区的结合分子,
j)包含SEQ ID NO:268所示重链CDR1区、SEQ ID NO:2所示重链CDR269区和SEQ ID NO:270所示重链CDR3区的结合分子,
k)包含SEQ ID NO:274所示重链CDR1区、SEQ ID NO:275所示重链CDR2区和SEQ ID NO:276所示重链CDR3区的结合分子,
1)包含SEQ ID NO:280所示重链CDR1区、SEQ ID NO:281所示重链CDR2区和SEQ ID NO:282所示重链CDR3区的结合分子,
m)包含SEQ ID NO:286所示重链CDR1区、SEQ ID NO:287所示重链CDR2区和SEQ ID NO:288所示重链CDR3区的结合分子,
n)包含SEQ ID NO:292所示重链CDR1区、SEQ ID NO:293所示重链CDR2区和SEQ ID NO:294所示重链CDR3区的结合分子,
o)包含SEQ ID NO:304所示重链CDR1区、SEQ ID NO:305所示重链CDR2区和SEQ ID NO:306所示重链CDR3区的结合分子,及
p)包含SEQ ID NO:310所示重链CDR1区、SEQ ID NO:311所示重链CDR2区和SEQ ID NO:312所示重链CDR3区的结合分子。
在一个优选的实施方案中,本发明的结合分子用作药物,优选用于诊断、治疗和/或预防流感病毒感染。在这种应用的一个方面中,所述流感病毒感染是由于与流行性爆发相关的或者具有与流行性爆发相关的潜力的流感病毒所致(见WO 2007/045674及其中的表)。优选地,与流行性爆发相关的、且由这些毒株导致的疾病可以由本发明的结合分子治疗的所述流感病毒毒株选自由H1N1、H5N1、H5N2、H5N8、H5N9、基于H2的病毒和H9N2组成的一组。
本发明还涉及包含本发明的结合分子以及药物可接受的赋形剂的药物组合物。
在另一个实施方案中,本发明涉及本发明的结合分子在制备诊断、预防和/或治疗流感病毒感染的药物中的应用。这种感染可以在小群体中发生,但是也可以以季节流行病方式在世界范围传播,或者更严重地在全球蔓延,数百万个体处于危险之中。本发明提供了可以中和导致这种季节流行病以及潜在的全球性流行病的流感病毒毒株的感染的结合分子。重要的是,目前可以预期利用本发明的结合分子对于多种流感病毒毒株起到防护和治疗作用,因为已经揭示了由于与在不同流感病毒毒株的HA蛋白之间共享的表位的结合,因此目前可以使用本发明的结合分子在这些毒株之间进行交叉中和作用。这是特别有利的,因为在感染之前或者之后给予所述结合分子可以保护哺乳动物(如实施例揭示),因此在还不清楚所述感染是否由基于H1、H2、H5、H6或H9的毒株的引起时(在发病的早期阶段)也起到如此作用。可以使用本发明的结合分子预防性治疗或者感染时治疗健康工人、军人以及普通人群。潜在地,本发明的结合分子可以大量库存形式制备和贮存,因为其提供了针对不同的流行性毒株的保护作用,且对于为将来可能发生的流感爆发做准备是有利的。
在一个优选的实施方案中,本发明的人结合分子特征在于所述人结合分子选自如下一组:a)包含具有SEQ ID NO:1所示氨基酸序列的重链CDR1区、具有SEQ ID NO:2所示氨基酸序列的重链CDR2区、具有SEQ ID NO:3所示氨基酸序列的重链CDR3区、具有SEQ ID NO:4所示氨基酸序列的轻链CDR1区、具有SEQ ID NO:5所示氨基酸序列的轻链CDR2区以及具有SEQ ID NO:6所示氨基酸序列的轻链CDR3区的人结合分子,b)包含具有SEQ ID NO:1所示氨基酸序列的重链CDR1区、具有SEQ ID NO:2所示氨基酸序列的重链CDR2区、具有SEQ ID NO:3所示氨基酸序列的重链CDR3区、具有SEQ ID NO:7所示氨基酸序列的轻链CDR1区、具有SEQ ID NO:8所示氨基酸序列的轻链CDR2区以及具有SEQ ID NO:9所示氨基酸序列的轻链CDR3区的人结合分子,c)包含具有SEQ ID NO:1所示氨基酸序列的重链CDR1区、具有SEQ ID NO:2所示氨基酸序列的重链CDR2区、具有SEQ ID NO:3所示氨基酸序列的重链CDR3区、具有SEQ ID NO:10所示氨基酸序列的轻链CDR1区、具有SEQ ID NO:11所示氨基酸序列的轻链CDR2区以及具有SEQ ID NO:12所示氨基酸序列的轻链CDR3区的人结合分子,d)包含具有SEQ ID NO:1所示氨基酸序列的重链CDR1区、具有SEQ IDNO:2所示氨基酸序列的重链CDR2区、具有SEQ ID NO:3所示氨基酸序列的重链CDR3区、具有SEQ ID NO:13所示氨基酸序列的轻链CDR1区、具有SEQ ID NO:14所示氨基酸序列的轻链CDR2区以及具有SEQ ID NO:15所示氨基酸序列的轻链CDR3区的人结合分子,e)包含具有SEQ ID NO:16所示氨基酸序列的重链CDR1区、具有SEQ ID NO:17所示氨基酸序列的重链CDR2区、具有SEQ ID NO:18所示氨基酸序列的重链CDR3区、具有SEQ ID NO:19所示氨基酸序列的轻链CDR1区、具有SEQ ID NO:20所示氨基酸序列的轻链CDR2区以及具有SEQ ID NO:21所示氨基酸序列的轻链CDR3区的人结合分子,f)包含具有SEQ ID NO:1所示氨基酸序列的重链CDR1区、具有SEQ ID NO:22所示氨基酸序列的重链CDR2区、具有SEQID NO:23所示氨基酸序列的重链CDR3区、具有SEQ ID NO:24所示氨基酸序列的轻链CDR1区、具有SEQ ID NO:25所示氨基酸序列的轻链CDR2区以及具有SEQ ID NO:26所示氨基酸序列的轻链CDR3区的人结合分子,g)包含具有SEQ ID NO:27所示氨基酸序列的重链CDR1区、具有SEQ IDNO:28所示氨基酸序列的重链CDR2区、具有SEQ ID NO:29所示氨基酸序列的重链CDR3区、具有SEQ ID NO:30所示氨基酸序列的轻链CDR1区、具有SEQ ID NO:31所示氨基酸序列的轻链CDR2区以及具有SEQ IDNO:32所示氨基酸序列的轻链CDR3区的人结合分子,h)包含具有SEQ IDNO:1所示氨基酸序列的重链CDR1区、具有SEQ ID NO:2所示氨基酸序列的重链CDR2区、具有SEQ ID NO:3所示氨基酸序列的重链CDR3区、具有SEQ ID NO:33所示氨基酸序列的轻链CDR1区、具有SEQ ID NO:34所示氨基酸序列的轻链CDR2区以及具有SEQ ID NO:35所示氨基酸序列的轻链CDR3区的人结合分子,i)包含具有SEQ ID NO:1所示氨基酸序列的重链CDR1区、具有SEQ ID NO:2所示氨基酸序列的重链CDR2区、具有SEQ IDNO:3所示氨基酸序列的重链CDR3区、具有SEQ ID NO:36所示氨基酸序列的轻链CDR1区、具有SEQ ID NO:37所示氨基酸序列的轻链CDR2区以及具有SEQ ID NO:38所示氨基酸序列的轻链CDR3区的人结合分子,j)包含具有SEQ ID NO:39所示氨基酸序列的重链CDR1区、具有SEQ ID NO:40所示氨基酸序列的重链CDR2区、具有SEQ ID NO:41所示氨基酸序列的重链CDR3区、具有SEQ ID NO:42所示氨基酸序列的轻链CDR1区、具有SEQ ID NO:43所示氨基酸序列的轻链CDR2区以及具有SEQ ID NO:44所示氨基酸序列的轻链CDR3区的人结合分子,k)包含具有SEQ ID NO:45所示氨基酸序列的重链CDR1区、具有SEQ ID NO:46所示氨基酸序列的重链CDR2区、具有SEQ ID NO:47所示氨基酸序列的重链CDR3区、具有SEQID NO:7所示氨基酸序列的轻链CDR1区、具有SEQ ID NO:8所示氨基酸序列的轻链CDR2区以及具有SEQ ID NO:48所示氨基酸序列的轻链CDR3区的人结合分子,1)包含具有SEQ ID NO:1所示氨基酸序列的重链CDR1区、具有SEQ ID NO:49所示氨基酸序列的重链CDR2区、具有SEQ IDNO:50所示氨基酸序列的重链CDR3区、具有SEQ ID NO:33所示氨基酸序列的轻链CDR1区、具有SEQ ID NO:34所示氨基酸序列的轻链CDR2区以及具有SEQ ID NO:51所示氨基酸序列的轻链CDR3区的人结合分子,m)包含具有SEQ ID NO:52所示氨基酸序列的重链CDR1区、具有SEQ IDNO:53所示氨基酸序列的重链CDR2区、具有SEQ ID NO:54所示氨基酸序列的重链CDR3区、具有SEQ ID NO:55所示氨基酸序列的轻链CDR1区、具有SEQ ID NO:56所示氨基酸序列的轻链CDR2区以及具有SEQ IDNO:57所示氨基酸序列的轻链CDR3区的人结合分子,n)包含具有SEQ IDNO:262所示氨基酸序列的重链CDR1区、具有SEQ ID NO:263所示氨基酸序列的重链CDR2区、具有SEQ ID NO:264所示氨基酸序列的重链CDR3区、具有SEQ ID NO:265所示氨基酸序列的轻链CDR1区、具有SEQ IDNO:266所示氨基酸序列的轻链CDR2区以及具有SEQ ID NO:267所示氨基酸序列的轻链CDR3区的人结合分子,o)包含具有SEQ ID NO:268所示氨基酸序列的重链CDR1区、具有SEQ ID NO:269所示氨基酸序列的重链CDR2区、具有SEQ ID NO:270所示氨基酸序列的重链CDR3区、具有SEQID NO:271所示氨基酸序列的轻链CDR1区、具有SEQ ID NO:272所示氨基酸序列的轻链CDR2区以及具有SEQ ID NO:273所示氨基酸序列的轻链CDR3区的人结合分子,p)包含具有SEQ ID NO:274所示氨基酸序列的重链CDR1区、具有SEQ ID NO:275所示氨基酸序列的重链CDR2区、具有SEQID NO:276所示氨基酸序列的重链CDR3区、具有SEQ ID NO:277所示氨基酸序列的轻链CDR1区、具有SEQ ID NO:278所示氨基酸序列的轻链CDR2区以及具有SEQ ID NO:279所示氨基酸序列的轻链CDR3区的人结合分子,q)包含具有SEQ ID NO:280所示氨基酸序列的重链CDR1区、具有SEQ ID NO:281所示氨基酸序列的重链CDR2区、具有SEQ ID NO:282所示氨基酸序列的重链CDR3区、具有SEQ ID NO:283所示氨基酸序列的轻链CDR1区、具有SEQ ID NO:284所示氨基酸序列的轻链CDR2区以及具有SEQ ID NO:285所示氨基酸序列的轻链CDR3区的人结合分子,r)包含具有SEQ ID NO:286所示氨基酸序列的重链CDR1区、具有SEQ ID NO:287所示氨基酸序列的重链CDR2区、具有SEQ ID NO:288所示氨基酸序列的重链CDR3区、具有SEQ ID NO:289所示氨基酸序列的轻链CDR1区、具有SEQ ID NO:290所示氨基酸序列的轻链CDR2区以及具有SEQ IDNO:291所示氨基酸序列的轻链CDR3区的人结合分子,s)包含具有SEQ IDNO:292所示氨基酸序列的重链CDR1区、具有SEQ ID NO:293所示氨基酸序列的重链CDR2区、具有SEQ ID NO:294所示氨基酸序列的重链CDR3区、具有SEQ ID NO:295所示氨基酸序列的轻链CDR1区、具有SEQ IDNO:296所示氨基酸序列的轻链CDR2区以及具有SEQ ID NO:297所示氨基酸序列的轻链CDR3区的人结合分子,t)包含具有SEQ ID NO:304所示氨基酸序列的重链CDR1区、具有SEQ ID NO:305所示氨基酸序列的重链CDR2区、具有SEQ ID NO:306所示氨基酸序列的重链CDR3区、具有SEQ IDNO:307所示氨基酸序列的轻链CDR1区、具有SEQ ID NO:308所示氨基酸序列的轻链CDR2区以及具有SEQ ID NO:309所示氨基酸序列的轻链CDR3区的人结合分子,u)包含具有SEQ ID NO:310所示氨基酸序列的重链CDR1区、具有SEQ ID NO:311所示氨基酸序列的重链CDR2区、具有SEQID NO:312所示氨基酸序列的重链CDR3区、具有SEQ ID NO:313所示氨基酸序列的轻链CDR1区、具有SEQ ID NO:314所示氨基酸序列的轻链CDR2区以及具有SEQ ID NO:315所示氨基酸序列的轻链CDR3区的人结合分子,v)包含具有SEQ ID NO:238所示氨基酸序列的重链CDR1区、具有SEQ ID NO:239所示氨基酸序列的重链CDR2区、具有SEQ ID NO:240所示氨基酸序列的重链CDR3区、具有SEQ ID NO:241所示氨基酸序列的轻链CDR1区、具有SEQ ID NO:242所示氨基酸序列的轻链CDR2区以及具有SEQ ID NO:243所示氨基酸序列的轻链CDR3区的人结合分子,w)包含具有SEQ ID NO:244所示氨基酸序列的重链CDR1区、具有SEQ IDNO:245所示氨基酸序列的重链CDR2区、具有SEQ ID NO:246所示氨基酸序列的重链CDR3区、具有SEQ ID NO:247所示氨基酸序列的轻链CDR1区、具有SEQ ID NO:248所示氨基酸序列的轻链CDR2区以及具有SEQ IDNO:249所示氨基酸序列的轻链CDR3区的人结合分子,x)包含具有SEQ IDNO:250所示氨基酸序列的重链CDR1区、具有SEQ ID NO:251所示氨基酸序列的重链CDR2区、具有SEQ ID NO:252所示氨基酸序列的重链CDR3区、具有SEQ ID NO:253所示氨基酸序列的轻链CDR1区、具有SEQ IDNO:254所示氨基酸序列的轻链CDR2区以及具有SEQ ID NO:255所示氨基酸序列的轻链CDR3区的人结合分子,y)包含具有SEQ ID NO:256所示氨基酸序列的重链CDR1区、具有SEQ ID NO:257所示氨基酸序列的重链CDR2区、具有SEQ ID NO:258所示氨基酸序列的重链CDR3区、具有SEQID NO:259所示氨基酸序列的轻链CDR1区、具有SEQ ID NO:260所示氨基酸序列的轻链CDR2区以及具有SEQ ID NO:261所示氨基酸序列的轻链CDR3区的人结合分子,以及z)包含具有SEQ ID NO:298所示氨基酸序列的重链CDR1区、具有SEQ ID NO:299所示氨基酸序列的重链CDR2区、具有SEQ ID NO:300所示氨基酸序列的重链CDR3区、具有SEQ ID NO:301所示氨基酸序列的轻链CDR1区、具有SEQ ID NO:302所示氨基酸序列的轻链CDR2区以及具有SEQ ID NO:303所示氨基酸序列的轻链CDR3区的人结合分子。
在特定的实施方案中,本发明的结合分子包含具有SEQ ID NO:1所示氨基酸序列的重链CDR1区、具有SEQ ID NO:2所示氨基酸序列的重链CDR2区及具有SEQ ID NO:3所示氨基酸序列的重链CDR3区。本发明的结合分子的CDR区在表7中示出。根据Kabat et al.(1991)所述,CDR区是免疫学感兴趣的蛋白质的序列。在本发明的实施方案中,结合分子可包含本文揭示的二、三、四、五或者所有六个CDR区。优选地,本发明的结合分子包含本文揭示的至少两个CDR。
在一个实施方案中,本发明的结合分子包含VH种系VH1-69(见Tomlinson IM,Williams SC,Ignatovitch O,Corbett SJ,Winter G.V-BASESequence Directory.Cambridge United Kingdom:MRC Centre for ProteinEngineering(1997))。在另一个实施方案中,本发明的结合分子包含重链,所述重链包含具有选自如下一组中的氨基酸序列的可变重链:SEQ IDNO:59、SEQ ID NO:61、SEQ ID NO:63、SEQ ID NO:65、SEQ ID NO:67、SEQ ID NO:69、SEQ ID NO:71、SEQ ID NO:73、SEQ ID NO:75、SEQ IDNO:77、SEQ ID NO:79、SEQ ID NO:81、SEQ ID NO:83、SEQ ID NO:317、SEQ ID NO:321、SEQ ID NO:325、SEQ ID NO:329、SEQ ID NO:333、SEQID NO:337、SEQ ID NO:341、SEQ ID NO:345、SEQ ID NO:349、SEQ IDNO:353、SEQ ID NO:357、SEQ ID NO:361和SEQ ID NO:365。在另一个实施方案中,本发明的结合分子包含轻链,所述轻链包含具有选自如下一组中的氨基酸序列的可变轻链:SEQ ID NO:85、SEQ ID NO:87、SEQ IDNO:89、SEQ ID NO:91、SEQ ID NO:93、SEQ ID NO:95、SEQ ID NO:97、SEQ ID NO:99、SEQ ID NO:101、SEQ ID NO:103、SEQ ID NO:105、SEQ IDNO:107、SEQ ID NO:109、SEQ ID NO:319、SEQ ID NO:323、SEQ ID NO:327、SEQ ID NO:331、SEQ ID NO:335、SEQ ID NO:339、SEQ ID NO:343、SEQID NO:347、SEQ ID NO:351、SEQ ID NO:355、SEQ ID NO:359、SEQ IDNO:363和SEQ ID NO:367。表8列出了本发明结合分子的重链和轻链可变区。
本发明的另一方面包括本文所述结合分子的功能变体。如果变体能与亲代结合分子竞争特异性结合流感病毒H5N1或其片段,则认为该变体分子是本发明结合分子的功能变体。换句话说,所述功能变体仍能结合流感病毒H5N1或其片段。优选地,所述功能变体能竞争性特异性结合由亲代结合分子特异性结合的至少两(或更多个)不同的流感病毒H5N1毒株或其片段。此外,如果某分子对于亲代结合分子对其具有中和活性的流感病毒H5N1、优选对于至少两(或多个)流感病毒H5N1毒株具有中和活性,则认为该分子是本发明结合分子的功能变体。功能变体包括但不限于一级结构序列基本相似、但是含有例如在亲代结合分子中未发现的体外或体内化学和/或生物化学修饰的衍生物。这种修饰包括乙酰化、酰化、核苷酸或者核苷酸衍生物的共价附着、脂质或者脂质衍生物的共价附着、交联、二硫键形成、糖基化、羟基化、甲基化、氧化、聚乙二醇化、蛋白酶解加工、磷酸化等。
或者,功能变体可以是本发明所述的结合分子,其包含这样的氨基酸序列,所述氨基酸序列与亲代结合分子的氨基酸序列相比含有一或多个氨基酸的取代、插入、缺失或者这种修饰的组合。此外,功能变体可包含氨基酸序列在氨基末端或者羧基末端或者这两端的截短。本发明的功能变体与亲代结合分子相比可具有相同或不同的、更高或更低的结合亲和性,但是仍能结合流感病毒H5N1或其片段。例如,本发明的功能变体与亲代结合分子相比对于流感病毒H5N1或其片段可具有增加或降低的结合亲和性。优选地,可变区包括但不限于构架区、高变区、特别是CDR3区的氨基酸序列被修饰。通常,轻链和重链可变区包含三个高变区,包括三个CDR,以及更保守的区域,即所谓的构架区(FR)。高变区包含来自CDR的氨基酸残基和来自高变环的氨基酸残基。在本发明范围内的功能变体与本文所述亲代结合分子具有至少大约50%至大约99%、优选至少大约60%至大约99%、更优选至少大约70%至大约99%、甚至更优选至少大约80%至大约99%、最优选至少大约90%至大约99%、特别是至少大约95%至大约99%,以及特别是至少大约97%至大约99%的氨基酸序列同源性。本领域技术人员已知的计算机算法如Gap或者Bestfit可用于最佳地排列氨基酸序列以进行对比以及明确相似或相同的氨基酸残基。功能变体可以通过使用本领域已知的普通分子生物学方法改变亲代结合分子或其一部分而获得,所述方法包括但不限于易错PCR、寡核苷酸指导的诱变、定点诱变以及重链和/或轻链改组法。在一个实施方案中,本发明的功能变体对于流感病毒H5N1具有中和活性。所述中和活性与亲代结合分子相比可以相同或者更高或更低。此后,当使用术语(人)结合分子时,其也涵盖所述(人)结合分子的功能变体。
另一方面,本发明包括免疫缀合物,即包含本文所述至少一个结合分子以及进一步包含至少一个标记如可检测的部分/物质的分子。本发明还涉及本发明免疫缀合物的混合物或者至少一种本发明免疫缀合物与另一分子的混合物,所述另一分子如治疗剂或者另一结合分子或免疫缀合物。在另一个实施方案中,本发明的免疫缀合物可包含一个以上的标记。这些标记可以彼此相同或不同,并且可以与结合分子非共价地结合/缀合。所述标记也可以通过共价键与人结合分子直接结合/缀合。或者,所述标记可以通过一或多种连接化合物与所述结合分子结合/缀合。标记与结合分子的缀合技术为本领域技术人员所熟知。
本发明的免疫缀合物的标记可以是治疗剂,但是它们也可以是可检测的部分/物质。适于治疗和/或预防的标记可以是毒素或者其功能部分、抗生素、酶、增强吞噬作用或者免疫刺激作用的其它结合分子。包含可检测物质的免疫缀合物可诊断性地用于例如评定对象是否已经感染流感病毒H5N1毒株或者作为临床实验程序的一部分监测流感病毒H5N1感染的发生或进展以例如确定指定治疗方案的功效。然而,它们也可以用于其它检测和/或分析和/或诊断目的。可检测的部分/物质包括但不限于酶、辅基、荧光材料、发光材料,生物发光材料、放射性材料、正电子发射金属以及非放射性顺磁性金属离子。为了检测和/或分析和/或诊断目的用于标记结合分子的标记依赖于使用的特定检测/分析/诊断技术和/或方法例如免疫组织化学染色(组织)样品、流式细胞计量术、激光扫描细胞计量术检测、荧光免疫测定、酶联免疫吸附测定(ELISA)、放射免疫测定(RIA)、生物测定(例如吞噬作用测定)、蛋白质印迹应用等。对于本领域已知的检测/分析/诊断技术和/或方法合适的标记为本领域技术人员所熟知。
此外,本发明的人结合分子或者免疫缀合物也可以附着于固体支持物上,其特别用于流感病毒H5N1或其片段的体外免疫测定或者纯化。这种固体支持物可以是多孔或者无孔的、平面或非平面的。本发明的结合分子可以与标记序列如肽融合以便于纯化。所述标记序列的例子包括但不限于六组氨酸标记、血凝素(HA)标记、myc标记或者flag标记。或者,一种抗体可以与另一种抗体缀合形成抗体异源缀合物(heteroconjugate)。另一方面,本发明的结合分子可以与一或多个抗原缀合/附着。优选地,这些抗原是由给予了结合分子-抗原缀合物的对象的免疫系统识别的抗原。所述抗原可以彼此相同,但也可以是不同的。使附着抗原和结合分子的缀合方法为本领域所熟知,包括但不限于使用交联剂。本发明的结合分子结合流感病毒H5N1并且附着于结合分子的抗原将引发对于所述缀合物的有力T细胞攻击,最终导致流感病毒H5N1的破坏。
除了通过直接或间接(例如通过接头)缀合而化学产生免疫缀合物之外,所述免疫缀合物可以作为融合蛋白而产生,所述融合蛋白包含本发明的结合分子及合适的标记。融合蛋白可以通过本领域已知方法产生,例如通过构建核酸分子以及随后表达所述核酸分子而重组产生,所述核酸分子包含符合读框的编码结合分子的核苷酸序列以及编码合适标记的核苷酸序列。
本发明另一方面提供了编码本发明的至少一种结合分子、其功能变体或者免疫缀合物的核酸分子。这种核酸分子可以用作中间物以进行克隆,例如用于如上述的亲和力成熟方法中。在一个优选的实施方案中,所述核酸分子是分离或纯化的。
技术人员将意识到这些核酸分子的功能变体也是本发明的一部分。功能变体是这样的核酸序列,通过使用标准遗传密码可以将其直接翻译以提供与从亲代核酸分子中翻译的序列相同的氨基酸序列。
优选地,所述核酸分子编码包含上述CDR区的结合分子。在另一个实施方案中,所述核酸分子编码包含本发明的结合分子的2、3、4、5或者甚至所有6个CDR区的结合分子。
在另一个实施方案中,所述核酸分子编码包含重链的结合分子,所述重链包含上述可变重链序列。在另一个实施方案中,所述核酸分子编码包含轻链的结合分子,所述轻链包含上述可变轻链序列。本发明的结合分子的核苷酸序列在实施例章节中提供(见例如表6和表8)。
本发明另一方面提供了载体,即核酸构建体,其包含一或多个本发明的核酸分子。载体可以衍生自质粒如F、R1、RP1、Co1、pBR322、TOL、Ti等;粘粒;噬菌体如λ噬菌体、λ形噬菌体、M13、Mu、P1、P22、Qβ、T-even、T-odd、T2、T4、T7等;植物病毒。载体可用于克隆和/或表达本发明的结合分子,甚至可用于基因治疗目的。本发明也包含与一或多个表达调节核酸分子可操纵地连接的包含本发明的一或多个核酸分子的载体。载体的选择依赖于随后的重组程序以及使用的宿主。将载体导入宿主细胞中可以通过如下方法实现:磷酸钙转染、病毒感染、DEAE-葡聚糖介导的转染、lipofectamin转染或者电穿孔。载体可以自主复制或者可以与其整合进入其中的染色体一起复制。优选地,所述载体含有一或多个选择标记。标记的选择依赖于选择的宿主细胞,尽管如本领域技术人员所熟知-这对于本发明不是至关重要的。所述标记包括但不限于卡那霉素、新霉素、嘌呤霉素、潮霉素、zeocin、单纯疱疹病毒的胸苷激酶基因(HSV-TK)、小鼠的二氢叶酸还原酶基因(dhfr)。本发明也包括这样的载体,其包含与编码可用于分离人结合分子的蛋白质或肽的一或多个核酸分子可操纵地连接的编码人结合分子的一或多个核酸分子。这些蛋白质或肽包括但不限于谷胱甘肽-S-转移酶、麦芽糖结合蛋白、结合金属的多组氨酸、绿色荧光蛋白、荧光素酶以及β-半乳糖苷酶。
含有上述载体的一或多个拷贝的载体的宿主是本发明的另一方面。优选地,所述宿主是宿主细胞。宿主细胞包括但不限于源于哺乳动物、植物、昆虫、真菌或者细菌的细胞。细菌细胞包括但不限于革兰氏阳性菌或者革兰氏阴性菌的细胞,例如肠杆菌属的一些菌种如大肠杆菌(E.coli)以及假单胞菌属。在真菌细胞中,优选使用酵母细胞。在酵母中的表达可以通过使用酵母菌株而实现,所述酵母菌株如巴斯德毕赤酵母(Pichia pastoris)、酿酒酵母(Saccharomyces cerevisiae)和多形汉逊酵母(Hansenula polymorpha)。此外,昆虫细胞如果蝇和Sf9细胞可以用作宿主细胞。除此之外,宿主细胞可以是植物细胞,例如农作物如森林植物的细胞,或者提供食品和原材料的植物细胞,如谷类植物或者药用植物,或者观赏植物的细胞,或者花球根农作物(flower bulb crop)的细胞。转化的(转基因)植物或植物细胞通过已知方法产生,例如农杆菌介导的基因转移、叶盘转化、通过聚乙二醇诱导的DNA转移进行的原生质体转化、电穿孔、超声、显微注射或者bolistic基因转移法。另外,合适的表达系统可以是杆状病毒系统。本发明优选使用哺乳动物细胞的表达系统,例如中国仓鼠卵巢(CHO)细胞、COS细胞、BHK细胞、NSO细胞或者Bowes黑素瘤细胞。哺乳动物细胞提供具有翻译后修饰的表达的蛋白质,与哺乳动物来源的天然分子最相似。由于本发明涉及给予人的分子,因此特别优选完全人表达系统。因此,更优选的宿主细胞是人细胞。人细胞的例子是HeLa、911、AT1080、A549、293和HEK293T细胞。在优选的实施方案中,人生产细胞包含可表达形式的编码腺病毒E1区的核酸序列的至少功能部分。在更优选的实施方案中,所述宿主细胞衍生自人视网膜并且用包含腺病毒E1序列的核酸永生化,例如911细胞或者于1996年2月29日保藏在位于CAMR,Salisbury,Wiltshire SP4 OJG,GreatBritain的欧洲细胞培养物中心(European Collection of Cell Cultures(ECACC))中的细胞系,保藏号为96022940,以(PER.C6是Crucell Holland B.V.的注册商标)商标销售。为本申请的目的,“PER.C6细胞”是指以保藏号96022940保藏的细胞或者祖细胞,保藏细胞的祖细胞的上游或下游传代和后代以及子代,以及任何前述细胞的衍生物。在宿主细胞中重组蛋白的产生可以根据本领域熟知的方法进行。以商标销售的细胞作为感兴趣的蛋白质的生产平台的应用在WO 00/63403中描述,所述文献以其全部内容并入本文作参考。
产生本发明的结合分子的方法是本发明的另一部分。所述方法包括如下步骤:a)在有益于结合分子表达的条件下培养本发明的宿主,b)任选地回收表达的结合分子。表达的结合分子可以从无细胞提取物中回收,但是优选从培养基中回收。上述产生方法也可用于产生本发明的结合分子和/或免疫缀合物的功能变体。从无细胞提取物或者培养基中回收蛋白质如结合分子的方法为本领域技术人员所熟知。通过上述方法可获得的结合分子、其功能变体和/或免疫缀合物也是本发明的一部分。
或者,在宿主如宿主细胞中表达之后,本发明的结合分子和免疫缀合物可以通过常规的肽合成仪合成产生或者在无细胞翻译系统中使用衍生自本发明的DNA分子的RNA核酸合成产生。通过上述合成产生方法或者无细胞翻译系统可获得的结合分子和免疫缀合物也是本发明的一部分。
在另一个实施方案中,本发明的结合分子也可以在转基因非人哺乳动物如兔、山羊或者牛中产生,并且分泌进例如其乳中。
在又一个实施方案中,本发明的结合分子、优选特异性结合流感病毒H5N1或其片段的人结合分子可以由表达人免疫球蛋白基因的转基因非人哺乳动物如转基因小鼠或兔产生。优选地,所述转基因非人哺乳动物具有这样的基因组,其包含如上述编码所有或部分人结合分子的人重链转基因和人轻链转基因。所述转基因非人哺乳动物可以用纯化的或者富集的流感病毒H5N1或其片段的制备物免疫接种。免疫接种非人哺乳动物的方案在本领域已经充分建立。见Using Antibodies:A Laboratory Manual,Edited by:E.Harlow,D.Lane(1998),Cold Spring Harbor Laboratory,Cold Spring Harbor,New York和Current Protocols in Immunology,Edited by:J.E.Coligan,A.M.Kruisbeek,D.H.Margulies,E.M.Shevach,W.Strober(2001),John Wiley &Sons Inc.,New York,所述文献均并入本文作参考。免疫接种方案通常包括有或无佐剂的多次免疫接种,所述佐剂如弗氏完全佐剂和弗氏不完全佐剂,也可以包括裸DNA免疫接种方法。在另一个实施方案中,所述人结合分子由衍生自所述转基因动物的B细胞、浆细胞和/或记忆细胞产生。在另一个实施方案中,所述人结合分子由杂交瘤产生,所述杂交瘤是通过得自上述转基因非人哺乳动物的B细胞与永生化细胞融合而制备的。可得自上述转基因非人哺乳动物的B细胞、浆细胞和杂交瘤以及可得自上述转基因非人哺乳动物、B细胞、浆细胞和/或记忆细胞和杂交瘤的人结合分子也是本发明的一部分。
另一方面,本发明提供了鉴别特异性结合流感病毒H5N1的结合分子或者编码这种结合分子的核酸分子的方法,所述结合分子例如是人结合分子如人单克隆抗体或其片段,所述方法包括如下步骤:(a)在有益于结合的条件下将可复制遗传包装(genetic package)表面上的结合分子集合与流感病毒H5N1或其片段接触,(b)至少选择一次与流感病毒H5N1或其片段结合的可复制遗传包装,(c)从与流感病毒H5N1或其片段不结合的可复制遗传包装中分离并回收与流感病毒H5N1或其片段结合的可复制遗传包装。如本文所用,可复制遗传包装可以是原核或者真核生物,包括细胞、孢子、酵母、细菌、病毒、(细菌)噬菌体、核糖体和多核糖体。优选的可复制遗传包装是噬菌体。所述结合分子例如单链Fv展示在可复制遗传包装上,即它们附着于位于可复制遗传包装外表面的基团或分子。所述可复制遗传包装是可筛选的单位,其包含与编码结合分子的核酸分子连接的待被筛选的结合分子。所述核酸分子应可以在体内(例如作为载体)或者体外(例如通过PCR、转录和翻译)复制。体内复制可以是自主复制(就细胞而言),借助于宿主因子复制(就病毒而言)或者借助于宿主和辅助病毒二者复制(就噬菌粒而言)。展示结合分子集合的可复制遗传包装是这样形成的,即将编码待被展示的外源结合分子的核酸分子导入可复制遗传包装的基因组中以与从可复制遗传包装的外表面正常表达的内源蛋白形成融合蛋白。所述融合蛋白的表达、转运至外表面及组装导致外源结合分子从可复制遗传包装的外表面展示。
本发明方法中的选择步骤可以用流感病毒H5N1进行,所述病毒是活的且仍具有感染性或者是失活的。流感病毒H5N1的失活可以通过本领域技术人员熟知的病毒失活方法进行,例如用甲醛、β-丙酸内酯(BPL)、硫柳汞和/或紫外线处理。检测流感病毒H5N1是否仍是活的、感染性的和/或可存活或者部分或完全失活的方法为本领域技术人员所熟知。上述方法中使用的流感病毒H5N1可以是未分离的,例如存在于被感染的个体的血清和/或血液中。使用的流感病毒H5N1也可以分离自于合适培养基中的细胞培养物。
在一个实施方案中,流感病毒H5N1当与可复制遗传包装接触时是在悬浮液中。或者,当发生接触时,它们也可以与载体偶联。在一个实施方案中,第一次和进一步的选择可以针对同一进化枝的流感病毒H5N1毒株进行。或者,第一次和进一步的选择可以针对不同进化枝的流感病毒H5N1毒株进行(例如第一次选择针对进化枝1毒株进行,第二次选择针对进化枝2或3毒株进行)。
或者,选择步骤可以在存在流感病毒H5N1的片段例如细胞膜制备物、重组H5N1蛋白或多肽、包含H5N1蛋白或多肽的融合蛋白、表达重组H5N1的蛋白质或多肽的细胞等的条件下进行。这些蛋白质或多肽的胞外暴露部分也可以用作选择材料。流感病毒H5N1的片段在使用之前可以被固定在合适的材料上或者可以悬浮液使用。在一个实施方案中,所述选择可以针对流感病毒H5N1的不同片段或者不同流感病毒H5N1毒株的片段进行。发现合适的选择组合为本领域技术人员所熟知。可以通过ELISA或FACS进行选择。
再一方面,本发明提供了获得特异性结合流感病毒H5N1毒株或其片段的结合分子或者编码这种结合分子的核酸分子的方法,其中所述方法包括如下步骤:a)进行上述鉴别结合分子的方法,b)从回收的可复制遗传包装中分离所述结合分子和/或编码所述结合分子的核酸分子。可复制遗传包装表面上的结合分子的集合可以是scFv或Fab的集合。一旦用上述鉴别结合分子或者编码所述结合分子的核酸分子的方法确定或鉴别了新的scFv或Fab,则可以从细菌或噬菌体中分离编码所述scFv或Fab的DNA并与标准分子生物学技术组合产生编码希望特异性的scFv、二价scFv、Fab或者完全人免疫球蛋白(例如IgG、IgA或IgM)的构建体。可以将这些构建体转染进细胞系中,最终可以产生完全人单克隆抗体(见Huls et al.,1999;Boel et al.,2000)。
如前所述,优选的可复制遗传包装是噬菌体。鉴别并获得(人)结合分子例如(人)单克隆抗体的噬菌体展示方法为本领域技术人员所熟知。所述方法例如在美国专利No.5,696,108;Burton and Barbas,1994;de Kruif et al.,1995b;和Phage Display:A Laboratory Manual.Edited by:CF Barbas,DR Burton,JKScott and GJ Silverman(2001),Cold Spring Harbor Laboratoty Press,ColdSpring Harbor,New York中描述。所有这些参考文献均以其全部内容并入本文作参考。为了构建噬菌体展示文库,使人单克隆抗体重链和轻链可变区基因的集合在噬菌体优选丝状噬菌体、颗粒的表面上以例如单链Fv(scFv)或者Fab形式表达(见de Kruif et al.,1995b)。表达抗体片段的噬菌体的大文库典型含有超过1.0×109种抗体特异性,且可以从在免疫或未免疫的个体的B淋巴细胞中表达的免疫球蛋白V区组装。在本发明的一个特定实施方案中,结合分子的噬菌体文库、优选scFv噬菌体文库是从分离自细胞的RNA中制备,所述细胞得自已经接种流感病毒(例如H5N1)、最近接种不相关的病原体、最近经历流感病毒H5N1感染的对象的细胞或者得自健康个体的细胞。RNA可以分离自骨髓或者外周血,优选分离自外周血淋巴细胞或者分离的B细胞或者甚至B细胞的亚群如记忆B细胞。所述对象可以是动物,优选人。在一个优选实施方案中,所述文库可以从由IgM记忆B细胞表达的免疫球蛋白V区组装。
或者,噬菌体展示文库可以从已经在体外部分组装的免疫球蛋白可变区中构建以在文库(半合成文库)中导入另外的抗体多样性。例如,在体外组装的可变区在对于抗体特异性重要的那些分子区域(例如CDR区)中含有合成产生的、随机化或部分随机化的DNA序列。特异于流感病毒H5N1的噬菌体抗体可以选自文库,通过将病毒或其片段暴露于噬菌体文库以使得结合表达特异于所述病毒或其片段的抗体片段的噬菌体。未结合的噬菌体通过洗涤除去,洗脱结合的噬菌体以感染大肠杆菌并随后增殖。通常需要多次选择和增殖循环以足以富集特异性结合所述病毒或其片段的噬菌体。如果需要,在噬菌体文库暴露于所述病毒或其片段之前,可以首先通过将噬菌体文库暴露于非靶材料如不同毒株的病毒或其片段(即非H5N1流感病毒)而消减所述噬菌体文库。这些消减(subtractor)病毒或其片段可以与固相结合或者可以是在悬浮液中。也可以针对与复合抗原的结合选择噬菌体,所述复合抗原例如是任选补加了其它材料的H5N1蛋白或(多)肽的复合混合物。表达流感病毒H5N1的一或多种蛋白质或(多)肽的宿主细胞也可以用于选择目的。使用这些宿主细胞的噬菌体展示方法可以通过如下方式得以扩展和改良,所述方式是在筛选期间通过加入过量的不包含靶分子的宿主细胞或者包含与靶分子相似但不同的非靶分子的宿主细胞而消减不相关的结合物,从而强力地增加发现相关结合分子的机会。当然,所述消减可以在用病毒或其片段筛选之前、期间或之后进行。所述方法称作方法(是Crucell Holland B.V.的注册商标,也见于并入本文作参考的美国专利6,265,150)。
再一方面,本发明提供了获得潜在具有对于流感病毒H5N1、优选至少进化枝1、2和3的流感病毒H5N1毒株的中和活性的结合分子的方法,所述方法包括如下步骤:(a)进行如上述获得特异性结合流感病毒H5N1或其片段的结合分子或者编码这种结合分子的核酸分子的方法,(b)检验分离的结合分子对于所述病毒、优选对于至少进化枝1和2的流感病毒H5N1毒株是否具有中和活性。检验结合分子是否具有中和活性的测定方法为本领域所熟知(见WHO Manual on Animal Influenza Diagnosis and Surveillance,Geneva:World Health Organisation,2005 version 2002.5)。
另一方面,本发明涉及通过上述方法可获得的具有中和活性的结合分子。
再一方面,本发明提供了包含至少本发明的结合分子优选人单克隆抗体、至少其功能变体、至少本发明的免疫缀合物或者其组合的组合物。除此之外,所述组合物可包含稳定分子如白蛋白或者聚乙二醇或者盐。优选地,所用的盐是保留结合分子的希望的生物学活性且不导致任何不希望的毒性作用的盐。如果需要,本发明的人结合分子可以包被于一种材料之中或之上以保护其免于酸的作用或可以使所述结合分子失活的其它天然或非天然条件的影响。
再一方面,本发明提供了包含至少一种本发明核酸分子的组合物。所述组合物可包含水溶液如含有盐(例如NaCl或者如上述盐)、去污剂(例如SDS)和/或其它合适成分的水溶液。
此外,本发明涉及药物组合物,其包含至少一种结合分子如本发明的人单克隆抗体(或其功能片段或变体)、至少一种本发明的免疫缀合物、至少一种本发明的组合物或其组合。本发明的药物组合物进一步包含至少一种药物可接受的赋形剂。药物可接受的赋形剂为本领域技术人员所熟知。本发明的药物组合物可进一步包含至少一种其它治疗剂。合适的药剂也为本领域技术人员所熟知。
在一个实施方案中,所述药物组合物可包含两或多个对于流感病毒H5N1具有中和活性的结合分子。在一个实施方案中,当组合应用时,所述结合分子呈现协同中和活性。换句话说,所述组合物包含至少两种具有中和活性的结合分子,特征在于所述结合分子在中和流感病毒H5N1中起协同作用。如本文所用,术语“协同”是指当组合应用时,结合分子的组合作用高于单独应用时的加合作用。所述协同作用的结合分子可以结合流感病毒H5N1的相同或不同片段上的不同结构。计算协同作用的方式是通过组合指数计算。组合指数(CI)的概念已经由Chou and Talalay(1984)描述。所述组合物也可包含具有中和活性的一种结合分子以及一种非中和性H5N1特异性结合分子。所述非中和性及中和性H5N1特异性结合分子在中和流感病毒H5N1中也可以协同作用。
本发明的药物组合物可进一步包含至少一种其它治疗剂、预防剂和/或诊断剂。优选地,所述药物组合物包含至少一种其它预防剂和/或治疗剂。优选地,所述进一步的治疗剂和/或预防剂是能预防和/或治疗流感病毒H5N1感染和/或得自这种感染的病症的药剂。所述治疗剂和/或预防剂包括但不限于抗病毒剂。这种药剂可以是结合分子、小分子、有机或无机化合物、酶、多核苷酸序列、抗病毒肽等。目前用于治疗感染流感病毒H5N1患者的其它药剂是M2抑制剂(例如amantidine、金刚乙胺)和/或神经氨酸酶抑制剂(例如扎那米韦、奥司他韦)。这些药剂可以与本发明的结合分子组合应用。在实验阶段的能预防和/或治疗流感病毒H5N1感染和/或得自这种感染的病症的药剂也可以用作可用于本发明的其它治疗剂和/或预防剂。
本发明的结合分子或药物组合在用于人体之前可以在合适的动物模型系统中检测。这种动物模型系统包括但不限于小鼠、雪貂(ferret)和猴。
典型地,药物组合物在生产和贮存条件下必须是无菌且稳定的。本发明的结合分子、免疫缀合物、核酸分子或组合物可以是粉末形式,在输送之前或者在输送时在合适的药物可接受的赋形剂中重建(reconstitution)。在用于制备无菌可注射溶液的无菌粉末的情况中,优选的制备方法是真空干燥和冷冻干燥(冻干),产生活性成分粉末加上来自先前过滤灭菌溶液的任何其它希望成分。
或者,本发明的结合分子、免疫缀合物、核酸分子或者组合物可以在溶液中并且在输送之前或者输送时可以加入或者与合适的药物可接受的赋形剂混合以提供可注射形式的单位剂量。优选地,本发明中使用的药物可接受的赋形剂适于高药物浓度,可以保持适当流动性,且如果需要时可以延迟吸收。
药物组合物的最佳给予途径的选择受到一些因素的影响,所述因素包括组合物中活性分子的物理-化学性质、临床状况的紧急性以及活性分子的血浆浓度与希望的治疗作用的关系。例如,如果需要,本发明的结合分子可以与载体一起制备,以保护其免于快速释放,例如控制释放配制品,包括植入体、经皮贴剂以及微胶囊化输送系统。可以使用可生物降解的、生物相容的聚合物,例如乙烯-醋酸乙烯酯、聚酐、聚乙醇酸、胶原、多正酯类以及聚乳酸。此外,也许必需用防止所述人结合分子失活的材料或化合物包被所述结合分子或者与这些材料或化合物一起给予所述结合分子。例如,所述结合分子可以在合适的载体中给予对象,所述载体例如是脂质体或者稀释剂。
给予途径可以分为两种主要类型:口服和胃肠外给予。优选的给予途径是静脉内给药或者通过吸入。
口服剂型可以配制为片剂(tablets)、片剂(troches)、锭剂(lozenges)、水溶液悬浮液或者油悬浮液、可分散的粉末或颗粒、乳状液、硬胶囊、软明胶胶囊、糖浆或酏剂、丸剂、糖衣丸剂、液体、凝胶或者浆剂(slurries)。这些配方可含有药物赋形剂,包括但不限于惰性稀释剂、粒化剂和分解剂、结合剂、润滑剂、防腐剂、色素、调味剂或者甜味剂、植物油或矿物质油、增湿剂以及增稠剂。
本发明的药物组合物也可以配制为用于胃肠外给药。胃肠外给药的制剂可以是水溶液或者非水溶液等渗无菌无毒注射或者灌注溶液或者悬浮液形式。所述溶液或悬浮液可包含在所用剂量和浓度对于受体无毒的物质,例如1,3-丁二醇、Ringer’s溶液、Hank’s溶液、等渗氯化钠溶液、油、脂肪酸、局部麻醉剂、防腐剂、缓冲液、增稠剂或增溶剂、水溶性抗氧化剂、油溶性抗氧化剂以及金属螯合剂。
另一方面,本发明的结合分子如人单克隆抗体(其功能片段和变体)、免疫缀合物、组合物或者药物组合物可以用作药物。因此,使用本发明的结合分子、免疫缀合物、组合物或者药物组合物治疗和/或预防流感病毒H5N1感染的方法是本发明的另一部分。上述分子可用于流感病毒H5N1感染的诊断、预防、治疗或其组合中。它们适合治疗经历流感病毒H5N1感染但仍未治疗的患者以及已经治疗或者治疗了流感病毒H5N1感染的患者。它们可用于这样的患者,例如卫生保健从业者、感染对象的亲属、(禽类)饲养者等。
上述分子或组合物可以与可用于诊断、预防和/或治疗的其它分子联合应用。它们可以在体外、离体(ex vivo)或在体内使用。例如,本发明的结合分子如人单克隆抗体(或其功能变体)、免疫缀合物、组合物或者药物组合物可以与流感病毒H5N1的疫苗(如果可获得)共同给予。或者,疫苗也可以在给予本发明的分子之前或之后给予。代替疫苗,抗病毒剂也可以与本发明的结合分子联合应用。合适的抗病毒剂是上述那些。
所述分子典型以治疗或诊断有效量配制在本发明的组合物和药物组合物中。或者,它们可以单独配制和给予。例如,其它分子如抗病毒剂可以全身性应用,而本发明的结合分子可以静脉内给予。
可以调整给药方案以提供最佳的所需应答(例如治疗应答)。合适的剂量范围可例如是0.1-100mg/kg体重,优选0.5-15mg/kg体重。此外,例如可以给予一次推注、随时间给予多次分开剂量或者根据治疗情况的紧急性而可以按比例降低或增加剂量。本发明的分子和组合物优选是无菌的。使得这些分子和组合物无菌的方法为本领域所熟知。用于诊断、预防和/或治疗的其它分子可以以与本发明的结合分子相似的给药方案给予。如果单独给予其它分子,则可以在给予本发明的一或多种人结合分子或药物组合物之前(例如2分钟、5分钟、10分钟、15分钟、30分钟、45分钟、60分钟、2小时、4小时、6小时、8小时、10小时、12小时、14小时、16小时、18小时、20小时、22小时、24小时、2天、3天、4天、5天、7天、2周、4周或6周之前)、同时或者之后(例如2分钟、5分钟、10分钟、15分钟、30分钟、45分钟、60分钟、2小时、4小时、6小时、8小时、10小时、12小时、14小时、16小时、18小时、20小时、22小时、24小时、2天、3天、4天、5天、7天、2周、4周或者6周之后)给予患者。对于人患者的精确给药方案通常在临床实验期间挑选出。
当作为体内治疗剂给予人时,人结合分子和包含所述人结合分子的药物组合物是特别有益且通常是优选的,因为受体对于给予的抗体的免疫应答通常基本上低于给予单克隆鼠的、嵌合或人源化结合分子的应答。
另一方面,本发明涉及本发明的结合分子如中和性人单克隆抗体(其功能片段和变体)、免疫缀合物、核酸分子、组合物或者药物组合物在制备用于诊断、预防、治疗流感病毒H5N1感染或其组合的药物中的应用。
接下来,试剂盒也是本发明的一部分,所述试剂盒包含本发明的至少一种结合分子如中和性人单克隆抗体(其功能片段和变体)、至少一种免疫缀合物、至少一种核酸分子、至少一种组合物、至少一种药物组合物、至少一种载体、至少一种宿主或其组合。任选地,本发明试剂盒的上述成分包装在合适的容器中,并标示出诊断、预防和/或治疗指定病症。上述成分可以贮存在单位剂量或者多剂量容器中,以水溶液优选无菌水溶液形式或者作为待重建的冻干优选无菌冻干制剂形式贮存。所述容器可以由各种材料制成,例如玻璃或者塑料,并且可具有无菌进入孔(例如容器可以是静脉内注射溶液袋或者可由皮下注射针头刺穿的塞子的小瓶)。所述试剂盒可进一步包含多个容器,其中包含药物可接受的缓冲液。所述试剂盒可进一步包括为商业和使用者所需的其它材料,包括其它缓冲液、稀释剂、过滤器、针头、注射器、一或多种合适宿主的培养基,甚至可能包含至少一种其它治疗剂、预防剂或诊断剂。该试剂盒附带通常在治疗、预防或诊断产品的商业包装中包含的说明书,该说明书含有关于例如这种治疗、预防或诊断产品的应用的指征、使用方法、剂量、生产、给药、禁忌症和/或注意事项的信息。
本发明进一步涉及检测样品中流感病毒H5N1的方法,其中所述方法包括如下步骤:(a)将样品与诊断有效量的本发明的结合分子(其功能片段和变体)或者免疫缀合物接触,(b)确定所述结合分子或者免疫缀合物是否特异性结合样品的分子。所述样品可以是来自(潜在)感染对象的生物学样品,包括但不限于血液、血清、大便、唾液、鼻咽部吸出物(nasophargyal aspirates)、支气管灌洗物(bronchial lavages)、尿液、组织或者其它生物学材料,或者非生物学样品如水、饮料等。所述(潜在)感染对象可以是人,但是也可以对怀疑携带流感病毒H5N1的动物进行检测所述病毒的存在情况,使用本发明的人结合分子或者免疫缀合物进行。首先可以对样品进行处理以使其更适于检测方法。处理意味着对怀疑含有和/或含有所述病毒的样品进行处理,由此该病毒分解成抗原性成分如蛋白质、(多)肽或者其它抗原性片段。优选地,将本发明的人结合分子或者免疫缀合物与样品在使得人结合分子与样品中也许存在的病毒或其抗原性成分之间形成免疫复合物的条件下接触。然后通过合适方式检测和测量所述免疫复合物的形成,所述免疫复合物的形成表示样品中存在所述病毒。这种方法包括均质和异质结合免疫测定,例如放射性免疫测定(RIA)、ELISA、免疫荧光方法、免疫组织化学方法、FACS、BIACORE和蛋白质印迹分析。
优选的测定技术、尤其是大规模临床筛选患者血清和血液以及血液衍生制品的测定技术是ELISA和蛋白质印迹技术。特别优选ELISA测试。为了在这些测定方法用作试剂,将本发明的结合分子或者免疫缀合物便利地结合在微滴定孔的内表面上。本发明的结合分子或者免疫缀合物可以被直接结合在微滴定孔上。然而,本发明的结合分子或者免疫缀合物与孔的最大结合可以通过用多赖氨酸预处理孔之后加入本发明的结合分子或者免疫缀合物而实现。此外,本发明的结合分子或者免疫缀合物可以通过已知方式与孔共价附着。通常,使用0.01-100μg/ml的结合分子或者免疫缀合物用于包被,但是也可以使用更高浓度以及更低的量。然后将样品加入用本发明的结合分子或者免疫缀合物包被的孔中。
此外,本发明的结合分子可用于鉴别流感病毒H5N1的特异性结合结构。所述结合结构可以是蛋白质和/或多肽上的表位。它们可以是线性的,但是也可以是结构和/或构象的。在一个实施方案中,所述结合结构可以通过PEPSCAN分析方法(见WO 84/03564,WO 93/09872,Slootstra et al.,1996)分析。或者,可以针对能结合本发明的结合分子的肽筛选包含来自流感病毒H5N1蛋白质的肽的随机肽文库。发现的结合结构/肽/表位可以用作疫苗以及用于诊断流感病毒H5N1感染。在除了蛋白质和/或多肽之外的片段由所述结合分子结合的情况中,结合结构可以通过质谱法、高效液相层析以及核磁共振方法鉴别。
另一方面,本发明提供了筛选特异性结合与由本发明的人结合分子结合的表位相同的流感病毒H5N1的表位的结合分子(或其功能片段或变体)的方法,其中所述方法包括如下步骤:(a)将待被筛选的结合分子、本发明的结合分子与流感病毒H5N1或其片段接触,(b)测量待被筛选的结合分子是否能与本发明的结合分子竞争特异性结合流感病毒H5N1或其片段。在进一步的步骤中,可以确定能竞争特异性结合流感病毒H5N1或其片段的被筛选的结合分子是否具有中和活性。能与本发明的结合分子竞争特异性结合流感病毒H5N1或其片段的结合分子是本发明的另一部分。在上述筛选方法中,“特异性结合相同表位”还包含特异性结合与本发明的结合分子结合的表位基本(substantially)或者基本(essentially)相同的表位。阻断或者竞争本发明的结合分子与流感病毒H5N1结合的能力典型是指待被筛选的结合分子结合与本发明的结合分子免疫特异性识别的流感病毒H5N1上的结合位点结构重叠的流感病毒H5N1上的表位或结合位点。或者,这是指待被筛选的结合分子结合与由本发明的结合分子免疫特异性识别的结合位点在空间排列上十分接近的表位或结合位点或者抑制本发明的结合分子与流感病毒H5N1的结合。
通常,竞争性抑制通过这样的测定方法测量,其中将抗原组合物即包含流感病毒H5N1或其片段的组合物与参考结合分子即本发明的结合分子以及待被筛选的结合分子混合。通常,待被筛选的结合分子过量存在。基于ELISA和蛋白质印迹的方案适用于这种简便的竞争性研究中。通过使用物种或同种型二级抗体,本领域技术人员可以仅检测到结合的参考结合分子,其结合由于基本上识别相同表位的待被筛选的结合分子的存在而降低。在进行参考结合分子与待被筛选的任何结合分子(不管物种或者同种型)之间进行的结合分子竞争性研究中,本领域技术人员可以首先用可检测的标记对参考结合分子加以标记以进行随后的鉴别,所述标记例如是生物素、酶标记、放射性标记或者其它标记,通过这些竞争性测定方法鉴别的结合分子(竞争性结合分子或者交叉反应性结合分子)包括但不限于结合由参考结合分子即本发明的结合分子结合的表位或者结合位点的抗体、抗体片段及其他结合剂,以及结合与所述参考结合分子结合的表位十分接近的表位或结合位点的抗体、抗体片段及其他结合剂,在所述待被筛选的结合分子与参考结合分子之间发生竞争性结合。优选地,当本发明的竞争性结合分子过量存在时,将抑制参考结合分子与选择的靶的特异性结合,抑制程度为至少10%、优选至少25%、更优选至少50%、更优选至少75%-90%或者更高。结合与本发明的结合分子结合的表位大约、基本(substantially)、基本(essentially)或者相同的表位的一或多种竞争性结合分子的鉴别是一种简明的技术方法。由于竞争性结合分子的鉴别是与参考结合分子即本发明的结合分子进行对比而确定的,因此应理解实际上不需要以任何方式确定所述参考结合分子和竞争性结合分子结合的表位以鉴别结合与参考结合分子结合的表位相同或基本相同的表位的竞争性结合分子。
实施例
为了例证本发明,提供了如下实施例。所述实施例不以任何方式限制本发明的范围。
实施例1
使用从记忆B细胞中提取的RNA构建scFv噬菌体展示文库
通过静脉穿刺从正常健康供体收集外周血置于EDTA抗凝样品管中。将血样(45ml)用PBS稀释两次,取30ml等分置于10ml Ficoll-Hypaque(Pharmacia)上,在900×g在室温不间断离心20分钟。小心取出在含有淋巴细胞和血小板级分的白色层上面的上清。接着,将该层小心取出(~10ml),移至新的50ml试管中,用40ml PBS洗涤3次,并且在室温在400×g离心10分钟以除去血小板。将获得的含有淋巴细胞的沉淀重悬于含有2%FBS的RPMI培养基中,通过细胞计数方法确定细胞数。使用CD24、CD27和表面IgM作为标记对大约1×108个淋巴细胞进行染色以进行荧光细胞分选以分离IgM记忆B细胞。使用设置为Yield Mode的Becton Dickinson DigitalVantage装置进行物理记忆B细胞分选和分离。淋巴细胞从FSC/SSC窗门控(gated)为小的致密群。记忆B细胞(CD24+/CD27+)随后与幼稚(naive)B细胞(CD24+/CD27-)和记忆T细胞(CD24-/CD27+)分开。接着,使用IgM表达从开关记忆B细胞(IgM-)中分离IgM记忆B细胞(IgM+)。在这个步骤中,IgM记忆B细胞在单独的样品管中分选。将1×105个细胞收集在DMEM/50%FBS中,在分选完成后将其在400×g离心10分钟,并在500μlTRIZOL总RNA提取溶液中裂解。使用200μl氯仿和异丙醇沉淀方法从裂解溶液中提取RNA,如TRIZOL溶液方案详细描述。接着,应用1μl PelletPaint(Novogen)增强和显现沉淀过程。将全部RNA制备物溶于23μl DEPC处理的超纯水(Invitrogen)中,并用SuperScript III逆转录酶(Invitrogen)进行cDNA转化。将1μl Random Hexamers(500ng/μl)(Promega)加入RNA样品中,混合,并在热盖PCR仪中在65℃解链5分钟。将样品在湿冰(wet-ice)上速冷,加入如下成分:8μl 5X RT缓冲液(250mM Tris-HCl pH8.3,375mMKCl,15mM MgCl2),2μl dNTP(每种10mM)(Invitrogen),2μl DTT(100mM),2μl RNAse抑制剂(40U/μl)(Promega),2μl SuperScript III(200U/μl)(Invitrogen)。首先将获得的混合物在室温保温5分钟,然后移至热盖PCR仪中在50℃运行1小时。通过加热直至75℃进行15分钟而终止反应。获得的cDNA用超纯水稀释至200μl,在-20℃贮存直至进一步使用。
应用两轮PCR扩增方法,使用如表1和表2所示引物组以从各自的供体库(repertoire)中分离免疫球蛋白VH和VL区。PCR扩增程序中使用的扩增成分如下:5μl cDNA模板,32.75μl超纯水,2.5μl每种引物(10μM),5μl10X PCR缓冲液(200mM Tris-HCl pH8.4,500mM KCl),1.5μl MgCl2(50mM),0.5μl dNTP(每种25mM),0.25μl Taq聚合酶(5U/μl)(Invitrogen)。使用表1示出的引物组对各自cDNA进行的第一轮扩增对于VH、Vκ和Vλ区分别产生大约650碱基对的7、6和9个产物。对于IgM记忆B细胞VH区扩增,使用OCM恒定引物组合OH1-OH7。第一轮扩增的热循环程序是:2分钟96℃(变性步骤),30次循环如下:30秒96℃/30秒55℃/60秒72℃,10分钟72℃最终延伸,以及在4℃冷却。将产物加样于1%琼脂糖凝胶上并使用凝胶-提取柱(Qiagen)从中分离,洗脱在50μl 1mM Tris-HCl pH8.0中。将10%的第一轮扩增产物(5μl)进行第二轮扩增,使用表2示出的引物。这些引物用限制位点延伸,使得各自的VL和VH区定向克隆进噬菌体展示载体PDV-C06中。第二轮PCR扩增程序如下:2分钟96℃(变性步骤),30次如下循环:30秒96℃/30秒60℃/60秒72℃,10分钟72℃最终延伸,以及在4℃冷却。根据在免疫球蛋白基因产物中发现的J节段的天然出现首先集合第二轮扩增产物(~350碱基对),对于VH、Vκ和Vλ可变区分别产生7、6和9个集合(见表3和表4)。为了获得免疫文库中免疫球蛋白序列的标准化分布,根据表3提及的百分比混合6个Vκ和9个Vλ轻链集合。将这个单一的最终VL集合(3μg)用SalI和NotI限制酶消化过夜,加样于1.5%琼脂糖凝胶(~350碱基对)中并使用Qiagen凝胶提取柱从中分离,如下连接在SalI-NotI切割的PDV-C06载体(~5000碱基对)中:10μl PDV-C06载体(50ng/μl),7μl VL插入体(10ng/μl),5μl 10X连接缓冲液(NEB),2.5T4 DNA连接酶(400U/μl)(NEB),25.5μl超纯水(载体与插入体比率为1∶2)。在16℃水浴中连接过夜。接着,用水使样品体积加倍,用等体积的苯酚-氯仿-异戊醇(75∶24∶1)(Invitrogen)提取,随后用氯仿(Merck)提取,并且用1μl Pellet Paint(Novogen)、10μl乙酸钠(3M pH5.0)和100μl异丙醇在-20℃沉淀2小时。随后将获得的样品在20.000×g在4℃离心30分钟。获得的沉淀用70%乙醇洗涤,在20.000×g在室温离心10分钟。通过真空抽吸除去乙醇,将沉淀在空气中干燥几分钟,然后溶解于含有10mM Tris-HCl(pH8.0)的50μl缓冲液中。1μl连接混合物用于在冷却的0.1cm电穿孔管(Biorad)中使用设定为1.7kV、200Ohm,25μF(时间常数~4,5msec)的Genepulser II设备(Biorad)转化40μl TG-1电感受态细胞(Stratagene)。在脉冲后,立即用37℃的1000μl含有5%(w/v)葡萄糖(Sigma)的SOC培养基(Invitrogen)从电穿孔管中冲洗细菌,转移至15ml圆底培养试管中。另外的500μl SOC/葡萄糖用于从电穿孔管中冲洗剩余的细菌,并将其加入培养试管中。通过在37℃在摇床孵箱中在220rpm培养正好1小时而回收细菌。将转化的细菌铺板于大的240mm方形培养皿(NUNC)中,所述培养皿中含有200ml 2TY琼脂(16g/l细菌用胰蛋白胨,10g/l细菌用酵母抽提物,5g/l NaCl,15g/l琼脂,pH7.0)补加有50μg/ml氨苄青霉素和5%(w/v)葡萄糖(Sigma)。将1-1000倍稀释液铺板于含有相同培养基的15cm培养皿上以进行计数。继续重复20次这个转化程序,将全部文库铺板于共30个大方形培养皿上,在37℃培养室(culture stove)中生长过夜。典型地,使用上述方案获得大约1×107cfu。通过轻轻刮取每个平板细菌置于10ml 2TY培养基中从平板中收获中间体VL轻链文库。细胞质量通过OD600测量确定,2倍500OD的细菌用于质粒DNA大量制备,使用两个P500maxiprep柱(Qiagen)根据厂商指导进行。
与VL可变区类似,首先将第二轮VH-JH产物混合在一起以获得正常的J节段使用分布(见表4),产生称作PH1-PH7的7个VH亚集合。使用表4所示百分比混合该集合以获得标准化的序列分布,获得一个VH级分,将其用SfiI和XhoI限制酶消化并且连接在如上述获得的SfiI-XhoI切割的PDV-VL中间体文库中。连接的设置、纯化方法、随后的TG1转化以及细菌的收获与针对VL中间体文库所述一致(见上文)。使用位于插入的VH-VL区两侧的引物组通过菌落PCR检测最终文库(大约5×106cfu)的插入频率。超过95%的菌落示出正确长度插入体(见表5)。菌落PCR产物用于随后的DNA序列分析以检测序列变化以及评定示出完全ORF的菌落百分比。这个百分比典型超过70%(见表5)。也分析了V基因中的突变频率。在50个序列中,有47个序列(94%)不是种系构型,表示成熟过程并与用作文库的RNA来源的B细胞的记忆表型一致。最后,使用CT辅助噬菌体(见WO 02/103012)拯救并扩增所述文库并用于通过下文所述淘选方法进行噬菌体抗体选择。
实施例2
携带针对H5N1的单链Fv片段的噬菌体的选择
使用基本如上述构建的抗体噬菌体展示文库以及通常的噬菌体展示技术和基本如美国专利6,265,150和WO 98/15833(这两篇文献均并入本文作参考)所述的技术选择抗体片段。此外,WO 02/103012(并入本文作参考)所述的方法和辅助噬菌体用于本发明中。
针对在昆虫细胞中使用杆状病毒载体产生的重组血凝素(HA)亚型H5(A/Vietnam/1203/2004;见SEQ ID NO:110)进行选择(Protein Sciences,CT,USA)。来自分离株A/Vietnam/1194/2004(H5N1TV)的HA的氨基酸序列以及来自在印尼和中国分离的毒株(H5N1IC)的代表性HA的共有氨基酸序列分别示于SEQ ID NO:111和SEQ ID NO:112。也针对来自H5N1的可溶重组HA(sHA)进行了选择。使用标准DNA克隆技术在含有myc-和his-标记的表达载体中克隆如下序列:编码来自分离株A/Vietnam/1194/2004(H5N1)的HA胞外(可溶)部分(sHA)的序列,该序列代表2004年在泰国和越南分离的流感病毒毒株(进化枝1)中鉴别的HA(H5N1TV的sHA,SEQ ID NO:113),以及代表2003/2004年在印尼和中国分离的H5N1毒株(进化枝2)的HA可溶部分的共有序列(H5N1IC的sHA,SEQ ID NO:114)。H5N1TV与H5N1IC的HA在9个氨基酸位置不同,均位于所述分子的HA1亚基中。使用标准技术在PER.C6细胞中进行DNA转染以瞬时和/或稳定表达。使用HisTrapTMFF柱(Amersham Biosciences)根据厂商指导通过金属螯合亲和层析从培养上清中纯化sHA。
将HA抗原(H5N1TV的重组HA和sHA)在PBS中稀释(5.0μg/ml),加入MaxiSorpTM Nunc-Immuno Tubes(Nunc)中,在转轮上在4℃保温过夜。倒空这些免疫试管(immunotubes)并用封闭缓冲液(于PBS中2%脱脂奶粉(ELK))洗涤3次。随后将免疫试管用封闭缓冲液填满,在室温保温1-2小时。另外,将免疫试管用抗-myc抗体包被过夜并且与含有5μg/ml myc-标记的H5N1TV的sHA的封闭缓冲液保温。将集合的噬菌体展示文库的等份(500-1000μl,0.5×1013-1×1013cfu,使用CT辅助噬菌体扩增(见WO 02/103012))在补加了10%非加热失活的胎牛血清和2%小鼠血清的封闭缓冲液中在室温封闭1-2小时。将封闭的噬菌体文库加入免疫试管中,在室温保温2小时,用洗涤缓冲液(0.05%(v/v)于PBS中的Tween-20)洗涤以除去未结合的噬菌体。结合的噬菌体通过在室温与1ml的100mM三乙胺(TEA)保温10分钟而从各自抗原中洗脱。随后,将洗脱的噬菌体与0.5ml的1M Tris-HCl(pH7.5)混合以中和pH。这个混合物用于感染已经在37℃生长至OD600nm为大约0.3的5ml的XL1-Blue大肠杆菌培养物。使噬菌体在37℃感染XL1-Blue细菌30分钟。然后将该混合物在室温以3000×g离心10分钟,将细菌沉淀重悬于0.5ml 2-胰蛋白胨酵母提取物(2TY培养基中。将获得的细菌悬浮液分到补加四环素、氨苄青霉素和葡萄糖的两个2TY琼脂平板中。将平板在37℃保温过夜后,从平板刮取菌落用于制备富集的噬菌体文库,基本如DeKruif et al.(1995a)和WO 02/103012所述进行。简而言之,将刮取的细菌用于接种含有氨苄青霉素、四环素和葡萄糖的2TY培养基,在37℃生长至OD 600nm为~0.3。加入CT辅助噬菌体,使其感染细菌,之后将培养基更换为含有氨苄青霉素、四环素和卡那霉素的2TY。在30℃继续保温过夜。第二天,通过离心从2TY培养基中除去细菌,之后使用聚乙二醇(PEG)6000/NaCl沉淀培养基中的噬菌体。最后,将噬菌体溶于具有1%牛血清白蛋白(BSA)的2ml PBS中,过滤灭菌并用于下一轮选择中。
或者使用全长HA表达细胞系进行噬菌体选择。为此,使用含有来自分离株A/Vietnam/1194/2004(H5N1TV)的全长HA的完整编码序列以及代表在印尼和中国分离的H5N1毒株(H5N1IC)的全长HA的共有序列的表达载体转染PER.C6细胞。使用抗HA抗体与每次噬菌体选择并行进行流式细胞计量术以保证H5N1TV-和H5N1IC-转染的PER.C6细胞的HA表达(数据未示出)。将10×106个未转染的PER.C6细胞重悬于0.5ml集合的噬菌体文库和补加4%ELK的0.5ml PER.C6培养基中,在翻滚式转子(end-over-endrotor)中以5rpm在4℃保温1小时。对噬菌体文库/未转染的PER.C6细胞混合物在4℃以300×g离心5分钟之后,含有噬菌体的上清用10×106未转染的PER.C6细胞进行第二次消减。随后将消减的噬菌体制备物与1×106个表达HA的PER.C6细胞混合,在翻滚式转子中以5rpm在4℃保温2小时。随后将细胞在3000×g旋转2分钟,将细胞沉淀重悬于1ml PBS/0.05%Tween-20中以洗去未结合的噬菌体。将细胞在3000×g离心2分钟,再重复洗涤5次。在每次洗涤之后,将细胞移至新的试管中。结合的噬菌体通过与1ml的100mM TEA在翻滚式转子中以5rpm在室温保温10分钟而从抗原洗脱。将细胞以3000×g旋转2分钟,将洗脱的噬菌体转移至含有0.5ml 1MTris-HCl(pH7.5)的50ml试管中。如上述对洗脱的噬菌体进行拯救和增殖。在分离各个单链噬菌体抗体之前进行两轮选择。在第二轮选择之后,各个大肠杆菌菌落用于制备单克隆噬菌体抗体。基本上使各个菌落在96孔平板中生长至对数期,并且用VCS-M13辅助噬菌体感染,之后使得噬菌体抗体产生进行过夜。含有噬菌体抗体的上清直接用于ELISA中以结合HA抗原。或者对噬菌体抗体进行PEG/NaCl-沉淀以及过滤灭菌以进行流式细胞计量分析。
实施例3
HA特异性单链噬菌体抗体的确认
在ELISA中确认在上述筛选方法中获得的选择的单链噬菌体抗体的特异性,即与HA抗原的结合。为此,将杆状病毒表达的重组HA(ProteinSciences,CT,USA)以及H5N1TV和H5N1IC的纯化的sHA包被MaxisorpTMELISA平板。将抗-myc mA 9E10(Roche)固定在MaxisorpTM ELISA平板上作为阴性对照抗原。在包被之后将平板在含有0.1%v/v Tween-20的PBS中洗涤3次并且在含有3%BSA或2%ELK的PBS中在室温封闭1小时。选择的单链噬菌体抗体在含有4%ELK的等体积PBS中保温1小时以获得封闭的噬菌体抗体。倒空平板,用PBS/0.1%Tween-20洗涤3次,将封闭的单链噬菌体抗体加入孔中。保温1小时,用PBS/0.1%Tween-20洗涤平板,使用与过氧化物酶缀合的抗-M13抗体检测结合的噬菌体抗体(使用OD492nm测量)。作为对照,同时进行不使用单链噬菌体抗体和使用阴性对照单链噬菌体抗体的相应程序。从用IgM记忆B细胞文库在不同HA抗原上进行的选择中获得特异于重组HA或者sHA的92个独特的单链噬菌体抗体。
或者,使用流式细胞计量分析检测针对与表达HA的PER.C6细胞的结合而选择的单链抗体的反应性。将PEG/NaCl沉淀的噬菌体与等体积的PBS/2%ELK混合,在冰上封闭30分钟。将封闭的噬菌体加入沉淀的细胞中(未转染的PER.C6细胞和表达HA的PER.C6细胞),在冰上保温1小时。将细胞用PBS/1%BSA洗涤3次,随后在300×g离心1分钟,使用生物素酰化的抗-M13抗体(Fitzgerald)及随后使用链霉抗生物素-藻红蛋白缀合物(Caltag)观测所述单链噬菌体抗体与细胞的结合。使用表达HA的PER.C6细胞进行的选择提供了24个独特的单链噬菌体抗体,在使用不同的重组HA蛋白选择期间未鉴别出这些抗体。
实施例4
HA特异性scFv的鉴定
从选择的特异性单链噬菌体抗体(scFv)克隆中获得质粒DNA,根据标准技术确定核苷酸和氨基酸序列。所述scFv的核苷酸序列和氨基酸序列以及VH和VL基因相同性(见Tomlinson IM et al.V-BASE Sequence Directory.Cambridge United Kingdom:MRC Centre for Protein Engineering(1997))示于表6。所述HA特异性免疫球蛋白的CDR区示于表7。
实施例5
从选择的单链Fv中构建完全人免疫球蛋白分子(人单克隆抗体)
通过限制消化直接克隆所述scFv的重链和轻链可变区以在IgG表达载体pIg-C911-HCγ1(见SEQ ID No:141)、pIG-C909-Cκ(见SEQ ID NO:142)或者pIg-C910-Cλ(见SEQ ID No:143)中表达。根据本领域技术人员已知的标准技术确认所有构建体的核苷酸序列。将编码人IgG1重链和轻链的所得表达构建体在293T细胞中组合瞬时表达,使用标准纯化方法获得和生产含有人IgG1抗体的上清。将所述人IgG1抗体在10-0.003μg/ml浓度范围针对H5滴定(数据未示出)。SARS-CoV特异性抗体作为对照抗体。IgG1分子示出与单链噬菌体抗体相同的反应性模式。
表8中示出了如下名称的抗体的重链和轻链的核苷酸与氨基酸序列以及其重链和轻链可变区:CR6141、CR6255、CR6257、CR6260、CR6261、CR6262、CR6268、CR6272、CR6296、CR6301、CR6307、CR6310、CR6314、CR6323、CR6325、CR6327、CR6328、CR6329、CR6331、CR6332、CR6334、CR6336、CR6339、CR6342、CR6343和CR6344。随后通过流式细胞计量术分析抗-HA IgG与表达HA的PER.C6细胞的结合。分析抗体与HA结合的流式细胞术表明抗体CR6255、CR6257、CR6260、CR6261、CR6262、CR6268、CR6307、CR6310、CR6314、CR6323、CR6325、CR6331和CR6344结合表达HA(H5N1TV)-的PER.C6细胞(见表9)。抗体CR6261和CR6344也显示出与未转染的对照细胞结合,但是获得的信号比与表达HA(H5N1TV)的PER.C6细胞的结合获得的信号低大约10倍(见表9)。未观测到对照抗体CR3014与表达HA的细胞和未转染对照细胞的结合。
实施例6
H5N1特异性IgG对于H5N1流感病毒的体外中和作用(病毒中和作用测定)
为了确定选择的IgG是否能阻断H5N1感染,进行体外病毒中和作用测定(VNA)。对MDCK细胞(ATCC CCL-34)进行VNA。将MDCK细胞在MDCK细胞培养基(MEM培养基,补加了抗生素、20mM Hepes和0.15%(w/v)碳酸氢钠(完全MEM培养基),补加10%(v/v)胎牛血清)中培养。将该测定中使用的H5N1重排列毒株NIBRG-14稀释为4×103TCID50/ml(50%组织培养物感染剂量每ml)的效价,根据Spearman和Karber的方法计算效价。将IgG制备物(200μg/ml)在一式两份的孔中在完全MEM培养基中系列稀释2倍(1∶2-1∶16)。将25μl各自的IgG稀释液与25μl病毒悬浮液(100TCID50/25μl)混合,在37℃保温1小时。然后将该悬浮液一式两份移至含有汇合的MDCK培养物的96孔平板的50μl完全MEM培养基中。在使用之前,将MDCK细胞接种在MDCK细胞培养基中,密度为3×104个细胞每孔,生长直至细胞达到汇合,用300-350μl PBS(pH7.4)洗涤,并且最后向每个孔中加入50μl完全MEM培养基。接种的细胞在33℃培养3-4天,每天观测致细胞病变效应(CPE)的发生情况。将该CPE与阳性对照(NIBRG-14-接种的细胞)和阴性对照(模拟接种的细胞)进行比较。各个细胞培养物中完全不存在CPF被限定为保护作用。绵羊抗-A/Vietnam/1194/04 H5N1流感病毒HA(04/214,NIBSC)在该测定中用作阳性对照。
另外,使用免疫组织化学方法检测培养物中病毒的存在情况。为此,弃去培养上清,将细胞用40%(v/v)丙酮和60%(v/v)甲醇固定15分钟。固定的细胞在补加2%(w/v)BSA和5%(v/v)山羊血清的封闭缓冲液(200mMNaCl,0.2%(w/v)牛血清白蛋白(BSA),0.01%硫柳汞,0.2%(v/v)Tween-20,20mM Tris-HCl,pH7.45)中在37℃封闭30分钟。随后,将细胞与在洗涤缓冲液中1∶1000稀释的50μl小鼠抗流感病毒A单克隆抗体混合物(Chemicon)在37℃保温1小时。在用洗涤缓冲液洗涤3次后,加入在洗涤缓冲液中1∶1000稀释的50μl生物素缀合的山羊抗小鼠IgG(Jackson),在37℃保温1小时。在用洗涤缓冲液洗涤3次后,加入在洗涤缓冲液中1∶3000稀释的50μl链霉抗生物素-过氧化物酶缀合物(Calbiochem),在37℃保温30分钟。在用洗涤缓冲液洗涤3次后,使用含有1μl H2O2/1ml AEC溶液的AEC溶液(0.12%(w/v)3-氨基-9-乙基咔唑,30%(v/v)N-N-二甲基甲酰胺和70%(v/v)乙酸盐缓冲液)观测染色情况。再用洗涤缓冲液洗涤3次后,在显微镜下分析染色情况。
对称作CR6255、CR6257、CR6260、CR6261、CR6262、CR6268、CR6307、CR6310、CR6314、CR6323、CR6325、CR6331和CR6344的人抗HA抗体进行上述VNA。所有抗体均中和H5N1重排列毒株NIBRG-14。这些抗体保护MDCK培养物对抗CPE的浓度(μg/ml)在表10中示出。在观测到CPE的孔中,通过免疫组织化学染色方法证实病毒的存在(数据未示出)。
为了更精确地确定H5N1特异性IgG的中和效力,重复用NIBRG-14进行的体外病毒中和作用测定,但这次对IgG制备物进一步稀释。将IgG制备物(200μg/ml)在完全MEM培养基中系列稀释2倍(1∶1-1∶512),在一式四份的孔中在如上述VNA中进行检测。在VNA中确定如下名称的人抗-H5N1抗体的中和效力:CR6255、CR6257、CR6260、CR6261、CR6262、CR6268、CR6272、CR6307、CR6310、CR6314、CR6323、CR6325、CR6327、CR6328、CR6329、CR6331、CR6332、CR6334、CR6336、CR6339、CR6342、CR6343和CR6344。除了CR6272和CR6339之外,所有抗体均中和H5N1重排列毒株NIBRG-14。这些抗体保护MDCK培养物对抗CPE的浓度(μg/ml,在存在100TCID50病毒的条件下)在表11中示出。在观测到CPE的孔中,通过免疫组织化学染色方法证实病毒的存在(数据未示出)。
实施例7
H5N1特异性IgG的免疫印迹分析
为了进一步研究抗HA抗体的特异性,对不同的重组血凝素流感病毒A抗原在还原条件下进行SDS-PAGE,随后进行抗HA免疫印迹分析。HA0多肽由HA1和HA2亚基组成。抗体CR5111,一种H5N1-特异性对照抗体,识别H5N1TV的sHA的HA1亚基和完整的(未裂解的)HA0多肽(见图1,右侧,泳道1)。另外,CR5111识别重组HA的HA1亚基,所述重组HA是使用杆状病毒载体在昆虫细胞中产生的亚型H5(A/Vietnam/1203/2004(H5N1),见SEQ ID NO:110)(Protein Sciences,CT,USA)(图1,右侧,泳道2)。未裂解的HA0多肽在这个HA制备物中未检测到。泳道1与泳道2中HA亚基之间大小的差异可以由昆虫细胞与PER.C6细胞中表达的HA的不同糖基化作用加以解释。CR5111不识别为亚型H1(A/New Caledonia/20/99(H1N1))(见图1,右侧,泳道4)或者亚型H3(A/Wyoming/3/2003(H3N2))(图1,右侧,泳道3)的重组HA的HA1和/或HA0多肽。
抗体CR6307和CR6323识别H5N1TV的sHA(见图1,左侧和中间部分,泳道1)以及亚型H5的重组HA(A/Vietnam/1203/2004(H5N1)(见图1,左侧和中间部分,泳道2)的HA2亚基。令人感兴趣地,当HA2亚基完整存在时,未裂解的HA0多肽不被识别。显然由CR6307和CR6323识别的表位在HA0裂解时变得可接近。另外,抗体CR6307和CR6323识别亚型H1(A/New Caledonia/20/99(H1N1))的重组HA的HA2亚基(见图1,左侧和中间部分,泳道4),但是不识别亚型H3(A/Wyoming/3/2003(H3N2))的重组HA的HA2亚基(见图1,左侧和中间部分,泳道3),这两个重组HA均是在昆虫细胞中使用杆状病毒载体产生的(Protein Sciences,CT,USA)。由于中和抗体CR6307和CR6323的结合位点在亚型H1和H5的流感病毒A毒株中是保守的,因此包含所述结合位点的分子可以被认为是能诱导广泛交叉反应性抗流感病毒抗体应答的疫苗(的一部分)。
在抗体CR6307和CR6323之后,称作CR6141、CR6296和CR6301的抗体用于免疫印迹分析中。这三个抗体中的每一个抗体均能结合H5N1TV的sHA以及亚型H5(A/Vietnam/1203/2004;H5N1)的重组HA的HA2亚基(数据未示出)。
实施例8
确定H5N1特异性IgG的亚基特异性的FACS分析
为了评估HA1亚基对于抗-H5N1抗体结合的贡献,进行测定,其中HA1亚基从表达HA的PER.C6细胞释放。将表达HA的PER.C6细胞用PBS(pH7.4)洗涤3次,并且在酸化PBS(pH4.9)中保温10分钟。随后,将细胞用PBS(pH7.4)洗涤,用在PBS(pH7.4)中的10μg/ml胰蛋白酶处理10分钟以使得HA0分子裂解为二硫键连接的HA1和HA2亚基。最后,将细胞在于PBS(pH7.4)中的20mM DTT中保温20分钟以从膜锚定的HA2亚基中释放HA1亚基。未处理的以及酸/胰蛋白酶/DTT处理的细胞用含有1%w/vBSA的PBS洗涤两次。为了进行流式细胞计量分析,每次染色使用2.5×105个细胞。观测到用阴性对照抗体CR3014处理和未处理的细胞无染色。抗体CR5111在免疫印迹分析中结合HA1亚基,其使得未处理的表达HA的PER.C6细胞染色,而处理的细胞未被识别(数据未示出)。这个结果提供了CR5111识别HA1亚基的进一步证据。处理和未处理的细胞被抗体CR6307和CR6323相似程度染色(数据未示出)。HA1亚基的释放显然不影响这些抗体的结合,进一步证实得自所述抗体结合HA2亚基的免疫印迹分析的结果。抗体CR6325和CR6331结合未处理的细胞,而与结合未处理的细胞相比与处理的细胞的结合明显降低(数据未示出)。这个结果提示抗体对于其表位的亲和性由于构象改变而明显降低,所述构象改变是通过酸处理或者通过还原连接HA1与HA2亚基的二硫键而诱导的。
实施例9
利用噬菌体抗体和IgG进行血凝素竞争性ELISA
为了鉴别结合非重叠非竞争性表位的抗体,进行血凝素竞争性ELISA。将Nunc-ImmunoTM Maxisorp F96平板用在PBS中的0.5μg/ml亚型H5(A/Vietnam/1203/2004(H5N1)(Protein Sciences)的重组HA在4℃包被过夜。洗去未包被的蛋白质,之后将孔用含有2%w/v脱脂奶粉的300μl PBS(封闭溶液)在室温封闭1小时。弃去封闭溶液,在每个孔中加入于封闭溶液中的50μl的10μg/ml抗-H5N1IgG,在室温保温1小时。随后向每个孔中加入于封闭溶液中的50l噬菌体抗体,浓度为导致50%最大结合的浓度(在先前测定中确定)的两倍,在室温再保温1小时。用含有0.1%v/v Tween-20的PBS洗涤孔3次。使用过氧化物酶缀合的抗-M13抗体检测结合的噬菌体抗体。如上述再次洗涤孔并且通过加入100μl的OPD试剂(Sigma)进一步显色ELISA。反应通过加入50μl 1M H2SO4而终止,然后测量在492nm的OD。在存在IgG的条件下,噬菌体抗体的结合以与在不存在IgG的条件下的结合的百分比表示,在不存在IgG条件下的结合设定为100%。识别H5血凝素的HA1亚基中表位的噬菌体抗体SC05-111及相应的IgG CR5111用作对照。
结果表明大多数噬菌体抗体和IgG结合亚型H5(A/Vietnam/1203/2004(H5N1))的重组HA上的重叠表位(数据未示出)。SC05-111噬菌体抗体的结合由CR5111 IgG阻断,但是不由任何其它IgG阻断,提示其它IgG识别与CR5111的结合区不同的表位。5个IgG CR6262、CR6272、CR6307、CR6339和CR6343与剩余的IgG较低程度地竞争结合(25%以上的剩余结合)。对于IgG CR6262、CR6272、CR6339和CR6343,这可以由对于HA的较低亲和性解释。这由这样的观测结果支持,即相应于这些抗体的噬菌体抗体被其它IgG更有效地竞争。噬菌体抗体SC06-307的结合被IgG CR6307阻断,但是其它IgG对其影响较低。这提示SC06-307和CR6307识别与其它IgG识别的表位不同的独特表位。
实施例10
使用抗-H5N1 IgG的交叉反应性ELISA
为了检测抗-H5N1抗体的表位在除了亚型H5之外的HA中是否是保守的,进行血凝素交叉反应性ELISA。将Nunc-ImmunoTM Maxisorp F96平板(Nunc)用如下材料在4℃包被过夜:在PBS中的0.5μg/ml亚型H1(A/NewCaledonia/20/99(H1N1))、亚型H3(A/Wyoming/3/03(H3N2))、亚型H5(A/Vietnam/1203/04(H5N1))、亚型H7(A/Netherlands/219/03(H7N7))以及亚型H9(A/Hong Kong/1073/99(H9N2))(Protein Sciences Corp.)的重组HA。另外,将含有0.5μg/ml的A/New Caledonia/20/99(H1N1)和重排列毒株NIBRG-14(A/Vietnam/1194/04(H5N1))的HA的BPL-失活的病毒制备物于PBS中在平板上包被过夜。用含有0.1%v/v Tween-20的PBS洗涤孔3次以除去未包被的蛋白质,随后用含有2%w/v脱脂奶粉的300μl PBS(封闭溶液)在室温封闭1小时。弃去封闭溶液,每孔加入于封闭溶液中的100μl的5μg/ml抗-H5N1抗体,在室温保温1小时。用含有0.1%v/v Tween-20的PBS洗涤孔3次,使用过氧化物酶缀合的小鼠抗人IgG抗体(Jackson)检测结合的抗体。如前述进行显色和测量。表12示出所有抗-H5N1 IgG均结合亚型H5(A/Vietnam/1203/2004(H5N1))和BPL-失活的NIBRG-14病毒制备物的重组HA,后者含有毒株A/Vietnam/1194/2004(H5N1)的HA。亚型H3和H7的重组HA不被任何检测的抗-H5N1 IgG识别。令人感兴趣地,除了CR5111和CR6307之外所有抗-H5N1 IgG均结合亚型H1和H9以及BPL-失活的毒株A/New Caledonia/20/99(H1N1)的病毒制备物的重组HA。这表明大多数抗-H5N1 IgG的表位在不同亚型的HA分子中是保守的。
实施例11
抗-H5N1 IgG的表位作图
Okuno et al.(1993)和Smirnov et al.(1999)证实流感病毒A亚型H1、H2和H5的HA共享的一个共有表位的存在以及针对这个表位的鼠单克隆抗体C179对这些亚型的中和作用。这个构象表位由位于HA1和HA2亚基中的两个不同位点组成。这两个位点在HA分子的干区中间紧密相邻。为了评估前述抗HA抗体是否识别这个表位,产生在这个区域中含有氨基酸取代的HA分子。
由抗体C179(Takara Bio Inc.)识别的表位已经被归属为包含HA1亚基的第318-322位残基和HA2亚基的第47-58残基的区域(氨基酸编号如Okuno et al.1999所述)。含有这样的HA的逃逸病毒不再由C179识别和中和,所述HA在HA1亚基第318位具有Thr至Lys的取代或者在HA2亚基第52位具有Val至Glu的取代。这些突变(第318位Thr至Lys,突变体I;第52位Val至Glu,突变体II)、HA1亚基第320位的Leu至Met取代(突变体III,Met320存在于亚型H3和H7的HA1的第318-322位区域中)、HA2亚基第54位的Ser至Arg取代(突变体IV,Arg54存在于亚型H3和H7的HA2的第47-58位区域中)以及HA2亚基第57位的Asp至Asn取代(突变体V,Asn57存在于毒株A/Hong Kong/156/97(H5N1)的HA2的第47-58位区域中)导入分离株A/Vietnam/1194/2004(H5N1TV)的全长HA中,并且在PER.C6细胞中转染。如前述C179和人抗HA抗体与表达这些突变体的PER.C6细胞的结合通过FACA分析评估。抗HA1亚基中表位的抗体CR5111以及多克隆抗H5绵羊血清证实转染的PER.C6细胞表达H5N1TV和HA突变体(数据未示出)。观测到用阴性对照抗体CR3014或者在不存在抗体的条件下无染色(数据未示出)。正如所预期的,抗体C179不识别突变体I和II,其具有与C179逃逸病毒中HA相同的氨基酸取代(见Okuno et al.,1993)。此外,C179不结合突变体IV,而C179与突变体III和V的结合不受影响。针对抗体CR6342观测到相似的反应性模式,这提示抗体C179和CR6342识别相似的表位。抗体CR6261、CR6325和CR6329识别除了突变体II之外的所有突变体。这提示抗体CR6261、CR6325和CR6329的表位与C179的表位不同。由于HA1亚基中的取代不消除这些抗体的结合,因此其表位很可能位于HA2亚基中。抗体CR6307和CR6323识别所有突变体,提示这些抗体的表位也与C179的表位不同。关于突变体的序列和抗体结合的概况在表13中示出。总之,结果表明抗体CR6261、CR6325、CR6329、CR6307和CR6323是结合并中和流感病毒的理想候选物,其在由鼠单克隆抗体C179识别的表位中具有突变并因此不再由这个抗体中和。
实施例12
人IgG单克隆抗体在体内抗致死H5N1攻击的预防活性
给予小鼠致死剂量的流感病毒H5N1毒株A/HongKong/156/97以研究人单克隆IgG抗体CR6261、CR6323和CR6325的预防作用。在感染每组10只小鼠的8组动物的前一天为每只小鼠经腹膜内注射不同剂量的抗体。作为阴性对照,一组小鼠注射不相关的对照抗体(CR3014)。监测临床症状、体重丧失以及死亡率直至感染后21天。进行这项研究是为了评定所述单克隆人抗H5N1 IgG抗体在体内的预防作用。
H5N1毒株最初得自患有呼吸系统疾病的3岁儿童。将该病毒在MDCK细胞上传代两次。用于感染小鼠的批次[效价8.1log TCID50/ml]在鸡胚中增殖一次。
将80只雌性7周龄Balb/c小鼠分成8组,每组10只,在用H5N1病毒攻击之前为每只小鼠进行如下注射:
1.15mg/kg CR6261.
2.5mg/kg CR6261.
3.2mg/kg CR6261.
4.0.7mg/kg CR6261.
5.15mg/kg CR6323.
6.15mg/kg CR6325
7.500μl兔抗-H5N3免疫血清(100×稀释)
8.15mg/kg CR3014.
使所有动物适应环境并饲养6天,之后开始研究。在用H5N1病毒感染前一天,通过腹膜内注射给予500μl抗体。在第0天用25LD50病毒(大约50μl)经鼻内接种动物,并继续进行21天。给予的病毒的实际剂量通过滴定得自完成动物接种后剩余的接种物的几个同样样品而估定。接种物的病毒效价(TCID50/mL)在MDCK细胞上确定。结果示出在制备或给予所述接种物期间未无意发生病毒的失活。第8组作为阴性对照。在第0天为这组动物注射不相关的单克隆抗体(CR3014)。第7组假定作为阳性对照。为这组小鼠注射抗H5N3流感病毒产生的兔多克隆血清抗体。
从接种病毒后第-1天直至第21天每天监测临床症状和体重。临床症状用评分系统评分并记录(0=无临床症状;1=被毛粗糙(rough coat);2=被毛粗糙,反应性降低,操作期间顺从;3=被毛粗糙,卷起,用力呼吸,操作期间顺从;4=被毛粗糙,卷起,用力呼吸,当背向下放置时不退回至胃向下状态)。存活的动物在第21天安乐死并取血。为了分析血清IgG抗体水平,在第0天收集每只小鼠的血样。根据标准程序制备血清。为了产生感染后血清,第21天从存活的动物中收集血液。将血清贮存在-20℃±2℃直至进行分析病毒特异性抗体的存在。使用4HAU的H5N1 HK/97底物一式两份检测血清。效价以示出HI的最高血清稀释度的倒数表示,在1/10稀释度开始。
在适应环境期间,所有小鼠均是活跃的而且看起来是健康的,未示出疾病迹象。每天计算平均临床得分(总临床得分除以每组存活动物数),结果示于图2(每组平均临床得分)、表14(临床得分)和表15(呼吸窘迫)。在感染后第3天,在用阴性对照Ab CR3014接种的组(第8组)中观测到阴性临床症状发生。呼吸窘迫在第6天首次记录,持续1-4天。在用15mg/kg的CR6325处理的小鼠(第6组)中未观测到临床症状。在第5组(CR6323)中,一只小鼠在第5-8天示出轻微的临床症状(得分1)并且在次日死亡。在第1组中,一只小鼠在第13天死亡,但是先前未示出任何临床症状。较高的CR6261的Ab剂量与较晚发生临床症状以及较低的平均临床得分相关。在最低剂量(0.7mg/kg)组中观测到呼吸窘迫,但是在较高剂量(2、5和15mg/kg)组中未观测到。所有小鼠均示出在第9-13天(第2、3和5组)或者从第17天开始(第4组)其临床状况得以改善。注射兔多克隆抗体的小鼠(第7组)在3天内发生严重疾病且随后死亡,表明兔抗体在体内不能发挥抗感染的保护作用。在第10天对两只动物安乐死(第4组一只及第8组一只)并且不再用于研究中,因为该动物被认为患有严重疾病(得分4)。
H5N1感染的动物示出不同程度的体重丧失(图3)。成比例的体重丧失和发作时刻与抗体剂量相关。在用最高剂量抗体处理的组中,随着时间的推移体重稳定增加,与年龄相关的体重增加一致。接种最低剂量CR6261的动物组比接受较高剂量抗体的动物组体重更快速降低。在较低剂量组中,体重丧失的总量较大,在接种2和0.7mg/kg CR6261的组中平均体重与起始体重相比分别降低大约15%和40%。在较低剂量组中,在动物示出一些临床症状改善的同时表现出平均体重增加。
图4示出每天每组存活的小鼠数。存在给予的抗体量与平均存活时间之间清晰的剂量应答关系。图5示出剂量应答方式的死亡率。在最低剂量组(0.7mg/kg)和接受阴性对照抗体CR3014的小鼠组中,在接种7天后第一只小鼠死亡。当给予0.7mg/kg的CR6261抗体时,低于50%的动物得以保护免于死亡。然而当给予最高剂量的抗体时,9-10只小鼠存活。阴性对照组(CR3014)中无小鼠存活,表明这项研究中使用的确实是100%致死攻击剂量。
为了评定IgG抗体是否能呈现对抗感染的完全保护作用,进行HI测定,使用在第21天从接受15mg/kg的CR6261(第1组)的小鼠收集的血清进行测定。这个数据应表明虽然小鼠无临床表现,但是经历了H5N1感染。
这些结果示出如本文所述鉴别和开发的至少三种人抗-H5N1抗体(CR6261、CR6323和CR6325)均能独立地提供在体内对抗致死剂量流感病毒H5N1的保护作用。观测到在给予的CR6261抗体量与平均存活时间之间的清晰剂量应答关系。结果表明当在感染前一天给予小鼠15mg/kg剂量的检测的每种单克隆抗-H5N1IgG抗体时,所述抗体在小鼠中均能预防H5N1感染的临床表现。
实施例13
在致死剂量的流感病毒H5N1感染后给予人单克隆抗-H5N1抗体的体内保护和治疗作用
在感染后模型中进行研究以检测本文所述的单克隆抗体例如CR6261对抗致死H5N1 A/HK/97流感病毒攻击的体内治疗作用。所述病毒批次和类型以及小鼠年龄与实施例12所用相同。作为阴性对照,一组小鼠注射不相关的对照抗体(CR2006)。监测临床症状、体重丧失情况以及死亡率直至感染后第21天。
将58只雌性7周龄Balb/c小鼠分成5组,如下所述在感染后不同阶段接受抗体:
1.10只小鼠,在感染后4小时给予15mg/kg CR6261
2.14只小鼠,在感染后1天给予15mg/kg CR6261
3.10只小鼠,在感染后2天给予15mg/kg CR6261
4.10只小鼠,在感染后3天给予15mg/kg CR6261
5.14只小鼠,在感染后1天给予15mg/kg CR2006。
使所有动物适应环境并饲养6天,之后开始研究。在第0天为动物经鼻内接种25LD50的H5N1流感病毒(大约50μl)并监测21天。给予的病毒的实际剂量通过滴定得自接种动物完成后剩余的接种物的几个同样样品而估定。接种物的病毒效价(TCID50/mL)在MDCK细胞上确定。结果表明在制备或给予接种物期间未无意发生病毒失活。在接种后的特定时间点通过腹膜内注射给予500μl抗体。第5组作为阴性对照。这个组中动物在感染后第1天注射不相关的单克隆抗体(CR2006)。
从第-1天直至第21天每天评定临床症状和体重。临床症状如实施例12所述评分,得分范围是0-4。存活的动物在第21天被行安乐死并取血。为了评定病理学改变,在攻击后第6天处死第2组和第5组的4只动物。这些动物在第0天已经进行预选择,并且与其它动物分别安置。为此,第2组和第5组在开始时有14只动物,在选择后剩余10只动物。在病毒接种后第-1天直至第21天每天评定临床症状和体重。
在适应环境期间所有动物均是活跃的且看起来是健康的,无疾病迹象。每天计算平均临床得分(总临床得分除以每组存活动物数),结果示于图6(每组平均临床得分)、表16(临床得分)和表17(呼吸窘迫)。显然,所有组均包含在感染后第1天示出临床症状的小鼠。根据给予抗体的时间,所述临床症状消除,且在第15天所有组中临床症状均再不存在。在对照组5中,在第9天所有动物均出现严重临床症状且所有动物均死亡或者被行安乐死,因为这些动物达到临床得分4。这表明给予动物的是致死剂量的流感病毒。在第1组中,动物在感染后4小时接受抗体,一些动物不出现临床症状,而其它动物出现临床症状。表16中提供了出现可以评分的临床症状的动物的数目。由于流感病毒对于呼吸器官可具有显著作用,因此也测量呼吸窘迫情况并在表17中提供。图7和表18分别示出所有组的存活动物数目和死亡率。由于未知原因,在感染后4小时接受抗体的第1组中一只动物在第10天死亡。在流感病毒感染后接受抗体的动物组中所有剩余动物在第21天均存活且健康。这在从所有小鼠获得的体重数据中清晰可见。图8示出在研究的21天期间每组小鼠的平均体重。尽管所有小鼠的体重在感染时均降低,但是在给予抗体之后小鼠的体重恢复至正常水平。显然,恢复至正常体重水平依赖于抗体治疗的时间选择,在暴露后4小时治疗的动物迅速康复且在第7天达到正常水平;在感染后3天治疗的动物在第17天达到其正常体重。所有动物在研究结束即第21天时均达到相似且健康的体重。显然,接受阴性对照抗体的动物未恢复体重,在第9天死亡则终止测量。
这些结果表明在用致死剂量H5N1流感病毒攻击后,在感染后用本发明揭示的抗H5N1流感病毒的单克隆抗体例如CR6261进行治疗可以拯救哺乳动物对象,如本文在小鼠中所示。甚至在晚期阶段,感染后3天,所述抗体仍能使临床症状倒退至临床症状不再可监测到的水平。令人吃惊的是在感染后第21天,所有经抗体治疗的动物均达到正常体重水平且未示出任何残存的临床症状。
实施例14
使用针对H5N1的HA的单克隆抗体抗由异源流感病毒亚型致死攻击的体内交叉保护作用
如前所述(实施例11),本发明的一些抗体显然识别H5血凝素蛋白的HA2结构域中的单一表位。实施例7示出本发明的某些结合分子可以非构象方式与HA2表位相互作用,换句话说,血凝素蛋白的折叠形式似乎不妨碍本发明揭示的这些抗体的中和活性和保护作用。
本领域已知流感病毒血凝素蛋白的无抗原性漂移倾向的那部分的序列(抗原性漂移=所述蛋白质的HA1区域中免疫决定区的改变,导致需要每年更新流感病毒疫苗)。由CR6261、CR6325和CR6329识别的HA2中的表位包含于氨基酸序列GVTNKVN4IIDK(SEQ ID NO:368,见表13)中,也存在于H1和H9亚型的血凝素蛋白中,见表22。实施例10示出本发明的结合分子与表位的相互作用非限于H5的HA,也可以识别H1和H9的HA(见表12)。因此,本发明的结合分子识别存在于不同流感病毒血清型的多个HA蛋白中的表位。
为了研究这些抗体用于体内治疗的交叉应用性,在小鼠中进行实验,与实施例13中描述的实验的给药方案一致。在这个实验中,给予小鼠极高致死剂量的另一种流感病毒H1N1,该病毒与1918年流行性爆发、目前在季节性感染人体相关。随后,用本发明的抗体例如CR6261治疗小鼠,在感染后监测小鼠的临床症状、呼吸窘迫和体重共3周。如下文所述,这些结合分子可以拯救H5N1感染的小鼠,也能拯救H1N1感染的哺乳动物对象。
在感染后模型中进行研究以检测单克隆抗体例如CR6261对抗致死H1N1 A/WSN/33流感病毒攻击的体内治疗作用。该病毒批次得自ATCC(VR-219)并且在鸡胚中增殖一次。效价为8.5log TCID50/ml。作为阴性对照,一组小鼠注射不相关的单克隆抗体(IgG1,λ,称作CR57,同种型匹配的阴性对照抗体)。监测临床症状、体重丧失以及死亡率直至感染后21天。
将50只雌性6-8周龄的Balb/c小鼠分为5组,如下所述在感染相关的不同阶段接受抗体:
1.10只小鼠,在感染前1天给予15mg/kg CR6261
2.10只小鼠,在感染后1天给予15mg/kg CR6261
3.10只小鼠,在感染后2天给予15mg/kg CR6261
4.10只小鼠,在感染后3天给予15mg/kg CR6261
5.10只小鼠,在感染后1天给予15mg/kg阴性对照CR57
使所有动物适应环境并饲养至少4天,之后开始研究。在第0天为动物接种大约50μl的致死剂量H1N1病毒(6.6log TCID50;25×LD50等价物)并监测。在接种之前/之后的指定时间点通过腹膜内注射给予500μl抗体。在研究期间监测小鼠的一般健康情况。从第-1天直至第21天每天评定临床症状和体重。利用实施例12和13所述的评分等级对临床症状评分,得分范围是0-4。存活的动物在第21天被行安乐死并取血。
表19提供了每组的死亡率,示出在研究期间每个研究组中活小鼠数目。两只小鼠在接种后不久死亡(在第1天,第2组一只,第3组一只),如研究计划中预先指定将其从分析中排除。对照组5中的所有小鼠在第9天全部死亡,与先前用H5N1进行的研究一样(见表18)。这个致死攻击剂量H1N1下存活的动物的百分比在图9中绘出。每组中示出相关临床症状的小鼠的数目在表20中提供。在第1组中未观测到临床症状,而在第2、3和4组中一些小鼠出现临床症状,这些症状在接种后第14天完全消失。第5组的所有小鼠在第2天开始出现临床症状。这个组无小鼠康复。出现得分2或3的呼吸窘迫症状的小鼠的数目在表21中提供。在第1-4组中,在第13天后未观测到临床症状,而对照组5中所有剩余的小鼠均出现严重的呼吸窘迫。
图10示出每个研究组中小鼠的平均体重。显然,在第5组中在第8天后无测量数据可提供。从这个图可以看出,接受抗-H5N1抗体且均从临床症状中康复的所有小鼠在第21天均达到其预期体重水平。
在感染之前或之后给予所述抗体可以保护这些小鼠。显然,感染剂量相当高:25×LD50剂量,表明当所述抗体在肺中高效价存在时,提供非常强的抗病毒保护作用。这是临床相关的,因为高致病性病毒如H5N1在感染后复制为高效价且这些高病毒荷载与感染的人体中频繁出现的严重后果相关。此外,所有被保护的小鼠随着时间均从这个致死感染中完全康复。因此推断结合不具有抗原性漂移倾向的HA2区中的(单一)表位的本发明的抗-H5N1抗体(如CR6261、CR6325和CR6329)提供了对抗多种流感病毒血清型的体内交叉保护作用,不再需要针对高突变敏感性HA1区的抗体。应理解不受仅存在于H5流感病毒血清型的HA中的表位限制,本发明的结合分子也可以用于预防或者治疗在HA2的稳定区中含有相同表位的所有流感病毒血清型如H1N1以及包含H2、H6和H9血凝素蛋白的流感病毒。
实施例15
亲和性研究
使用表面等离子共振分析进行亲和性研究,使用BIAcore3000分析系统在25℃和37℃使用HBS-EP(Biacore AB,Sweden)作为运行缓冲液以75μl/分钟流速进行。使用胺偶联方法将IgG固定在研究级CM5 4-flow channel(Fc)传感器芯片(Biacore AB,Sweden)上。注射不同量的H5N1病毒(A/Vietnam/1203/2004)的HA以分析所述HA蛋白与固定的IgG之间的结合相互作用。在每次测量结束时使用20mM NaOH再生以除去结合的HA,同时使芯片上剩余固定的IgG。
确定CR6261、CR6323和CR6325抗体的亲和性常数。注射五种浓度的4倍稀释的HA(每次注射100μl),随后解离3600秒,使用10μl 20mMNaOH再生。使用1∶1(Langmuir)模型拟合所得数据。然而,不可计算精确的解离常数(KD)。这是由于在25℃非常低的解离速率(甚至用扩展的测量方法测量)导致计算中不可接受的误差所致。当在37℃重复实验时,可辨别的解离发生,但是仍不足以精确测量KD。进行实验以确定抗体的精确KD。据估计这些至少是在单数位nM范围的亲和性,很可能是在pM范围的亲和性。这些实验示出本发明的结合分子对于流感病毒HA蛋白中存在的其表位具有极高的亲和性。
下文提供了本文称作SEQ ID NO:58-143、SEQ ID NO:212-237以及SEQID NO:316-367的核酸和氨基酸序列的详细描述。
SEQ ID NO:58
SEQ ID NO:59
SEQ ID NO:60
SEQ ID NO:61
SEQ ID NO:62
SEQ ID NO:63
SEQ ID NO:64
SEQ ID NO:65
SEQ ID NO:66
SEQ ID NO:67
SEQ ID NO:68
SEQ ID NO:69
SEQ ID NO:70
SEQ ID NO:71
SEQ ID NO:72
SEQ ID NO:73
SEQ ID NO:74
SEQ ID NO:75
SEQ ID NO:76
SEQ ID NO:77
SEQ ID NO:78
SEQ ID N0:79
SEQ ID NO:80
SEQ ID NO:81
SEQ ID NO:82
SEQ ID NO:83
SEQ ID NO:84
SEQ ID NO:85
SEQ ID NO:86
SEQ ID NO:87
SEQ ID NO:88
SEQ ID NO:89
SEQ ID NO:90
SEQ ID NO:91
SEQ ID NO:92
SEQ ID NO:93
SEQ ID NO:94
SEQ ID NO:95
SEQ ID NO:96
SEQ ID NO:97
SEQ ID NO:98
SEQ ID NO:99
SEQ ID NO:100
SEQ ID NO:101
SEQ ID NO:102
SEQ ID NO:103
SEQ ID NO:104
SEQ ID NO:105
SEQ ID NO:106
SEQ ID NO:107
SEQ ID NO:108
SEQ ID NO:109
SEQ ID NO:110
SEQ ID NO:111
SEQ ID NO:112
SEQ ID NO:113
SEQ ID NO:114
SEQ ID NO:115
SEQ ID NO:116
SEQ ID NO:117
SEQ ID NO:118
SEQ ID NO:119
SEQ ID NO:120
SEQ ID NO:121
SEQ ID NO:122
SEQ ID NO:123
SEQ ID NO:124
SEQ ID NO:125
SEQ ID NO:126
SEQ ID NO:127
SEQ ID NO:128
SEQ ID NO:129
SEQ ID NO:130
SEQ ID NO:131
SEQ ID NO:132
SEQ ID NO:133
SEQ ID NO:134
SEQ ID NO:135
SEQ ID NO:136
SEQ ID NO:137
SEQ ID NO:138
SEQ ID NO:139
SEQ ID NO:140
SEQ ID NO:141
SEQ ID NO:142
SEQ ID NO:143
SEQ ID NO:212
SEQ ID NO:213
SEQ ID NO:214
1
SEQ ID NO:215
SEQ ID NO:216
>
SEQ ID NO:217
E
SEQ ID NO:218
SEQ ID NO:219
SEQ ID NO:220
SEQ ID NO:221
SEQ ID NO:222
SEQ ID NO:223
SEQ ID NO:224
SEQ ID NO:225
SEQ ID NO:226
SEQ ID NO:227
SEQ ID NO:228
SEQ ID NO:229
SEQ ID NO:230
SEQ ID NO:231
SEQ ID NO:232
SEQ ID NO:233
SEQ ID NO:234
SEQ ID NO:235
SEQ ID NO:236
SEQ ID NO:237
SEQ ID NO:316
SEQ ID NO:317
SEQ ID NO:318
SEQ ID NO:319
SEQ ID NO:320
SEQ ID NO:321
SEQ ID N0:322
SEQ ID NO:323
SEQ ID NO:324
SEQ ID NO:325
SEQ ID NO:326
SEQ ID NO:327
SEQ ID NO:328
SEQ ID NO:329
SEQ ID NO:330
SEQ ID NO:331
SEQ ID N0:332
SEQ ID NO:333
SEQ ID NO:334
SEQ ID NO:335
SEQ ID NO:336
SEQ ID NO:337
SEQ ID NO:338
SEQ ID NO:339
SEQ ID NO:340
SEQ ID NO:341
SEQ ID NO:342
SEQ ID NO:343
SEQ ID NO:344
SEQ ID NO:345
SEQ ID NO:346
SEQ ID NO:347
SEQ ID NO:348
SEQ ID NO:349
SEQ ID NO:350
SEQ ID NO:351
SEQ ID NO:352
SEQ ID NO:353
SEQ ID NO:354
SEQ ID NO:355
SEQ ID NO:356
SEQ ID NO:357
SEQ ID NO:358
SEQ ID NO:359
SEQ ID NO:360
SEQ ID NO:361
SEQ ID NO:362
SEQ ID NO:363
SEQ ID NO:364
SEQ ID NO:365
SEQ ID NO:366
SEQ ID NO:367
表1:第一轮Vκ,Vλ和VH扩增
*以1∶1∶1比率混合
#以1∶1比率混合
X以1∶1比率混合
+以1∶1比率混合
表2:第二轮Vκ,Vλ和VH扩增
*以1∶1∶1比率混合
#以1∶1比率混合
+以1∶1比率混合
表3.第二轮VL区扩增概括
表4.第二轮VH区扩增概括
表5:个体IgM记忆B细胞文库的特征
表6:HA特异性单链Fv的数据
*括号中示出组成重链可变区(VH)和轻链可变区(VL)的氨基酸
表7:HA特异性免疫球蛋白的CDR区的数据。SEQ ID NO在括号中给出
表8.HA特异性IgG的数据
*括号中示出组成重链可变区(VH)和轻链可变区(VL)的氨基酸
表9.IgG对表达HA(H5N1TV)的PER.C6细胞的结合
*表示在一单独实验中进行的FACS分析
表10.在中和抗体效价测定中的抗HA抗体的效力
*在50μg/ml未观察到中和
表11.在中和抗体效价测定中的抗HA抗体的效力
-是指在100μg/ml未观察到中和
表12.由ELISA(OD 492nm)测定的抗-H5N1 IgG对不同HA亚型的HA分子的交叉反应性.ND:未确定
表13.人抗HA抗体的表位作图.
表22.不同流感病毒亚型中的HA2表位的序列。下划线的氨基酸代表H2N2逃逸突变株(突变体II;表13)中的缬氨酸(V)→谷氨酸(E)取代
参考文献
Boel E et al.(2000),Functional human monoclonal antibodies of allisotypes constructed from phage display library-derived single-chain Fvantibody fragments.J.Immunol.Methods 239:153-166
Burton DR and Barbas CF(1994),Human antibodies from combinatoriallibraries.Adv.Immunol.57:191-280
Chou TC and P Talalay(1984)Quantitative analysis of dose-effectrelationships:the combined effects of multiple drugs or enzyme inhibitors.AdvEnzyme Regul 22:27-55
De Kruif J et al.(1995a),Rapid selection of cell subpopulation-specifichuman monoclonal antibodies from a synthetic phage antibody library.Proc NatlAcad Sci USA 92:3938
De Kruif J et al.(1995b)Selection and application of human single-chainFv antibody fragments from a semi-synthetic phage antibody display librarywith designed CDR3 regions.J.Mol.Biol.248:97-105.
Huls G et al.(1999)Antitumor immune effector mechanisms recruited byphage display-derived fully human IgG1 and IgA1 monoclonal antibodies.Cancer Res 59:5778-5784
Okuno Y et al(1993)A common neutralizing epitope conserved betweenthe hemagglutinins of Influenza A virus H1 and H2 strains.J.Virol.67:2552-2558.
Slootstra JW et al.(1996)Structural aspects of antibody-antigen interactionrevealed through small random peptide libraries.Mol.Divers.1:87-96.
Smirnov YA et al(1999)An epitope shared by the hemagglutinins of H1,H2,H5 and H6 subtypes of influenza A virus.Acta Virol.43:237-244.
The World Health Organization Global Influenza Program SurveillanceNetwork(2005),Evolution of H5N1 Avian Influenza Viruses in Asia.EmergInfect Dis 11:1515-1521
序列表
<110>克鲁塞尔荷兰公司
<120>能中和流感病毒H5N1的人结合分子及其应用
<130>0145WO 00ORD
<140>PCT/EP2007/059356
<141>2007-09-06
<150>US 60/842,930
<151>2006-09-07
<150>EP 06120316.2
<151>2006-09-07
<150>EP 06120644.7
<151>2006-09-14
<150>EP 06125107.0
<151>2006-11-30
<150>EP 07111235.3
<151>2007-06-28
<160>377
<170>PatentIn version 3.3
<210>1
<211>5
<212>PRT
<213>Homo sapiens
<400>1
Ser Tyr Ala Ile Ser
1 5
<210>2
<211>17
<212>PRT
<213>Homo sapiens
<400>2
Gly Ile Ile Pro Ile Phe Gly Thr Thr Lys Tyr Ala Pro Lys Phe Gln
1 5 10 15
Gly
<210>3
<211>12
<212>PRT
<213>Homo sapiens
<400>3
Gis Met Gly Tyr Gln Val Arg Glu Thr Met Asp Val
1 5 10
<210>4
<211>13
<212>PRT
<213>Homo sapiens
<400>4
Ser Gly Ser Thr Phe Asn Ile Gly Ser Asn Ala Val Asp
1 5 10
<210>5
<211>7
<212>PRT
<213>Homo sapiens
<400>5
Ser Asn Asn Gln Arg Pro Ser
1 5
<210>6
<211>11
<212>PRT
<213>Homo sapiens
<400>6
Ala Ala Trp Asp Asp Ile Leu Asn Val Pro Val
1 5 10
<210>7
<211>14
<212>PRT
<213>Homo sapiens
<400>7
Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr Asn Tyr Val Ser
1 5 10
<210>8
<211>7
<212>PRT
<213>Homo sapiens
<400>8
Glu Val Ser Asn Arg Pro Ser
1 5
<210>9
<211>10
<212>PRT
<213>Homo sapiens
<400>9
Ser Ser Tyr Thr Ser Ser Ser Thr Tyr Val
1 5 10
<210>10
<211>13
<212>PRT
<213>Homo sapiens
<400>10
Ser Gly Ser Arg Ser Asn Val Gly Asp Asn Ser Val Tyr
1 5 10
<210>11
<211>7
<212>PRT
<213>Homo sapiens
<400>11
Lys Asn Thr Gln Arg Pro Ser
1 5
<210>12
<211>11
<212>PRT
<213>Homo sapiens
<400>12
Val Ala Trp Asp Asp Ser Val Asp Gly Tyr Val
1 5 10
<210>13
<211>13
<212>PRT
<213>Homo sapiens
<400>13
Ser Gly Ser Ser Ser Asn Ile Gly Asn Asp Tyr Val Ser
1 5 10
<210>14
<211>7
<212>PRT
<213>Homo sapiens
<400>14
Asp Asn Asn Lys Arg Pro Ser
1 5
<210>15
<211>12
<212>PRT
<213>Homo sapiens
<400>15
Ala Thr Trp Asp Arg Arg Pro Thr Ala Tyr Val Val
1 5 10
<210>16
<211>5
<212>PRT
<213>Homo sapiens
<400>16
Gly Ser Ala Ile Ser
1 5
<210>17
<211>17
<212>PRT
<213>Homo sapiens
<400>17
Gly Ile Ser Pro Leu Phe Gly Thr Thr Asn Tyr Ala Gln Lys Phe Gln
1 5 10 15
Gly
<210>18
<211>11
<212>PRT
<213>Homo sapiens
<400>18
Gly Pro Lys Tyr Tyr Ser Glu Tyr Met Asp Val
1 5 10
<210>19
<211>11
<212>PRT
<213>Homo sapiens
<400>19
Arg Ala Ser Gln Gly Ile Ser Ser Tyr Leu Ala
1 5 10
<210>20
<211>7
<212>PRT
<213>Homo sapiens
<400>20
Asp Ala Ser Thr Leu Arg Ser
1 5
<210>21
<211>10
<212>PRT
<213>Homo sapiens
<400>21
Gln Arg Tyr Asn Ser Ala Pro Pro Ile Thr
1 5 10
<210>22
<211>17
<212>PRT
<213>Homo sapiens
<400>22
Gly Ile Met Gly Met Phe Gly Thr Thr Asn Tyr Ala Gln Lys Phe Gln
1 5 10 15
Gly
<210>23
<211>11
<212>PRT
<213>Homo sapiens
<400>23
Ser Ser Gly Tyr Tyr Pro Glu Tyr Phe Gln Asp
1 5 10
<210>24
<211>11
<212>PRT
<213>Homo sapiens
<400>24
Ser Gly His Lys Leu Gly Asp Lys Tyr Val Ser
1 5 10
<210>25
<211>7
<212>PRT
<213>Homo sapiens
<400>25
Gln Asp Asn Arg Arg Pro Ser
1 5
<210>26
<211>9
<212>PRT
<213>Homo sapiens
<400>26
Gln Ala Trp Asp Ser Ser Thr Ala Val
1 5
<210>27
<211>5
<212>PRT
<213>Homo sapiens
<400>27
Ser Tyr Ser Met Asn
1 5
<210>28
<211>17
<212>PRT
<213>Homo sapiens
<400>28
Ser Ile Ser Ser Ser Ser Ser Tyr Ile Tyr Tyr Val Asp Ser Val Lys
1 5 10 15
Gly
<210>29
<211>13
<212>PRT
<213>Homo sapiens
<400>29
Gly Gly Gly Ser Tyr Gly Ala Tyr Glu Gly Phe Asp Tyr
1 5 10
<210>30
<211>11
<212>PRT
<213>Homo sapiens
<400>30
Arg Ala Ser Gln Arg Val Ser Ser Tyr Leu Ala
1 5 10
<210>31
<211>7
<212>PRT
<213>Homo sapiens
<400>31
Gly Ala Ser Thr Arg Ala Ala
1 5
<210>32
<211>9
<212>PRT
<213>Homo sapiens
<400>32
Gln Gln Tyr Gly Arg Thr Pro Leu Thr
1 5
<210>33
<211>11
<212>PRT
<213>Homo sapiens
<400>33
Gly Gly Asn Asn Ile Gly Ser Lys Ser Val His
1 5 10
<210>34
<211>7
<212>PRT
<213>Homo sapiens
<400>34
Asp Asp Ser Asp Arg Pro Ser
1 5
<210>35
<211>11
<212>PRT
<213>Homo sapiens
<400>35
Gln Val Trp Asp Ser Ser Ser Asp His Ala Val
1 5 10
<210>36
<211>13
<212>PRT
<213>Homo sapiens
<400>36
Ser Gly Ser Ser Ser Asn Ile Gly Ser Asn Tyr Val Tyr
1 5 10
<210>37
<211>7
<212>PRT
<213>Homo sapiens
<400>37
Arg Asp Gly Gln Arg Pro Ser
1 5
<210>38
<211>11
<212>PRT
<213>Homo sapiens
<400>38
Ala Thr Trp Asp Asp Asn Leu Ser Gly Pro Val
1 5 10
<210>39
<211>5
<212>PRT
<213>Homo sapiens
<400>39
Ser Tyr Gly Ile Ser
1 5
<210>40
<211>17
<212>PRT
<213>Homo sapiens
<400>40
Asp Ile Ile Gly Met Phe Gly Ser Thr Asn Tyr Ala Gln Asn Phe Gln
1 5 10 15
Gly
<210>41
<211>11
<212>PRT
<213>Homo sapiens
<400>41
Ser Ser Gly Tyr Tyr Pro Ala Tyr Leu Pro His
1 5 10
<210>42
<211>12
<212>PRT
<213>Homo sapiens
<400>42
Arg Ala Ser Gln Ser Val Ser Ser Ser Tyr Leu Ala
1 5 10
<210>43
<211>7
<212>PRT
<213>Homo sapiens
<400>43
Gly Ala Ser Ser Arg Ala Thr
1 5
<210>44
<211>9
<212>PRT
<213>Gomo sapiens
<400>44
Gln Gln Tyr Gly Ser Ser Pro Arg Thr
1 5
<210>45
<211>5
<212>PRT
<213>Homo sapiens
<400>45
Phe Tyr Ser Met Ser
1 5
<210>46
<211>17
<212>PRT
<213>Homo sapiens
<400>46
Gly Ile Ile Pro Met Phe Gly Thr Thr Asn Tyr Ala Gln Lys Phe Gln
1 5 10 15
Gly
<210>47
<211>12
<212>PRT
<213>Homo sapiens
<400>47
Gly Asp Lys Gly Ile Tyr Tyr Tyr Tyr Met Asp Val
1 5 10
<210>48
<211>10
<212>PRT
<213>Homo sapiens
<400>48
Ser Ser Tyr Thr Ser Ser Ser Thr Leu Val
1 5 10
<210>49
<211>17
<212>PRT
<213>Homo sapiens
<400>49
Gly Ile Ile Gly Met Phe Gly Thr Ala Asn Tyr Ala Gln Lys Phe Gln
1 5 10 15
Gly
<210>50
<211>11
<212>PRT
<213>Homo sapiens
<400>50
Gly Asn Tyr Tyr Tyr Glu Ser Ser Leu Asp Tyr
1 5 10
<210>51
<211>11
<212>PRT
<213>Homo sapiens
<400>51
Gln Val Trp Asp Ser Ser Ser Asp His Tyr Val
1 5 10
<210>52
<211>5
<212>PRT
<213>Homo sapiens
<400>52
Asn Tyr Ala Met Ser
1 5
<210>53
<211>17
<212>PRT
<213>Homo sapiens
<400>53
Gly Ile Ile Ala Ile Phe Gly Thr Pro Lys Tyr Ala Gln Lys Phe Gln
1 5 10 15
Gly
<210>54
<211>14
<212>PRT
<213>Homo sapiens
<400>54
Ile Pro His Tyr Asn Phe Gly Ser Gly Ser Tyr Phe Asp Tyr
1 5 10
<210>55
<211>14
<212>PRT
<213>Homo sapiens
<400>55
Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly Tyr Asp Val His
1 5 10
<210>56
<211>7
<212>PRT
<213>Homo sapiens
<400>56
Gly Asn Ser Asn Arg Pro Ser
1 5
<210>57
<211>11
<212>PRT
<213>Homo sapiens
<400>57
Gly Thr Trp Asp Ser Ser Leu Ser Ala Tyr Val
1 5 10
<210>58
<211>1353
<212>DNA
<213>Homo sapiens
<220>
<221>CDS
<222>(1)..(1353)
<400>58
gag gtg cag ctg gtg gag tct ggg gct gag gtg aag aag cct ggg tcc 48
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aaa gtc tct tgc aag gct tct gga ggc ccc ttc cgc agc tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Arg Ser Tyr
20 25 30
gct atc agc tgg gtg cga cag gcc cct gga caa ggg cct gag tgg atg 144
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Pro Glu Trp Met
3 540 45
gga ggg atc atc cct att ttt ggt aca aca aaa tac gca ccg aag ttc 192
Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Lys Tyr Ala Pro Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac gat ttc gcg ggc aca gtt tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Asp Phe Ala Gly Thr Val Tyr
65 70 75 80
atg gag ctg agc agc ctg cga tct gag gac acg gcc atg tac tac tgt 288
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
gcg aaa cat atg ggg tac cag gtg cgc gaa act atg gac gtc tgg ggc 336
Ala Lys His Met Gly Tyr Gln yal Arg Glu Thr Met Asp Val Trp Gly
100 105 110
aaa ggg acc acg gtc acc gtc tcg agt gct agc acc aag ggc ccc agc 384
Lys Gly Thr Thr Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser
115 120 125
gtg ttc ccc ctg gcc ccc agc agc aag agc acc agc ggc ggc aca gcc 432
Vel Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala
130 135 140
gcc ctg ggc tgc ctg gtg aag gac tacttc ccc gag ccc gtg acc gtg 480
Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val
145 150 155 160
agc tgg aac agc ggc gcc ttg acc agc ggc gtg cac acc ttc ccc gcc 528
Ser Trp Asp Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala
165 170 175
gtg ctg cag agc agc ggc ctg tac agc ctg agc agc gtg gtg acc gtg 576
Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val
180 185 190
ccc agc agc agc ctg ggc acc cag acc tec atc tgc aac gtg aac cac 624
Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Vel Asn His
195 200 205
aag ccc agc aac acc aag gtg gac aaa cgc gtg gag ccc aag agc tgc 672
Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys
210 215 220
gac aag acc cac acc tgc ccc ccc tgc cct gcc ccc gag ctg ctg ggc 720
Asp Lys Thr Gis Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Lgu Gly
225 230 235 240
gga ccc tcc gtg ttc ctg ttc ccc ccc aag ccc aag gac acc ctc atg 768
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met
245 250 255
atc agc cgg acc ccc gag gtg acc tgc gtg gtg gtg gac gtg agc cac 816
Lle Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His
260 265 270
gag gac ccc gag gtg aag ttc aac tgg tac gtg gac ggc gtg gag gtg 864
Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp GlyVal Glu Val
275 280 285
cac aac gcc aag acc aag ccc cgg gag gag cag tac aac agc acc tac 912
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr
290 295 300
cgg gtg gtg agc gtg ctc acc gtg ctg cac cag gac tgg ctg aac ggc 960
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly
305 310 315 320
aag gag tac aag tgc aag gtg agc aac aag gcc ctg cct gcc ccc atc 1008
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile
325 330 335
gag aag acc arc agc aag gcc aag ggc cag ccc cgg gag ccc cag gtg 1056
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val
340 345 350
tac acc ctg ccc ccc agc cgg gag gag atg acc aag aac cag gtg tcc 1104
Tyr Thr Leu Pro Pro Ser Arb Glu Glu Met Thr Lys Asn Gln Val Ser
355 360 365
ctc acc tgt ctg gtg aag ggc ttc tac ccc agc gac atc gcc gtg gag 1152
Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu
370 375 380
tgg gag agc aac ggc cag ccc gag aac aac tac aag acc acc ccc cct 1200
Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro
385 390 395 400
gtg ctg gac agc gac ggc agc ttc ttc ctg tac agc aag ctc acc gtg 1248
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val
405 410 415
gac aag agc cgg tgg cag cag ggc aac gtg ttc agc tgc agc gtg atg 1296
Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met
420 425 430
cac gag gcc ctg cac aac cac tac acc cag aag agc ctg agc ctg agc 1344
His Glu Ala Leu His Asn His Tyr Thr Gln LyS Ser Leu Ser Leu Ser
435 440 445
ccc ggc aag 1353
Pro Gly Lys
450
<210>59
<211>451
<212>PRT
<213>Homo sapiens
<400>59
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Arg Ser Tyr
20 25 30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Pro Glu Trp Met
35 40 45
Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Lys Tyr Ala Pro Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Asp Phe Ala Gly Thr Val Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Lys His Met Gly Tyr Gln Val Arg Glu Thr Met Asp Val Trp Gly
100 105 110
Lys Gly Thr Thr Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser
115 120 125
Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala
130 135 140
Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val
145 150 155 160
Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala
165 170 175
Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val
180 185 190
Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His
195 200 205
Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys
210 215 220
Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly
225 230 235 240
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met
245 250 255
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His
260 265 270
Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val
275 280 285
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr
290 295 300
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly
305 310 315 320
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile
325 330 335
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val
340 345 350
Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser
355 360 365
Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu
370 375 380
Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro
385 390 395 400
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val
405 410 415
Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met
420 425 430
His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser
435 440 445
Pro Gly Lys
450
<210>60
<211>1353
<212>DNA
<213>Homo sapiens
<220>
<221>CDS
<222>(1)..(1353)
<400>60
cag gtc cag ctg gtg cag tct ggg gct gag gtg aag aag cct ggg tcc 48
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aaa gtc tct tgc aag gct tct gga ggc ccc ttc cgc agc tat
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Arg Ser Tyr 96
20 25 30
gct atc agc tgg gtg cga cag gcc cct gga caa ggg cct gag tgg atg 144
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Pro Glu Trp Met
35 40 45
gga ggg atc atc cct att ttt ggt aca aca aaa tac gca ccg aag ttc 192
Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Lys Tyr Ala Pro Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac gat ttc gcg ggc aca gtt tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Asp Phe Ala Gly Thr Val Tyr
65 70 75 80
atg gag ctg agc agc ctg cga tct gag gac acg gcc atg tac tac tgt 288
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
gcg aaa cat atg ggg tac cag gtg cgc gaa act atg gac gtc tgg ggc 336
Ala Lys His Met Gly Tyr Gln Val Arg Glu Thr Met Asp Val Trp Gly
100 105 110
aaa ggg acc acg gtc acc gtc tcg agt gct agc acc aag ggc ccc agc 384
Lys Gly Thr Thr Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser
115 120 125
gtg ttc ccc ctg gcc ccc agc agc aag agc acc agc ggc ggc aca gcc 432
Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala
130 135 140
gcc ctg ggc tgc ctg gtg aag gac tac ttc ccc gag ccc gtg acc gtg 480
Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val
145 150 155 160
agc tgg aac agc ggc gcc ttg acc agc ggc gtg cac acc ttc ccc gcc 528
Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala
165 170 175
gtg ctg cag agc agc ggc ctg tac agc ctg agc agc gtg gtg acc gtg 576
Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val
180 185 190
ccc agc agc agc ctg ggc acc cag acc tac atc tgc aac gtg aac cac 624
Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His
195 200 205
aag ccc agc aac acc aag gtg gac aaa cgc gtg gag ccc aag agc tgc 672
Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys
210 215 220
gac aag acc cac acc tgc ccc ccc tgc cct gcc ccc gag ctg ctg ggc 720
Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly
225 230 235 240
gga ccc tcc gtg ttc ctg ttc ccc ccc aag ccc aag gac acc ctc atg 768
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro LysAsp Thr Leu Met
245 250 255
atc agc cgg acc ccc ag gt acc tgc gtg gtg gtg gac gtg agc cac 816
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His
260 265 270
gag gac ccc gag gtg aag ttc aac tgg tac gtg gac ggc gtg gag gtg 864
Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val
275 280
cac aac gcc aag acc aag ccc cgg gag gag cag tac aac agc acc tac 912
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr
290 295 300
cgg gtg gtg agc gtg ctc acc gtg ctg cac cag gac tgg ctg aac ggc
Arg Val Val Ser Val Leu Thr Val Leu Gis Gln Asp Trp Leu Asn Gly
305 310 315 320
aag Gag tac aag tgc aag gtg agc aac aag gcc ctg cct gcc ccc atc
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile 1008
325 330 335
gag aag acc atc agc aag gcc aag ggc cag ccc cgg gag ccc cag gtg 1056
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val
340 345 350
tac acc ctg ccc ccc agc cgg gag gag atg acc aag aac cag gtg tcc 1104
Tyr Thr Leu Pro Pro Ser Arg Gluu Glu Met Thr Lys Asn Gln Val Ser
355 360 365
ctc acc tgt ctg gtg aag ggc ttc tac ccc agc gac atc gcc gtg gag 1152
Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp lle Ala Val Glu
370 375 380
tgg gag agc aac ggc cag ccc gag aac aac tac aag acc acc ccc cct 1200
Trp Gluu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro
385 390 395 400
gtg ctg gac agc gac ggc agc ttc ttc ctg tac agc aag ctc acc gtg 1248
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val
405 410 415
gac aag agc cgg tgg cag cag ggc aac gtg ttc agc tgc agc gtg atg 1296
Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met
420 425 430
cac gag gcc ctg cac aac cac tac acc cag aag agc ctg agc ctg agc 1344
His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser
435 440 445
ccc ggc aag 1353
Pro Gly Lys
450
<210>61
<211>451
<212>PRT
<213>Homo sapiens
<400>61
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Arg Ser Tyr
20 25 30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Pro Glu Trp Met
35 40 45
Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Lys Tyr Ala Pro Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Asp Phe Ala Gly Thr Val Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Lys His Met Gly Tyr Gln Val Arg Glu Thr Met Asp Val Trp Gly
100 105 110
Lys Gly Thr Thr Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser
115 120 125
Val Phe Pro Leu hla Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala
130 135 140
Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val
145 150 155 160
Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala
165 170 175
Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val
180 185 190
Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His
195 200 205
Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys
210 215 220
Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly
225 230 235 240
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met
245 250 255
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His
260265270
Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val
275 280 285
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr
290 295 300
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly
305 310 315 320
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile
325 330 335
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val
340 345 350
Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser
355 360 365
Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu
370 375 380
Trp Glu Ser Asn Gly Gln Pro Glu Ash Asn Tyr Lys Thr Thr Pro Pro
385 390 395 400
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val
405 410 415
Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met
420 430 425
His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser
435 440 445
Pro Gly Lys
450
<210>62
<21l>1353
<212>DNA
<213>Homo sapiens
<220>
<221>CDS
<222>(1)..(1353)
<400>62
gag gtg cag ctg gtg gag tct ggg gct gag gtg aag aag cct ggg tcc 48
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aaa gtc tct tgc aag gct tct gga ggc ccc ttc cgc agc tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Arg Ser Tyr
20 25 30
gct atc agc tgg gtg cga cag gcc cct gga caa ggg cct gag tgg atg 144
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Pro Glu Trp Met
35 40 45
gga ggg atc atc cct att ttt ggt aca aca aaa tac gca ccg aag ttc 192
Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Lys Tyr Ala Pro Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac gat ttc gcg ggc aca gtt tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Asp Phe Ala Gly Thr Val Tyr
65 70 75 80
atg gag ctg agc agc ctg cga tct gag gac acg gcc atg tac tac tgt 288
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
gcg aaa cat atg ggg tac cag gtg cgc gaa act atg gac gtc tgg ggc 336
Ala Lys His Met Gly Tyr Gln Val Arg Glu Thr Met Asp Val Trp Gly
100 105 110
aaa ggg acc acg gtc acc gtc tcg agt gct agc acc aag ggc ccc agc 384
Lys Gly Thr Thr Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser
115 120 125
gtg ttc ccc ctg gcc ccc agc agc aag agc acc agc ggc ggc aca gcc 432
Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala
130 135 140
gcc ctg ggc tgc ctg gtg aag gac tac ttc ccc gag ccc gtg acc gtg 480
Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val
145 150 155 160
agc tgg aac agc ggc gcc ttg acc agc ggc gtg cac acc ttc ccc gcc 528
Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala
165 170 175
gtg ctg cag agc agc ggc ctg tac agc ctg agc agc gtg gtg acc gtg 576
Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val
180 185 190
ccc agc agc agc ctg ggc acc cag acc tac atc tgc aac gtg aac cac 624
Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His
195 200 205
aag ccc agc aac acc aag gtg gac aaa cgc gtg gag ccc aag agc tgc 672
Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys
210 215 220
gac aag acc cac acc tgc ccc ccc tgc cct gcc ccc gag ctg ctg ggc 720
Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly
225 230 235 240
gga ccc tcc gtg ttc ctg ttc ccc ccc aag ccc aag gac acc ctc atg 768
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met
245 250 255
atc agc cgg acc ccc gag gtg acc tgc gtg gtg gtg gac gtg agc cac 816
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His
260 265 270
gag gac ccc gag gtg aag ttc aac tgg tac gtg gac ggc gtg gag gtg 864
Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val
275 280 285
cac aac gcc aag acc aag ccc cgg gag gag cag tac aac agc acc tac 912
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr
290 295 300
cgg gtg gtg agc gtg ctc acc gtg ctg cac cag gac tgg ctg aac ggc 960
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly
305 310 315 320
aag gag tac aag tgc aag gtg agc aac aag gcc ctg cct gcc ccc atc 1008
Lys Glu Tyr Lys Cys Lys Val Leu Ser Lys Ala Leu Pro Ala Pro Ile
325 330 335
gag aag acc atc agc aag gcc aag ggc cag ccc cgg gag ccc cag gtg 1056
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val
340 345 350
tac acc ctg ccc ccc agc cgg gag gag atg acc aag aac cag gtg tcc 1104
Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser
355 360 365
ctc acc tgt ctg gtg aag ggc ttc tac ccc agc gac atc gcc gtg gag 1152
Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu
370 375 380
tgg gag agc aac ggc cag ccc gag aac aac tac aag acc acc ccc cct 1200
Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro
385 390 395 400
gtg ctg gac agc gac ggc agc ttc ttc ctg tac agc aag ctc acc gtg 1248
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val
405 410 415
gac aag agc cgg tgg cag cag ggc aac gtg ttc agc tgc agc gtg atg 1296
Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met
420 425 430
cac gag gcc ctg cac aac cac tac acc cag aag agc ctg agc ctg agc 1344
His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser
435 440 445
ccc ggc aag 1353
Pro Gly Lys
450
<210>63
<211>451
<212>PRT
<213>Homo sapiens
<400>63
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Arg Ser Tyr
20 25 30
Ala lle Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Pro Glu Trp Met
35 40 45
Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Lys Tyr Ala Pro Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Asp Phe Ala Gly Thr Val Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Lys His Met Gly Tyr Gln Val Arg Glu Thr Met Asp Val Trp Gly
100 105 110
Lys Gly Thr Thr Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser
115 120 125
Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala
130 135 140
Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val
145 150 155 160
Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala
165 170 175
Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val
180 185 190
Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Ash Val Asn His
195 200 205
Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys
210 215 220
Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly
225 230 235 240
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met
245 250 255
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His
260 265 270
Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly ValGlu Val
275 280 285
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr
290 295 300
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly
305 310 315 320
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile
325 330 335
Glu Lys Thr Ile Ser Lys Ala Lys GlyGln Pro Arg Glu Pro Gln Val
340 345 350
Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln ValSer
355 360 365
Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu
370 375 380
Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro
385 390 395 400
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val
405 410 415
Asp Lys Ser Arg Trp Gln Gln Gly Asn ValPhe Ser Cys Ser Val Met
420 425 430
His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser
435 440 445
Pro Gly Lys
450
<210>64
<211>1353
<212>DNA
<213>Homo sapiens
<220>
<221>CDS
<222>(1)..(1353)
<400>64
gag gtg cag ctg gtg gag tct ggg gct gag gtg aag aag cct ggg tcc 48
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aaa gte tct tgc aag gct tct gga ggc ccc ttc cgc agc tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Arg Ser Tyr
20 25 30
gcg atc agc tgg gtg cga cag gcc cct gga caa ggg cct gag tgg atg 144
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Pro Glu Trp Met
35 40 45
gga ggg atc atc cct att ttt ggt aca aca aaa tac gca ccg aag ttc 192
Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Lys Tyr Ala Pro Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac gat ttc gcg ggc aca gtt tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Asp Phe Ala Gly Thr Val Tyr
65 70 75 80
atg gag ctg agc agc ctg cga tct gag gac acg gcc atg tac tac tgt 288
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
gcg aaa cat atg ggg tac cag gtg cgc gaa act atg gac gtc tgg ggc 336
Ala Lys His Met Gly Tyr Gln Val Arg Glu Thr Met Asp Val Trp Gly
100 105 110
aaa ggg acc acg gtc acc gtc tcg agt gct agc acc aag ggc ccc agc 384
Lys Gly Thr Thr Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser
115 120 125
gtg ttc ccc ctg gcc ccc agc agc aag agc acc agc ggc ggc aca gcc 432
Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala
130 135 140
gcc ctg ggc tgc ctg gtg aag gac tac ttc ccc gag ccc gtg acc gtg 480
Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val
145 150 155 160
agc tgg aac agc ggc gcc ttg acc agc ggc gtg cac acc ttc ccc gcc 528
Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Acc
165 170 175
gtg ctg cag agc agc ggc ctg tac agc ctg agc agc gtg gtg acc gtg 576
Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val
180 185 190
ccc agc agc agc ctg ggc acc cag acc tac atc tgc aac gtg aac cac 624
Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His
195 200 205
aag ccc agc aac acc aag gtg gac aaa cgc gtg gag ccc aag agc tgc 672
Lys Pro Ser Asn Thr Lys Val Asp Lys Arg ValGlu Pro Lys Ser Cys
210 215 220
gac aag acc cac acc tgc ccc ccc tgc cct gcc ccc gag ctg ctg ggc 720
Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly
225 230 235 240
gga ccc tcc gtg ttc ctg ttc ccc ccc aag ccc aag gac acc ctc atg 768
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met
245 250 255
atc agc cgg acc ccc gag gtg acc tgc gtg gtg gtg gac gtg agc cac 816
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His
260 265 270
gag gac ccc gag gtg aag ttc aac tgg tac gtg gac ggc gtg gag gtg 864
Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val
275 280 285
cac aac gcc aag acc aag ccc cgg gag gag cag tac aac agc acc tac 912
His Asn Ala Lys Thr Lys Pro Arg GluGlu Gln Tyr Asn Ser Thr Tyr
290 295 300
cgg gtg gtg agc gtg ctc acc gtg ctg cac cag gac tgg ctg aac ggc 960
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly
305 310 315 320
aag gag tac aag tgc aag gtg agc aac aag gcc ctg cct gcc ccc atc 1008
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile
325 330 335
gag aag acc atc agc aag gcc aag ggc cag ccc cgg gag ccc cag gtg 1056
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val
340 345 350
tac acc ctg ccc ccc agc cgg gag gag atg acc aag aac cag gtg tcc 1104
Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser
355 360 365
ctc acc tgt ctg gtg aag ggc ttc tac ccc agc gac atc gcc gtg gag 1152
Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu
370 375 380
tgg gag agc aac ggc cag ccc gag aac aac tac aag acc acc ccc cct 1200
Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro
385 390 395 400
gtg ctg gac agc gac ggc agc ttc ttc ctg tac agc aag ctc acc gtg 1248
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val
405 410 415
gac aag agc cgg tgg cag cag ggc aac gtg ttc agc tgc agc gtg atg 1296
Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met
420 425 430
cac gag gcc ctg cac aac cac tac acc cag aag agc ctg agc ctg agc 1344
His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser
435 440 445
ccc ggc aag 1353
Pro Gly Lys
450
<210>65
<211>451
<212>PRT
<213>Homo sapiens
<400>65
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Arg Ser Tyr
20 25 30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Pro Glu Trp Met
35 40 45
Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Lys Tyr Ala Pro Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Asp Phe Ala Gly Thr Val Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Lys His Met Gly Tyr Gln Val Arg Glu Thr Met Asp Val Trp Gly
100 105 110
Lys Gly Thr Thr Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser
115 120 125
Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala
130 135 140
Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val
145 150 155 160
Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala
165 170 175
Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val
180 185 190
Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His
195 200 205
Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys
210 215 220
Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly
225 230 235 240
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met
245 250 255
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Sar His
260 265 270
Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val
275 280 285
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr
290 295 300
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly
305 310 315 320
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile
325 330 335
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val
340 345 350
Tyr Thr Leu Pro Pro SerArg Glu Glu Mer Thr Lys Asn Gln Val Ser
355 360 365
Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu
370 375 380
Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro
385 390 395 400
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val
405 410 415
Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met
420 425 430
His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser
435 440 445
Pro Gly Lys
450
<210>66
<211>1350
<212>DNA
<213>Homo sapiens
<220>
<221>CDS
<222>(1)..(1350)
<400>66
cag gta cag ctg cag cag tca ggg gct gag gtg aag aag cct ggg tcc 48
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aag gtc tcc tgc aag gtt tcc ga gtc att ttc agc ggc agt 96
Ser Val Lys Val Ser Cys Lys Val Ser Gly Val Ile Phe Ser Gly Ser
20 25 30
gcg atc agc tgg gtg cga cag gcc cct gga caa ggc ctt gag tgg atg
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga ggg atc agc cct ctc ttt ggc aca aca aat tac gca caa aag ttc 192
Gly Gly Ile Ser Pro Leu Phe Gly Thr Thr Asn Tyr Ala Gln Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac caa tcc acg aac aca acc tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Gln Ser Thr Asn Thr Thr Tyr
65 70 75 80
atg gag gtg aac agc ctg aga tat gag gac acg gcc gtg tat ttc tgt 288
Met Glu Val Asn Ser Leu Arg Tyr Glu Asp Thr Ala Val Tyr Phe Cys
85 90 95
gcg cga ggt cca aaa tat tac agt gag tac atg gac gtc tgg ggc aaa 336
Ala Arg Gly Pro Lys Tyr Tyr Ser Glu Tyr Met Asp Val Trp Gly Lys
100 105 110
ggg acc acg gtc acc gtc tcg agt gct agc acc aag ggc ccc agc gtg 384
Gly Thr Thr Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val
115 120 125
ttc ccc ctg gcc ccc agc agc aag agc acc agc ggc ggc aca gcc gcc 432
Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly ThrAla Ala
130 135 140
ctg ggc tgc ctg gtg aag gac tac ttc ccc gag ccc gtg acc gtg agc 480
Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser
145 150 155 160
tgg aac agc ggc gcc ttg acc agc ggc gtg cac acc ttc ccc gcc gtg 528
Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val
165 170 175
ctg cag agc agc ggc ctg tac agc ctg agc agc gtg gtg acc gtg ccc 576
Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro
180 185 190
agc agc agc ctg ggc acc cag acc tac atc tgc aac gtg aac cac aag 624
Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys
195 200 205
ccc agc aac acc aag gtg gac aaa cgc gtg gag ccc aag agc tgc gac 672
Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp
210 215 220
aag acc cac acc tgc ccc ccc tgc cct gcc ccc gag ctg ctg ggc gga 720
Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly
225 230 235 240
ccc tcc gtg ttc ctg ttc ccc ccc aag ccc aag gac acc ctc atg atc 768
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
agc cgg acc ccc gag gtg acc tgc gtg gtg gtg gac gtg agc cac gag 816
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu
260 265 270
gac ccc gag gtg aag ttc aac tgg tac gtg gac ggc gtg gag gtg cac 864
Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
aac gcc aag acc aag ccc cgg gag gag cag tac aac agc acc tac cgg 912
Asn Ala Lys Thr Lys Pro ArgGluGlu Gln Tyr Asn Ser Thr Tyr Arg
290 295 300
gtg gtg agc gtg ctc acc gtg ctg cac caggac tgg ctg aac ggc aag 960
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
gag tac aag tgc aag gtg agc aac aag gcc ctg cct gcc ccc atc gag 1008
Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu
325 330 335
aag acc atc agc aag gcc aag ggc cag ccc cgg gag ccc cag gtg tac 1056
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
acc ctg ccc ccc agc cgg gag gag atg acc aag aac cag gtg tcc ctc 1104
Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
acc tgt ctg gtg aag ggc ttc tac ccc agc gac atc gcc gtg gag tgg 1152
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
gag agc aac ggc cag ccc gag aac aac tac aag acc acc ccc cct gtg 1200
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
ctg gac agc gac ggc agc ttc ttc ctg tac agc aag ctc acc gtg gac 1248
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp
405 410 415
aag agc cgg tgg cag cag ggc aac gtg ttc agc tgc agc gtg atg cac 1296
Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
gag gcc ctg cac aac cac tac acc cag aag agc ctg agc ctg agc ccc 1344
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro
435 440 445
ggc aag 1350
Gly Lys
450
<210>67
<211>450
<212>PRT
<213>Homo sapiens
<400>67
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Val Ser Gly Val Ile Phe Ser Gly Ser
20 25 30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Mer
35 40 45
Gly Gly Ile Ser Pro Leu Phe Gly Thr Thr Asn Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Gln Ser Thr Asn Thr Thr Tyr
65 70 75 80
Met Glu Val Asn Ser Leu Arg Tyr Glu Asp Thr Ala Val Tyr Phe Cys
85 90 95
Ala Arg Gly Pro Lys Tyr Tyr Ser Glu Tyr Met Asp Val Trp Gly Lys
100 105 110
Gly Thr Thr Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val
115 120 125
Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala
130 135 140
Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser
145 150 155 160
Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val
165 170 175
Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro
180 185 190
Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys
195 200 205
Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp
210 215 220
Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly
225 230 235 240
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu
260 265 270
Asp Pro Glu Val Lys Phe Ash Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
Ash Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Ash Ser Thr Tyr Arg
290 295 300
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu
325 330 335
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp
405 410 415
Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro
435 440 445
Gly Lys
450
<210>68
<211>1350
<212>DNA
<213>Homo sapiens
<220>
<221>CDS
<222>(1)..(1350)
<400>68
cag gtc cag ctg gta cag tct ggg gct gag gtg aag aag cct ggg tcc 48
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aag gtc tcc tgc aag gct tct gga ggc acc ttc agt agt tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr
20 25 30
gct atc agc tgg gtg cga cag gcc cct gga caa ggg ctt gag tgg atg 144
Ala Ile Ser Trp Val Arg GlnAla Pro Gly Gln Gly LeuGlu Trp Met
35 40 45
gga gga atc atg ggt atg ttt ggc aca act aac tac gca cag aag ttc 192
Gly Gly Ile Met Gly Met Phe Gly Thr Thr Asn Tyr Ala Gln Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac gaa ttc acg agc gca gcc tac
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Phe Thr Ser Ala Ala Tyr 240
65 70 75 80
atg gag ctg agg agc ctg aga tct gag gac acg gcc gtc tac tac tgt 288
Met Glu Leu Arg Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
gcg agg tct agt ggt tat tac ccc gaa tac ttc cag gac tgg ggc cag 336
Ala Arg Ser Ser Gly Tyr Tyr Pro Glu Tyr Phe Gln Asp Trp Gly Gln
100 105 110
ggc acc ctg gtc acc gtc tcg agt gct agc acc aag ggc ccc agc gtg 384
Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val
115 120 125
ttc ccc ctg gcc ccc agc agc aag agc acc agc ggc ggc aca gcc gcc 432
Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala
130 135 140
ctg ggc tgc ctg gtg aag gac tac ttc ccc gag ccc gtg acc gtg agc 480
Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser
145 150 155 160
tgg aac agc ggc gcc ttg acc agc ggc gtg cac acc ttc ccc gcc gtg 528
Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val
165 170 175
ctg cag agc agc ggc ctg tac agc ctg agc agc gtg gtg acc gtg ccc 576
Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro
180 185 190
agc agc agc ctg ggc acc cag acc tac atc tgc aac gtg aac cac aag 624
Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys
195 200 205
ccc agc aac acc aag gtg gac aaa cgc gtg gag ccc aag agc tgc gac 672
Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp
210 215 220
aag acc cac acc tgc ccc ccc tgc cct gcc ccc gag ctg ctg ggc gga 720
Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly
225 230 235 240
ccc tcc gtg ttc ctg ttc ccc ccc aag ccc aag gac acc ctc atg atc 768
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
agc cgg acc ccc gag gtg acc tgc gtg gtg gtg gac gtg agc cac gag
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu 816
260 265 270
gac ccc gag gtg aag ttc aac tgg tac gtg gac ggc gtg gag gtg cac 864
Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
aac gcc aag acc aag ccc cgg gag gag cag tac aac agc acc tac cgg 912
Ash Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg
290 295 300
gtg gtg agc gtg ctc acc gtg ctg cac cag gac tgg ctg aac ggc aag 960
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
gag tac aag tgc aag gtg agc aac aag gcc ctg cct cc ccc atc gag 1008
Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu
325 330 335
aag acc atc agc aag gcc aag ggc cag ccc cgg gag ccc cag gtg tac 1056
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
acc ctg ccc ccc agc cgg gag gag atg acc aag aac cag gtg tcc ctc 1104
Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
acc tgt ctg gtg aag ggc ttc tac ccc agc gac atc gcc gtg gag tgg 1152
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
gag agc aac ggc cag ccc gag aac aac tac aag acc acc ccc cct gtg 1200
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
ctg gac agc gac ggc agc ttc ttc ctg tac agc aag ctc acc gtg gac 1248
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp
405 410 415
aag agc cgg tgg cag cag ggc aac gtg ttc agc tgc agc gtg atg cac 1296
Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
gag gcc ctg cac aac cac tac acc cag aag agc ctg agc ctg agc ccc 1344
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro
435 440 445
ggc aag 1350
Gly Lys
450
<210>69
<211>450
<212>PRT
<213>Homo sapiens
<400>69
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr
20 25 30
Ala Ile Ser Trp ValArg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Gly Ile Met Gly Met Phe Gly Thr Thr Ash Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Phe Thr Ser Ala Ala Tyr
65 70 75 80
Met Glu Leu Arg Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ser Ser Gly Tyr Tyr Pro Glu Tyr Phe Gln Asp Trp Gly Gln
100 105 110
Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val
115 120 125
Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala
130 135 140
Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser
145 150 155 160
Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val
165 170 175
Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro
180 185 190
Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys
195 200 205
Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp
210 215 220
Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly
225 230 235 240
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu
260 265 270
Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Set Thr Tyr Arg
290 295 300
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu
325 330 335
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp
405 410 415
Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro
435 440 445
Gly Lys
450
<210>70
<211>1356
<212>DNA
<213>Homo sapiens
<220>
<221>CDS
<222>(1)..(1356)
<400>70
cag gtc cag ctg gtg cag tct ggg gga ggc ctg gtc aag cct ggg ggg 48
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Leu Val Lys Pro Gly Gly
1 5 10 15
tcc ctg aga ctc tcc tgt gca gcc tct gga ttc acc ttc agt agc tat 96
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
20 25 30
agc atg aac tgg gtc cgc cag gct cca ggg aag ggg ctg gag tgg gtc 144
Ser Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
tca tcc att agt agt agt agt agt tac ata tac tac gta gac tca gtg 192
Ser Ser Ile Ser Ser Ser Ser Ser Tyr Ile Tyr Tyr Val Asp Ser Val
50 55 60
aag ggc cga ttc acc atc tcc aga gac aac gcc aag aac tca ctg tat 240
Lys Gly Arg Phe Thr Ile Ser ArgAsp AsnAla Lys Asn Ser Leu Tyr
65 70 75 80
ctg caa atg aac agc ctg aga gcc gag gac acg gct gtg tat tac tgt
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 288
85 90 95
gcg aga ggt ggt ggg agc tac ggg gcc tac gaa ggc ttt gac tac tgg 336
Ala Arg Gly Gly Gly Ser Tyr Gly Ala Tyr Glu Gly Phe Asp Tyr Trp
100 105 110
ggc cag ggc acc ctg gtc acc gtc tcg agt gct agc acc aag ggc ccc 384
Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro
115 120 125
agc gtg ttc ccc ctg gcc ccc agc agc aag agc acc agc ggc ggc aca
Ser Vag Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr 432
130 135 140
gcc gcc ctg ggc tgc ctg gtg aag gac tac ttc ccc gag ccc gtg acc 480
Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr
145 150 155 160
gtg agc tgg aac agc ggc gcc ttg acc agc ggc gtg cac acc ttc ccc 528
Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro
165 170 175
gcc gtg ctg cag agc agc ggc ctg tac agc ctg agc agc gtg gtg acc 576
Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr
180 185 190
gtg ccc agc agc agc ctg ggc acc cag acc tac atc tgc aac gtg aac 624
Val Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn
195 200 205
cac aag ccc agc aac acc aag gtg gac aaa cgc gtg gag ccc aag agc 672
His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser
210 215 220
tgc gac aag acc cac acc tgc ccc ccc tgc cct gcc ccc gag ctg ctg 720
Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu
225 230 235 240
ggc gga ccc tcc gtg ttc ctg ttc ccc ccc aag ccc aag gac acc ctc 768
Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu
245 250 255
atg atc agc cgg acc ccc gag gtg acc tgc gtg gtg gtg gac gtg agc 816
Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser
260 265 270
cac gag gac ccc gag gtg aag ttc aac tgg tac gtg gac ggc gtg gag 864
His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu
275 280 285
gtg cac aac gcc aag acc aag ccc cgg gag gag cag tac aac agc acc 912
Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr
290 295 300
tac cgg gtg gtg agc gtg ctc acc gtg ctg cac cag gac tgg ctg aac 960
Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn
305 310 315 320
ggc aag gag tac aag tgc aag gtg agc aac aag gcc ctg cct gcc ccc 1008
Gly Lys Glu Tyr Lys Cys Lys Val Set Asn Lys Ala Leu Pro Ala Pro
325 330 335
atc gag aag acc atc agc aag gcc aag ggc cag ccc cgg gag ccc cag 1056
Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln
340 345 350
gtg tac acc ctg ccc ccc agc cgg gag gag atg acc aag aac cag gtg 1104
Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val
355 360 365
tcc ctc acc tgt ctg gtg aag ggc ttc tac ccc agc gac atc gcc gtg 1152
Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val
370 375 380
gag tgg gag agc aac ggc cag ccc gag aac aac tac aag acc acc ccc 1200
Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro
385 390 395 400
cct gtg ctg gac agc gac ggc agc ttc ttc ctg tac agc aag ctc acc 1248
Pro Val Leu Asp Set Asp Gly Ser Phe Phe Leu Tyr Set Lys Leu Thr
405 410 415
gtg gac aag agc cgg tgg cag cag ggc aac gtg ttc agc tgc agc gtg 1296
Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val
420 425 430
atg cac gag gcc ctg cac aac cac tac acc cag aag agc ctg agc ctg 1344
Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu
435 440 445
agc ccc ggc aag 1356
Ser Pro Gly Lys
450
<210>71
<211>452
<212>PRT
<213>Homo sapiens
<400>71
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Leu Val Lys Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
20 25 30
Ser Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ser Ser Ile Ser Ser Ser Ser Ser Tyr Ile Tyr Tyr Val Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Gly Gly Ser Tyr Gly Ala Tyr Glu Gly Phe Asp Tyr Trp
100 105 110
Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro
115 120 125
Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr
130 135 140
Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr
145 150 155 160
Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro
165 170 175
Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr
180 185 190
Val Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn
195 200 205
His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser
210 215 220
Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu
225 230 235 240
Cly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu
245 250 255
Met Ile Set Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser
260 265 270
His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu
275 280 285
Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr
290 295 300
Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Ash
305 310 315 320
Gly Lys Glu Tyr Lys Cys Lys Val Ser Ash Lys Ala Leu Pro Ala Pro
325 330 335
Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln
340 345 350
Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val
355 360 365
Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val
370 375 380
Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro
385 390 395 400
Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr
405 410 415
Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val
420 425 430
Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu
435 440 445
Ser Pro Gly Lys
450
<210>72
<211>1353
<212>DNA
<213>Homo sapiens
<220>
<221>CDS
<222>(1)..(1353)
<400>72
gag gtg cag ctg gtg gag tct ggg gct gag gtg aag aag cct ggg tcc 48
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aaa gtc tct tgc aag gct tct gga ggc ccc ttc cgc agc tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Arg Ser Tyr
20 25 30
gct atc agc tgg gtg cga cag gcc cct gga caa ggg cct gag tgg atg 144
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Pro Glu Trp Met
35 40 45
gga ggg atc atc cct att ttt ggt aca aca aaa tac gca ccg aag ttc 192
Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Lys Tyr Ala Pro Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac gat ttc gcg ggc aca gtt tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Asp Phe Ala Gly Thr Val Tyr
65 70 75 80
atg gag ctg agc agc ctg cga tct gag gac acg gcc atg tac tac tgt 288
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
gcg aaa cat atg ggg tac cag gtg cgc gaa act atg gac gtc tgg ggc 336
Ala Lys His Met Gly Tyr Gln Val Arg Glu Thr Met Asp Val Trp Gly
100 105 110
aaa ggg acc acg gtc acc gtc tcg agt gct agc acc aag ggc ccc agc 384
Lys Gly Thr Thr Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser
115 120 125
gtg ttc ccc ctg gcc ccc agc agc aag agc acc agc ggc ggc aca gcc 432
Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala
130 135 140
gcc ctg ggc tgc ctg gtg aag gac tac ttc ccc gag ccc gtg acc gtg 480
Ala Leu Gly Cys Leu Val Lys AspTyr Phe Pro Glu Pro Val Thr Val
145 150 155 160
agc tgg aac agc ggc gcc ttg acc agc ggc gtg cac acc ttc ccc gcc 528
Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala
165 170 175
gtg ctg cag agc agc ggc ctg tac agc ctg agc agc gtg gtg acc gtg 576
Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val
180 185 190
ccc agc agc agc ctg ggc acc cag acc tac atc tgc aac gtg aac cac 624
Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asp His
195 200 205
aag ccc agc aac acc aag gtg gac aaa cgc gtg gag ccc aag agc tgc 672
Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys
210 215 220
gac aag acc cac acc tgc ccc ccc tgc cct gcc ccc gag ctg ctg ggc 720
Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly
225 230 235 240
gga ccc tcc gtg ttc ctg ttc ccc ccc aag ccc aag gac acc ctc atg 768
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met
245 250 255
atc agc cgg acc ccc gag gtg acc tgc gtg gtg gtg gac gtg agc cac 816
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His
260 265 270
gag gac ccc gag gtg aag ttc aac tgg tac gtg gac ggc gtg gag gtg 864
Glu Asp Pro Glu Val Lys Phe Asp Trp Tyr Val Asp Gly Val Glu Val
275 280 285
cac aac gcc aag acc aag ccc cgg gag gag cag tac aac agc acc tac 912
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr
290 295 300
cgg gtg gtg agc gtg ctc acc gtg ctg cac cag gac tgg ctg aac ggc 960
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly
305 310 315 320
aag gag tac aag tgc aag gtg agc aac aag gcc ctg cct gcc ccc atc 1008
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile
325 330 335
gag aag acc atc agc aag gcc aag ggc cag ccc cgg gag ccc cag gtg 1056
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val
340 345 350
tac acc ctg ccc ccc agc cgg gag gag atg acc aag aac cag gtg tcc 1104
Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser
355 360 365
ctc acc tgt ctg gtg aag ggc ttc tac ccc agc gac atc gcc gtg gag 1152
Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu
370 375 380
tgg gag agc aac ggc cag ccc gag aac aac tac aag acc acc ccc cct 1200
Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro
385 390 395 400
gtg ctg gac agc gac ggc agc ttc ttc ctg tac agc aag ctc acc gtg 1248
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val
405 410 415
gac aag agc cgg tgg cag cag ggc aac gtg ttc agc tgc agc gtg atg 1296
Asn Lys Ser Arg Trn Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met
420 425 430
cac gag gcc ctg cac aac cac tac acc cag aag agc ctg agc ctg agc 1344
His Glu Ala Leu His Asp His Tyr Thr Glp Lys Ser Leu Ser Leu Ser
435 440 445
ccc ggc aag 1353
Pro Gly Lys
450
<210>73
<211>451
<212>PRT
<213>Homo sapiens
<400>73
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Arg Ser Tyr
20 25 30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Pro Glu Trp Met
35 40 45
Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Lys Tyr Ala Pro Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Aso Asp Phe Ala Gly Thr Val Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Lys His Met Gly Tyr Gln Val Arg Glu Thr Met Asp Val Trp Gly
100 105 110
Lys Gly Thr Thr Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser
115 120 125
Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala
130 135 140
Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val
145 150 155 160
Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala
165 170 175
Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val
180 185 190
Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His
195 200 205
Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys
210 215 220
Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly
225 230 235 240
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met
245 250 255
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His
260 265 270
Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val
275 280 285
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr
290 295 300
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly
305 310 315 320
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile
325 330 335
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val
340 345 350
Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser
355 360 365
Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu
370 375 380
Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro
385 390 395 400
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val
405 410 415
Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met
420 425 430
His Glu Ala Leu His Asn His Tyr Thr Glp Lys Ser Leu Ser Leu Ser
435 440 445
Pro Gly Lys
450
<210>74
<211>1353
<212>DNA
<213>Homo sapiens
<220>
<221>CDS
<222>(1)..(1353)
<400>74
gag gtg cag ctg gtg gag tct ggg gct gag gtg aag aag cct ggg tcc 48
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aaa gtc tct tgc aag gct tct gga ggc ccc ttc cgc agc tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Arg Ser Tyr
20 25 30
gct atc agc tgg gtg cga cag gcc cct gga caa ggg cct gag tgg atg 144
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Pro Glu Trp Met
35 40 45
gga ggg atc atc cct att ttt ggt aca aca aaa tac gca ccg aag ttc 192
Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Lys Tyr Ala Pro Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac gat ttc gcg ggc aca gtt tac 240
Glp Gly Arg Val Thr Ile Thr Ala Asp Asp Phe Ala Gly Thr Val Tyr
65 70 75 80
atg gag ctg agc agc ctg cga tct gag gac acg gcc atg tac tac tgt 288
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
gcg aaa cat atg ggg tac cag gtg cgc gaa act atg gac gtc tgg ggc 336
Ala Lys His Met Gly Tyr Gln Val Arg Glu Tnr Met Asp Val Trp Gly
100 105 110
aaa ggg acc acg gtc acc gtc tcg agt gct agc acc aag ggc ccc agc 384
Lys Gly Thr Thr Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser
115 120 125
gtg ttc ccc ctg gcc ccc agc agc aag agc acc agc ggc ggc aca gcc 432
Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala
130 135 140
gcc ctg ggc tgc ctg gtg aag gac tac ttc ccc gag ccc gtg acc gtg 480
Ala Leu Gly Cys Leu Va lLys Asp Tyr Phe Pro Glu Pro Val Thr Val
145 150 155 160
agc tgg aac agc ggc gcc ttg acc agc ggc gtg cac acc ttc ccc gcc 528
Ser Trp Asp Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala
165 170 175
gtg ctg cag agc agc ggc ctg tac agc ctg agc agc gtg gtg acc gtg 576
Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val
180 185 190
ccc agc agc agc ctg ggc acc cag acc tac atc tgc aac gtg aac cac 624
Pro Ser Ser Ser Leu Gly Thr Glp Thr Tyr Ile Cys Asp Val Asp His
195 200 205
aag ccc agc aac acc aag gtg gac aaa cgc gtg gag ccc aag agc tgc 672
Lys Pro Ser Asp Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys
210 215 220
gac aag acc cac acc tgc ccc ccc tgc cct gcc ccc gag ctg ctg ggc 720
Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly
225 230 235 240
gga ccc tcc gtg ttc ctg ttc ccc ccc aag ccc aag gac acc ctc atg 768
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met
245 250 255
atc agc cgg acc ccc gag gtg acc tgc gtg gtg gtg gac gtg agc cac 816
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Va lVal Asp Val Ser His
260 265 270
gag gac ccc gag gtg aag ttc aac tgg tac gtg gac ggc gtg gag gtg 864
Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val
275 280 285
cac aac gcc aag acc aag ccc cgg gag gag cag tac aac agc acc tac 912
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr
290 295 300
cgg gtg gtg agc gtg ctc acc gtg ctg cac cag gac tgg ctg aac ggc 960
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly
305 310 315 320
aag gag tac aag tgc aag gtg agc aac aag gcc ctg cct gcc ccc atc 1008
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile
325 330 335
gag aag acc atc agc aag gcc aag ggc cag ccc cgg gag ccc cag gtg 1056
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val
340 345 350
tac acc ctg ccc ccc agc cgg gag gag atg acc aag aac cag gtg tcc 1104
Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser
355 360 365
ctc acc tgt ctg gtg aag ggc ttc tac ccc agc gac atc gcc gtg gag 1152
Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu
370 375 380
tgg gag agc aac ggc cag ccc gag aac aac tac aag acc acc ccc cct 1200
Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro
385 390 395 400
gtg ctg gac agc gac ggc agc ttc ttc ctg tac agc aag ctc acc gtg 1248
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val
405 410 415
gac aag agc cgg tgg cag cag ggc aac gtg ttc agc tgc agc gtg atg 1296
Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met
420 425 430
cac gag gcc ctg cac aac cac tac acc cag aag agc ctg agc ctg agc 1344
His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser
435 440 445
ccc ggc aag 1353
Pro Gly Lys
450
<210>75
<211>451
<212>PRT
<213>Homo sapiens
<400>75
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe ArgSer Tyr
20 25 30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Pro Glu Trp Met
35 40 45
Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Lys Tyr Ala Pro LysPhe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Asp Phe Ala Gly Thr Val Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Lys His Met Gly Tyr Gln Val Arg Glu Thr Met Asp Val Trp Gly
100 105 110
Lys Gly Thr Thr Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser
115 120 125
Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala
130 135 140
Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val
145 150 155 160
Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val Hi s Thr PhePro Ala
165 170 175
Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val
180 185 190
Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His
195 200 205
Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys
210 215 220
Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly
225 230 235 240
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met
245 250 255
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His
260 265 270
Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val
275 280 285
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr
290 295 300
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly
305 310 315 320
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile
325 330 335
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val
340 345 350
Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser
355 360 365
Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile AlaVal Glu
370 375 380
Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro
385 390 395 400
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val
405 410 415
Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met
420 425 430
His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser
435 440 445
Pro Gly Lys
450
<210>76
<211>1350
<212>DNA
<213>Homo sapiens
<220>
<221>CDS
<222>(1)..(1350)
<400>76
gag gtg cag ctg gtg gag tct ggg gct gag gtg aag aag cca ggg tcc 48
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aag gtc tcc tgt aag gcc tct gga ggc acc ttc tcc agc tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr
20 25 30
ggt atc agc tgg gtg cga cag gcc cct gga caa ggg ctt gag tgg atg 144
Gly Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga gac atc atc ggt atg ttt ggt tca aca aac tac gca cag aac ttc 192
Gly Asp Ile Ile Gly Met Phe Gly Ser Thr Asn Tyr Ala Gln Asn Phe
50 55 60
cag ggc aga ctc acg att acc gcg gac gaa tcc acg agc aca gcc tac 240
Gln Gly Arg Leu Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr
65 70 75 80
atg gag ctg agc agc ctg aga tct gag gac acg gcc gtg tat tac tgt 288
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
gcg aga agt agt ggt tat tac cct gca tac ctc ccc cac tgg ggc cag 336
Ala Arg Ser Ser Gly Tyr Tyr Pro Ala Tyr Leu Pro His Trp Gly Gln
100 105 110
ggc acc ttg gtc acc gtc tcg agt gct agc acc aag ggc ccc agc gtg 384
Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val
115 120 125
ttc ccc ctg gcc ccc agc agc aag agc acc agc ggc ggc aca gcc gcc 432
rhe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala
130 135 140
ctg ggc tgc ctg gtg aag gac tac ttc ccc gag ccc gtg acc gtg agc 480
Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser
145 150 155 160
tgg aac agc ggc gcc ttg acc agc ggc gtg cac acc ttc ccc gcc gtg 528
Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val
165 170 175
ctg cag agc agc ggc ctg tac agc ctg agc agc gtg gtg acc gtg ccc 576
Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro
180 185 190
agc agc agc ctg ggc acc cag acc tac atc tgc aac gtg aac cac aag 624
Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn Gis Lys
195 200 205
ccc agc aac acc aag gtg gac aaa cgc gtg gag ccc aag agc tgc gac 672
Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp
210 215 220
aag acc cac acc tgc ccc ccc tgc cct gcc ccc gag ctg ctg ggc gga 720
Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly
225 230 235 240
ccc tcc gtg ttc ctg ttc ccc ccc aag ccc aag gac acc ctc atg atc 768
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro lys Asp Thr Leu Met Ile
245 250 255
agc cgg acc ccc gag gtg acc tgc gtg gtg gtg gac gtg agc cac gag 816
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu
260 265 270
gac ccc gag gtg aag ttc aac tgg tac gtg gac ggc gtg gag gtg cac 864
Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val Gis
275 280 285
aac gcc aag acc aag ccc cgg gag gag cag tac aac agc acc tac cgg 912
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg
290 295 300
gtg gtg agc gtg ctc acc gtg ctg cac cag gac tgg ctg aac ggc aag 960
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
gag tac aag tgc aag gtg agc aac aag gcc ctg cct gcc ccc atc gag 1008
Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu
325 330 335
aag acc atc agc aag gcc aag ggc cag ccc cgg gag ccc cag gtg tac 1056
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
acc ctg ccc ccc agc cgg gag gag atg acc aag aac cag gtg tcc ctc 1104
Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
acc tgt ctg gtg aag ggc ttc tac ccc agc gac atc gcc gtg gag tgg 1152
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
gag agc aac ggc cag ccc gag aac aac tac aag acc acc ccc cct gtg 1200
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
ctg gac agc gac ggc agc ttc ttc ctg tac agc aag ctc acc gtg gac 1248
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp
405 410 415
aag agc cgg tgg cag cag ggc aac gtg ttc agc tgc agc gtg atg cac 1296
Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
gag gcc ctg cac aac cac tac acc cag aag agc ctg agc ctg agc ccc 1344
Glu Ala Leu His Asp His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Prg
435 440 445
ggc aag 1350
Gly Lys
450
<210>77
<211>450
<212>PRT
<213>Homo sapiens
<400>77
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr
20 25 30
Gly Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trn Met
35 40 45
Gly Asp Ile Ile Gly Met Phe Gly Ser Thr Asn Tyr Ala Gln Asn Phe
50 55 60
Gln Gly Arg Leu Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ser Ser Gly Tyr Tyr Pro Ala Tyr Leu Pro His Trp Gly Gln
100 105 110
Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val
115 120 125
Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala
130 135 140
Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser
145 150 155 160
Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val
165 170 175
Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro
180 185 190
Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys
195 200 205
Pro Ser Asn Thr Lys Val Asp Lys ArgVal Glu Pro Lys Ser Cys Asp
210 215 220
Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly
225 230 235 240
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu
260 265 270
Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg
290 295 300
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu
325 330 335
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp
405 410 415
Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro
435 440 445
Gly Lys
450
<210>78
<211>1353
<212>DNA
<213>Homo sapiens
<220>
<221>CDS
<222>(1)..(1353)
<400>78
gag gtg cag ctg gtg gag tct ggg gct gag gtg aag aag ccg ggg tcc 48
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aag gtc tcc tgc aag gct tct gga ggc acc ttc agc ttc tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Phe Tyr
20 25 30
tct atg agc tgg gtg cga cag gcc cct gga caa gga ctt gag tgg atg 144
Ser Met Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga ggg atc atc cct atg ttt ggt aca aca aac tac gca cag aag ttc 192
Gly Gly Ile Ile Pro Met Phe Gly Thr Thr Asn Tyr Ala Gln Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gtc gaa tcc acg agc aca gcc tac 240
Gln Gly Arg Val Thr Ile Thr Ala Val Glu Ser Thr Ser Thr Ala Tyr
65 70 75 80
atg gag gtg agc agc ctg aga tct gag gac acg gcc gtt tat tac tgt 288
Met Glu Val Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
gcg aga ggt gat aag ggt atc tac tac tac tac atg gac gtc tgg ggc 336
Ala Arg Gly Asp Lys Gly Ile Tyr Tyr Tyr Tyr Met Asp Val Trp Gly
100 105 110
aaa ggg acc acg gtc acc gtc tcg agt gct agc acc aag ggc ccc agc 384
Lys Gly Thr Thr Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser
115 120 125
gtg ttc ccc ctg gcc ccc agc agc aag agc acc agc ggc ggc aca gcc 432
Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala
130 135 140
gcc ctg ggc tgc ctg gtg aag gac tac ttc ccc gag ccc gtg acc gtg 480
Ala Leu Gly Cys Leu Val Lys Asp Tyr Pne Pro Glu Pro Val Tnr Val
145 150 155 160
agc tgg aac agc ggc gcc ttg acc agc ggc gtg cac acc ttc ccc gcc 528
Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala
165 170 175
gtg ctg cag agc agc ggc ctg tac agc ctg agc agc gtg gtg acc gtg 576
Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val
180 185 190
ccc agc agc agc ctg ggc acc cag acc tac atc tgc aac gtg aac cac 624
Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His
195 200 205
aag ccc agc aac acc aag gtg gac aaa cgc gtg gag ccc aag agc tgc 672
Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys
210 215 220
gac aag acc cac acc tgc ccc ccc tgc cct gcc ccc gag ctg ctg ggc 720
Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly
225 230 235 240
gga ccc tcc gtg ttc ctg ttc ccc ccc aag ccc aag gac acc ctc atg 768
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met
245 250 255
atc agc cgg acc ccc gag gtg acc tgc gtg gtg gtg gac gtg agc cac 816
Tle Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His
260 265 270
gag gac ccc gag gtg aag ttc aac tgg tac gtg gac ggc gtg gag gtg 864
Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val
275 280 285
cac aac gcc aag acc aag ccc cgg gag gag cag tac aac agc acc tac 912
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr
290 295 300
cgg gtg gtg agc gtg ctc acc gtg ctg cac cag gac tgg ctg aac ggc 960
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly
305 310 315 320
aag gag tac aag tgc aag gtg agc aac aag gcc ctg cct gcc ccc atc 1008
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile
325 330 335
gag aag acc atc agc aag gcc aag ggc cag ccc cgg gag ccc cag gtg 1056
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val
340 345 350
tac acc ctg ccc ccc agc cgg gag gag atg acc aag aac cag gtg tcc 1104
Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser
355 360 365
ctc acc tgt ctg gtg aag ggc ttc tac ccc agc gac atc gcc gtg gag 1152
Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu
370 375 380
tgg gag agc aac ggc cag ccc gag aac aac tac aag acc acc ccc cct 1200
Trn Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro
385 390 395 400
gtg ctg gac agc gac ggc agc ttc ttc ctg tac agc aag ctc acc gtg 1248
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val
405 410 415
gac aag agc cgg tgg cag cag ggc aac gtg ttc agc tgc agc gtg atg 1296
Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met
420 425 430
cac gag gcc ctg cac aac cac tac acc cag aag agc ctg agc ctg agc 1344
His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser
435 440 445
ccc ggc aag 1353
Pro Gly Lys
450
<210>79
<211>451
<212>PRT
<213>Homo sapiens
<400>79
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Phe Tyr
20 25 30
Ser Met Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Gly Ile Ile Pro Met Phe Gly Thr Thr Asn Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Val Glu Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Val Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asp Lys Gly Ile Tyr Tyr Tyr Tyr Met Asp Val Trp Gly
100 105 110
Lys Gly Thr Thr Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser
115 120 125
Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala
130 135 140
Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val
145 150 155 160
Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala
165 170 175
Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val
180 185 190
Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His
195 200 205
Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys
210 215 220
Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly
225 230 235 240
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met
245 250 255
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His
260 265 270
Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val
275 280 285
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr
290 295 300
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly
305 310 315 320
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile
325 330 335
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val
340 345 350
Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser
355 360 365
Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu
370 375 380
Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro
385 390 395 400
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val
405 410 415
Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met
420 425 430
His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser
435 440 445
Pro Gly Lys
450
<210>80
<211>1350
<212>DNA
<213>Homo sapiens
<220>
<221>CDS
<222>(1)..(1350)
<400>80
gag gtg cag ctg gtg gag tct ggg gct gag gtg aag aag cct ggg tcc 48
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aag gtc tcc tgc aag gct tct gga ggc acc ttc agc agc tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr
20 25 30
gct atc agc tgg gtg cga cag gcc cct gga caa ggg ctt gag tgg atg 144
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga ggg atc atc ggt atg ttc ggt aca gca aac tac gca cag aag ttc 192
Gly Gly Ile Ile Gly Met Phe Gly Thr Ala Asn Tyr Ala Gln Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac gaa ttt acg agc aca gcc tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Phe Thr Ser Thr Ala Tyr
65 70 75 80
atg gag ctg agc agc ctg aga tct gag gac acg gcc gtg tat tac tgt 288
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
gcg aga gga aat tat tac tat gag agt agt ctc gac tac tgg ggc cag 336
Ala Arg Gly Asn Tyr Tyr Tyr Glu Ser Ser Leu Asp Tyr Trp Gly Gln
100 105 110
gga acc ctg gtc acc gtc tcg agt gct agc acc aag ggc ccc agc gtg 384
Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val
115 120 125
ttc ccc ctg gcc ccc agc agc aag agc acc agc ggc ggc aca gcc gcc 432
Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala
130 135 140
ctg ggc tgc ctg gtg aag gac tac ttc ccc gag ccc gtg acc gtg agc 480
Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser
145 150 155 160
tgg aac agc ggc gcc ttg acc agc ggc gtg cac acc ttc ccc gcc gtg 528
Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val
165 170 175
ctg cag agc agc ggc ctg tac agc ctg agc agc gtg gtg acc gtg ccc 576
Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro
180 185 190
agc agc agc ctg ggc acc cag acc tac atc tgc aac gtg aac cac aag 624
Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys
195 200 205
ccc agc aac acc aag gtg gac aaa cgc gtg gag ccc aag agc tgc gac 672
Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp
210 215 220
aag acc cac acc tgc ccc ccc tgc cct gcc ccc gag ctg ctg ggc gga 720
Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly
225 230 235 240
ccc tcc gtg ttc ctg ttc ccc ccc aag ccc aag gac acc ctc atg atc 768
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
agc cgg acc ccc gag gtg acc tgc gtg gtg gtg gac gtg agc cac gag 816
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu
260 265 270
gac ccc gag gtg aag ttc aac tgg tac gtg gac ggc gtg gag gtg cac 864
Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
aac gcc aag acc aag ccc cgg gag gag cag tac aac agc acc tac cgg 912
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg
290 295 300
gtg gtg agc gtg ctc acc gtg ctg cac cag gac tgg ctg aac ggc aag 960
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
gag tac aag tgc aag gtg agc aac aag gcc ctg cct gcc ccc atc gag 1008
Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu
325 330 335
aag acc atc agc aag gcc aag ggc cag ccc cgg gag ccc cag gtg tac 1056
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
acc ctg ccc ccc agc cgg gag gag atg acc aag aac cag gtg tcc ctc 1104
Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
acc tgt ctg gtg aag ggc ttc tac ccc agc gac atc gcc gtg gag tgg 1152
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
gag agc aac ggc cag ccc gag aac aac tac aag acc acc ccc cct gtg 1200
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
ctg gac agc gac ggc agc ttc ttc ctg tac agc aag ctc acc gtg gac 1248
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp
405 410 415
aag agc cgg tgg cag cag ggc aac gtg ttc agc tgc agc gtg atg cac 1296
Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
gag gcc ctg cac aac cac tac acc cag aag agc ctg agc ctg agc ccc 1344
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro
435 440 445
ggc aag 1350
Gly Lys
450
<210>81
<211>450
<212>PRT
<213>Homo sapiens
<400>81
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr
20 25 30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Gly Ile Ile Gly Met Phe Gly Thr Ala Asn Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Phe Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Tyr Tyr Glu Ser Ser Leu Asp Tyr Trp Gly Gln
100 105 110
Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val
115 120 125
Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala
130 135 140
Leu Gly Cys Leu Val Lys Aso Tyr Phe Pro Glu Pro Val Thr Val Ser
145 150 155 160
Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val
165 170 175
Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro
180 185 190
Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys
195 200 205
Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp
210 215 220
Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly
225 230 235 240
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu
260 265 270
Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg
290 295 300
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu
325 330 335
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp
405 410 415
Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro
435 440 445
Gly Lys
450
<210>82
<211>1359
<212>DNA
<213>Homo sapiens
<220>
<221>CDS
<222>(1)..(1359)
<400>82
cag gtg cag ctg gtg cag tct ggg gct gag gtg aag aag cct ggg tcc 48
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aga gtc tcc tgc aag gct tct gga agc atc ttc aga aac tat 96
Ser Val Arg Val Ser Cys Lys Ala Ser Gly Ser Ile Phe Arg Asn Tyr
20 25 30
gct atg agc tgg gtg cga cag gcc cct gga caa ggg ctt gag tgg atg 144
Ala Met Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga ggg atc atc gct att ttt ggg aca cca aag tac gca cag aag ttc 192
Gly Gly Ile Ile Ala Ile Phe Gly Thr Pro Lys Tyr Ala Gln Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac gaa tcg acg agc act gtc tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Val Tyr
65 70 75 80
atg gaa ctg agc gga ctg aga tct gag gac acg gcc atg tat tac tgt 288
Met Glu Leu Ser Gly Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
gcg agg att ccc cac tat aat ttt ggt tcg ggg agt tat ttc gac tac 336
Ala Arg Ile Pro His Tyr Asn Phe Gly Ser Gly Ser Tyr Phe Asp Tyr
100 105 110
tgg ggc cag gga acc ctg gtc acc gtc tcg agt gct agc acc aag ggc 384
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly
115 120 125
ccc agc gtg ttc ccc ctg gcc ccc agc agc aag agc acc agc ggc ggc 432
Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly
130 135 140
aca gcc gcc ctg ggc tgc ctg gtg aag gac tac ttc ccc gag ccc gtg 480
Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val
145 150 155 160
acc gtg agc tgg aac agc ggc gcc ttg acc agc ggc gtg cac acc ttc 528
Thr Val Ser Trn Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe
165 170 175
ccc gcc gtg ctg cag agc agc ggc ctg tac agc ctg agc agc gtg gtg 576
Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val
180 185 190
acc gtg ccc agc agc agc ctg ggc acc cag acc tac atc tgc aac gtg 624
Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Lle Cys Asn Val
195 200 205
aac cac aag ccc agc aac acc aag gtg gac aaa cgc gtg gag ccc aag 672
Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys
210 215 220
agc tgc gac aag acc cac acc tgc ccc ccc tgc cct gcc ccc gag ctg 720
Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu
225 230 235 240
ctg ggc gga ccc tcc gtg ttc ctg ttc ccc ccc aag ccc aag gac acc 768
Leu Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr
245 250 255
ctc atg atc agc cgg acc ccc gag gtg acc tgc gtg gtg gtg gac gtg 816
Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val
260 265 270
agc cac gag gac ccc gag gtg aag ttc aac tgg tac gtg gac ggc gtg 864
Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val
275 280 285
gag gtg cac aac gcc aag acc aag ccc cgg gag gag cag tac aac agc 912
Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser
290 295 300
acc tac cgg gtg gtg agc gtg ctc acc gtg ctg cac cag gac tgg ctg 960
Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu
305 310 315 320
aac ggc aag gag tac aag tgc aag gtg agc aac aag gcc ctg cct gcc 1008
Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala
325 330 335
ccc atc gag aag acc atc agc aag gcc aag ggc cag ccc cgg gag ccc 1056
Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro
340 345 350
cag gtg tac acc ctg ccc ccc agc cgg gag gag atg acc aag aac cag 1104
Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln
355 360 365
gtg tcc ctc acc tgt ctg gtg aag ggc ttc tac ccc agc gac atc gcc 1152
Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala
370 375 380
gtg gag tgg gag agc aac ggc cag ccc gag aac aac tac aag acc acc 1200
Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr
385 390 395 400
ccc cct gtg ctg gac agc gac ggc agc ttc ttc ctg tac agc aag ctc 1248
Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu
405 410 415
acc gtg gac aag agc cgg tgg cag cag ggc aac gtg ttc agc tgc agc 1296
Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser
420 425 430
gtg atg cac gag gcc ctg cac aac cac tac acc cag aag agc ctg agc 1344
Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser
435 440 445
ctg agc ccc ggc aag 1359
Leu Ser Pro Gly Lys
450
<210>83
<211>453
<212>PRT
<213>Homo sapiens
<400>83
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Arg Val Ser Cys Lys Ala Ser Gly Ser Ile Phe Arg Asn Tyr
20 25 30
Ala Met Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Gly Ile Ile Ala Ile Phe Gly Thr Pro Lys Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Val Tyr
65 70 75 80
Met Glu Leu Ser Gly Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Arg Ile Pro His Tyr Asn Phe Gly Ser Gly Ser Tyr Phe Asp Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly
115 120 125
Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly
130 135 140
Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val
145 150 155 160
Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe
165 170 175
Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val
180 185 190
Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val
195 200 205
Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys
210 215 220
Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu
225 230 235 240
Leu Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asn Thr
245 250 255
Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val
260 265 270
Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val
275 280 285
Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser
290 295 300
Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln Asn Trn Leu
305 310 315 320
Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala
325 330 335
Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro
340 345 350
Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln
355 360 365
Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala
370 375 380
Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr
385 390 395 400
Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu
405 410 415
Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser
420 425 430
Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser
435 440 445
Leu Ser Pro Gly Lys
450
<210>84
<211>660
<212>DNA
<213>Homo sapiens
<220>
<221>CDS
<222>(1)..(660)
<400>84
tcc tat gtg ctg act cag cca ccc tca gcg tct ggg acc ccc ggg cag 48
Ser Tyr Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln
1 5 10 15
agg gtc acc atc tct tgt tct gga agc acg ttc aac atc gga agt aat 96
Arg yal Thr Ile Ser Cys Ser Gly Ser Thr Phe Asn Ile Gly Ser Asn
20 25 30
gct gta gac tgg tac cgg cag ctc cca gga acg gcc ccc aaa ctc ctc 144
Ala Val Asp Trp Tyr Arg Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu
35 40 45
atc tat agt aat aat cag cgg ccc tca ggg gtc cct gac cga ttc tct 192
Ile Tyr Ser Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser
50 55 60
ggc tcc agg tct ggc acc tca gcc tcc ctg gcc atc agt ggg ctc cag 240
Gly Ser Arg Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln
65 70 75 80
tct gag gat gag gct gat tat tac tgt gca gca tgg gat gac atc ctg 288
Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ala Trp Asp Asp Ile Leu
85 90 95
aat gtt ccg gta ttc ggc gga ggg acc aag ctg acc gtc cta ggt gcg 336
Asn Val Pro Val Pne Gly Gly Gly Thr Lys Leu Thr Val Leu Gly Ala
100 105 110
gcc gca ggc cag ccc aag gcc gct ccc agc gtg acc ctg ttc ccc ccc 384
Ala Ala Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro
115 120 125
tcc tcc gag gag ctg cag gcc aac aag gcc acc ctg gtg tgc ctc atc 432
Ser Ser Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile
130 135 140
agc gac ttc tac cct ggc gcc gtg acc gtg gcc tgg aag gcc gac agc 480
Ser Asn Phe Tyr Pro Gly Ala Val Thr Val Ala Trn Lys Ala Asn Ser
145 150 155 160
agc ccc gtg aag gcc ggc gtg gag acc acc acc ccc agc aag cag agc 528
Ser Pro Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser
165 170 175
aac aac aag tac gcc gcc agc agc tac ctg agc ctc acc ccc gag cag 576
Asn Asn Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln
180 18 5190
tgg aag agc cac cgg agc tac agc tgc cag gtg acc cac gag ggc agc 624
Trp Lys Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser
195 200 205
acc gtg gag aag acc gtg gcc ccc acc gag tgc agc 660
Thr Val Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215 220
<210>85
<211>220
<212>PRT
<213>Homo sapiens
<400>85
Ser Tyr Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln
1 5 10 15
Arg Val Thr Ile Ser Cys Ser Gly Ser Thr Phe Asn Ile Gly Ser Asn
20 25 30
Ala Val Asp Trp Tyr Arg Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu
35 40 45
Ile Tyr Ser Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser
50 55 60
Gly Ser Arg Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln
65 70 75 80
Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ala Trp Asp Asp Ile Leu
85 90 95
Asn Val Pro Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu Gly Ala
100 105 110
Ala Ala Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro
115 120 125
Ser Ser Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile
130 135 140
Ser Asp Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser
145 150 155 160
Ser Pro Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser
165 170 175
Asn Asn Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln
180 185 190
Trp Lys Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser
195 200 205
Thr Val Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215 220
<210>86
<211>660
<212>DNA
<213>Homo sapiens
<220>
<221>CDS
<222>(1)..(660)
<400>86
cag tct gcc ctg act cag cct gcc gcc gtg tct ggg tct cct gga cag 48
Gln Ser Ala Leu Thr Gln Pro Ala Ala Val Ser Gly Ser Pro Gly Gln
1 5 10 15
tcg atc acc atc tcc tgc act gga acc agc agt gac gtt ggt ggt tat 96
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asn Val Gly Gly Tyr
20 25 30
aac tat gtc tcc tgg tac caa cag cac cca ggc aaa gcc ccc aaa ctc 144
Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
35 40 45
atg att tat gag gtc agt aat cgg ccc tca ggg gtt tct aat cgc ttc 192
Met Ile Tyr Glu Val Ser Asn Arg Pro Ser Gly Val Ser Asn Arg Phe
50 55 60
tct ggc tcc aag tct ggc aac acg gcc tcc ctg acc atc tct ggg ctc 240
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu
65 70 75 80
cag gct gag gac gag gct gat tat tac tgc agc tca tat aca agc agc 288
Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser
85 90 95
agc act tat gtc ttc gga act ggg acc aag gtc acc gtc cta ggt gcg 336
Ser Thr Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu Gly Ala
100 105 110
gcc gca ggc cag ccc aag gcc gct ccc agc gtg acc ctg ttc ccc ccc 384
Ala Ala Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro
115 120 125
tcc tcc gag gag ctg cag gcc aac aag gcc acc ctg gtg tgc ctc atc 432
Ser Ser Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile
130 135 140
agc gac ttc tac cct ggc gcc gtg acc gtg gcc tgg aag gcc gac agc 480
Ser Asp Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser
145 150 155 160
agc ccc gtg aag gcc ggc gtg gag acc acc acc ccc agc aag cag agc 528
Ser Pro Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser
165 170 175
aac aac aag tac gcc gcc agc agc tac ctg agc ctc acc ccc gag cag 576
Asn Asn Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln
180 185 190
tgg aag agc cac cgg agc tac agc tgc cag gtg acc cac gag ggc agc 624
Trp Lys Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser
195 200 205
acc gtg gag aag acc gtg gcc ccc acc gag tgc agc 660
Thr Val Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215 220
<210>87
<211>220
<212>PRT
<213>Homo sapiens
<400>87
Gln Ser Ala Leu Thr Gln Pro Ala Ala Val Ser Gly Ser Pro Gly Gln
1 5 10 15
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asn Val Gly Gly Tyr
20 25 30
Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
35 40 45
Met Ile Tyr Glu Val Ser Asn Arg Pro Ser Gly Val Ser Asn Arg Phe
50 55 60
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu
65 70 75 80
Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser
85 90 95
Ser Thr Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu Gly Ala
100 105 110
Ala Ala Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro
115 120 125
Ser Ser Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile
130 135 140
Ser Asp Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser
145 150 155 160
Ser Pro Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser
165 170 175
Asn Asn Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln
180 185 190
Trp Lys Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser
195 200 205
Thr Val Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215 220
<210>88
<211>660
<212>DNA
<213>Homo sapiens
<220>
<221>CDS
<222>(1)..(660)
<400>88
tcc tat gtg ctg act cag cca ccc tca gtc tct ggg acc ccc ggg cag 48
Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Gly Thr Pro Gly Gln
1 5 10 15
agg gtc acc atc tct tgc tct gga agc cgc tcc aac gtc gga gat aat 96
Arg Val Thr Ile Ser Cys Ser Gly Ser Arg Ser Asn Val Gly Asp Asn
20 25 30
tct gta tat tgg tat caa cac gtc cca gaa atg gcc ccc aaa ctc ctc 144
Ser Val Tyr Trp Tyr Gln His Val Pro Glu Met Ala Pro Lys Leu Leu
35 40 45
gtc tat aag aat act caa cgg ccc tca gga gtc cct gcc cgg ttt tcc 192
Val Tyr Lys Asn Thr Gln Arg Pro Ser Gly Val Pro Ala Arg Phe Ser
50 55 60
ggc tcc aag tct ggc act tca gcc tcc ctg gcc atc att ggc ctc cag 240
Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ile Gly Leu Gln
65 70 75 80
tcc ggc gat gag gct gat tat tat tgt gtg gca tgg gat gac agc gta 288
Ser Gly Asp Glu Ala Asp Tyr Tyr Cys Val Ala Trp Asp Asp Ser Val
85 90 95
gat ggc tat gtc ttc gga tct ggg acc aag gtc acc gtc cta ggt gcg 336
Asp Gly Tyr Val Phe Gly Ser Gly Thr Lys Val Thr Val Leu Gly Ala
100 105 110
gcc gca ggc cag ccc aag gcc gct ccc agc gtg acc ctg ttc ccc ccc 384
Ala Ala Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro
115 120 125
tcc tcc gag gag ctg cag gcc aac aag gcc acc ctg gtg tgc ctc atc 432
Ser Ser Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile
130 135 140
agc gac ttc tac cct ggc gcc gtg acc gtg gcc tgg aag gcc gac agc 480
Ser Asp Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser
145 150 155 160
agc ccc gtg aag gcc ggc gtg gag acc acc acc ccc agc aag cag agc 528
Ser Pro Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser
165 170 175
aac aac aag tac gcc gcc agc agc tac ctg agc ctc acc ccc gag cag 576
Asn Asn Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln
180 185 190
tgg aag agc cac cgg agc tac agc tgc cag gtg acc cac gag ggc agc 624
Trp Lys Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser
195 200 205
acc gtg gag aag acc gtg gcc ccc acc gag tgc agc 660
Thr Val Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215 220
<210>89
<211>220
<212>PRT
<213>Homo sapiens
<400>89
Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Gly Thr Pro Gly Gln
1 5 10 15
Arg Val Thr Ile Ser Cys Ser Gly Ser Arg Ser Asn Val Gly Asp Asn
20 25 30
Ser Val Tyr Trp Tyr Gln His Val Pro Glu Met Ala Pro Lys Leu Leu
35 40 45
Val Tyr Lys Asn Thr Gln Arg Pro Ser Gly Val Pro Ala Arg Phe Ser
50 55 60
Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ile Gly Leu Gln
65 70 75 80
Ser Gly Asp Glu Ala Asp Tyr Tyr Cys Val Ala Trp Asp Asp Ser Val
85 90 95
Asp Gly Tyr Val Phe Gly Ser Gly Thr Lys Val Thr Val Leu Gly Ala
100 105 110
Ala Ala Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro
115 120 125
Ser Ser Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile
130 135 140
Ser Asp Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser
145 150 155 160
Ser Pro Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser
165 170 175
Asn Asn Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln
180 185 190
Trn Lys Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser
195 200 205
Thr Val Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215 220
<210>90
<211>663
<212>DNA
<213>Homo sapiens
<220>
<221>CDS
<222>(1)..(663)
<400>90
cag tct gtg ttg acg cag ccg ccc tca gtg tct gcg gcc cca gga cag 48
Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Ala Ala Pro Gly Gln
1 5 10 15
aag gtc acc atc tcc tgc tct gga agc agc tcc aac att ggg aat gat 96
Lys Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Asn Asp
20 25 30
tat gta tcc tgg tac cag cag ctc cca gga aca gcc ccc aaa ctc ctc 144
Tyr Val Ser Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu
35 40 45
att tat gac aat aat aag cga ccc tca ggg att cct gac cga ttc tct 192
Ile Tyr Asp Asn Asn Lys Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser
50 55 60
ggc tcc aag tct ggc acg tca gcc acc ctg ggc atc acc gga ctc cag 240
Gly Ser Lys Ser Gly Thr Ser Ala Thr Leu Gly Ile Thr Gly Leu Gln
65 70 75 80
act ggg gac gag gcc aac tat tac tgc gca aca tgg gat cgc cgc ccg 288
thr Gly Asp Glu Ala Asn Tyr Tyr Cys Ala Tnr Trp Asp Arg Arg Pro
85 90 95
act gct tat gtt gtc ttc ggc gga ggg acc aag ctg acc gtc cta ggt 336
Tnr Ala Tyr Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu Gly
100 105 110
gcg gcc gca ggc cag ccc aag gcc gct ccc agc gtg acc ctg ttc ccc 384
Ala Ala Ala Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro
115 120 125
ccc tcc tcc gag gag ctg cag gcc aac aag gcc acc ctg gtg tgc ctc 432
Pro Ser Ser Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu
130 135 140
atc agc gac ttc tac cct ggc gcc gtg acc gtg gcc tgg aag gcc gac 480
Ile Ser Asp Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp
145 150 155 160
agc agc ccc gtg aag gcc ggc gtg gag acc acc acc ccc agc aag cag 528
Ser Ser Pro Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln
165 170 175
agc aac aac aag tac gcc gcc agc agc tac ctg agc ctc acc ccc gag 576
Ser Asn Asn Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu
180 185 190
cag tgg aag agc cac cgg agc tac agc tgc cag gtg acc cac gag ggc 624
Gln Trp Lys Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly
195 200 205
agc acc gtg gag aag acc gtg gcc ccc acc gag tgc agc 663
Ser Thr Val Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215 220
<210>91
<211>221
<212>PRT
<213>Homo sapiens
<400>91
Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Ala Ala Pro Gly Gln
1 5 10 15
Lys Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Asn Asp
20 25 30
Tyr Val Ser Trn Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu
35 40 45
Ile Tyr Asp Asn Asn Lys Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser
50 55 60
Gly Ser Lys Ser Gly Thr Ser Ala Thr Leu Gly Ile Thr Gly Leu Gln
65 70 75 80
Thr Gly Asp Glu Ala Asn Tyr Tyr Cys Ala Thr Trp Asp Arg Arg Pro
85 90 95
Thr Ala Tyr Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu Gly
100 105 110
Ala Ala Ala Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro
115 120 125
Pro Ser Ser Glu Glu Leu G1n Ala Asn Lys Ala Thr Leu Val Cys Leu
130 135 140
Ile Ser Asp Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp
145 150 155 160
Ser Ser Pro Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln
165 170 175
Ser Asn Asn Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu
180 185 190
Gln Trp Lys Ser His ArgSer Tyr Ser Cys Gln Val Thr His Glu Gly
195 200 205
Ser Thr Val Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215 220
<210>92
<211>642
<212>DNA
<213>Homo sapiens
<220>
<221>CDS
<222>(1)..(642)
<400>92
gac atc cag atg acc cag tct cca tcc tcc ctg tct gca tct gta gga 48
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
gac aga gtc acc atc act tgc cgg gcg agt cag ggc att agc agt tat 96
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr
20 25 30
tta gcc tgg tat cag cag aag cca ggg aaa gtt cct aca ctc ctg atc 144
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Val Pro Thr Leu Leu Ile
35 40 45
tat gat gca tcc act ttg cga tca ggg gtc cca tct cgc ttc agt ggc 192
Tyr Asn Ala Ser Tnr Leu Arg Ser Gly Val rro Ser Arg Phe Ser Gly
50 55 60
agt gga tct gcg aca gat ttc act ctc acc atc agc agc ctg cag cct 240
Ser Gly Ser Ala Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
gaa gat gtt gca act tat tac tgt caa agg tat aac agt gcc ccc ccg 288
Glu Asp Val Ala Thr Tyr Tyr Cys Gln Arg Tyr Asn Ser Ala Pro Pro
85 90 95
atc acc ttc ggc caa ggg aca cga ctg gag att aaa cgt gcg gcc gca 336
Ile Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys Arg Ala Ala Ala
100 105 110
ccc agc gtg ttc atc ttc ccc ccc tcc gac gag cag ctg aag agc ggc 384
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
acc gcc agc gtg gtg tgc ctg ctg aac aac ttc tac ccc cgg gag gcc 432
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
aag gtg cag tgg aag gtg gac aac gcc ctg cag agc ggc aac agc cag 480
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
gag agc gtg acc gag cag gac agc aag gac tcc acc tac agc ctg agc 528
Glu Ser Val Thr Glu Gln Asn Ser Lys Asn Ser Thr Tyr Ser Leu Ser
165 170 175
agc acc ctc acc ctg agc aag gcc gac tac gag aag cac aag gtg tac 576
Ser Thr Leu Thr Leu Ser Lys Ala Asn Tyr Glu Lys His Lys Val Tyr
180 185 190
gcc tgc gag gtg acc cac cag ggc ctg agc agc ccc gtg acc aag agc 624
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
ttc aac cgg ggc gag tgt 642
Phe Asn Arg Gly Glu Cys
210
<210>93
<211>214
<212>PRT
<213>Homo sapiens
<400>93
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Val Pro Thr Leu Leu Ile
35 40 45
Tyr Asp Ala Ser Thr Leu Arg Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Ala Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Val Ala Thr Tyr Tyr Cys Gln Arg Tyr Asn Ser Ala Pro Pro
85 90 95
Ile Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys Arg Ala Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210>94
<211>648
<212>DNA
<213>Homo sapiens
<220>
<221>CDS
<222>(1)..(648)
<400>94
cag tct gtg ctg act cag cca ccc tca gag tcc gtg tcc cca gga cag 48
Gln Ser Val Leu Thr Gln Pro Pro Ser Glu Ser Val Ser Pro Gly Gln
1 5 10 15
aca gcc agc gtc acc tgc tct gga cat aaa ttg ggg gat aaa tat gtt 96
Thr Ala Ser Val Thr Cys Ser Gly His Lys Leu Gly Asp Lys Tyr Val
20 25 30
tcg tgg tat cag cag aag cca ggc cag tcc cct gta tta ctc atc tat 144
Ser Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro Val Leu Leu Ile Tyr
35 40 45
caa gat aac agg cgg ccc tca ggg atc cct gag cga ttc ata ggc tcc 192
Gln Asp Asn Arg Arg Pro Ser Gly Ile Pro Glu Arg Phe Ile Gly Ser
50 55 60
aac tct ggg aac aca gcc act ctg acc atc agc ggg acc cag gct ctg 240
Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Leu
65 70 75 80
gat gag gct gac tat tac tgt cag gcg tgg gac agc agc act gcg gtt 288
Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Ser Thr Ala Val
85 90 95
ttc ggc gga ggg acc aag ctg acc gtc cta ggt gcg gcc gca ggc cag 336
Phe Gly Gly Gly Thr Lys Leu Thr Val Leu Gly Ala Ala Ala Gly Gln
100 105 110
ccc aag gcc gct ccc agc gtg acc ctg ttc ccc ccc tcc tcc gag gag 384
Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro Ser Ser Glu Glu
115 120 125
ctg cag gcc aac aag gcc acc ctg gtg tgc ctc atc agc gac ttc tac 432
Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile Ser Asp Pne Tyr
130 135 140
cct ggc gcc gtg acc gtg gcc tgg aag gcc gac agc agc ccc gtg aag 480
Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser Ser Pro Val Lys
145 150 155 160
gcc ggc gtg gag acc acc acc ccc agc aag cag agc aac aac aag tac 528
Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser Asn Asn Lys Tyr
165 170 175
gcc gcc agc agc tac ctg agc ctc acc ccc gag cag tgg aag agc cac 576
Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln Trp Lys Ser His
180 185 190
cgg agc tac agc tgc cag gtg acc cac gag ggc agc acc gtg gag aag 624
Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly SerThr Val Glu Lys
195 200 205
acc gtg gcc ccc acc gag tgc agc 648
Thr Val Ala Pro Thr Glu Cys Ser
210 215
<210>95
<211>216
<212>PRT
<213>Homo sapiens
<400>95
Gln Ser Val Leu Thr Gln Pro Pro Ser Glu Ser Val Ser Pro Gly Gln
1 5 10 15
Thr Ala Ser Val Thr Cys Ser Gly His Lys Leu Gly Asp Lys Tyr Val
20 25 30
Ser Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro Val Leu Leu Ile Tyr
35 40 45
Gln Asp Asn Arg Arg Pro Ser Gly Ile Pro Glu Arg Phe Ile Gly Ser
50 55 60
Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Leu
65 70 75 80
Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Ser Thr Ala Val
85 90 95
Phe Gly Gly Gly Thr Lys Leu Thr Val Leu Gly Ala Ala Ala Gly Gln
100 105 110
Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro Ser Ser Glu Glu
115 120 125
Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile Ser Asp Phe Tyr
130 135 140
Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser Ser Pro Val Lys
145 150 155 160
Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser Asn Asn Lys Tyr
165 170 175
Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln Trp Lys Ser His
180 185 190
Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser Thr Val Glu Lys
195 200 205
Thr Val Ala Pro Thr Glu Cys Ser
210 215
<210>96
<211>639
<212>DNA
<213>Homo sapiens
<220>
<221>CDS
<222>(1)..(639)
<400>96
gaa att gtg ctg act cag tct cca ggc acc ctg tct ttg tct cca ggg 48
Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly
1 5 10 15
gaa aga gcc acc ctc tcc tgc agg gcc agt cag cgt gtt agc agc tac 96
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Arg Val Ser Ser Tyr
20 25 30
tta gcc tgg tac caa cag aaa cct ggc cag gct ccc agg ctc ctc atc 144
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile
35 40 45
tat ggt gca tcc acc agg gcc gct ggc atc cca gac agg ttc agt ggc 192
Tyr Gly Ala Ser Thr Arg Ala Ala Gly Ile Pro Asp Arg Phe Ser Gly
50 55 60
agt ggg tct ggg aca gac ttc act ctc acc atc agc aga ctg gag cct 240
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu Pro
65 70 75 80
gaa gat tct gca gtg tat tac tgt cag cag tat ggt agg aca ccg ctc 288
Glu Asn Ser Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Arg Thr Pro Leu
85 90 95
act ttc ggc gga ggg acc aag gtg gag atc aaa cgt gcg gcc gca ccc 336
Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Ala Ala Ala Pro
100 105 110
agc gtg ttc atc ttc ccc ccc tcc gac gag cag ctg aag agc ggc acc 384
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
gcc agc gtg gtg tgc ctg ctg aac aac ttc tac ccc cgg gag gcc aag 432
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
gtg cag tgg aag gtg gac aac gcc ctg cag agc ggc aac agc cag gag 480
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
agc gtg acc gag cag gac agc aag gac tcc acc tac agc ctg agc agc 528
Ser Val Thr Glu Gln Asn Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
acc ctc acc ctg agc aag gcc gac tac gag aag cac aag gtg tac gcc 576
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
tgc gag gtg acc cac cag ggc ctg agc agc ccc gtg acc aag agc ttc 624
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
aac cgg ggc gag tgt 639
Asn Arg Gly Glu Cys
210
<210>97
<211>213
<212>PRT
<213>Homo sapiens
<400>97
Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly
1 5 10 15
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Arg Val Ser Ser Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile
35 40 45
Tyr Gly Ala Ser Thr Arg Ala Ala Gly Ile Pro Asp Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu Pro
65 70 75 80
Glu Asp Ser Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Arg Thr Pro Leu
85 90 95
Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Ala Ala Ala Pro
100 105 110
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
Asn Arg Gly Glu Cys
210
<210>98
<211>654
<212>DNA
<213>Homo sapiens
<220>
<221>CDS
<222>(1)..(654)
<400>98
tcc tat gtg ctg act cag cca ccc tcg gtg tca gtg gcc cca gga cag 48
Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Gln
1 5 10 15
acg gcc agg att acc tgt ggg gga aac aac att gga agt aaa agt gtg 96
Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Ser Val
20 25 30
cac tgg tac cag cag aag cca ggc cag gcc cct gtg ctg gtc gtc tat 144
His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr
35 40 45
gat gat agc gac cgg ccc tca ggg atc cct gag cga ttc tct ggc tcc 192
Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser
50 55 60
aac tct ggg aac acg gcc acc ctg acc atc agc agg gtc gaa gcc ggg 240
Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly
65 70 75 80
gat gag gcc gac tat tac tgt cag gtg tgg gat agt agt agt gat cat 288
Asp Glu Ala Asp Tyr Tyr Cys Glp Val Trp Asp Ser Ser Ser Asp His
85 90 95
gct gtg ttc gga gga ggc acc cag ctg acc gtc ctc ggt gcg gcc gca 336
Ala Val Phe Gly Gly Gly Thr Gln Leu Thr Val Leu Gly Ala Ala Ala
100 105 110
ggc cag ccc aag gcc gct ccc agc gtg acc ctg ttc ccc ccc tcc tcc 384
Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro Ser Ser
115 120 125
gag gag ctg cag gcc aac aag gcc acc ctg gtg tgc ctc atc agc gac 432
Glu Glu Leu Gln Ala Asn Lys Ala Tnr Leu Val Cys Leu Ile Ser Asp
130 135 140
ttc tac cct ggc gcc gtg acc gtg gcc tgg aag gcc gac agc agc ccc 480
Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser Ser Pro
145 150 155 160
gtg aag gcc ggc gtg gag acc acc acc ccc agc aag cag agc aac aac 528
Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser Asn Asn
165 170 175
aag tac gcc gcc agc agc tac ctg agc ctc acc ccc gag cag tgg aag 576
Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln Trp Lys
180 185 190
agc cac cgg agc tac agc tgc cag gtg acc cac gag ggc agc acc gtg 624
Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser Thr Val
195 200 205
gag aag acc gtg gcc ccc acc gag tgc agc 654
Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215
<210>99
<211>218
<212>PRT
<213>Homo sapiens
<400>99
Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Gln
1 5 10 15
Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Ser Val
20 25 30
His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr
35 40 45
Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser
50 55 60
Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly
65 70 75 80
Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His
85 90 95
Ala Val Phe Gly Gly Gly Thr Gln Leu Thr Val Leu Gly Ala Ala Ala
100 105 110
Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro Ser Ser
115 120 125
Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile Ser Asp
130 135 140
Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser Ser Pro
145 150 155 160
Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser Asn Asn
165 170 175
Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln Trp Lys
180 185 190
Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser Thr Val
195 200 205
Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215
<210>100
<211>660
<212>DNA
<213>Homo sapiens
<220>
<221>CDS
<222>(1)..(660)
<400>100
tcc tat gtg ctg act cag cca ccc tca gcg tct ggg acc ccc ggg cag 48
Ser Tyr Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Tnr Pro Gly Gln
1 5 10 15
agg gtc acc atc tct tgt tct gga agc agc tcc aac atc gga agt aat 96
Arg Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Ser Asn
20 25 30
tat gta tac tgg tac cag cag ctc cca ggc acg gcc ccc aaa ctc ctc 144
Tyr Val Tyr Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu
35 40 45
atc tat agg gat ggt cag cgg ccc tca ggg gtc cct gac cga ttc tct 192
Ile Tyr Arg Asp Gly Gln Arg Pro Ser Gly Val Pro Asp Arg Pne Ser
50 55 60
ggc tcc aag tct ggc acc tca gcc tcc ctg gcc atc agt gga ctc cgg 240
Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Arg
65 70 75 80
tcc gat gat gag gct gat tat tac tgt gca aca tgg gat gac aac ctg 288
Ser Asp Asp Glu Ala Asp Tyr Tyr Cys Ala Thr Trp Asp Asp Asn Leu
85 90 95
agt ggt cca gta ttc ggc gga ggg acc aag ctg acc gtc cta ggt gcg 336
Ser Gly Pro Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu Gly Ala
100 105 110
gcc gca ggc cag ccc aag gcc gct ccc agc gtg acc ctg ttc ccc ccc 384
Ala Ala Gly Gln Pro Lys Ala Ala Pro Ser Val Tnr Leu Pne Pro Pro
115 120 125
tcc tcc gag gag ctg cag gcc aac aag gcc acc ctg gtg tgc ctc atc 432
Ser Ser Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile
130 135 140
agc gac ttc tac cct ggc gcc gtg acc gtg gcc tgg aag gcc gac agc 480
Ser Asp Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser
145 150 155 160
agc ccc gtg aag gcc ggc gtg gag acc acc acc ccc agc aag cag agc 528
Ser Pro Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser
165 170 175
aac aac aag tac gcc gcc agc agc tac ctg agc ctc acc ccc gag cag 576
Asp Asp Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln
180 185 190
tgg aag agc cac cgg agc tac agc tgc cag gtg acc cac gag ggc agc 624
Trp Lys Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser
195 200 205
acc gtg gag aag acc gtg gcc ccc acc gag tgc agc 660
Thr Val Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215 220
<210>101
<211>220
<212>PRT
<213>Homo sapiens
<400>101
Ser Tyr Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln
1 5 10 15
Arg Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Ser Asn
20 25 30
Tyr Val Tyr Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu
35 40 45
Ile Tyr Arg Aso Gly Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser
50 55 60
Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Arg
65 70 75 80
Ser Asp Asp Glu Ala Asp Tyr Tyr Cys Ala Thr Trp Asp Asp Asn Leu
85 90 95
Ser Gly Pro Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu Gly Ala
100 105 110
Ala Ala Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro
115 120 125
Ser Ser Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile
130 135 140
Ser Asp Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser
145 150 155 160
Ser Pro Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser
165 170 175
Asn Ash Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln
180 185 190
Trp Lys Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser
195 200 205
Thr Val Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215 220
<210>102
<211>642
<212>DNA
<213>Gomo sapiens
<220>
<221>CDS
<222>(1)..(642)
<400>102
gaa att gtg ttg acc cag tct cca ggc acc ctg tct ttg tct cca ggg 48
Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly
1 5 10 15
gaa aga gcc acc ctc tcc tgc agg gcc agt cag agt gtt agc agc agc 96
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser
20 25 30
tac tta gcc tgg tac cag cag aaa cct ggc cag gct ccc agg ctc ctc 144
Tyr Leu Ala Trp Tyr 5ln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu
35 40 45
atc tat ggt gca tcc agc agg gcc act ggc atc cca gac agg ttc agt 192
Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser
50 55 60
ggc agt ggg tct ggg aca gac ttc act ctc acc atc agc aga ctg gag 240
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu
65 70 75 80
cct gaa gat ttt gca gtg tat tac tgt cag cag tat ggt agc tca ccc 288
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro
85 90 95
aga act ttc ggc gga ggg acc aag gtg gag atc aaa cgt gcg gcc gca 336
Arg Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Ala Ala Ala
100 105 110
ccc agc gtg ttc atc ttc ccc ccc tcc gac gag cag ctg aag agc ggc 384
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
acc gcc agc gtg gtg tgc ctg ctg aac aac ttc tac ccc cgg gag gcc 432
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Pne Tyr Pro Arg Glu Ala
130 135 140
aag gtg cag tgg aag gtg gac aac gcc ctg cag agc ggc aac agc cag 480
Lys Val Gln Trn Lys Val Asn Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
gag agc gtg acc gag cag gac agc aag gac tcc acc tac agc ctg agc 528
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
agc acc ctc acc ctg agc aag gcc gac tac gag aag cac aag gtg tac 576
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
gcc tgc gag gtg acc cac cag ggc ctg agc agc ccc gtg acc aag agc 624
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Tnr Lys Ser
195 200 205
ttc aac cgg ggc gag tgt 642
Phe Asn Arg Gly Glu Cys
210
<210>103
<211>214
<212>PRT
<213>Homo sapiens
<400>103
Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly
1 5 10 15
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser
20 25 30
Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu
35 40 45
Tle Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser
50 55 60
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu
65 70 75 80
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro
85 90 95
Arg Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Ala Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Vel Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr Gis Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210>104
<211>660
<212>DNA
<213>Homo sapiens
<220>
<221>CDS
<222>(1)..(660)
<400>104
cag tct gcc ctg act cag cct gcc tcc gtg tct ggg tct cct gga cag 48
Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
1 5 10 15
tcg atc acc atc tcc tgc act gga acc agc agt gac gtt ggt ggt tat 96
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr
20 25 30
aac tat gtc tcc tgg tac caa cag cac cca ggc aaa gcc ccc aaa ctc 144
Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
35 40 45
atg att tat gag gtc agt aat cgg ccc tca ggg gtt tct aat cgc ttc 192
Met Ile Tyr Gln Val Ser Asn Arg Pro Ser Gly Val Ser Asn Arg Phe
50 55 60
tct ggc tcc aag tct ggc aac acg gcc tcc ctg acc atc tct ggg ctc 240
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu
65 70 75 80
cag gct gag gac gag gct gat tat tac tgc agc tca tat aca agc agc 288
Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser
85 90 95
agc act ctt gtc ttc gga act ggg acc aag gtc acc gtc cta ggt gcg 336
Ser Thr Leu Val Phe Gly Thr Gly Thr Lys Val lhr yal Leu Gly Ala
100 105 110
gcc gca ggc cag ccc aag gcc gct ccc agc gtg acc ctg ttc ccc ccc 384
Ala Ala Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro
115 120 125
tcc tcc gag gag ctg cag gcc aac aag gcc acc ctg gtg tgc ctc atc 432
Ser Ser Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile
130 135 140
agc gac ttc tac cct ggc gcc gtg acc gtg gcc tgg aag gcc gac agc 480
Ser Asp Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser
145 150 155 160
agc ccc gtg aag gcc ggc gtg gag acc acc acc ccc agc aag cag agc 528
Ser Pro Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser
165 170 175
aac aac aag tac gcc gcc agc agc tac ctg agc ctc acc ccc gag cag 576
Asp Asp Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln
180 185 190
tgg aag agc cac cgg agc tac agc tgc cag gtg acc cac gag ggc agc 624
Trp Lys Ser His Arg Ser Tyr Ser Cys Gln Val Thr Gis Glu Gly Ser
195 200 205
acc gtg gag aag acc gtg gcc ccc acc gag tgc agc 660
Thr Val Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215 220
<210>105
<211>220
<212>PRT
<213>Gomo sapiens
<400>105
Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
1 5 10 15
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr
20 25 30
Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
35 40 45
Met Ile Tyr Glu Val Ser Asn Arg Pro Ser Gly Val Ser Asn Arg Phe
50 55 60
Ser Gly Ser Lys Ser Gly Ash Thr Ala Ser Leu Thr Ile Ser Gly Leu
65 70 75 80
Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser
85 90 95
Ser Thr Leu Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu Gly Ala
100 105 110
Ala Ala Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro
115 120 125
Ser Ser Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile
130 135 140
Ser Asp Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser
145 150 155 160
Ser Pro Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser
165 170 175
Asn Asn Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln
180 185 190
Trp Lys Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser
195 200 205
Thr Val Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215 220
<210>106
<211>654
<212>DNA
<213>Homo sapiens
<220>
<221>CDS
<222>(1)..(654)
<400>106
cag tct gtc gtg acg cag ccg ccc tcg gtg tca gtg gcc cca gga cag 48
Gln Ser Val Val Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Gln
1 5 10 15
acg gcc agg att acc tgt ggg gga aac aac att gga agt aaa agt gtg 96
Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Ser Val
20 25 30
cac tgg tac cag cag aag cca ggc cag gcc cct gtg ctg gtc gtc tat 144
Gis Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr
35 40 45
gat gat agc gac cgg ccc tca ggg atc cct gag cga ttc tct ggc tcc 192
Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser
50 55 60
aac tct ggg aac acg gcc acc ctg acc atc agc agg gtc gaa gcc ggg 240
Asn Ser Gly Asp Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly
65 70 75 80
gat gag gcc gac tat tac tgt cag gtg tgg gat agt agt agt gat cat 288
Asp Glu Ala Asp Tyr Tyr Lys Glp Val Trp Asp Ser Ser Ser Asp His
85 90 95
tat gtc ttc gga act ggg acc aag gtc acc gtc cta ggt gcg gcc gca 336
Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu Gly Ala Ala Ala
100 105 110
ggc cag ccc aag gcc gct ccc agc gtg acc ctg ttc ccc ccc tcc tcc 384
Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro Ser Ser
115 120 125
gag gag ctg cag gcc aac aag gcc acc ctg gtg tgc ctc atc agc gac 432
Glu Glu Leu Glp Ala Asn Lys Ala Thr Leu Val Cys Leu Ile Ser Asp
130 135 140
ttc tac cct ggc gcc gtg acc gtg gcc tgg aag gcc gac agc agc ccc 480
Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser Ser Pro
145 150 155 160
gtg aag gcc ggc gtg gag acc acc acc ccc agc aag cag acc aac aac 528
Val Lys Ala Gly Val Glu Thr Thr Thr Prp Ser Lys Gln Ser Asn Asn
165 170 175
aag tac gcc gcc agc agc tac ctg agc ctc acc ccc gag cag tgg aag 576
Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln Trp Lys
180 185 190
agc cac cgg agc tac agc tgc cag gtg acc cac gag ggc agc acc gtg 624
Ser His Arg Ser Tyr Ser Cys Glp Val Thr His Glu Gly Ser Thr Val
195 200 205
gag aag acc gtg gcc ccc acc gag tgc agc 654
Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215
<210>107
<211>218
<212>PRT
<213>Homo sapiens
<400>107
Gln Ser Val Val Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Gln
1 5 10 15
Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Ser Val
20 25 30
His Trn Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr
35 40 45
Asn Asp Ser Asn Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser
50 55 60
Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly
65 70 75 80
Asn Glu Ala Asp Tyr Tyr Cys Gln Val Trn Asp Ser Ser Ser Asp His
85 90 95
Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu Gly Ala Ala Ala
100 105 110
Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro Ser Ser
115 120 125
Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile Ser Asp
130 135 140
Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser Ser Pro
145 150 155 160
Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser Asn Asn
165 170 175
Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln Trp Lys
180 185 190
Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser Thr Val
195 200 205
Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215
<210>108
<211>660
<212>DNA
<213>Homo sapiens
<220>
<221>CDS
<222>(1)..(660)
<400>108
act gtg ttg aca cag ccg ccc tca gtg tct ggg gcc cca ggg cag agg 48
Thr Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln Arg
1 5 10 15
gtc acc atc tcc tgc act ggg agc agc tcc aac atc ggg gca ggt tat 96
Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly Tyr
20 25 30
gat gta cac tgg tac cag cag ctt cca gga aca gcc ccc aaa ctc ctc 144
Asp Val His Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu
35 40 45
atc tat ggt aac agc aat cgg ccc tca ggg gtc cct gac cga ttc tct 192
Ile Tyr Gly Asn Ser Asn Arg Pro Ser Gly Val Pro Asn Arg Phe Ser
50 55 60
ggc tcc aag tct ggc acg tca gcc acc ctg ggc atc acc gga ctc cag 240
Gly Ser Lys Ser Gly Thr Ser Ala Thr Leu Gly Ile Thr Gly Leu Gln
65 70 75 80
act ggg gac gag gcc gat tat tac tgc gga aca tgg gat agc agc ctg 288
Thr Gly Asp Glu Ala Asp Tyr Tyr Cys Gly Thr Trp Asp Ser Ser Leu
85 90 95
agt gct tat gtc ttc gga act ggg acc aag gtc acc gtc cta ggt gcg 336
Ser Ala Tyg Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu Gly Ala
100 105 110
gcc gca ggc cag ccc aag gcc gct ccc agc gtg acc ctg ttc ccc ccc 384
Ala Ala Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro
115 120 125
tcc tcc gag gag ctg cag gcc aac aag gcc acc ctg gtg tgc ctc atc 432
Ser Ser Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile
130 135 140
agc gac ttc tac cct ggc gcc gtg acc gtg gcc tgg aag gcc gac agc 480
Ser Asp Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser
145 150 155 160
agc ccc gtg aag gcc ggc gtg gag acc acc acc ccc agc aag cag agc 528
Ser Pro Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser
165 170 175
aac aac aag tac gcc gcc agc agc tac ctg agc ctc acc ccc gag cag 576
Asn Asn Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln
180 185 190
tgg aag agc cac cgg agc tac agc tgc cag gtg acc cac gag ggc agc 624
Trn Lys Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser
195 200 205
acc gtg gag aag acc gtg gcc ccc acc gag tgc agc 660
Thr Val Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215 220
<210>109
<211>220
<212>PRT
<213>Homo sapiens
<400>109
Thr Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln Arg
1 5 10 15
Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly Tyr
20 25 30
Asp Val His Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu
35 40 45
Ile Tyr Gly Asn Ser Asn Arg Pro Ser Gly Val Pro Asn Arg Phe Ser
50 55 60
Gly Ser Lys Ser Gly Thr Ser Ala Thr Leu Gly Ile Thr Gly Leu Gln
65 70 75 80
Thr Gly Asp Glu Ala Asp Tyr Tyr Cys Gly Thr Trp Asp Ser Ser Leu
85 90 95
Ser Ala Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu Gly Ala
100 105 110
Ala Ala Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro
115 120 125
Ser Ser Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile
130 135 140
Ser Asp Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser
145 150 155 160
Ser Pro Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser
165 170 175
Asn Asn Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln
180 185 190
Trp Lys Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser
195 200 205
Thr Val Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215 220
<210>110
<211>565
<212>PRT
<213>Influenza A virus
<220>
<221>MISC_FEATURE
<222>(1).(565)
<223>GA protein of influenza virus H5N1isolate A/Vietnam/1203/2004
<400>110
Met Glu Lys Ile Val Leu Leu Phe Ala Ile Val Ser Leu Val Lys Ser
1 5 10 15
Asp Gln Ile Cys Ile Gly Tyr His Ala Asn Asn Ser Thr Glu Gln Val
20 25 30
Asp Thr Ile Met Glu Lys Asn Val Thr Val Thr His Ala Gln Asp Ile
35 40 45
Leu Glu Lys Lys His Asn Gly Lys Leu Cys Asp Leu Asp Gly Val Lys
50 55 60
Pro Leu Ile Leu Arg Asp Cys Ser Val Ala Gly Trp Leu Leu Gly Asn
65 70 75 80
Pro Met Cys Asp Glu Phe Ile Asn Val Pro Glu Trp Ser Tyr Ile Val
85 90 95
Glu Lys Ala Asn Pro Val Asn Asp Leu Cys Tyr Pro Gly Asp Phe Asn
100 105 110
Asp Tyr Glu Glu Leu Lys Gis Leu Leu Ser Arg Ile Asn His Phe Glu
115 120 125
Lys Ile Gln Ile Ile Pro Lys Ser Ser Trp Ser Ser Gis Glu Ala Ser
130 135 140
Leu Gly Val Ser Ser Ala Cys Pro Tyr Gln Gly Lys Ser Ser Phe Phe
145 150 155 160
Arg Asn Val Val Trp Leu Ile Lys Lys Asn Ser Thr Tyr Pro Thr Ile
165 170 175
Lys Arg Ser Tyr Asn Asn Thr Asn Gln Glu Asp Leu Leu Val Leu Trp
180 185 190
Gly Ile Gis Gis Pro Asn Asp Ala Ala Glu Gln Thr Lys Leu Tyr Gln
195 200 205
Asn Pro Thr Thr Tyr Ile Ser Val Gly Thr Ser Thr Leu Asn Gln Arg
210 215 220
Leu Val Pro Arg Ile Ala Thr Arg Ser Lys Val Asn Gly Gln Ser Gly
225 230 235 240
Arg Met Glu Phe Phe Trp Thr Ile Leu Lys Pro Asn Asp Ala Ile Asn
245 250 255
Phe Glu Ser Asn Gly Asn Phe Ile Ala Pro Glu Tyr Ala Tyr Lys Ile
260 265 270
Val Lys Lys Gly Asp Ser Thr Ile Met Lys Ser Glu Leu Glu Tyr Gly
275 280 285
Asn Cys Asn Thr Lys Cys Gln Thr Pro Met Gly Ala Ile Asn Ser Ser
290 295 300
Met Pro Phe His Asn Ile His Pro Leu Thr Ile Gly Glu Cys Pro Lys
305 310 315 320
Tyr Val Lys Ser Asn Arg Leu Val Leu Ala Thr Gly Leu Arg Asn Ser
325 330 335
Pro Gln Arg Glu Arg Arg Arg Lys Lys Arg Gly Leu Phe GIy Ala Ile
340 345 350
Ala Gly Phe Ile Glu Gly Gly Trp Gln Gly Met Val Asp Gly Trp Tyr
355 360 365
Gly Tyr His His Ser Asn Glu Gln Gly Ser Gly Tyr Ala Ala Asp Lys
370 375 380
Glu Ser Thr Gln Lys Ala Ile Asp Gly Val Thr Asn Lys Val Asn Ser
385 390 395 400
Ile Ile Asp Lys Met Asn Thr Gln Phe Glu Ala Val Gly Arg Glu Phe
405 410 415
Asn Asn Leu Glu Arg Arg Ile Glu Asn Leu Asn Lys Lys Met Glu Asp
420 425 430
Gly Phe Leu Asp Val Trp Thr Tyr Asn Ala Glu Leu Leu Val Leu Met
435 440 445
Glu Asn Glu Arg Thr Leu Asp Phe Gis Asp Ser Asn Val Lys Asn Leu
450 455 460
Tyr Asp Lys Val Arg Leu Gln Leu Arg Asp Asn Ala Lys Glu Leu Gly
465 470 475 480
Asn Gly Cys Phe Glu Phe Tyr His Lys Cys Asp Asn Glu Cys Met Glu
485 490 495
Ser Val Arg Asn Gly Thr Tyr Asp Tyr Pro Gln Tyr Ser Glu Glu Ala
500 505 510
Arg Leu Lys Arg Glu Glu Ile Ser Gly Val Lys Leu Glu Ser Ile Gly
515 520 525
Ile Tyr Gln Ile Leu Ser Ile Tyr Ser Thr Val Ala Ser Ser Leu Ala
530 535 540
Leu Ala Ile Met Val Ala Gly Leu Ser Leu Trp Met Cys Ser Asn Gly
545 550 555 560
Ser Leu Gln Cys Arg
565
<210>111
<211>565
<212>PRT
<213>Influenza A virus
<220>
<221>MISC_FEATURE
<223>HA prootein of influenza virus H5N1isolate A/Vietnam/1194/2004
(H5N1TV)
<400>111
Met Glu Lys Ile Val Leu Leu Phe Ala Ile Val Ser Leu Val Lys Ser
1 5 10 15
Asp Gln Ile Cys Ile Gly Tyr His Ala Asn Asn Ser Thr Glu Gln Val
20 25 30
Asp Thr Ile Met Glu Lys Asn Val Thr Val Thr His Ala Gln Asp Ile
35 40 45
Leu Glu Lys Thr His Asp Gly Lys Leu Cys Asp Leu Asp Gly Val Lys
50 55 60
Pro Leu Ile Leu Arg Asp Cys Ser Val Ala Gly Trp Leu Leu Gly Asn
65 70 75 80
Pro Met Cys Asp Glu Phe Ile Asn Val Pro Glu Trp Ser Tyr Ile Val
85 90 95
Glu Lys Ala Asn Pro Val Asn Asp Leu Cys Tyr Pro Gly Asp Phe Asn
100 105 110
Asp Tyr Glu Glu Leu Lys His Leu Leu Ser Arg Ile Asn His Phe Glu
115 120 125
Lys Ile Gln Ile Ile Pro Lys Ser Ser Trp Ser Ser His Glu Ala Ser
130 135 140
Leu Gly Val Ser Ser Ala Cys Pro Tyr Gln Gly Lys Ser Ser Phe Phe
145 150 155 160
Arg Asn Val Val Trp Leu Ile Lys Lys Asn Ser Thr Tyr Pro Thr Ile
165 170 175
Lys Arg Ser Tyr Asn Asn Thr Asn Gln Glu Asp Leu Leu Val Leu Trp
180 185 190
Gly Ile His His Pro Asn Asp Ala Ala Glu Gln Thr Lys Leu Tyr Gln
195 200 205
Asn Pro Thr Thr Tyr Ile Ser Val Gly Thr Ser Thr Leu Asn Gln Arg
210 215 220
Leu Val Pro Arg Ile Ala Thr Arg Ser Lys Val Asn Gly Gln Ser Gly
225 230 235 240
Arg Mer Glu Phe Phe Trp Thr Ile Leu Lys Pro Asn Asp Ala Ile Asn
245 250 255
Phe Glu Ser Asn Gly Asn Phe Ile Ala Pro Glu Tyr Ala Tyr Lys Ile
260 265 270
Val Lys Lys Gly Asp Ser Thr Ile Met Lys Ser Glu Leu Glu Tyr Gly
275 280 285
Asn Cys Asn Thr Lys Cys Gln Thr Pro Met Gly Ala Ile Asn Ser Ser
290 295 300
Met Pro Phe His Asn Ile His Pro Leu Thr Ile Gly Glu Cys Pro Lys
305 310 315 320
Tyr Val Lys Ser Asn Arg Leu Val Leu Ala Thr Gly Leu Arg Asn Ser
325 330 335
Pro Gln Arg Glu Arg Arg Arg Lys Lys Arg Gly Leu Phe Gly Ala Ile
340 345 350
Ala Gly Phe Ile Glu Gly Gly Trp Gln Gly Met Val Asp Gly Trp Tyr
355 360 365
Gly Tyr His His Ser Asn Glu Gln Gly Ser Gly Tyr Ala Ala Asp Lys
370 375 380
Glu Ser Thr Gln Lys Ala Ile Asp Gly Val Thr Asn Lys Val Asn Ser
385 390 395 400
Ile Ile Asp Lys Met Asn Thr Gln Phe Glu Ala Val Gly Arg Glu Phe
405 410 415
Asn Asn Leu Glu Arg Arg Ile Glu Asn Leu Asn Lys Lys Met Glu Asp
420 425 430
Gly Phe Leu Asp Val Trp Thr Tyr Asn Ala Glu Leu Leu Val Leu Met
435 440 445
Glu Asn Glu Arg Thr Leu Asp Phe His Asp Ser Asn Val Lys Asn Leu
450 455 460
Tyr Asp Lys Val Arg Leu Gln Leu Arg Asp Asn Ala Lys Glu Leu Gly
465 470 475 480
Asn G1y Cys Phe Glu Phe Tyr His Lys Cys Asp Asn Glu Cys Met Glu
485 490 495
Ser Val Arg Asn Gly Thr Tyr Asp Tyr Pro Gln Tyr Ser Glu Glu Ala
500 505 510
Arg Leu Lys Arg Glu Glu Ile Ser Gly Val Lys Leu Glu Ser Ile Gly
515 520 525
Ile Tyr Gln Ile Leu Ser Ile Tyr Ser Thr Val Ala Ser Ser Leu Ala
530 535 540
Leu Ala Ile Met Val Ala Gly Leu Ser Leu Trp Met Cys Ser Asn Gly
545 550 555 560
Ser Leu Gln Cys Arg
565
<210>112
<211>565
<212>PRT
<213>Influenza A virus
<220>
<221>MISC_FEATURE
<223>Consensus amino acid sequence representing HAs from strains
isolated in Indonesia and China (H5N1IC)
<400>112
Met Glu Lys Ile Val Leu Leu Leu Ala Ile Val Ser Leu Val Lys Ser
1 5 10 15
Asp Gln Ile Cys Ile Gly Tyr His Ala Asn Asn Ser Thr Glu Gln Val
20 25 30
Asp Thr Ile Met Glu Lys Asn Val Thr Val Thr His Ala Gln Asp Ile
35 40 45
Leu Glu Lys Thr His Asn Gly Lys Leu Cys Asp Leu Asp Gly Val Lys
50 55 60
Pro Leu lle Leu Arg Asp Cys Ser Val Ala Gly Trp Leu Leu Gly Asn
65 70 75 80
Pro Met Cys Asp Glu Phe Ile Asn Val Pro Glu Trp Ser Tyr Ile Val
85 90 95
Glu Lys Ala Asn Pro Ala Asn Asp Leu Cys Tyr Pro Gly Asn Phe Asn
100 105 110
Asp Tyr Glu Glu Leu Lys His Leu Leu Ser Arg Ile Asn His Phe Glu
115 120 125
Lys Ile Gln Ile Ile Pro Lys Ser Ser Trp Ser Asp His Hlu Ala Ser
130 135 140
Ser Gly Val Ser Ser Ala Cys Pro Tyr Gln Gly Lys Ser Ser Phe Phe
145 150 155 160
Arg Asn Val Val Trp Leu Ile Lys Lys Asn Ser Ser Tyr Pro Thr Ile
165 170 175
Lys Arg Ser Tyr Asn Asn Thr Asn Gln Glu Asp Leu Leu Val Leu Trp
180 185 190
Gly Ile His His Pro Asn Asp Ala Ala Glu Gln Thr Arg Leu Tyr Gln
195 200 205
Asn Pro Thr Thr Tyr Ile Ser Val Gly Thr Ser Thr Leu Asn Gln Arg
210 215 220
Leu Val Pro Lys Ile Ala Thr Arg Ser Lys Val Asn Gly Gln Ser Gly
225 230 235 240
Arg Met Glu Phe Phe Trp Thr Ile Leu Lys Pro Asn Asp Ala Ile Asn
245 250 255
Phe Glu Ser Asn Gly Asn Phe Ile Ala Pro Glu Tyr Ala Tyr Lys Ile
260 265 270
Val Lys Lys Gly Asp Ser Ala Ile Met Lys Ser Glu Leu Glu Tyr Gly
275 280 285
Asn Cys Asn Thr Lys Cys Gln Thr Pro Met Gly Ala Ile Asn Ser Ser
290 295 300
Met Pro Phe His Asn Ile His Pro Leu Thr Ile Gly Glu Cys Pro Lys
305 310 315 320
Tyr Val Lys Ser Asn Arg Leu Val Leu Ala Thr Gly Leu Arg Asn Ser
325 330 335
Pro Gln Arg Glu Arg Arg Arg Lys Lys Arg Gly Leu Phe Gly Ala Ile
340 345 350
Ala Gly Phe Ile Glu Gly Gly Trp Gln Gly Met Val Asp Gly Trp Tyr
355 360 365
Gly Tyr His His Ser Asn Glu Gln Gly Ser Gly Tyr Ala Ala Asp Lys
370 375 380
Glu Ser Thr Gln Lys Ala lle Asp Gly Val Thr Asn Lys Val Asn Ser
385 390 395 400
Ile Ile Asp Lys Met Asn Thr Gln Phe Glu Ala Val Gly Arg Glu Phe
405 410 415
Asn Asn Leu Glu Arg Arg Ile Glu Asn Leu Asn Lys Lys Met Glu Asp
420 425 430
Gly Phe Leu Asp Val Trp Thr Tyr Asn Ala Glu Leu Leu Val Leu Met
435 440 445
Glu Asn Glu Arg Thr Leu Asp Phe His Asp Ser Asn Val Lys Asn Leu
450 455 460
Tyr Asp Lys Val Arg Leu Gln Leu Arg Asp Asn Ala Lys Glu Leu Gly
465 470 475 480
Asn Gly Cys Phe Glu Phe Tyr His Lys Cys Asp Asn Glu Cys Met Glu
485 490 495
Ser Val Arg Asn Gly Thr Tyr Asp Tyr Pro Gln Tyr Ser Glu Glu Ala
500 505 510
Arg Leu Lys Arg Glu Glu Ile Ser Gly Val Lys Leu Glu Ser Ile Gly
515 520 525
Ile Tyr Gln Ile Leu Ser Ile Tyr Ser Thr Val Ala Ser Ser Leu Ala
530 535 540
Leu Ala Ile Met Val Ala Gly Leu Ser Leu Trp Met Cys Ser Asn Gly
545 550 555 560
Ser Leu Gln Cys Arg
565
<210>113
<211>567
<212>PRT
<213>Influenza A yirus
<220>
<221>MISC_FEATURE
<223>Solublle part of HA from H5N1TV
<220>
<221>MISC_FEATURE
<222>(533)..(546)
<223>Spacer
<220>
<221>MISC_FEATURE
<222>(547).(556)
<223>Myc-tag
<220>
<221>MISC_FEATURE
<222>(557)..(561)
<223>Spacer
<220>
<221>MISC_FEATURE
<222>(562)..(567)
<223>His-tag
<400>113
Met Glu Lys Ile Val Leu Leu Phe Ala Ile Val Ser Leu Val Lys Ser
1 5 10 15
Asp Gln Ile Cys Ile Gly Tyr His Ala Asn Asn Ser Thr Glu Gln Val
20 25 30
Asp Thr Ile Met Glu Lys Asn Val Thr Val Thr His Ala Gln Asp Ile
35 40 45
Leu Glu Lys Thr His Asn Gly Lys Leu Cys Asp Leu Asp Gly Val Lys
50 55 60
Pro Leu Ile Leu Arg Asp Cys Ser Val Ala Gly Trp Leu Leu Gly Asn
65 70 75 80
Pro Met Cys Asp Glu Phe Ile Asn Val Pro Glu Trp Ser Tyr Ile Val
85 90 95
Glu Lys Ala Asn Pro Val Asn Asp Leu Cys Tyr Pro Gly Asp Phe Asn
100 105 110
Asp Tyr Glu Glu Leu Lys His Leu Leu Ser Arg Ile Asn His Phe Glu
115 120 125
Lys Ile Gln Ile Ile Pro Lys Ser Ser Trp Ser Ser His Glu Ala Ser
130 135 140
Leu Gly Val Ser Ser Ala Cys Pro Tyr Gln Gly Lys Ser Ser Phe Phe
145 150 155 160
Arg Asn Val Val Trp Leu Ile Lys Lys Asn Ser Thr Tyr Pro Thr Ile
165 170 175
Lys Arg Ser Tyr Asn Asn Thr Asn Gln Glu Asp Leu Leu Val Leu Trp
180 185 190
Gly Ile His His Pro Asn Asp Ala Ala Glu Gln Thr Lys Leu Tyr Gln
195 200 205
Asn Pro Thr Thr Tyr Ile Ser Val Gly Thr Ser Thr Leu Asn Gln Arg
210 215 220
Leu Val Pro Arg Ile Ala Thr Arg Ser Lys Val Asn Gly Gln Ser Gly
225 230 235 240
Arg Met Glu Phe Phe Trp Thr Ile Leu Lys Pro Asn Asp Ala Ile Asn
245 250 255
Phe Glu Ser Asn Gly Asn Phe Ile Ala Pro Glu Tyr Ala Tyr Lys Ile
260 265 270
Val Lys Lys Gly Asp Ser Thr Ile Met Lys Ser Glu Leu Glu Tyr Gly
275 280 285
Asn Cys Asn Thr Lys Cys Gln Thr Pro Met Gly Ala Ile Asn Ser Ser
290 295 300
Met Pro Phe His Asn Ile His Pro Leu Thr Ile Gly Glu Cys Pro Lys
305 310 315 320
Tyr Val Lys Ser Asn Arg Leu Val Leu Ala Thr Gly Leu Arg Asn Ser
325 330 335
Pro Gln Arg Glu Arg Arg Arg Lys Lys Arg Gly Leu Phe Gly Ala Ile
340 345 350
Ala Gly Phe Ile Glu Gly Gly Trp Gln Gly Met Val Asp Gly Trp Tyr
355 360 365
Gly Tyr His His Ser Asn Glu Gln Gly Ser Gly Tyr Ala Ala Asp Lys
370 375 380
Glu Ser Thr Gln Lys Ala Ile Asp Gly Val Thr Asn Lys Val Asn Ser
385 390 395 400
Ile Ile Asp Lys Met Asn Thr Gln Phe Glu Ala ValGly Arg Glu Phe
405 410 415
Asn Asn Leu Glu Arg Arg Ile Glu Asn Leu Asn Lys Lys Met Glu Asp
420 425 430
Gly Phe Leu Asp ValTrp Thr Tyr Asn Ala Glu Leu Leu Val Leu Met
435 440 445
Glu Asn Glu Arg Thr Leu Asp Phe His Asp Ser Asn Val Lys Asn Leu
450 455 460
Tyr Asp Lys Val Arg Leu Gln Leu Arg Asp Asn Ala Lys Glu Leu Gly
465 470 475 480
Asn Gly Cys Phe Glu Phe Tyr His Lys Cys Asp Asn Glu Cys Met Glu
485 490 495
Ser Val Arg Asn Gly Thr Tyr Asp Tyr Pro Gln Tyr Ser Glu Glu Ala
500 505 510
Arg Leu Lys Arg Glu Glu Ile Ser Gly ValLys Leu Glu Ser Ile Gly
515 520 525
Ile Tyr Gln Ile Gln His Ser Gly Gly Arg Ser Ser Leu Glu Gly Pro
530 535 540
Arg Phe Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu Asn Met His Thr
545 550 555 560
Gly His His His His His His
565
<210>114
<211>567
<212>PRT
<213>Influenza A yirus
<220>
<221>MISC_FEATURE
<223>Soluble part of HA from H5N1IC
<220>
<221>MISC_FEATURE
<222>(533)..(546)
<223>Spacer
<220>
<221>MISC_FEATURE
<222>(547)..(556)
<223>Myc-tag
<220>
<221>MISC_FEATURE
<222>(557)..(561)
<223>Spacer
<220>
<221>MISC_ FEATURE
<222>(562)..(567)
<223>His-tag
<400>114
Met Glu Lys Ile Val Leu Leu Leu Ala Ile Val Ser Leu Val Lys Ser
1 5 10 15
Asp Gln Ile Cys Ile Gly Tyr His Ala Asn Asn Ser Thr Glu Gln Val
20 25 30
Asp Thr Ile Met Glu Lys Asn Val Thr Val Thr His Ala Gln Asp Ile
35 40 45
Leu Glu Lys Thr His Asn Gly Lys Leu Cys Asp Leu Asp Gly Val Lys
50 55 60
Pro Leu lle Leu Arg Asp Cys Ser Val Ala Gly Trp Leu Leu Gly Asn
65 70 75 80
Pro Met Cys Asp Glu Phe Ile Asn Val Pro Glu Trp Ser Tyr Ile Val
85 90 95
Glu Lys Ala Asn Pro Ala Asn Asp Leu Cys Tyr Pro Gly Asn Phe Asn
100 105 110
Asp Tyr Glu Glu Leu Lys His Leu Leu Ser Arg Ile Asn His Phe Glu
115 120 125
Lys Ile Gln Ile Ile Pro Lys Ser Ser Trp Ser Asp His Glu Ala Ser
130 135 140
Ser Gly Val Ser Ser Ala Cys Pro Tyr Gln Gly Lys Ser Ser Phe Phe
145 150 155 160
Arg Asn Val Val Trp Leu Ile Lys Lys Asn Ser Ser Tyr Pro Thr Ile
165 170 175
Lys Arg Ser Tyr Asn Asn Thr Asn Gln Glu Asp Leu Leu Val Leu Trp
180 185 190
Gly Ile His His Pro Asn Asp Ala Ala Glu Gln Thr Arg Leu Tyr Gln
195 200 205
Asn Pro Thr Thr Tyr Ile Ser Val Gly Thr Ser Thr Leu Asn Gln Arg
210 215 220
Leu Val Pro Lys Ile Ala Thr Arg Ser Lys Val Asn Gly Gln Ser Gly
225 230 235 240
Arg Met Glu Phe Phe Trp Thr Ile Leu Lys Pro Asn Asp Ala Ile Asn
245 250 255
Phe Glu Ser Asn Gly Asn Phe Ile Ala Pro Glu Tyr Ala Tyr Lys Ile
260 265 270
Val Lys Lys Gly Asp Ser Ala Ile Met Lys Ser Glu Leu Glu Tyr Gly
275 280 285
Asn Cys Asn Thr Lys Cys Gln Thr Pro Met Gly Ala Ile Asn Ser Ser
290 295 300
Met Pro Phe His Asn Ile His Pro Leu Thr Ile Gly Glu Cys Pro Lys
305 310 315 320
Tyr Val Lys Ser Asn Arg Leu Val Leu Ala Thr Gly Leu Arg Asn Ser
325 330 335
Pro Gln Arg Glu Arg Arg Arg Lys Lys Arg Gly Leu Phe Gly Ala Ile
340 345 350
Ala Gly Phe Ile Glu Gly Gly Trp Gln Gly Met Val Asp Gly Trp Tyr
355 3603 65
Gly Tyr His His Ser Asn Glu Gln Gly Ser Gly Tyr Ala Ala Asp Lys
370 375 380
Glu Ser Thr Gln Lys Ala Ile Asp Gly Val Thr Asn Lys Val Asn Ser
385 390 395 400
Ile Ile Asp Lys Met Asn Thr Gln Phe Glu Ala Val Gly Arg Glu Phe
405 410 415
Asn Asn Leu Glu Arg Arg Ile Glu Asn Leu Asn Lys Lys Met Glu Asp
420 425 430
Gly Phe Leu Asp Val Trp Thr Tyr Asn Ala Glu Leu Leu Val Leu Met
435 440 445
Glu Asn Glu Arg Thr Leu Asp Phe His Asp Ser Asn Val Lys Asn Leu
450 455 460
Tyr Asp Lys Val Arg Leu Gln Leu Arg Asp Asn Ala Lys Glu Leu Gly
465 470 475 480
Asn Gly Cys Phe Glu Phe Tyr His Lys Cys Asp Asn Glu Cys Met Glu
485 490 495
Ser Val Arg Asn Gly Thr Tyr Asp Tyr Pro Gln Tyr Ser Glu Glu Ala
500 505 510
Arg Leu Lys Arg Glu Glu Ile Ser Gly Val Lys Leu Glu Ser Ile GIy
515 520 525
Ile Tyr Gln Ile Gln His Ser Gly Gly Arg Ser Ser Leu Glu Gly Pro
530 535 540
Arg Phe Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu Asn Met Gis Thr
545 550 555 560
Gly His His His His His His
565
<210>115
<211>744
<212>DNA
<213>Artificial
<220>
<223>SC06-255
<220>
<221>CDS
<222>(1)..(744)
<400>115
gag gtg cag ctg gtg gag tct ggg gct gag gtg aag aag cct ggg tcc 48
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aaa gtc tct tgc aag gct tct gga ggc ccc ttc cgc agc tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Arg Ser Tyr
20 25 30
gct atc agc tgg gtg cga cag gcc cct gga caa ggg cct gag tgg atg 144
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Pro Glu Trp Met
35 40 45
gga ggg atc atc cct att ttt ggt aca aca aaa tac gca ccg aag ttc 192
Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Lys Tyr Ala Pro Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac gat ttc gcg ggc aca gtt tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Asp Phe Ala Gly Thr Val Tyr
65 70 75 80
atg gag ctg agc agc ctg cga tct gag gac acg gcc atg tac tac tgt 288
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
gcg aaa cat atg ggg tac cag gtg cgc gaa act atg gac gtc tgg ggc 336
Ala Lys His Met Gly Tyr Gln Val Arg Glu Thr Met Asp Val Trp Gly
100 105 110
aaa ggg acc acg gtc acc gtc tcg agc ggt acg ggc ggt tca ggc gga 384
Lys Gly Thr Thr Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly
115 120 125
acc ggc agc ggc act ggc ggg tcg acg tcc tat gtg ctg act cag cca 432
Thr Gly Ser Gly Thr Gly Gly Ser Thr Ser Tyr Val Leu Thr Gln Pro
130 135 140
ccc tca gcg tct ggg acc ccc ggg cag agg gtc acc atc tct tgt tct 480
Pro Ser Ala Ser Gly Thr Pro Gly Gln Arg Val Thr Ile Ser Cys Ser
145 150 155 160
gga agc acg ttc aac atc gga agt aat gct gta gac tgg tac cgg cag 528
Gly Ser Tnr Phe Asn Ile Gly Ser Asn Ala Val Asp Trp Tyr Arg Gln
16 5170 175
ctc cca gga acg gcc ccc aaa ctc ctc atc tat agt aat aat cag cgg 576
Leu Pro Gly Thr Ala Pro Lys Leu Leu Ile Tyr Ser Asn Asn Gln Arg
180 185 190
ccc tca ggg gtc cct gac cga ttc tct ggc tcc agg tct ggc acc tca 624
Pro Ser Gly Val Pro Asp Arg Phe Ser Gly Ser Arg Ser Gly Thr Ser
195 200 205
gcc tcc ctg gcc atc agt ggg ctc cag tct gag gat gag gct gat tat 672
Ala Ser Leu Ala Ile Ser Gly Leu Gln Ser Glu Asp Glu Ala Asp Tyr
210 215 220
tac tgt gca gca tgg gat gac atc ctg aat gtt ccg gta ttc ggc gga 720
Tyr Cys Ala Ala Trp Asp Asp Ile Leu Asn Val Pro Val Phe Gly Gly
225 230 235 240
ggg acc aag ctg acc gtc cta ggt 744
Gly Thr Lys Leu Thr yal Leu Gly
245
<210>116
<211>248
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>116
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Arg Ser Tyr
20 25 30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Pro Glu Trp Met
35 40 45
Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Lys Tyr Ala Pro Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Asp Phe Ala Gly Thr Val Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Lys His Met Gly Tyr Gln Val Arg Glu Thr Met Asp Val Trp Gly
100 105 110
Lys Gly Thr Thr Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly
115 120 125
Thr Gly Ser Gly Thr Gly Gly Ser Thr Ser Tyr Val Leu Thr Gln Pro
130 135 140
Pro Ser Ala Ser Gly Thr Pro Gly Gln Arg Val Thr Ile Ser Cys Ser
145 150 155 160
Gly Ser Thr Phe Asn Ile Gly Ser Asn Ala Val Asp Trp Tyr Arg Gln
165 170 175
Leu Pro Gly Thr Ala Pro Lys Leu Leu Ile Tyr Ser Asn Asn Gln Arg
180 185 190
Pro Ser Gly Val Pro Asp Arg Phe Ser Gly Ser Arg Ser Gly Thr Ser
195 200 205
Ala Ser Leu Ala Ile Ser Gly Leu Gln Ser Glu Asp Glu Ala Asp Tyr
210 215 220
Tyr Cys Ala Ala Trp Asp Asp Ile Leu Asn Val Pro Val Phe Gly Gly
225 230 235 240
Gly Thr Lys Leu Thr Val Leu Gly
245
<210>117
<211>744
<212>DNA
<213>Artificial
<220>
<223>SC06-257
<220>
<221>CDS
<222>(1)..(744)
<400>117
cag gtc cag ctg gtg cag tct ggg gct gag gtg aag aag cct ggg tcc 48
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aaa gtc tct tgc aag gct tct gga ggc ccc ttc cgc agc tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Arg Ser Tyr
20 25 30
gct atc agc tgg gtg cga cag gcc cct gga caa ggg cct gag tgg atg 144
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Pro Glu Trp Met
35 40 45
gga ggg atc atc cct att ttt ggt aca aca aaa tac gca ccg aag ttc 192
Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Lys Tyr Ala Pro Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac gat ttc gcg ggc aca gtt tac 240
Gln Gly Arg Val Thr lle Thr Ala Asp Asp Phe Ala Gly Thr Val Tyr
65 70 75 80
atg gag ctg agc agc ctg cga tct gag gac acg gcc atg tac tac tgt 288
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
gcg aaa cat atg ggg tac cag gtg cgc gaa act atg gac gtc tgg ggc 336
Ala Lys Gis Met Gly Tyr Gln Val Arg Glu Thr Met Asp Val Trp Gly
100 105 110
aaa ggg acc acg gtc acc gtc tcg agc ggt acg ggc ggt tca ggc gga 384
Lys Gly Thr Thr Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly
115 120 125
acc ggc agc ggc act ggc ggg tcg acg cag tct gcc ctg act cag cct 432
Thr Gly Ser Gly Thr Gly Gly Ser Thr Gln Ser Ala Leu Thr Gln Pro
130 135 140
gcc gcc gtg tct ggg tct cct gga cag tcg atc acc atc tcc tgc act 480
Ala Ala Val Ser Gly Ser Pro Gly Gln Ser Ile Thr Ile Ser Cys Thr
145 150 155 160
gga acc agc agt gac gtt ggt ggt tat aac tat gtc tcc tgg tac caa 528
Gly Thr Ser Ser Asp Val Gly Gly Tyr Asn Tyr Val Ser Trp Tyr Gln
165 170 175
cag cac cca ggc aaa gcc ccc aaa ctc atg att tat gag gtc agt aat 576
Gln His Pro Gly Lys Ala Pro Lys Leu Met Ile Tyr Glu Val Ser Asn
180 185 190
cgg ccc tca ggg gtt tct aat cgc ttc tct ggc tcc aag tct ggc aac 624
Arg Pro Ser Gly Val Ser Asn Arg Phe Ser Gly Ser Lys Ser Gly Asn
195 200 205
acg gcc tcc ctg acc atc tct ggg ctc cag gct gag gac gag gct gat 672
Thr Ala Ser Leu Thr Ile Ser Gly Leu Gln Ala Glu Asp Glu Ala Asp
210 215 220
tat tac tgc agc tca tat aca agc agc agc act tat gtc ttc gga act 720
Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser Ser Thr Tyr Val Phe Gly Thr
225 230 235 240
ggg acc aag gtc acc gtc cta ggt 744
Gly Thr Lys Val Thr Val Leu Gly
245
<210>118
<211>248
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>118
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Arg Ser Tyr
20 25 30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Pro Glu Trp Met
35 40 45
Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Lys Tyr Ala Pro Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Asp Phe Ala Gly Thr Val Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Lys Gis Met Gly Tyr Gln Val Arg Glu Thr Met Asp Val Trp Gly
100 105 110
Lys Gly Thr Thr Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly
115 120 125
Thr Gly Ser Gly Thr Gly Gly Ser Thr Gln Ser Ala Leu Thr Gln Pro
130 135 140
Ala Ala Val Ser Gly Ser Pro Gly Gln Ser Ile Thr Ile Ser Cys Thr
145 150 155 160
Gly Thr Ser Ser Asp Val Gly Gly Tyr Asn Tyr Val Ser Trp Tyr Gln
165 170 175
Gln His Pro Gly Lys Ala Pro Lys Leu Met Ile Tyr Glu Val Ser Asn
180 185 190
Arg Pro Ser Gly Val Ser Asn Arg Phe Ser Gly Ser Lys Ser Gly Asn
195 200 205
Thr Ala Ser Leu Thr Ile Ser Gly Leu Gln Ala Glu Asp Glu Ala Asp
210 215 220
Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser Ser Thr Tyr Val Phe Gly Thr
225 230 235 240
Gly Thr Lys Val Thr Val Leu Gly
245
<210>119
<211>744
<212>DNA
<213>Artificial
<220>
<223>SC06-260
<220>
<221>CDS
<222>(1)..(744)
<400>119
gag gtg cag ctg gtg gag tct ggg gct gag gtg aag aag cct ggg tcc 48
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aaa gtc tct tgc aag gct tct gga ggc ccc ttc cgc agc tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Arg Ser Tyr
20 25 30
gct atc agc tgg gtg cga cag gcc cct gga caa ggg cct gag tgg atg 144
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Pro Glu Trp Met
35 40 45
gga ggg atc atc cct att ttt ggt aca aca aaa tac gca ccg aag ttc 192
Gly Gly Ile Ile Pro Ile Phe Gly lhr lhr Lys Tyr Ala Pro Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac gat ttc gcg ggc aca gtt tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Asp Phe Ala Gly Thr Val Tyr
65 70 75 80
atg gag ctg agc agc ctg cga tct gag gac acg gcc atg tac tac tgt 288
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
gcg aaa cat atg ggg tac cag gtg cgc gaa act atg gac gtc tgg ggc 336
Ala Lys His Met Gly Tyr Gln Val Arg Glu Thr Met Asp Val Trp Gly
100 105 110
aaa ggg acc acg gtc acc gtc tcg agc ggt acg ggc ggt tca ggc gga 384
Lys Gly Thr Thr Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly
115 120 125
acc ggc agc ggc act ggc ggg tcg acg tcc tat gtg ctg act cag cca 432
Thr Gly Ser Gly Thr Gly Gly Ser Thr Ser Tyr Val Leu Thr Gln Pro
130 135 140
ccc tca gtc tct ggg acc ccc ggg cag agg gtc acc atc tct tgc tct 480
Pro Ser Val Ser Gly Thr Pro Gly Gln Arg Val Thr Ile Ser Cys Ser
145 150 155 160
gga agc cgc tcc aac gtc gga gat aat tct gta tat tgg tat caa cac 528
Gly Ser Arg Ser Ash Val Gly Asp Asn Ser Val Tyr Trp Tyr Gln Gis
165 170 175
gtc cca gaa atg gcc ccc aaa ctc ctc gtc tat aag aat act caa cgg 576
Val Pro Glu Met Ala Pro Lys Leu Leu Val Tyr Lys Asn Thr Gln Arg
180 185 190
ccc tca gga gtc cct gcc cgg ttt tcc ggc tcc aag tct ggc act tca 624
Pro Ser Gly Val Pro Ala Arg Phe Ser Gly Ser Lys Ser Gly Thr Ser
195 200 205
gcc tcc ctg gcc atc att ggc ctc cag tcc ggc gat gag gct gat tat 672
Ala Ser Leu Ala Ile Ile Gly Leu Gln Ser Gly Asp Glu Ala Asp Tyr
210 215 220
tat tgt gtg gca tgg gat gac agc gta gat ggc tat gtc ttc gga tct 720
Tyr Cys Val Ala Trp Asp Asp Ser Val Asp Gly Tyr Val Phe Gly Ser
225 230 235 240
ggg acc aag gtc acc gtc cta ggt 744
Gly Thr Lys Val Thr Val Leu Gly
245
<210>120
<211>248
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>120
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Arg Ser Tyr
20 25 30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Pro Glu Trp Met
35 40 45
Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Lys Tyr Ala Pro Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Asp Phe Ala Gly Thr Val Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Lys His Met Gly Tyr Gln Val Arg Glu Thr Met Asp Val Trp Gly
100 105 110
Lys Gly Thr Thr Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly
115 120 125
Thr Gly Ser Gly Thr Gly Gly Ser Thr Ser Tyr Val Leu Thr Gln Pro
130 135 140
Pro Ser Val Ser Gly Thr Pro Gly Gln Arg Val Thr Ile Ser Cys Ser
145 150 155 160
Gly Ser Arg Ser Asn Val Gly Asp Asn Ser Val Tyr Trp Tyr Gln His
165 170 175
Val Pro Glu Met Ala Pro Lys Leu Leu Val Tyr Lys Asn Thr Gln Arg
180 185 190
Pro Ser Gly Val Pro Ala Arg Phe Ser Gly Ser Lys Ser Gly Thr Ser
195 200 205
Ala Ser Leu Ala Ile Ile Gly Leu Gln Ser Gly Asp Glu Ala Asp Tyr
210 215 220
Tyr Cys Val Ala Trp Asp Asp Ser Val Asp Gly Tyr Val Phe Gly Ser
225 230 235 240
Gly Thr Lys Val Thr Val Leu Gly
245
<210>121
<211>747
<212>DNA
<213>Artificial
<220>
<223>SC06-261
<220>
<221>CDS
<222>(1)..(747)
<400>121
gag gtg cag ctg gtg gag tct ggg gct gag gtg aag aag cct ggg tcc 48
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aaa gtc tct tgc aag gct tct gga ggc ccc ttc cgc agc tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly G1y Pro Phe Arg Ser Tyr
20 25 30
gct atc agc tgg gtg cga cag gcc cct gga caa ggg cct gag tgg atg 144
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Pro Glu Trp Met
35 40 45
gga ggg atc atc cct att ttt ggt aca aca aaa tac gca ccg aag ttc 192
Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Lys Tyr Ala Pro Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac gat ttc gcg ggc aca gtt tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Asp Phe Ala Gly Thr Val Tyr
65 70 75 80
atg gag ctg agc agc ctg cga tct gag gac acg gcc atg tac tac tgt 288
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
gcg aaa cat atg ggg tac cag gtg cgc gaa act atg gac gtc tgg ggc 336
Ala Lys His Met Gly Tyr Gln Val Arg Glu Thr Met Asp yal Trp Gly
100 105 110
aaa ggg acc acg gtc acc gtc tcg agc ggt acg ggc ggt tca ggc gga 384
Lys Gly Thr Thr Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly
115 120 125
acc ggc agc ggc act ggc ggg tcg acg cag tct gtg ttg acg cag ccg 432
Thr G1y Ser Gly Thr Gly Gly Ser Thr Gln Ser Val Leu Thr Gln Pro
130 135 140
ccc tca gtg tct gcg gcc cca gga cag aag gtc acc atc tcc tgc tct 480
Pro Ser Val Ser Ala Ala Pro Gly Gln Lys Val Thr Ile Ser Cys Ser
145 150 155 160
gga agc agc tcc aac att ggg aat gat tat gta tcc tgg tac cag cag 528
Gly Ser Ser Ser Asn Ile Gly Asn Asp Tyr Val Ser Trp Tyr Gln Gln
165 170 175
ctc cca gga aca gcc ccc aaa ctc ctc att tat gac aat aat aag cga 576
Leu Pro Gly Thr Ala Pro Lys Leu Leu lle Tyr Asp Asn Asn Lys Arg
180 185 190
ccc tca ggg att cct gac cga ttc tct ggc tcc aag tct ggc acg tca 624
Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser Lys Ser Gly Thr Ser
195 200 205
gcc acc ctg ggc atc acc gga ctc cag act ggg gac gag gcc aac tat 672
Ala Thr Leu Gly Ile Thr Gly Leu Gln Thr Gly Asp Glu Ala Asn Tyr
210 215 220
tac tgc gca aca tgg gat cgc cgc ccg act gct tat gtt gtc ttc ggc 720
Tyr Cys Ala Thr Trp Asp Arg Arg Pro Thr Ala Tyr Val Val Phe Gly
225 230 235 240
gga gga acc aag ctg acc gtc cta ggt 747
Gly Gly Thr Lys Leu Thr Val Leu Gly
245
<210>122
<211>249
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>122
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Arg Ser Tyr
20 25 30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Pro Glu Trp Met
35 40 45
Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Lys Tyr Ala Pro Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Asp Phe Ala Gly Thr Val Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Lys His Met Gly Tyr Gln Val Arg Glu Thr Met Asp Val Trp Gly
100 105 110
Lys Gly Thr Thr Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly
115 120 125
Thr Gly Ser Gly Thr Gly Gly Ser Thr Gln Ser Val Leu Thr Gln Pro
130 135 140
Pro Ser Val Ser Ala Ala Pro Gly Gln Lys Val Thr Ile Ser Cys Ser
145 150 155 160
Gly Ser Ser Ser Asn Ile Gly Asn Asp Tyr Val Ser Trp Tyr Gln Gln
165 170 175
Leu Pro Gly Thr Ala Pro Lys Leu Leu Ile Tyr Asp Ash Asn Lys Arg
180 185 190
Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser Lys Ser Gly Thr Ser
195 200 205
Ala Thr Leu Gly Ile Thr Gly Leu Gln Thr Gly Asp Glu Ala Asn Tyr
210 215 220
Tyr Cys Ala Thr Trp Asp Arg Arg Pro Thr Ala Tyr Val Val Phe Gly
225 230 235 240
Gly Gly Thr Lys Leu Thr Val Leu Gly
245
<210>123
<211>735
<212>DNA
<213>Artificial
<220>
<223>SC06-262
<220>
<221>CDS
<222>(1)..(735)
<400>123
cag gta cag ctg cag cag tca ggg gct gag gtg aag aag cct ggg tcc 48
Gln Val Gln Leu Gln Gln Ser G1y Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aag gtc tcc tgc aag gtt tcc gga gtc att ttc agc ggc agt 96
Ser Val Lys Val Ser Cys Lys Val Ser Gly Val Ile Phe Ser Gly Ser
20 25 30
gcg atc agc tgg gtg cga cag gcc cct gga caa ggc ctt gag tgg atg 144
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu GlG Trp Met
35 40 45
gga ggg atc agc cct ctc ttt ggc aca aca aat tac gca caa aag ttc 192
Gly Gly Ile Ser Pro Leu Phe Gly Thr Thr Asn Tyr Ala Gln Lys Pne
50 55 60
cag ggc aga gtc acg att acc gcg gac caa tcc acg aac aca acc tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Gln Ser Thr Asn Thr Thr Tyr
65 70 75 80
atg gag gtg aac agc ctg aga tat gag gac acg gcc gtg tat ttc tgt 288
Met Glu Val Asn Ser Leu Arg Tyr Glu Asp Thr Ala Val Tyr Phe Cys
85 90 95
gcg cga ggt cca aaa tat tac agt gag tac atg gac gtc tgg ggc aaa 336
Ala Arg Gly Pro Lys Tyr Tyr Ser Glu Tyr Met Asp Val Trp Gly Lys
100 105 110
ggg acc acg gtc acc gtc tcg agc ggt acg ggc ggt tca ggc gga acc 384
Gly Thr Thr Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly Thr
115 120 125
ggc agc ggc act ggc ggg tcg acg gac atc cag atg acc cag tct cca 432
Gly Ser Gly Thr Gly Gly Ser Thr Asp Ile Gln Met Thr Gln Ser Pro
130 135 140
tcc tcc ctg tct gca tct gta gga gac aga gtc acc atc act tgc cgg 480
Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg
145 150 155 160
gcg agt cag ggc att agc agt tat tta gcc tgg tat cag cag aag cca 528
Ala Ser Gln Gly Ile Ser Ser Tyr Leu Ala Trp Tyr Gln Gln Lys Pro
165 170 175
ggg aaa gtt cct aca ctc ctg atc tat gat gca tcc act ttg cga tca 576
Gly Lys Val Pro Thr Leu Leu Ile Tyr Asp Ala Ser Thr Leu Arg Ser
180 185 190
ggg gtc cca tct cgc ttc agt ggc agt gga tct gcg aca gat ttc act 624
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Ala Thr Asp Phe Thr
195 200 205
ctc acc atc agc agc ctg cag cct gaa gat gtt gca act tat tac tgt 672
Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Val Ala Thr Tyr Tyr Cys
210 215 220
caa agg tat aac agt gcc ccc ccg atc acc ttc ggc caa ggg aca cga 720
Gln Arg Tyr Asn Ser Ala Pro Pro Ile Thr Phe Gly Gln Gly Thr Arg
225 230 235 240
ctg gag att aaa cst 735
Leu Glu Ile Lys Arg
245
<210>124
<211>245
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>124
Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Val Ser Gly Val Ile Phe Ser Gly Ser
20 25 30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Gly Ile Ser Pro Leu Phe Gly Thr Thr Asn Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Gln Ser Thr Asn Thr Thr Tyr
65 70 75 80
Met Glu Val Asn Ser Leu Arg Tyr Glu Asp Thr Ala Val Tyr Phe Cys
85 90 95
Ala Arg Gly Pro Lys Tyr Tyr Ser Glu Tyr Met Asp Val Trp Gly Lys
100 105 110
Gly Thr Thr Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly Thr
115 120 125
Gly Ser Gly Thr Gly Gly Ser Thr Asp Ile Gln Met Thr Gln Ser Pro
130 135 140
Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg
145 150 155 160
Ala Ser Gln Gly Ile Ser Ser Tyr Leu Ala Trp Tyr Gln Gln Lys Pro
165 170 175
Gly Lys Val Pro Thr Leu Leu Ile Tyr Asp Ala Ser Thr Leu Arg Ser
180 185 190
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Ala Thr Asp Phe Thr
195 200 205
Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Val Ala Thr Tyr Tyr Cys
210 215 220
Gln Arg Tyr Asn Ser Ala Pro Pro Ile Thr Phe Gly Gln Gly Thr Arg
225 230 235 240
Leu Glu Ile Lys Arg
245
<210>125
<211>729
<212>DNA
<213>Artificial
<220>
<223>SC06-268
<220>
<221>CDS
<222>(1)..(729)
<400>125
cag gtc cag ctg gta cag tct ggg gct gag gtg aag aag cct ggg tcc 48
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aag gtc tcc tgc aag gct tct gga ggc acc ttc agt agt tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr
20 25 30
gct atc agc tgg gtg cga cag gcc cct gga caa ggg ctt gag tgg atg 144
Ala Ile Ser Trn Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga gga atc atg ggt atg ttt ggc aca act aac tac gca cag aag ttc 192
Gly Gly Ile Met Gly Met Phe Gly Thr Thr Asn Tyr Ala Gln Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac gaa ttc acg agc gca gcc tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Phe Thr Ser Ala Ala Tyr
65 70 75 80
atg gag ctg agg agc ctg aga tct gag gac acg gcc gtc tac tac tgt 288
Met Glu Leu Arg Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
gcg agg tct agt ggt tat tac ccc gaa tac ttc cag gac tgg ggc cag 336
Ala Arg Ser Ser Gly Tyr Tyr Pro Glu Tyr Phe Gln Asp Trp Gly Gln
100 105 110
ggc acc ctg gtc acc gtc tcg agc ggt acg ggc ggt tca ggc gga acc 384
Gly Thr Leu Val Thr Val Ser Ser Gly Tnr Gly Gly Ser Gly Gly Thr
115 120 125
ggc agc ggc act ggc ggg tcg acg cag tct gtg ctg act cag cca ccc 432
Gly Ser Gly Thr Gly Gly Ser Thr Gln Ser Val Leu Thr Gln Pro Pro
130 135 140
tca gag tcc gtg tcc cca gga cag aca gcc agc gtc acc tgc tct gga 480
Ser Glu Ser Val Ser Pro Gly Gln Thr Ala Ser Val Thr Cys Ser Gly
145 150 155 160
cat aaa ttg ggg gat aaa tat gtt tcg tgg tat cag cag aag cca ggc 528
His Lys Leu Gly Asp Lys Tyr Val Ser Trp Tyr Gln Gln Lys Pro Gly
165 170 175
cag tcc cct gta tta ctc atc tat caa gat aac agg cgg ccc tca ggg 576
Gln Ser Pro Val Leu Leu Ile Tyr Gln Asp Asn Arg Arg Pro Ser Gly
180 185 190
arc cct gag cga ttc ata ggc tcc aac tct ggg aac aca gcc act ctg 624
Ile Pro Glu Arg Phe Ile Gly Ser Asn Ser Gly Asn Thr Ala Thr Leu
195 200 205
acc atc agc ggg acc cag gct ctg gat gag gct gac tat tac tgt cag 672
Thr Ile Ser Gly Thr Gln Ala Leu Asp Glu Ala Asp Tyr Tyr Cys Gln
210 215 220
gcg tgg gac agc agc act gcg gtt ttc ggc gga ggg acc aag ctg acc 720
Ala Trp Asp Ser Ser Thr Ala Val Phe Gly Gly Gly Thr Lys Leu Thr
225 230 235 240
gtc cta ggt 729
Val Leu Gly
<210>126
<211>243
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>126
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr
20 25 30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Gly Ile Met Gly Met Phe Gly Thr Thr Ash Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Phe Thr Ser Ala Ala Tyr
65 70 75 80
Met Glu Leu Arg Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ser Ser Gly Tyr Tyr Pro Glu Tyr Phe Gln Asp Trp Gly Gln
100 105 110
Gly Thr Leu Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly Thr
115 120 125
Gly Ser Gly Thr Gly Gly Ser Thr Gln Ser Val Leu Thr Gln Pro Pro
130 135 140
Ser Glu Ser Val Ser Pro Gly Gln Thr Ala Ser Val Thr Cys Ser Gly
145 150 155 160
His Lys Leu Gly Asp Lys Tyr Val Ser Trp Tyr Gln Gln Lys Pro Gly
165 170 175
Gln Ser Pro Val Leu Leu Ile Tyr Gln Asp Asn Arg Arg Pro Ser Gly
180 185 190
Ile Pro Glu Arg Phe Ile Gly Ser Asn Ser Gly Asn Thr Ala Thr Leu
195 200 205
Thr Ile Ser Gly Thr Gln Ala Leu Asp Glu Ala Asp Tyr Tyr Cys Gln
210 215 220
Ala Trp Asp Ser Ser Thr Ala Val Phe Gly Gly Gly Thr Lys Leu Thr
225 230 235 240
Val Leu Gly
<210>127
<211>738
<212>DNA
<213>Artificial
<220>
<223>SC06-307
<220>
<221>CDS
<222>(1)..(738)
<400>127
cag gtc cag ctg gtg cag tct ggg gga ggc ctg gtc aag cct ggg ggg 48
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Leu Val Lys Pro Gly Gly
1 5 10 15
tcc ctg aga ctc tcc tgt gca gcc tct gga ttc acc ttc agt agc tat 96
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
20 25 30
agc atg aac tgg gtc cgc cag gct cca ggg aag ggg ctg gag tgg gtc 144
Ser Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
tca tcc att agt agt agt agt agt tac ata tac tac gta gac tca gtg 192
Ser Ser Ile Ser Ser Ser Ser Ser Tyr Ile Tyr Tyr Val Asp Ser Val
50 55 60
aag ggc cga ttc acc atc tcc aga gac aac gcc aag aac tca ctg tat 240
Lys Gly Arg Phe Thr Ile Set Arg Asp Asn Ala Lys Asn Ser Leu Tyr
65 70 75 80
ctg caa atg aac agc ctg aga gcc gag gac acg gct gtg tat tac tgt 288
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
gcg aga ggt ggt ggg agc tac ggg gcc tac gaa ggc ttt gac tac tgg 336
Ala Arg Gly Gly Gly Ser Tyr Gly Ala Tyr Glu Gly Phe Asp Tyr Trp
100 105 110
ggc cag ggc acc ctg gtc acc gtc tcg agc ggt acg ggc ggt tca ggc 384
Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly
115 120 125
gga acc ggc agc ggc act ggc ggg tcg acg gaa att gtg ctg act cag 432
Gly Thr Gly Ser Gly Thr Gly Gly Ser Thr Glu Ile Val Leu Tnr Gln
130 135 140
tct cca ggc acc ctg tct ttg tct cca ggg gaa aga gcc acc ctc tcc 480
Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly Glu Arg Ala Tnr Leu Ser
145 150 155 160
tgc agg gcc agt cag cgt gtt agc agc tac tta gcc tgg tac caa cag 528
Cys Arg Ala Ser Gln Arg Val Ser Ser Tyr Leu Ala Trp Tyr Gln Gln
165 170 175
aaa cct ggc cag gct ccc agg ctc ctc atc tat ggt gca tcc acc agg 576
Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile Tyr Gly Ala Ser Thr Arg
180 185 190
gcc gct ggc atc cca gac agg ttc agt ggc agt ggg tct ggg aca gac 624
Ala Ala Gly Ile Pro Asp Arg Pne Ser Gly Ser Gly Ser Gly Tnr Asp
195 200 205
ttc act ctc acc atc agc aga ctg gag cct gaa gat tct gca gtg tat 672
Phe Thr Leu Thr Ile Ser Arg Leu Glu Pro Glu Asp Ser Ala Val Tyl
210 215 220
tac tgt cag cag tat ggt agg aca ccg ctc act ttc ggc gga ggg acc 720
Tyr Cys Gln Gln Tyr Gly Arg Thr Pro Leu Thr Phe Gly Gly Gly Thr
225 230 235 240
aag gtg gag atc aaa cgt 738
Lys Val Glu Ile Lys Arg
245
<210>128
<211>246
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>128
Gln Val Gln Leu Val Gln Ser Gly Gly Gly Leu Val Lys Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
20 25 30
Ser Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ser Ser Ile Ser Ser Ser Ser Ser Tyr Ile Tyr Tyr Val Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Gly Gly Ser Tyr Gly Ala Tyr Glu Gly Phe Asp Tyr Trp
100 105 110
Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly
115 120 125
Gly Thr Gly Ser Gly Thr Gly Gly Ser Thr Glu Ile Val Leu Thr Gln
130 135 140
Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly Glu Arg Ala Thr Leu Ser
145 150 155 160
Cys Arg Ala Ser Gln Arg Val Ser Ser Tyr Leu Ala Trp Tyr Gln Gln
165 170 175
Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile Tyr Gly Ala Ser Thr Arg
180 185 190
Ala Ala Gly Ile Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp
195 200 205
Phe Thr Leu Thr Ile Ser Arg Leu Glu Pro Glu Asp Ser Ala Val Tyr
210 215 220
Tyr Cys Gln Gln Tyr Gly Arg Thr Pro Leu Thr Phe Gly Gly Gly Thr
225 230 235 240
Lys Val Glu Ile Lys Arg
245
<210>129
<211>738
<212>DNA
<212>Artificial
<220>
<223>SC06-310
<220>
<221>CDS
<222>(1)..(738)
<400>129
gag gtg cag ctg gtg gag tct ggg gct gag gtg aag aag cct ggg tcc 48
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aaa gtc tct tgc aag gct tct gga ggc ccc ttc cgc agc tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Arg Ser Tyr
20 25 30
gct atc agc tgg gtg cga cag gcc cct gga caa ggg cct gag tgg atg 144
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Pro Glu Trp Met
35 40 45
gga ggg atc atc cct att ttt ggt aca aca aaa tac gca ccg aag ttc 192
Gly Gly Ile Ile Pro Ile Phe Gly Thr lhr Lys Tyr Ala Pro Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac gat ttc gcg ggc aca gtt tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Asp Phe Ala Gly Thr Val Tyr
65 70 75 80
atg gag ctg agc agc ctg cga tct gag gac acg gcc atg tac tac tgt 288
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
gcg aaa cat atg ggg tac cag gtg cgc gaa act atg gac gtc tgg ggc 336
Ala Lys His Met Gly Tyr Gln Val Arg Glu Thr Met Asp Val Trp Gly
100 105 110
aaa ggg acc acg gtc acc gtc tcg agc ggt acg ggc ggt tca ggc gga 384
Lys Gly Thr Thr Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly
115 120 125
acc ggc agc ggc act ggc ggg tcg acg tcc tat gtg ctg act cag cca 432
Thr Gly Ser Gly Thr Gly Gly Ser Thr Ser Tyr Val Leu Thr Gln Pro
130 135 140
ccc tcg gtg tca gtg gcc cca gga cag acg gcc agg att acc tgt ggg 480
Pro Ser Val Ser Val Ala Pro Gly Gln Thr Ala Arg Ile Thr Cys Gly
145 150 155 160
gga aac aac att gga agt aaa agt gtg cac tgg tac cag cag aag cca 528
Gly Asn Asn Ile Gly Ser Lys Ser Val Gis Trp Tyr Gln Gln Lys Pro
165 170 175
ggc cag gcc cct gtg ctg gtc gtc tat gat gat agc gac cgg ccc tca 576
Gly Gln Ala Pro Val Leu Val yal Tyr Asp Asp Ser Asp Arg Pro Ser
180 185 190
ggg atc cct gag cga ttc tct ggc tcc aac tct ggg aac acg gcc acc 624
Gly Ile Pro Glu Arg Phe Ser Gly Ser Asn Ser Gly Asn Thr Ala Thr
195 200 205
ctg acc atc agc agg gtc gaa gcc ggg gat gag gcc gac tat tac tgt 672
Leu Thr lle Ser Arg ValGlu Ala Gly Asp Glu Ala Asp Tyr Tyr Cys
2l0 215 220
cag gtg tgg gat agt agt agt gat cat gct gtg ttc gga gga ggc acc 720
Gln Val Trp Asp Ser Ser Ser Asp Gis Ala Val Phe Gly Gly Gly Thr
225 230 235 240
cag ctg acc gtc ctc ggt 738
Gln Leu Thr Val Leu Gly
245
<210>130
<211>246
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>130
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Arg Ser Tyr
20 25 30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Pro Glu Trp Met
35 40 45
Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Lys Tyr Ala Pro Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Asp Phe Ala Gly Thr Val Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Lys His Met Gly Tyr Gln Val Arg Glu Thr Met Asp Val Trp Gly
100 105 110
Lys Gly Thr Thr Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly
115 120 125
Thr Gly Ser Gly Thr Gly Gly Ser Thr Ser Tyr Val Leu Thr Gln Pro
130 135 140
Pro Ser Val Ser Val Ala Pro Gly Gln Thr Ala Arg Ile Thr Cys Gly
145 150 155 160
Gly Asn Asn Ile Gly Ser Lys Ser Val Gis Trp Tyr Gln Gln Lys Pro
165 170 175
Gly Gln Ala Pro Val Leu Val Val Tyr Asp Asp Ser Asp Arg Pro Ser
180 185 190
Gly Ile Pro Glu Arg Phe Ser Gly Ser Asn Ser Gly Asn Thr Ala Thr
195 200 205
Leu Thr Ile Ser Arg Val Glu Ala Gly Asp Glu Ala Asp Tyr Tyr Cys
210 215 220
Gln Val Trp Asp Ser Ser Ser Asp His Ala Val Phe Gly Gly Gly Thr
225 230 235 240
Gln Leu Thr Val Leu Gly
245
<210>131
<211>744
<212>DNA
<213>Artificial
<220>
<223>SC06-314
<220>
<221>CDS
<222>(1)..(744)
<400>131
gag gtg cag ctg gtg gag tct ggg gct gag gtg aag aag cct ggg tcc 48
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aaa gtc tct tgc aag gct tct gga ggc ccc ttc cgc agc tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Arg Ser Tyr
20 25 30
gct atc agc tgg gtg cga cag gcc cct gga caa ggg cct gag tgg atg 144
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Pro Glu Trp Met
35 40 45
gga ggg atc atc cct att ttt ggt aca aca aaa tac gca ccg aag ttc 192
Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Lys Tyr Ala Pro Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac gat ttc gcg ggc aca gtt tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Asp Phe Ala Gly Thr Val Tyr
65 70 75 80
atg gag ctg agc agc ctg cga tct gag gac acg gcc atg tac tac tgt 288
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
gcg aaa cat atg ggg tac cag gtg cgc gaa act atg gac gtc tgg ggc 336
Ala Lys His Met Gly Tyr Gln Val Arg Glu Thr Met Asp Val Trp Gly
100 105 110
aaa ggg acc acg gtc acc gtc tcg agc ggt acg ggc ggt tca ggc gga 384
Lys Gly Thr Thr Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly
115 120 125
acc ggc agc ggc act ggc ggg tcg acg tcc tat gtg ctg act cag cca 432
Thr Gly Ser Gly Thr Gly Gly Ser Thr Ser Tyr Val Leu Thr Gln Pro
130 135 140
ccc tca gcg tct ggg acc ccc ggg cag agg gtc acc atc tct tgt tct 480
Pro Ser Ala Ser Gly Thr Pro Gly Gln Arg Val Thr Ile Ser Cys Ser
145 150 155 160
gga agc agc tcc aac atc gga agt aat tat gta tac tgg tac cag cag 528
Gly Ser Ser Ser Asn Ile Gly Ser Asn Tyr Val Tyr Trp Tyr Gln Gln
165 170 175
ctc cca ggc acg gcc ccc aaa ctc ctc atc tat agg gat ggt cag cgg 576
Leu Pro Gly Thr Ala Pro Lys Leu Leu Ile Tyr Arg Asp Gly Gln Arg
180 185 190
ccc tca ggg gtc cct gac cga ttc tct ggc tcc aag tct ggc acc tca 624
Pro Ser Gly Val Pro Asp Arg Phe Ser Gly Ser Lys Ser Gly Thr Ser
195 200 205
gcc tcc ctg gcc atc agt gga ctc cgg tcc gat gat gag gct gat tat 672
Ala Ser Leu Ala Ile Ser Gly Leu Arg Ser Asp Asp Glu Ala Asp Tyr
210 215 220
tac tgt gca aca tgg gat gac aac ctg agt ggt cca gta ttc ggc gga 720
Tyr Cys Ala Thr Trp Asp Asp Asn Leu Ser Gly Pro Val Phe Gly Gly
225 230 235 240
ggg acc aag ctg acc gtc cta ggt 744
Gly Thr Lys Leu Thr Val Leu GIy
245
<210>132
<211>248
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>132
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Arg Ser Tyr
20 25 30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Pro Glu Trp Met
35 40 45
Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Lys Tyr Ala Pro Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Asp Phe Ala Gly Thr Val Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Lys His Met Gly Tyr Gln Val Arg Glu Thr Met Asp Val Trp Gly
100 105 110
Lys Gly Thr Thr Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly
115 120 125
Thr Gly Ser Gly Thr Gly Gly Ser Thr Ser Tyr Val Leu Thr Gln Pro
130 135 140
Pro Ser Ala Ser Gly Thr Pro Gly Gln Arg Val Thr Ile Ser Cys Ser
145 150 155 160
Gly Ser Ser Ser Asn Ile Gly Ser Ash Tyr Val Tyr Trp Tyr Gln Gln
165 170 175
Leu Pro Gly Thr Ala Pro Lys Leu Leu Ile Tyr Arg Asp Gly Gln Arg
180 185 190
Pro Ser Gly Val Pro Asp Arg Phe Ser Gly Ser Lys Ser GIy Thr Ser
195 200 205
Ala Ser Leu Ala Ile Ser Gly Leu Arg Ser Asp Asp Glu Ala Asp Tyr
210 215 220
Tyr Cys Ala Thr Trp Asp Asp Asn Leu Ser Gly Pro Val Phe Gly Gly
225 230 235 240
Gly Thr Lys Leu Thr Val Leu Gly
245
<210>133
<211>735
<212>DNA
<213>Artificial
<220>
<223>SC06-323
<220>
<221>CDS
<222>(1)..(735)
<400>133
gag gtg cag ctg gtg gag tct ggg gct gag gtg aag aag cca ggg tcc 48
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aag gtc tcc tgt aag gcc tct gga ggc acc ttc tcc agc tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr
20 25 30
ggt atc agc tgg gtg cga cag gcc cct gga caa ggg ctt gag tgg atg 144
Gly Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga gac atc atc ggt atg ttt ggt tca aca aac tac gca cag aac ttc 192
Gly Asp Ile lle Gly Met Phe Gly Ser Thr Asn Tyr Ala Gln Asn Phe
50 55 60
cag ggc aga ctc acg att acc gcg gac gaa tcc acg agc aca gcc tac 240
Gln Gly Arg Leu Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr
65 70 75 80
atg gag ctg agc agc ctg aga tct gag gac acg gcc gtg tat tac tgt 288
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
gcg aga agt agt ggt tat tac cct gca tac crc ccc cac tgg ggc cag 336
Ala Arg Ser Ser Gly Tyr Tyr Pro Ala Tyr Leu Pro Gis Trp Gly Gln
100 105 110
ggc acc ttg gtc acc gtc tcg agc ggt acg ggc ggt tca ggc gga acc 384
Gly Thr Leu Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly Thr
115 120 125
ggc agc ggc act ggc ggg tcg acg gaa att gtg ttg acc cag tct cca 432
Gly Ser Gly Thr Gly Gly Ser Thr Glu Ile Val Leu Thr Gln Ser Pro
130 135 140
ggc acc ctg tct ttg tct cca ggg gaa aga gcc acc ctc tcc tgc agg 480
Gly Thr Leu Ser Leu Ser Pro Gly Glu Arg Ala Thr Leu Ser Cys Arg
145 150 155 160
gcc agt cag agt gtt agc agc agc tac tta gcc tgg tac cag cag aaa 528
Ala Ser Gln Ser Val Ser Ser Ser Tyr Leu Ala Trp Tyr Gln Gln Lys
165 170 175
cct ggc cag gct ccc agg ctc ctc atc tat ggt gca tcc agc agg gcc 576
Pro Gly Gln Ala Pro Arg Leu Leu Ile Tyr Gly Ala Ser Ser Arg Ala
180 185 190
act ggc atc cca gac agg ttc agt ggc agt ggg tct ggg aca gac ttc 624
Thr Gly Ile Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe
195 200 205
act ctc acc atc agc aga ctg gag cct gaa gat ttt gca gtg tat tac 672
Thr Leu Thr Ile Ser Arg Leu Glu Pro Glu Asp Phe Ala Val Tyr Tyr
210 215 220
tgt cag cag tat ggt agc tca ccc aga act ttc ggc gga ggg acc aag 720
Cys Gln Gln Tyr Gly Ser Ser Pro Arg Thr Phe Gly Gly Gly Thr Lys
225 230 235 240
gtg gag atc aaa cgt 735
Val Glu Ile Lys Arg
245
<210>134
<211>245
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>134
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr
20 25 30
Gly Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Asp Ile Ile Gly Met Phe Gly Ser Thr Asn Tyr Ala Gln Asn Phe
50 55 60
Gln Gly Arg Leu Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ser Ser Gly Tyr Tyr Pro Ala Tyr Leu Pro His Trp Gly Gln
100 105 110
Gly Thr Leu Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly Thr
115 120 125
Gly Ser Gly Thr Gly Gly Ser Thr Glu Ile Val Leu Thr Gln Ser Pro
130 135 140
Gly Thr Leu Ser Leu Ser Pro Gly Glu Arg Ala Thr Leu Ser Cys Arg
145 150 155 160
Ala Ser Gln Ser Val Ser Ser Ser Tyr Leu Ala Trp Tyr Gln Gln Lys
165 170 175
Pro Gly Gln Ala Pro Arg Leu Leu Ile Tyr Gly Ala Ser Ser Arg Ala
180 185 190
Thr Gly Ile Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe
195 200 205
Thr Leu Thr Ile Ser Arg Leu Glu Pro Glu Asp Phe Ala Val Tyr Tyr
210 215 220
Cys Gln Gln Tyr Gly Ser Ser Pro Arg Thr Phe Gly Gly Gly Thr Lys
225 230 235 240
Val Glu Ile Lys Arg
245
<210>135
<211>744
<212>DNA
<213>Artificial
<220>
<223>SC06-325
<220>
<221>CDS
<222>(1)..(744)
<400>135
gag gtg cag ctg gtg gag tct ggg gct gag gtg aag aag ccg ggg tcc 48
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aag gtc tcc tgc aag gct tct gga ggc acc ttc agc ttc tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Phe Tyr
20 25 30
tct atg agc tgg gtg cga cag gcc cct ggg caa gga ctt gag tgg atg 144
Ser Met Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga ggg atc atc cct atg ttt ggt aca aca aac tac gca cag aag ttc 192
Gly Gly lle Ile Pro Met Phe Gly Thr Thr Asn Tyr Ala Gln Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gtc gaa tcc acg agc aca gcc tac 240
Gln Gly Arg Val Thr Ile Thr Ala Val Glu Ser Thr Ser Thr Ala Tyr
65 70 75 80
atg gag gtg agc agc ctg aga tct gag gac acg gcc gtt tat tac tgt 288
Met Glu Val Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
gcg aga ggt gat aag ggt atc tac tac tac tac atg gac gtc tgg ggc 336
Ala Arg Gly Asp Lys Gly Ile Tyr Tyr Tyr Tyr Met Asp Val Trp Gly
100 105 110
aaa ggg acc acg gtc acc gtc tcg agc ggt acg ggc ggt tca ggc gga 384
Lys Gly Thr Thr Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly
115 120 125
acc ggc agc ggc act ggc ggg tcg acg cag tct gcc ctg act cag cct 432
Thr Gly Ser Gly Thr Gly Gly Ser Thr Gln Ser Ala Leu Thr Gln Pro
130 135 140
gcc tcc gtg tct ggg tct cct gga cag tcg atc acc atc tcc tgc act 480
Ala Ser Val Ser Gly Ser Pro Gly Gln Ser Ile Thr Ile Ser Cys Thr
145 150 155 160
gga acc agc agt gac gtt ggt ggt tat aac tat gtc tcc tgg tac caa 528
Gly Thr Ser Ser Asp Val Gly Gly Tyr Asn Tyr Val Ser Trp Tyr Gln
165 170 175
cag cac cca ggc aaa gcc ccc aaa ctc atg att tat gag gtc agt aat 576
Gln His Pro Gly Lys Ala Pro Lys Leu Met Ile Tyr Glu Val Ser Asn
180 185 190
cgg ccc tca ggg gtt tct agt cgc ttc tct ggc tcc aag tct ggc aac 624
Arg Pro Ser Gly Val Ser Asn Arg Phe Ser Gly Ser Lys Ser Gly Asn
195 200 205
acg gcc tcc ctg acc atc tct ggg ctc cag gct gag gac gag gct gat 672
Thr Ala Ser Leu Thr Ile Ser Gly Leu Gln Ala Glu Asp Glu Ala Asp
210 215 220
tat tac tgc agc tca tat aca agc agc agc act ctt gtc ttc gga act 720
Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser Ser Thr Leu Val Pne Gly Tnr
225 230 235 240
ggg acc aag gtc acc gtc cta ggt 744
Gly Thr Lys Val Thr Val Leu Gly
245
<210>136
<211>248
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>136
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Phe Tyr
20 25 30
Ser Met Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Gly Ile Ile Pro Met Phe Gly Thr Thr Asn Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Val Glu Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Val Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asp Lys Gly Ile Tyr Tyr Tyr Tyr Met Asp Val Trp Gly
100 105 110
Lys Gly Thr Thr Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly
115 120 125
Thr Gly Ser Gly Thr Gly Gly Ser Thr Gln Ser Ala Leu Thr Gln Pro
130 135 140
Ala Ser Val Ser Gly Ser Pro GIy Gln Ser Ile Thr Ile Ser Cys Thr
145 150 155 160
Gly Thr Ser Ser Asp Val Gly Gly Tyr Asn Tyr Val Ser Trp Tyr Gln
165 170 175
Gln His Pro Gly Lys Ala Pro Lys Leu Met Ile Tyr Glu Val Ser Asn
180 185 190
Arg Pro Ser Gly Val Ser Asn Arg Phe Ser Gly Ser Lys Ser Gly Asn
195 200 205
Thr Ala Ser Leu Thr Ile Ser Gly Leu Gln Ala Glu Asp Glu Ala Asp
210 215 220
Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser Ser Thr Leu Val Phe Gly Thr
225 230 235 240
Gly Thr Lys Val Thr Val Leu Gly
245
<210>137
<211>735
<212>DNA
<213>Artificial
<220>
<223>SC06-331
<220>
<221>CDS
<222>(1)..(735)
<400>137
gag gtg cag ctg gtg gag tct ggg gct gag gtg aag aag cct ggg tcc 48
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aag gtc tcc tgc aag gct tct gga ggc acc ttc agc agc tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr
20 25 30
gct atc agc tgg gtg cga cag gcc cct gga caa ggg ctt gag tgg atg 144
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga ggg atc atc ggt atg ttc ggt aca gca aac tac gca cag aag ttc 192
Gly Gly Ile Ile Gly Met Phe Gly Thr Ala Asn Tyr Ala Gln Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac gaa ttt acg agc aca gcc tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Phe Thr Ser Thr Ala Tyr
65 70 75 80
atg gag ctg agc agc ctg aga tct gag gac acg gcc gtg tat tac tgt 288
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
gcg aga gga aat tat tac tat gag agt agt ctc gac tac tgg ggc cag 336
Ala Arg Gly Asn Tyr Tyr Tyr Glu Ser Ser Leu Asp Tyr Trp Gly Gln
100 105 110
gga acc ctg gtc acc gtc tcg agc ggt acg ggc ggt rca ggc gga acc 384
Gly Thr Leu Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly Thr
115 120 125
ggc agc ggc act ggc ggg tcg acg cag tct gtc gtg acg cag ccg ccc 432
Gly Ser Gly Thr Gly Gly Ser Thr Gln Ser Val Val Thr Gln Pro Pro
130 135 140
tcg gtg tca gtg gcc cca gga cag acg gcc agg att acc tgt ggg gga 480
Ser Val Ser Val Ala Pro Gly Gln Thr Ala Arg Ile Thr Cys Gly Gly
145 150 155 160
aac aac att gga agt aaa agt gtg cac tgg tac cag cag aag cca ggc 528
Asn Asn Ile Gly Ser Lys Ser Val His Trp Tyr Gln Gln Lys Pro Gly
165 170 175
cag gcc cct gtg ctg gtc gtc tat gat gat agc gac cgg ccc tca ggg 576
Gln Ala Pro Val Leu Val Val Tyr Asp Asp Ser Asp Arg Pro Ser Gly
180 185 190
atc cct gag cga ttc tct ggc tcc aac tct ggg aac acg gcc acc ctg 624
Ile Pro Glu Arg Phe Ser Gly Ser Asn Ser Gly Ash Thr Ala Thr Leu
195 200 205
acc atc agc agg gtc gaa gcc ggg gat gag gcc gac tat tac tgt cag 672
Thr Ile Ser Arg Val Glu Ala Gly Asp Glu Ala Asp Tyr Tyr Cys Gln
210 215 220
gtg tgg gat agt agt agt gat cat tat gtc ttc gga act ggg acc aag 720
Val Trp Asp Ser Ser Ser Asp His Tyr Val Phe Gly Thr Gly Thr Lys
225 230 235 240
gtc acc gtc cta ggt 735
Val Thr Val Leu Gly
245
<210>138
<211>245
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>138
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr
20 25 30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Gly Ile Ile Gly Met Phe Gly Thr Ala Ash Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Phe Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Asn Tyr Tyr Tyr Glu Ser Ser Leu Asp Tyr Trp Gly Gln
100 105 110
Gly Thr Leu Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly Thr
115 120 125
Gly Ser Gly Thr GIy Gly Ser Thr Gln Ser Val Val Thr Gln Pro Pro
130 135 140
Ser Val Ser Val Ala Pro Gly Gln Thr Ala Arg Ile Thr Cys Gly Gly
145 150 155 160
Asn Asn Ile Gly Ser Lys Ser Val His Trp Tyr Gln Gln Lys Pro Gly
165 170 175
Gln Ala Pro Val Leu Val Val Tyr Asp Asp Ser Asp Arg Pro Ser Gly
180 185 190
Ile Pro Glu Arg Phe Ser Gly Ser Asn Ser Gly Ash Thr Ala Thr Leu
195 200 205
Thr Ile Ser Arg Val Glu Ala Gly Asp Glu Ala Asp Tyr Tyr Cys Gln
210 215 220
Val Trp Asp Ser Ser Ser Asp His Tyr Val Phe Gly Thr Gly Thr Lys
225 230 235 240
Val Thr Val Leu Gly
245
<210>139
<211>750
<212>DNA
<213>Artificial
<220>
<223>SC06-344
<220>
<221>CDS
<222>(1)..(750)
<400>139
cag gtg cag ctg gtg cag tct ggg gct gag gtg aag aag cct ggg tcc 48
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aga gtc tcc tgc aag gct tct gga agc atc ttc aga aac tat 96
Ser Val Arg Val Ser Cys Lys Ala Ser Gly Ser Ile Phe Arg Asn Tyr
20 25 30
gct atg agc tgg gtg cga cag gcc cct gga caa ggg ctt gag tgg atg 144
Ala Met Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga ggg atc atc gct att ttt ggg aca cca aag tac gca cag aag ttc 192
Gly Gly Ile Ile Ala Ile Phe Gly lhr Pro Lys Tyr Ala Gln Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac gaa tcg acg agc act gtc tac 240
Gln Gly Arg Val Thr lle Thr Ala Asp Glu Ser Thr Ser Thr Val Tyr
65 70 75 80
atg gaa ctg agc gga ctg aga tct gag gac acg gcc atg tat tac tgt 288
Met Glu Leu Ser Gly Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
gcg agg att ccc cac tat aat ttt ggt tcg ggg agt tat ttc gac tac 336
Ala Arg Ile Pro His Tyr Asn Phe Gly Ser Gly Ser Tyr Phe Asp Tyr
100 105 110
tgg ggc cag gga acc ctg gtc acc gtc tcg agc ggt acg ggc ggt tca 384
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Thr Gly Gly Ser
115 120 125
ggc gga acc ggc agc ggc act ggc ggg tcg acg act gtg ttg aca cag 432
Gly Gly Thr Gly Ser Gly Thr Gly Gly Ser Thr Thr Val Leu Thr Gln
130 135 140
ccg ccc tca gtg tct ggg gcc cca ggg cag agg gtc acc atc tcc tgc 480
Pro Pro Ser Val Ser Gly Ala Pro Gly Gln Arg Val Thr Ile Ser Cys
145 150 155 160
act ggg agc agc tcc aac atc ggg gca ggt tat gat gta cac tgg tac 528
Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly Tyr Asp Val His Trp Tyr
165 170 175
cag cag ctt cca gga aca gcc ccc aaa ctc ctc atc tat ggt aac agc 576
Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu Ile Tyr Gly Asn Ser
180 185 190
aat cgg ccc tca ggg gtc cct gac cga ttc tct ggc tcc aag tct ggc 624
Asn Arg Pro Ser Gly Val Pro Asp Arg Phe Ser Gly Ser Lys Ser Gly
195 200 205
acg tca gcc acc ctg ggc atc acc gga ctc cag act ggg gac gag gcc 672
Thr Ser Ala Thr Leu Gly Ile Thr Gly Leu Gln Thr Gly Asp Glu Ala
210 215 220
gat tat tac tgc gga aca tgg gat agc agc ctg agt gct tat gtc ttc 720
Asp Tyr Tyr Cys Gly Thr Trp Asp Ser Ser Leu Ser Ala Tyr Val Phe
225 230 235 240
gga act ggg acc aag gtc acc gtc cta ggt 750
Gly Thr Gly Thr Lys Val Thr Val Leu Gly
245 250
<210>140
<211>250
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>140
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Arg Val Ser Cys Lys Ala Ser Gly Ser Ile Phe Arg Asn Tyr
20 25 30
Ala Met Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Gly Ile Ile Ala Ile Phe Gly Thr Pro Lys Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Val Tyr
65 70 75 80
Met Glu Leu Ser Gly Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Arg Ile Pro His Tyr Asn Phe Gly Ser Gly Ser Tyr Phe Asp Tyr
100 105 110
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Thr Gly Gly Ser
115 120 125
Gly Gly Thr Gly Ser Gly Thr Gly Gly Ser Thr Thr Val Leu Thr Gln
130 135 140
Pro Pro Ser Val Ser Gly Ala Pro Gly Gln Arg Val Thr Ile Ser Cys
145 150 155 160
Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly Tyr Asp Val His Trp Tyr
165 170 175
Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu Ile Tyr Gly Asn Ser
180 185 190
Asn Arg Pro Ser Gly Val Pro Asp Arg Phe Ser Gly Ser Lys Ser Gly
195 200 205
Thr Ser Ala Thr Leu Gly Ile Thr Gly Leu Gln Thr Gly Asp Glu Ala
210 215 220
Asp Tyr Tyr Cys Gly Thr Trp Asp Ser Ser Leu Ser Ala Tyr Val Phe
225 230 235 240
Gly Thr Gly Thr Lys Val Thr Val Leu Gly
245 250
<210>141
<211>10515
<212>DNA
<213>Artificial
<220>
<223>Vector pIg-C911-HCgammal
<220>
<221>misc_feature
<222>(1326)..(5076)
<223>Stuffer
<400>141
tcgacggatc gggagatctc ccgatcccct atggtgcact ctcagtacaa tctgctctga 60
tgccgcatag ttaagccagt atctgctccc tgcttgtgtg ttggaggtcg ctgagtagtg 120
cgcgagcaaa atttaagcta caacaaggca aggcttgacc gacaattgca tgaagaatct 180
gcttagggtt aggcgttttg cgctgcttcg ctaggtggtc aatattggcc attagccata 240
ttattcattg gttatatagc ataaatcaat attggctatt ggccattgca tacgttgtat 300
ccatatcata atatgtacat ttatattggc tcatgtccaa cattaccgcc atgttgacat 360
tgattattga ctagttatta atagtaatca attacggggt cattagttca tagcccatat 420
atggagttcc gcgttacata acttacggta aatggcccgc ctggctgacc gcccaacgac 480
ccccgcccat tgacgtcaat aatgacgtat gttcccatag taacgccaat agggactttc 540
cattgacgtc aatgggtgga gtatttacgg taaactgccc acttggcagt acatcaagtg 600
tatcatatgc caagtacgcc ccctattgac gtcaatgacg gtaaatggcc cgcctggcat 660
tatgcccagt acatgacctt atgggacttt cctacttggc agtacatcta cgtattagtc 720
atcgctatta ccatggtgat gcggttttgg cagtacatca atgggcgtgg atagcggttt 780
gactcacggg gatttccaag tctccacccc attgacgtca atgggagttt gttttggcac 840
caaaatcaac gggactttcc aaaatgtcgt aacaactccg ccccattgac gcaaatgggc 900
ggtaggcgtg tacggtggga ggtctatata agcagagctc gtttagtgaa ccgtcagatc 960
gcctggagac gccatccacg ctgttttgac ctccatagaa gacaccggga ccgatccagc 1020
ctccgcggcc gggaacggtg cattggaagc tggcctggat atcctgactc tcttaggtag 1080
ccttgcagaa gttggtcgtg aggcactggg caggtaagta tcaaggttac aagacaggtt 1140
taaggagatc aatagaaact gggcttgtcg agacagagaa gactcttgcg tttctgatag 1200
gcacctattg gtcttactga catccacttt gcctttctct ccacaggtgt ccactcccag 1260
ttcaattaca gctcgccacc atgggatgga gctgtatcat cctcttcttg gtactgctgc 1320
tggcccagcc ggccagtgac cttgaccggt gcaccacttt tgatgatgtt caagctccta 1380
attacactca acatacttca tctatgaggg gggtttacta tcctgatgaa atttttagat 1440
cggacactct ttatttaact caggatttat ttcttccatt ttattctaat gttacagggt 1500
ttcatactat taatcatacg tttggcaacc ctgtcatacc ttttaaggat ggtatttatt 1560
ttgctgccac agagaaatca aatgttgtcc gtggttgggt ttttggttct accatgaaca 1620
acaagtcaca gtcggtgatt attattaaca attctactaa tgttgttata cgagcatgta 1680
actttgaatt gtgtgacaac cctttctttg ctgtttctaa acccatgggt acacagacac 1740
atactatgat attcgataat gcatttaatt gcactttcga gtacatatct gatgcctttt 1800
cgcttgatgt ttcagaaaag tcaggtaatt ttaaacactt acgagagttt gtgtttaaaa 1860
ataaagatgg gtttctctat gtttataagg gctatcaacc tatagatgta gttcgtgatc 1920
taccttctgg ttttaacact ttgaaaccta tttttaagtt gcctcttggt attaacatta 1980
caaattttag agccattctt acagcctttt cacctgctca agacatttgg ggcacgtcag 2040
ctgcagccta ttttgttggc tatttaaagc caactacatt tatgctcaag tatgatgaaa 2100
atggtacaat cacagatgct gttgattgtt ctcaaaatcc acttgctgaa ctcaaatgct 2160
ctgttaagag ctttgagatt gacaaaggaa tttaccagac ctctaatttc agggttgttc 2220
cctcaggaga tgttgtgaga ttccctaata ttacaaactt gtgtcctttt ggagaggttt 2280
ttaatgctac taaattccct tctgtctatg catgggagag aaaaaaaatt tctaattgtg 2340
ttgctgatta ctctgtgctc tacaactcaa catttttttc aacctttaag tgctatggcg 2400
tttctgccac taagttgaat gatctttgct tctccaatgt ctatgcagat tcttttgtag 2460
tcaagggaga tgatgtaaga caaatagcgc caggacaaac tggtgttatt gctgattata 2520
attataaatt gccagatgat ttcatgggtt gtgtccttgc ttggaatact aggaacattg 2580
atgctacttc aactggtaat tataattata aatataggta tcttagacat ggcaagctta 2640
ggccctttga gagagacata tctaatgtgc ctttctcccc tgatggcaaa ccttgcaccc 2700
cacctgctct taattgttat tggccattaa atgattatgg tttttacacc actactggca 2760
ttggctacca accttacaga gttgtagtac tttcttttga acttttaaat gcaccggcca 2820
cggtttgtgg accaaaatta tccactgacc ttattaagaa ccagtgtgtc aattttaatt 2880
ttaatggact cactggtact ggtgtgttaa ctccttcttc aaagagattt caaccatttc 2940
aacaatttgg ccgtgatgtt tctgatttca ctgattccgt tcgagatcct aaaacatctg 3000
aaatattaga catttcacct tgctcttttg ggggtgtaag tgtaattaca cctggaacaa 3060
atgcttcatc tgaagttgct gttctatatc aagatgttaa ctgcactgat gtttctacag 3120
caattcatgc agatcaactc acaccagctt ggcgcatata ttctactgga aacaatgtat 3180
tccagactca ggcaggctgt cttataggag ctgagcatgt cgacacttct tatgagtgcg 3240
acattcctat tggagctggc atttgtgcta gttaccatac agtttcttta ttacgtagta 3300
ctagccaaaa atctattgtg gcttatacta tgtctttagg tgctgatagt tcaattgctt 3360
actctaataa caccattgct atacctacta acttttcaat tagcattact acagaagtaa 3420
tgcctgtttc tatggctaaa acctccgtag attgtaatat gtacatctgc ggagattcta 3480
ctgaatgtgc taatttgctt ctccaatatg gtagcttttg cacacaacta aatcgtgcac 3540
tctcaggtat tgctgctgaa caggatcgca acacacgtga agtgttcgct caagtcaaac 3600
aaatgtacaa aaccccaact ttgaaatatt ttggtggttt taatttttca caaatattac 3660
ctgaccctct aaagccaact aagaggtctt ttattgagga cttgctcttt aataaggtga 3720
cactcgctga tgctggcttc atgaagcaat atggcgaatg cctaggtgat attaatgcta 3780
gagatctcat ttgtgcgcag aagttcaatg gacttacagt gttgccacct ctgctcactg 3840
atgatatgat tgctgcctac actgctgctc tagttagtgg tactgccact gctggatgga 3900
catttggtgc tggcgctgct cttcaaatac cttttgctat gcaaatggca tataggttca 3960
atggcattgg agttacccaa aatgttctct atgagaacca aaaacaaatc gccaaccaat 4020
ttaacaaggc gattagtcaa attcaagaat cacttacaac aacatcaact gcattgggca 4080
agctgcaaga cgttgttaac cagaatgctc aagcattaaa cacacttgtt aaacaactta 4140
gctctaattt tggtgcaatt tcaagtgtgc taaatgatat cctttcgcga cttgataaag 4200
tcgaggcgga ggtacaaatt gacaggttaa ttacaggcag acttcaaagc cttcaaacct 4260
atgtaacaca acaactaatc agggctgctg aaatcagggc ttctgctaat cttgctgcta 4320
ctaaaatgtc tgagtgtgtt cttggacaat caaaaagagt tgacttttgt ggaaagggct 4380
accaccttat gtccttccca caagcagccc cgcatggtgt tgtcttccta catgtcacgt 4440
atgtgccatc ccaggagagg aacttcacca cagcgccagc aatttgtcat gaaggcaaag 4500
catacttccc tcgtgaaggt gtttttgtgt ttaatggcac ttcttggttt attacacaga 4560
ggaacttctt ttctccacaa ataattacta cagacaatac atttgtctca ggaaattgtg 4620
atgtcgttat tggcatcatt aacaacacag tttatgatcc tctgcaacct gagcttgact 4680
cattcaaaga agagctggac aagtacttca aaaatcatac atcaccagat gttgattttg 4740
gcgacatttc aggcattaac gcttctgtcg tcaacattca aaaagaaatt gaccgcctca 4800
atgaggtcgc taaaaattta aatgaatcac tcattgacct tcaagaactg ggaaaatatg 4860
agcaatatat taaatggcct ctcgacgaac aaaaactcat ctcagaagag gatctgaatg 4920
ctgtgggcca ggacacgcag gaggtcatcg tggtgccaca ctccttgccc tttaaggtgg 4980
tggtgatctc agccatcctg gccctggtgg tgctcaccat catctccctt atcatcctca 5040
tcatgctttg gcagaagaag ccacgttagg cggccgctcg agtgctagca ccaagggccc 5100
cagcgtgttc cccctggccc ccagcagcaa gagcaccagc ggcggcacag ccgccctggg 5160
ctgcctggtg aaggactact tccccgagcc cgtgaccgtg agctggaaca gcggcgcctt 5220
gaccagcggc gtgcacacct tccccgccgt gctgcagagc agcggcctgt acagcctgag 5280
cagcgtggtg accgtgccca gcagcagcct gggcacccag acctacatct gcaacgtgaa 5340
ccacaagccc agcaacacca aggtggacaa acgcgtggag cccaagagct gcgacaagac 5400
ccacacctgc cccccctgcc ctgcccccga gctgctgggc ggaccctccg tgttcctgtt 5460
cccccccaag cccaaggaca ccctcatgat cagccggacc cccgaggtga cctgcgtggt 5520
ggtggacgtg agccacgagg accccgaggt gaagttcaac tggtacgtgg acggcgtgga 5580
ggtgcacaac gccaagacca agccccggga ggagcagtac aacagcacct accgggtggt 5640
gagcgtgctc accgtgctgc accaggactg gctgaacggc aaggagtaca agtgcaaggt 5700
gagcaacaag gccctgcctg cccccatcga gaagaccatc agcaaggcca agggccagcc 5760
ccgggagccc caggtgtaca ccctgccccc cagccgggag gagatgacca agaaccaggt 5820
gtccctcacc tgtctggtga agggcttcta ccccagcgac atcgccgtgg agtgggagag 5880
caacggccag cccgagaaca actacaagac caccccccct gtgctggaca gcgacggcag 5940
cttcttcctg tacagcaagc tcaccgtgga caagagccgg tggcagcagg gcaacgtgtt 6000
cagctgcagc gtgatgcacg aggccctgca caaccactac acccagaaga gcctgagcct 6060
gagccccggc aagtgataat ctagagggcc cgtttaaacc cgctgatcag cctcgactgt 6120
gccttctagt tgccagccat ctgttgtttg cccctccccc gtgccttcct tgaccctgga 6180
aggtgccact cccactgtcc tttcctaata aaatgaggaa attgcatcgc attgtctgag 6240
taggtgtcat tctattctgg ggggtggggt ggggcaggac agcaaggggg aggattggga 6300
agacaatagc aggcatgctg gggatgcggt gggctctatg gcttctgagg cggaaagaac 6360
cagctggggc tctagggggt atccccacgc gccctgtagc ggcgcattaa gcgcggcggg 6420
tgtggtggtt acgcgcagcg tgaccgctac acttgccagc gccctagcgc ccgctccttt 6480
cgctttcttc ccttcctttc tcgccacgtt cgccggcttt ccccgtcaag ctctaaatcg 6540
ggggctccct ttagggttcc gatttagtgc tttacggcac ctcgacccca aaaaacttga 6600
ttagggtgat ggttcacgta gtgggccatc gccctgatag acggtttttc gccctttgac 6660
gttggagtcc acgttcttta atagtggact cttgttccaa actggaacaa cactcaaccc 6720
tatctcggtc tattcttttg atttataagg gattttgccg atttcggcct attggttaaa 6780
aaatgagctg atttaacaaa aatttaacgc gaattaattc tgtggaatgt gtgtcagtta 6840
gggtgtggaa agtccccagg ctccccagca ggcagaagta tgcaaagcat gcatctcaat 6900
tagtcagcaa ccaggtgtgg aaagtcccca ggctccccag caggcagaag tatgcaaagc 6960
atgcatctca attagtcagc aaccatagtc ccgcccctaa ctccgcccat cccgccccta 7020
actccgccca gttccgccca ttctccgccc catggctgac taattttttt tatttatgca 7080
gaggccgagg ccgcctctgc ctctgagcta ttccagaagt agtgaggagg cttttttgga 7140
ggcctaggct tttgcaaaaa gctcccggga gcttgtatat ccattttcgg atctgatcaa 7200
gagacaggat gaggatcgtt tcgcatgatt gaacaagatg gattgcacgc aggttctccg 7260
gccgcttggg tggagaggct attcggctat gactgggcac aacagacaat cggctgctct 7320
gatgccgccg tgttccggct gtcagcgcag gggcgcccgg ttctttttgt caagaccgac 7380
ctgtccggtg ccctgaatga actgcaggac gaggcagcgc ggctatcgtg gctggccacg 7440
acgggcgttc cttgcgcagc tgtgctcgac gttgtcactg aagcgggaag ggactggctg 7500
ctattgggcg aagtgccggg gcaggatctc ctgtcatctc accttgctcc tgccgagaaa 7560
gtatccatca tggctgatgc aatgcggcgg ctgcatacgc ttgatccggc tacctgccca 7620
ttcgaccacc aagcgaaaca tcgcatcgag cgagcacgta ctcggatgga agccggtctt 7680
gtcgatcagg atgatctgga cgaagagcat caggggctcg cgccagccga actgttcgcc 7740
aggctcaagg cgcgcatgcc cgacggcgag gatctcgtcg tgacccatgg cgatgcctgc 7800
ttgccgaata tcatggtgga aaatggccgc ttttctggat tcatcgactg tggccggctg 7860
ggtgtggcgg accgctatca ggacatagcg ttggctaccc gtgatattgc tgaagagctt 7920
ggcggcgaat gggctgaccg cttcctcgtg ctttacggta tcgccgctcc cgattcgcag 7980
cgcatcgcct tctatcgcct tcttgacgag ttcttctgag cgggactctg gggttcgaaa 8040
tgaccgacca agcgacgccc aacctgccat cacgagattt cgattccacc gccgccttct 8100
atgaaaggtt gggcttcgga atcgttttcc gggacgccgg ctggatgatc ctccagcgcg 8160
gggatctcat gctggagttc ttcgcccacc ccaacttgtt tattgcagct tataatggtt 8220
acaaataaag caatagcatc acaaatttca caaataaagc atttttttca ctgcattcta 8280
gttgtggttt gtccaaactc atcaatgtat cttatcatgt ctgtataccg tcgacctcta 8340
gctagagctt ggcgtaatca tggtcatagc tgtttcctgt gtgaaattgt tatccgctca 8400
caattccaca caacatacga gccggaagca taaagtgtaa agcctggggt gcctaatgag 8460
tgagctaact cacattaatt gcgttgcgct cactgcccgc tttccagtcg ggaaacctgt 8520
cgtgccagct gcattaatga atcggccaac gcgcggggag aggcggtttg cgtattgggc 8580
gctcttccgc ttcctcgctc actgactcgc tgcgctcggt cgttcggctg cggcgagcgg 8640
tatcagctca ctcaaaggcg gtaatacggt tatccacaga atcaggggat aacgcaggaa 8700
agaacatgtg agcaaaaggc cagcaaaagg ccaggaaccg taaaaaggcc gcgttgctgg 8760
cgtttttcca taggctccgc ccccctgacg agcatcacaa aaatcgacgc tcaagtcaga 8820
ggtggcgaaa cccgacagga ctataaagat accaggcgtt tccccctgga agctccctcg 8880
tgcgctctcc tgttccgacc ctgccgctta ccggatacct gtccgccttt ctcccttcgg 8940
gaagcgtggc gctttctcat agctcacgct gtaggtatct cagttcggtg taggtcgttc 9000
gctccaagct gggctgtgtg cacgaacccc ccgttcagcc cgaccgctgc gccttatccg 9060
gtaactatcg tcttgagtcc aacccggtaa gacacgactt atcgccactg gcagcagcca 9120
ctggtaacag gattagcaga gcgaggtatg taggcggtgc tacagagttc ttgaagtggt 9180
ggcctaacta cggctacact agaagaacag tatttggtat ctgcgctctg ctgaagccag 9240
ttaccttcgg aaaaagagtt ggtagctctt gatccggcaa acaaaccacc gctggtagcg 9300
gtttttttgt ttgcaagcag cagattacgc gcagaaaaaa aggatctcaa gaagatcctt 9360
tgatcttttc tacggggtct gacgctcagt ggaacgaaaa ctcacgttaa gggattttgg 9420
tcatgagatt atcaaaaagg atcttcacct agatcctttt aaattaaaaa tgaagtttta 9480
aatcaatcta aagtatatat gagtaaactt ggtctgacag ttaccaatgc ttaatcagtg 9540
aggcacctat ctcagcgatc tgtctatttc gttcatccat agttgcctga ctccccgtcg 9600
tgtagataac tacgatacgg gagggcttac catctggccc cagtgctgca atgataccgc 9660
gagacccacg ctcaccggct ccagatttat cagcaataaa ccagccagcc ggaagggccg 9720
agcgcagaag tggtcctgca actttatccg cctccatcca gtctattaat tgttgccggg 9780
aagctagagt aagtagttcg ccagttaata gtttgcgcaa cgttgttgcc attgctacag 9840
gcatcgtggt gtcacgctcg tcgtttggta tggcttcatt cagctccggt tcccaacgat 9900
caaggcgagt tacatgatcc cccatgttgt gcaaaaaagc ggttagctcc ttcggtcctc 9960
cgatcgttgt cagaagtaag ttggccgcag tgttatcact catggttatg gcagcactgc 10020
ataattctct tactgtcatg ccatccgtaa gatgcttttc tgtgactggt gagtactcaa 10080
ccaagtcatt ctgagaatag tgtatgcggc gaccgagttg ctcttgcccg gcgtcaatac 10140
gggataatac cgcgccacat agcagaactt taaaagtgct catcattgga aaacgttctt 10200
cggggcgaaa actctcaagg atcttaccgc tgttgagatc cagttcgatg taacccactc 10260
gtgcacccaa ctgatcttca gcatctttta ctttcaccag cgtttctggg tgagcaaaaa 10320
caggaaggca aaatgccgca aaaaagggaa taagggcgac acggaaatgt tgaatactca 10380
tactcttcct ttttcaatat tattgaagca tttatcaggg ttattgtctc atgagcggat 10440
acatatttga atgtatttag aaaaataaac aaataggggt tccgcgcaca tttccccgaa 10500
aagtgccacc tgacg 10515
<210>142
<211>8777
<212>DNA
<213>Artificial
<220>
<223>Vector pIg-C909-Ckappa
<220>
<221>misc_feature
<222>(1328)..(3860)
<223>Stuffer
<400>142
tcgacggatc gggagatctc ccgatcccct atggtgcact ctcagtacaa tctgctctga 60
tgccgcatag ttaagccagt atctgctccc tgcttgtgtg ttggaggtcg ctgagtagtg 120
cgcgagcaaa atttaagcta caacaaggca aggcttgacc gacaattgtt aattaacatg 180
aagaatctgc ttagggttag gcgttttgcg ctgcttcgct aggtggtcaa tattggccat 240
tagccatatt attcattggt tatatagcat aaatcaatat tggctattgg ccattgcata 300
cgttgtatcc atatcataat atgtacattt atattggctc atgtccaaca ttaccgccat 360
gttgacattg attattgact agttattaat agtaatcaat tacggggtca ttagttcata 420
gcccatatat ggagttccgc gttacataac ttacggtaaa tggcccgcct ggctgaccgc 480
ccaacgaccc ccgcccattg acgtcaataa tgacgtatgt tcccatagta acgccaatag 540
ggactttcca ttgacgtcaa tgggtggagt atttacggta aactgcccac ttggcagtac 600
atcaagtgta tcatatgcca agtacgcccc ctattgacgt caatgacggt aaatggcccg 660
cctggcatta tgcccagtac atgaccttat gggactttcc tacttggcag tacatctacg 720
tattagtcat cgctattacc atggtgatgc ggttttggca gtacatcaat gggcgtggat 780
agcggtttga ctcacgggga tttccaagtc tccaccccat tgacgtcaat gggagtttgt 840
tttggcacca aaatcaacgg gactttccaa aatgtcgtaa caactccgcc ccattgacgc 900
aaatgggcgg taggcgtgta cggtgggagg tctatataag cagagctcgt ttagtgaacc 960
gtcagatcgc ctggagacgc catccacgct gttttgacct ccatagaaga caccgggacc 1020
gatccagcct ccgcggccgg gaacggtgca ttggaatcga tgactctctt aggtagcctt 1080
gcagaagttg gtcgtgaggc actgggcagg taagtatcaa ggttacaaga caggtttaag 1140
gagatcaata gaaactgggc ttgtcgagac agagaagact cttgcgtttc tgataggcac 1200
ctattggtct tactgacatc cactttgcct ttctctccac aggtgtccac tcccagttca 1260
attacagctc gccaccatgc ggctgcccgc ccagctgctg ggccttctca tgctgtgggt 1320
gcccgcctcg agatctatcg atgcatgcca tggtaccaag cttgccacca tgagcagcag 1380
ctcttggctg ctgctgagcc tggtggccgt gacagccgcc cagagcacca tcgaggagca 1440
ggccaagacc ttcctggaca agttcaacca cgaggccgag gacctgttct accagagcag 1500
cctggccagc tggaactaca acaccaacat caccgaggag aacgtgcaga acatgaacaa 1560
cgccggcgac aagtggagcg ccttcctgaa ggagcagagc acactggccc agatgtaccc 1620
cctgcaggag atccagaacc tgaccgtgaa gctgcagctg caggccctgc agcagaacgg 1680
cagcagcgtg ctgagcgagg acaagagcaa gcggctgaac accatcctga acaccatgtc 1740
caccatctac agcaccggca aagtgtgcaa ccccgacaac ccccaggagt gcctgctgct 1800
ggagcccggc ctgaacgaga tcatggccaa cagcctggac tacaacgagc ggctgtgggc 1860
ctgggagagc tggcggagcg aagtgggcaa gcagctgcgg cccctgtacg aggagtacgt 1920
ggtgctgaag aacgagatgg ccagggccaa ccactacgag gactacggcg actactggag 1980
aggcgactac gaagtgaacg gcgtggacgg ctacgactac agcagaggcc agctgatcga 2040
ggacgtggag cacaccttcg aggagatcaa gcctctgtac gagcacctgc acgcctacgt 2100
gcgggccaag ctgatgaacg cctaccccag ctacatcagc cccatcggct gcctgcccgc 2160
ccacctgctg ggcgacatgt ggggccggtt ctggaccaac ctgtacagcc tgaccgtgcc 2220
cttcggccag aagcccaaca tcgacgtgac cgacgccatg gtggaccagg cctgggacgc 2280
ccagcggatc ttcaaggagg ccgagaagtt cttcgtgagc gtgggcctgc ccaacatgac 2340
ccagggcttt tgggagaaca gcatgctgac cgaccccggc aatgtgcaga aggccgtgtg 2400
ccaccccacc gcctgggacc tgggcaaggg cgacttccgg atcctgatgt gcaccaaagt 2460
gaccatggac gacttcctga ccgcccacca cgagatgggc cacatccagt acgacatggc 2520
ctacgccgcc cagcccttcc tgctgcggaa cggcgccaac gagggctttc acgaggccgt 2580
gggcgagatc atgagcctga gcgccgccac ccccaagcac ctgaagagca tcggcctgct 2640
gagccccgac ttccaggagg acaacgagac cgagatcaac ttcctgctga agcaggccct 2700
gaccatcgtg ggcaccctgc ccttcaccta catgctggag aagtggcggt ggatggtgtt 2760
taagggcgag atccccaagg accagtggat gaagaagtgg tgggagatga agcgggagat 2820
cgtgggcgtg gtggagcccg tgccccacga cgagacctac tgcgaccccg ccagcctgtt 2880
ccacgtgagc aacgactact ccttcatccg gtactacacc cggaccctgt accagttcca 2940
gttccaggag gccctgtgcc aggccgccaa gcacgagggc cccctgcaca agtgcgacat 3000
cagcaacagc accgaggccg gacagaaact gttcaacatg ctgcggctgg gcaagagcga 3060
gccctggacc ctggccctgg agaatgtggt gggcgccaag aacatgaatg tgcgccccct 3120
gctgaactac ttcgagcccc tgttcacctg gctgaaggac cagaacaaga acagcttcgt 3180
gggctggagc accgactgga gcccctacgc cgaccagagc atcaaagtgc ggatcagcct 3240
gaagagcgcc ctgggcgaca aggcctacga gtggaacgac aacgagatgt acctgttccg 3300
gagcagcgtg gcctatgcca tgcggcagta cttcctgaaa gtgaagaacc agatgatcct 3360
gttcggcgag gaggacgtga gagtggccaa cctgaagccc cggatcagct tcaacttctt 3420
cgtgaccgcc cccaagaacg tgagcgacat catcccccgg accgaagtgg agaaggccat 3480
ccggatgagc cggagccgga tcaacgacgc cttccggctg aacgacaact ccctggagtt 3540
cctgggcatc cagcccaccc tgggccctcc caaccagccc cccgtgagca tctggctgat 3600
cgtgtttggc gtggtgatgg gcgtgatcgt ggtgggaatc gtgatcctga tcttcaccgg 3660
catccgggac cggaagaaga agaacaaggc ccggagcggc gagaacccct acgccagcat 3720
cgatatcagc aagggcgaga acaaccccgg cttccagaac accgacgacg tgcagaccag 3780
cttctgataa tctagaacga gctcgaattc gaagcttctg cagacgcgtc gacgtcatat 3840
ggatccgata tcgccgtggc ggccgcaccc agcgtgttca tcttcccccc ctccgacgag 3900
cagctgaaga gcggcaccgc cagcgtggtg tgcctgctga acaacttcta cccccgggag 3960
gccaaggtgc agtggaaggt ggacaacgcc ctgcagagcg gcaacagcca ggagagcgtg 4020
accgagcagg acagcaagga ctccacctac agcctgagca gcaccctcac cctgagcaag 4080
gccgactacg agaagcacaa ggtgtacgcc tgcgaggtga cccaccaggg cctgagcagc 4140
cccgtgacca agagcttcaa ccggggcgag tgttaataga cttaagttta aaccgctgat 4200
cagcctcgac tgtgccttct agttgccagc catctgttgt ttgcccctcc cccgtgcctt 4260
ccttgaccct ggaaggtgcc actcccactg tcctttccta ataaaatgag gaaattgcat 4320
cgcattgtct gagtaggtgt cattctattc tggggggtgg ggtggggcag gacagcaagg 4380
gggaggattg ggaagacaat agcaggcatg ctggggatgc ggtgggctct atggcttctg 4440
aggcggaaag aaccagctgg ggctctaggg ggtatcccca cgcgccctgt agcggcgcat 4500
taagcgcggc gggtgtggtg gttacgcgca gcgtgaccgc tacacttgcc agcgccctag 4560
cgcccgctcc tttcgctttc ttcccttcct ttctcgccac gttcgccggc tttccccgtc 4620
aagctctaaa tcgggggctc cctttagggt tccgatttag tgctttacgg cacctcgacc 4680
ccaaaaaact tgattagggt gatggttcac gtagtgggcc atcgccctga tagacggttt 4740
ttcgcccttt gacgttggag tccacgttct ttaatagtgg actcttgttc caaactggaa 4800
caacactcaa ccctatctcg gtctattctt ttgatttata agggattttg gccatttcgg 4860
cctattggtt aaaaaatgag ctgatttaac aaaaatttaa cgcgaattaa ttctgtggaa 4920
tgtgtgtcag ttagggtgtg gaaagtcccc aggctcccca gcaggcagaa gtatgcaaag 4980
catgcatctc aattagtcag caaccaggtg tggaaagtcc ccaggctccc cagcaggcag 5040
aagtatgcaa agcatgcatc tcaattagtc agcaaccata gtcccgcccc taactccgcc 5100
catcccgccc ctaactccgc ccagttccgc ccattctccg ccccatggct gactaatttt 5160
ttttatttat gcagaggccg aggccgcctc tgcctctgag ctattccaga agtagtgagg 5220
aggctttttt ggaggcctag gcttttgcaa aaagctcccg ggagcttgta tatccatttt 5280
cggatctgat cagcacgtga tgaaaaagcc tgaactcacc gcgacgtctg tcgagaagtt 5340
tctgatcgaa aagttcgaca gcgtctccga cctgatgcag ctctcggagg gcgaagaatc 5400
tcgtgctttc agcttcgatg taggagggcg tggatatgtc ctgcgggtaa atagctgcgc 5460
cgatggtttc tacaaagatc gttatgttta tcggcacttt gcatcggccg cgctcccgat 5520
tccggaagtg cttgacattg gggaattcag cgagagcctg acctattgca tctcccgccg 5580
tgcacagggt gtcacgttgc aagacctgcc tgaaaccgaa ctgcccgctg ttctgcagcc 5640
ggtcgcggag gccatggatg cgatcgctgc ggccgatctt agccagacga gcgggttcgg 5700
cccattcgga ccacaaggaa tcggtcaata cactacatgg cgtgatttca tatgcgcgat 5760
tgctgatccc catgtgtatc actggcaaac tgtgatggac gacaccgtca gtgcgtccgt 5820
cgcgcaggct ctcgatgagc tgatgctttg ggccgaggac tgccccgaag tccggcacct 5880
cgtgcacgcg gatttcggct ccaacaatgt cctgacggac aatggccgca taacagcggt 5940
cattgactgg agcgaggcga tgttcgggga ttcccaatac gaggtcgcca acatcttett 6000
ctggaggccg tggttggctt gtatggagca gcagacgcgc tacttcgagc ggaggcatcc 6060
ggagcttgca ggatcgccgc ggctccgggc gtatatgctc cgcattggtc ttgaccaact 6120
ctatcagagc ttggttgacg gcaatttcga tgatgcagct tgggcgcagg gtcgatgcga 6180
cgcaatcgtc cgatccggag ccgggactgt cgggcgtaca caaatcgccc gcagaagcgc 6240
ggccgtctgg accgatggct gtgtagaagt actcgccgat agtggaaacc gacgccccag 6300
cactcgtccg agggcaaagg aatagcacgt gctacgagat ttcgattcca ccgccgcctt 6360
ctatgaaagg ttgggcttcg gaatcgtttt ccgggacgcc ggctggatga tcctccagcg 6420
cggggatctc atgctggagt tcttcgccca ccccaacttg tttattgcag cttataatgg 6480
ttacaaataa agcaatagca tcacaaattt cacaaataaa gcattttttt cactgcattc 6540
tagttgtggt ttgtccaaac tcatcaatgt atcttatcat gtctgtatac cgtcgacctc 6600
tagctagagc ttggcgtaat catggtcata gctgtttcct gtgtgaaatt gttatccgct 6660
cacaattcca cacaacatac gagccggaag cataaagtgt aaagcctggg gtgcctaatg 6720
agtgagctaa ctcacattaa ttgcgttgcg ctcactgccc gctttccagt cgggaaacct 6780
gtcgtgccag ctgcattaat gaatcggcca acgcgcgggg agaggcggtt tgcgtattgg 6840
gcgctcttcc gcttcctcgc tcactgactc gctgcgctcg gtcgttcggc tgcggcgagc 6900
ggtatcagct cactcaaagg cggtaatacg gttatccaca gaatcagggg ataacgcagg 6960
aaagaacatg tgagcaaaag gccagcaaaa ggccaggaac cgtaaaaagg ccgcgttgct 7020
ggcgtttttc cataggctcc gcccccctga cgagcatcac aaaaatcgac gctcaagtca 7080
gaggtggcga aacccgacag gactataaag ataccaggcg tttccccctg gaagctccct 7140
cgtgcgctct cctgttccga ccctgccgct taccggatac ctgtccgcct ttctcccttc 7200
gggaagcgtg gcgctttctc atagctcacg ctgtaggtat ctcagttcgg tgtaggtcgt 7260
tcgctccaag ctgggctgtg tgcacgaacc ccccgttcag cccgaccgct gcgccttatc 7320
cggtaactat cgtcttgagt ccaacccggt aagacacgac ttatcgccac tggcagcagc 7380
cactggtaac aggattagca gagcgaggta tgtaggcggt gctacagagt tcttgaagtg 7440
gtggcctaac tacggctaca ctagaagaac agtatttggt atctgcgctc tgctgaagcc 7500
agttaccttc ggaaaaagag ttggtagctc ttgatccggc aaacaaacca ccgctggtag 7560
cggttttttt gtttgcaagc agcagattac gcgcagaaaa aaaggatctc aagaagatcc 7620
tttgatcttt tctacggggt ctgacgctca gtggaacgaa aactcacgtt aagggatttt 7680
ggtcatgaga ttatcaaaaa ggatcttcac ctagatcctt ttaaattaaa aatgaagttt 7740
taaatcaatc taaagtatat atgagtaaac ttggtctgac agttaccaat gcttaatcag 7800
tgaggcacct atctcagcga tctgtctatt tcgttcatcc atagttgcct gactccccgt 7860
cgtgtagata actacgatac gggagggctt accatctggc cccagtgctg caatgatacc 7920
gcgagaccca cgctcaccgg ctccagattt atcagcaata aaccagccag ccggaagggc 7980
cgagcgcaga agtggtcctg caactttatc cgcctccatc cagtctatta attgttgccg 8040
ggaagctaga gtaagtagtt cgccagttaa tagtttgcgc aacgttgttg ccattgctac 8100
aggcatcgtg gtgtcacgct cgtcgtttgg tatggcttca ttcagctccg gttcccaacg 8160
atcaaggcga gttacatgat cccccatgtt gtgcaaaaaa gcggttagct ccttcggtcc 8220
tccgatcgtt gtcagaagta agttggccgc agtgttatca ctcatggtta tggcagcact 8280
gcataattct cttactgtca tgccatccgt aagatgcttt tctgtgactg gtgagtactc 8340
aaccaagtca ttctgagaat agtgtatgcg gcgaccgagt tgctcttgcc cggcgtcaat 8400
acgggataat accgcgccac atagcagaac tttaaaagtg ctcatcattg gaaaacgttc 8460
ttcggggcga aaactctcaa ggatcttacc gctgttgaga tccagttcga tgtaacccac 8520
tcgtgcaccc aactgatctt cagcatcttt tactttcacc agcgtttctg ggtgagcaaa 8580
aacaggaagg caaaatgccg caaaaaaggg aataagggcg acacggaaat gttgaatact 8640
catactcttc ctttttcaat attattgaag catttatcag ggttattgtc tcatgagcgg 8700
atacatattt gaatgtattt agaaaaataa acaaataggg gttccgcgca catttccccg 8760
aaaagtgcca cctgacg 8777
<210>143
<211>8792
<212>DNA
<213>Artificial
<220>
<223>Vector pIg-C910-Clambda
<220>
<221>misc_feature
<222>(1330)..(3869)
<223>Stuffer
<400>143
tcgacggatc gggagatctc ccgatcccct atggtgcact ctcagtacaa tctgctctga 60
tgccgcatag ttaagccagt atctgctccc tgcttgtgtg ttggaggtcg ctgagtagtg 120
cgcgagcaaa atttaagcta caacaaggca aggcttgacc gacaattgtt aattaacatg 180
aagaatctgc ttagggttag gcgttttgcg ctgcttcgct aggtggtcaa tattggccat 240
tagccatatt attcattggt tatatagcat aaatcaatat tggctattgg ccattgcata 300
cgttgtatcc atatcataat atgtacattt atattggctc atgtccaaca ttaccgccat 360
gttgacattg attattgact agttattaat agtaatcaat tacggggtca ttagttcata 420
gcccatatat ggagttccgc gttacataac ttacggtaaa tggcccgcct ggctgaccgc 480
ccaacgaccc ccgcccattg acgtcaataa tgacgtatgt tcccatagta acgccaatag 540
ggactttcca ttgacgtcaa tgggtggagt atttacggta aactgcccac ttggcagtac 600
atcaagtgta tcatatgcca agtacgcccc ctattgacgt caatgacggt aaatggcccg 660
cctggcatta tgcccagtac atgaccttat gggactttcc tacttggcag tacatctacg 720
tattagtcat cgctattacc atggtgatgc ggttttggca gtacatcaat gggcgtggat 780
agcggtttga ctcacgggga tttccaagtc tccaccccat tgacgtcaat gggagtttgt 840
tttggcacca aaatcaacgg gactttccaa aatgtcgtaa caactccgcc ccattgacgc 900
aaatgggcgg taggcgtgta cggtgggagg tctatataag cagagctcgt ttagtgaacc 960
gtcagatcgc ctggagacgc catccacgct gttttgacct ccatagaaga caccgggacc 1020
gatccagcct ccgcggccgg gaacggtgca ttggaatcga tgactctctt aggtagcctt 1080
gcagaagttg gtcgtgaggc actgggcagg taagtatcaa ggttacaaga caggtttaag 1140
gagatcaata gaaactgggc ttgtcgagac agagaagact cttgcgtttc tgataggcac 1200
ctattggtct tactgacatc cactttgcct ttctctccac aggtgtccac tcccagttca 1260
attacagctc gccaccatgc ggttctccgc tcagctgctg ggccttctgg tgctgtggat 1320
tcccggcgtc tcgagatcta tcgatgcatg ccatggtacc aagcttgcca ccatgagcag 1380
cagctcttgg ctgctgctga gcctggtggc cgtgacagcc gcccagagca ccatcgagga 1440
gcaggccaag accttcctgg acaagttcaa ccacgaggcc gaggacctgt tctaccagag 1500
cagcctggcc agctggaact acaacaccaa catcaccgag gagaacgtgc agaacatgaa 1560
caacgccggc gacaagtgga gcgccttcct gaaggagcag agcacactgg cccagatgta 1620
ccccctgcag gagatccaga acctgaccgt gaagctgcag ctgcaggccc tgcagcagaa 1680
cggcagcagc gtgctgagcg aggacaagag caagcggctg aacaccatcc tgaacaccat 1740
gtccaccatc tacagcaccg gcaaagtgtg caaccccgac aacccccagg agtgcctgct 1800
gctggagccc ggcctgaacg agatcatggc caacagcctg gactacaacg agcggctgtg 1860
ggcctgggag agctggcgga gcgaagtggg caagcagctg cggcccctgt acgaggagta 1920
cgtggtgctg aagaacgaga tggccagggc caaccactac gaggactacg gcgactactg 1980
gagaggcgac tacgaagtga acggcgtgga cggctacgac tacagcagag gccagctgat 2040
cgaggacgtg gagcacacct tcgaggagat caagcctctg tacgagcacc tgcacgccta 2100
cgtgcgggcc aagctgatga acgcctaccc cagctacatc agccccatcg gctgcctgcc 2160
cgcccacctg ctgggcgaca tgtggggccg gttctggacc aacctgtaca gcctgaccgt 2220
gcccttcggc cagaagccca acatcgacgt gaccgacgcc atggtggacc aggcctggga 2280
cgcccagcgg atcttcaagg aggccgagaa gttcttcgtg agcgtgggcc tgcccaacat 2340
gacccagggc ttttgggaga acagcatgct gaccgacccc ggcaatgtgc agaaggccgt 2400
gtgccacccc accgcctggg acctgggcaa gggcgacttc cggatcctga tgtgcaccaa 2460
agtgaccatg gacgacttcc tgaccgccca ccacgagatg ggccacatcc agtacgacat 2520
ggcctacgcc gcccagccct tcctgctgcg gaacggcgcc aacgagggct ttcacgaggc 2580
cgtgggcgag atcatgagcc tgagcgccgc cacccccaag cacctgaaga gcatcggcct 2640
gctgagcccc gacttccagg aggacaacga gaccgagatc aacttcctgc tgaagcaggc 2700
cctgaccatc gtgggcaccc tgcccttcac ctacatgctg gagaagtggc ggtggatggt 2760
gtttaagggc gagatcccca aggaccagtg gatgaagaag tggtgggaga tgaagcggga 2820
gatcgtgggc gtggtggagc ccgtgcccca cgacgagacc tactgcgacc ccgccagcct 2880
gttccacgtg agcaacgact actccttcat ccggtactac acccggaccc tgtaccagtt 2940
ccagttccag gaggccctgt gccaggccgc caagcacgag ggccccctgc acaagtgcga 3000
catcagcaac agcaccgagg ccggacagaa actgttcaac atgctgcggc tgggcaagag 3060
cgagccctgg accctggccc tggagaatgt ggtgggcgcc aagaacatga atgtgcgccc 3120
cctgctgaac tacttcgagc ccctgttcac ctggctgaag gaccagaaca agaacagctt 3180
cgtgggctgg agcaccgact ggagccccta cgccgaccag agcatcaaag tgcggatcag 3240
cctgaagagc gccctgggcg acaaggccta cgagtggaac gacaacgaga tgtacctgtt 3300
ccggagcagc gtggcctatg ccatgcggca gtacttcctg aaagtgaaga accagatgat 3360
cctgttcggc gaggaggacg tgagagtggc caacctgaag ccccggatca gcttcaactt 3420
cttcgtgacc gcccccaaga acgtgagcga catcatcccc cggaccgaag tggagaaggc 3480
catccggatg agccggagcc ggatcaacga cgccttccgg ctgaacgaca actccctgga 3540
gttcctgggc atccagccca ccctgggccc tcccaaccag ccccccgtga gcatctggct 3600
gatcgtgttt ggcgtggtga tgggcgtgat cgtggtggga atcgtgatcc tgatcttcac 3660
cggcatccgg gaccggaaga agaagaacaa ggcccggagc ggcgagaacc cctacgccag 3720
catcgatatc agcaagggcg agaacaaccc cggcttccag aacaccgacg acgtgcagac 3780
cagcttctga taatctagaa cgagctcgaa ttcgaagctt ctgcagacgc gtcgacgtca 3840
tatggatccg atatcgccgt ggcggccgca ggccagccca aggccgctcc cagcgtgacc 3900
ctgttccccc cctcctccga ggagctgcag gccaacaagg ccaccctggt gtgcctcatc 3960
agcgacttct accctggcgc cgtgaccgtg gcctggaagg ccgacagcag ccccgtgaag 4020
gccggcgtgg agaccaccac ccccagcaag cagagcaaca acaagtacgc cgccagcagc 4080
tacctgagcc tcacccccga gcagtggaag agccaccgga gctacagctg ccaggtgacc 4140
cacgagggca gcaccgtgga gaagaccgtg gcccccaccg agtgcagcta atagacttaa 4200
gtttaaaccg ctgatcagcc tcgactgtgc cttctagttg ccagccatct gttgtttgcc 4260
cctcccccgt gccttccttg accctggaag gtgccactcc cactgtcctt tcctaataaa 4320
atgaggaaat tgcatcgcat tgtctgagta ggtgtcattc tattctgggg ggtggggtgg 4380
ggcaggacag caagggggag gattgggaag acaatagcag gcatgctggg gatgcggtgg 4440
gctctatggc ttctgaggcg gaaagaacca gctggggctc tagggggtat ccccacgcgc 4500
cctgtagcgg cgcattaagc gcggcgggtg tggtggttac gcgcagcgtg accgctacac 4560
ttgccagcgc cctagcgccc gctcctttcg ctttcttccc ttcctttctc gccacgttcg 4620
ccggctttcc ccgtcaagct ctaaatcggg ggctcccttt agggttccga tttagtgctt 4680
tacggcacct cgaccccaaa aaacttgatt agggtgatgg ttcacgtagt gggccatcgc 4740
cctgatagac ggtttttcgc cctttgacgt tggagtccac gttctttaat agtggactct 4800
tgttccaaac tggaacaaca ctcaacccta tctcggtcta ttcttttgat ttataaggga 4860
ttttggccat ttcggcctat tggttaaaaa atgagctgat ttaacaaaaa tttaacgcga 4920
attaattctg tggaatgtgt gtcagttagg gtgtggaaag tccccaggct ccccagcagg 4980
cagaagtatg caaagcatgc atctcaatta gtcagcaacc aggtgtggaa agtccccagg 5040
ctccccagca ggcagaagta tgcaaagcat gcatctcaat tagtcagcaa ccatagtccc 5100
gcccctaact ccgcccatcc cgcccctaac tccgcccagt tccgcccatt ctccgcccca 5160
tggctgacta atttttttta tttatgcaga ggccgaggcc gcctctgcct ctgagctatt 5220
ccagaagtag tgaggaggct tttttggagg cctaggcttt tgcaaaaagc tcccgggagc 5280
ttgtatatcc attttcggat ctgatcagca cgtgatgaaa aagcctgaac tcaccgcgac 5340
gtctgtcgag aagtttctga tcgaaaagtt cgacagcgtc tccgacctga tgcagctctc 5400
ggagggcgaa gaatctcgtg ctttcagctt cgatgtagga gggcgtggat atgtcctgcg 5460
ggtaaatagc tgcgccgatg gtttctacaa agatcgttat gtttatcggc actttgcatc 5520
ggccgcgctc ccgattccgg aagtgcttga cattggggaa ttcagcgaga gcctgaccta 5580
ttgcatctcc cgccgtgcac agggtgtcac gttgcaagac ctgcctgaaa ccgaactgcc 5640
cgctgttctg cagccggtcg cggaggccat ggatgcgatc gctgcggccg atcttagcca 5700
gacgagcggg ttcggcccat tcggaccgca aggaatcggt caatacacta catggcgtga 5760
tttcatatgc gcgattgctg atccccatgt gtatcactgg caaactgtga tggacgacac 5820
cgtcagtgcg tccgtcgcgc aggctctcga tgagctgatg ctttgggccg aggactgccc 5880
cgaagtccgg cacctcgtgc acgcggattt cggctccaac aatgtcctga cggacaatgg 5940
ccgcataaca gcggtcattg actggagcga ggcgatgttc ggggattccc aatacgaggt 6000
cgccaacatc ttcttctgga ggccgtggtt ggcttgtatg gagcagcaga cgcgctactt 6060
cgagcggagg catccggagc ttgcaggatc gccgcggctc cgggcgtata tgctccgcat 6120
tggtcttgac caactctatc agagcttggt tgacggcaat ttcgatgatg cagcttgggc 6180
gcagggtcga tgcgacgcaa tcgtccgatc cggagccggg actgtcgggc gtacacaaat 6240
cgcccgcaga agcgcggccg tctggaccga tggctgtgta gaagtactcg ccgatagtgg 6300
aaaccgacgc cccagcactc gtccgagggc aaaggaatag cacgtgctac gagatttcga 6360
ttccaccgcc gccttctatg aaaggttggg cttcggaatc gttttccggg acgccggctg 6420
gatgatcctc cagcgcgggg atctcatgct ggagttcttc gcccacccca acttgtttat 6480
tgcagcttat aatggttaca aataaagcaa tagcatcaca aatttcacaa ataaagcatt 6540
tttttcactg cattctagtt gtggtttgtc caaactcatc aatgtatctt atcatgtctg 6600
tataccgtcg acctctagct agagcttggc gtaatcatgg tcatagctgt ttcctgtgtg 6660
aaattgttat ccgctcacaa ttccacacaa catacgagcc ggaagcataa agtgtaaagc 6720
ctggggtgcc taatgagtga gctaactcac attaattgcg ttgcgctcac tgcccgcttt 6780
ccagtcggga aacctgtcgt gccagctgca ttaatgaatc ggccaacgcg cggggagagg 6840
cggtttgcgt attgggcgct cttccgcttc ctcgctcact gactcgctgc gctcggtcgt 6900
tcggctgcgg cgagcggtat cagctcactc aaaggcggta atacggttat ccacagaatc 6960
aggggataac gcaggaaaga acatgtgagc aaaaggccag caaaaggcca ggaaccgtaa 7020
aaaggccgcg ttgctggcgt ttttccatag gctccgcccc cctgacgagc atcacaaaaa 7080
tcgacgctca agtcagaggt ggcgaaaccc gacaggacta taaagatacc aggcgtttcc 7140
ccctggaagc tccctcgtgc gctctcctgt tccgaccctg ccgcttaccg gatacctgtc 7200
cgcctttctc ccttcgggaa gcgtggcgct ttctcatagc tcacgctgta ggtatctcag 7260
ttcggtgtag gtcgttcgct ccaagctggg ctgtgtgcac gaaccccccg ttcagcccga 7320
ccgctgcgcc ttatccggta actatcgtct tgagtccaac ccggtaagac acgacttatc 7380
gccactggca gcagccactg gtaacaggat tagcagagcg aggtatgtag gcggtgctac 7440
agagttcttg aagtggtggc ctaactacgg ctacactaga agaacagtat ttggtatctg 7500
cgctctgctg aagccagtta ccttcggaaa aagagttggt agctcttgat ccggcaaaca 7560
aaccaccgct ggtagcggtt tttttgtttg caagcagcag attacgcgca gaaaaaaagg 7620
atctcaagaa gatcctttga tcttttctac ggggtctgac gctcagtgga acgaaaactc 7680
acgttaaggg attttggtca tgagattatc aaaaaggatc ttcacctaga tccttttaaa 7740
ttaaaaatga agttttaaat caatctaaag tatatatgag taaacttggt ctgacagtta 7800
ccaatgctta atcagtgagg cacctatctc agcgatctgt ctatttcgtt catccatagt 7860
tgcctgactc cccgtcgtgt agataactac gatacgggag ggcttaccat ctggccccag 7920
tgctgcaatg ataccgcgag acccacgctc accggctcca gatttatcag caataaacca 7980
gccagccgga agggccgagc gcagaagtgg tcctgcaact ttatccgcct ccatccagtc 8040
tattaattgt tgccgggaag ctagagtaag tagttcgcca gttaatagtt tgcgcaacgt 8100
tgttgccatt gctacaggca tcgtggtgtc acgctcgtcg tttggtatgg cttcattcag 8160
ctccggttcc caacgatcaa ggcgagttac atgatccccc atgttgtgca aaaaagcggt 8220
tagctccttc ggtcctccga tcgttgtcag aagtaagttg gccgcagtgt tatcactcat 8280
ggttatggca gcactgcata attctcttac tgtcatgcca tccgtaagat gcttttctgt 8340
gactggtgag tactcaacca agtcattctg agaatagtgt atgcggcgac cgagttgctc 8400
ttgcccggcg tcaatacggg ataataccgc gccacatagc agaactttaa aagtgctcat 8460
cattggaaaa cgttcttcgg ggcgaaaact ctcaaggatc ttaccgctgt tgagatccag 8520
ttcgatgtaa cccactcgtg cacccaactg atcttcagca tcttttactt tcaccagcgt 8580
ttctgggtga gcaaaaacag gaaggcaaaa tgccgcaaaa aagggaataa gggcgacacg 8640
gaaatgttga atactcatac tcttcctttt tcaatattat tgaagcattt atcagggtta 8700
ttgtctcatg agcggataca tatttgaatg tatttagaaa aataaacaaa taggggttcc 8760
gcgcacattt ccccgaaaag tgccacctga cg 8792
<210>144
<211>23
<212>DNA
<213>Artificial
<220>
<223>Primer OK1(HuVK1B)
<400>144
gacatccagw tgacccagtc tcc 23
<210>145
<211>23
<212>DNA
<213>Artificial
<220>
<223>Primer OK2(HuVK2)
<400>145
gatgttgtga tgactcagtc tcc 23
<210>146
<211>23
<212>DNA
<213>Artificial
<220>
<223>Primer OK3(HuVK2B2)
<400>146
gatattgtga tgacccagac tcc 23
<210>147
<211>23
<212>DNA
<213>Artificial
<220>
<223>Primer OK4(HuVK3B)
<400>147
gaaattgtgw tgacrcagtc tcc 23
<210>148
<211>23
<212>DNA
<213>Artificial
<220>
<223>Primer OK5(HuVK5)
<400>148
gaaacgacac tcacgcagtc tcc 23
<210>149
<211>23
<212>DNA
<213>Artificial
<220>
<223>Primer OK6(HuVK6)
<400>149
gaaattgtgc tgactcagtc tcc 23
<210>150
<211>24
<212>DNA
<213>Artificial
<220>
<223>Primer OCK (HuCK)
<400>150
acactctccc ctgttgaagc tctt 24
<210>151
<211>23
<212>DNA
<213>Artificial
<220>
<223>Primer OL1(HuVL1A)
<400>151 23
cagtctgtgc tgactcagcc acc
<210>152
<211>23
<212>DNA
<213>Artificial
<220>
<223>Primer OL1(HuVL1B)
<400>152
cagtctgtgy tgacgcagcc gcc 23
<210>153
<211>23
<212>DNA
<213>Artificial
<220>
<223>Primer OL1(HuVL1C)
<400>153
cagtctgtcg tgacgcagcc gcc 23
<210>154
<211>20
<212>DNA
<213>Artificial
<220>
<223>OL2(HuVL2B)
<400>154
cagtctgccc tgactcagcc 20
<210>155
<211>23
<212>DNA
<213>Artificial
<220>
<223>OL3(HuVL3A)
<400>155
tcctatgwgc tgactcagcc acc 23
<210>156
<211>23
<212>DNA
<213>Artificial
<220>
<223>OL4(HuVL3B)
<400>156
tcttctgagc tgactcagga ccc 23
<210>157
<211>20
<212>DNA
<213>Artificial
<220>
<223>OL5(HuVL4B)
<400>157
cagcytgtgc tgactcaatc 20
<210>158
<211>23
<212>DNA
<213>Artificial
<220>
<223>OL6(HuVL5)
<400>15823
caggctgtgc tgactcagcc gtc 23
<210>159
<211>23
<212>DNA
<213>Artificial
<220>
<223>OL7(HuVL6)
<400>159
aattttatgc tgactcagcc cca 23
<210>160
<211>23
<212>DNA
<213>Artificial
<220>
<223>OL8(HuVL7/8)
<400>160
cagrctgtgg tgacycagga gcc 23
<210>161
<211>23
<212>DNA
<213>Artificial
<220>
<223>OL9(HuVL9)
<400>161
cwgcctgtgc tgactcagcc mcc 23
<210>162
<211>18
<212>DNA
<213>Artificial
<220>
<223>OL9(HuVL10)
<400>162
caggcagggc tgactcag 18
<210>163
<211>23
<212>DNA
<213>Artificial
<220>
<223>OCL (HuCL2)
<400>163
tgaacattct gtaggggcca ctg 23
<210>164
<211>23
<212>DNA
<213>Artificial
<220>
<223>OCL (HuCL7)
<400>164
agagcattct gcaggggcca ctg 23
<210>165
<211>23
<212>DNA
<213>Artificial
<220>
<223>OH1(HuVH1B7A)
<400>165
cagrtgcagc tggtgcartc tgg 23
<210>166
<211>23
<212>DNA
<213>Artificial
<220>
<223>OH1(HuVH1C)
<400>166
saggtccagc tggtrcagtc tgg 23
<210>167
<211>23
<212>DNA
<213>Artificial
<220>
<223>OH2(HuVH2B)
<400>167
cagrtcacct tgaaggagtc tgg 23
<210>168
<211>18
<212>DNA
<213>Artificial
<220>
<223>OH3(HuVH3A)
<400>168
gaggtgcagc tggtggag 18
<210>169
<211>23
<212>DNA
<213>Artificial
<220>
<223>OH4(HuVH3C)
<400>169
gaggtgcagc tggtggagwc ygg 23
<210>170
<211>23
<212>DNA
<213>Artificial
<220>
<223>OH5(HuVH4B)
<400>170
caggtgcagc tacagcagtg ggg 23
<210>171
<211>23
<212>DNA
<213>Artificial
<220>
<223>OH6(HuVH4C)
<400>171
cagstgcagc tgcaggagtc sgg 23
<210>172
<211>23
<212>DNA
<213>Artificial
<220>
<223>OH7(HuVH6A)
<400>172
caggtacagc tgcagcagtc agg 23
<210>173
<211>24
<212>DNA
<213>Artificial
<220>
<223>OCM(HuCIgM)
<400>173
tggaagaggc acgttctttt cttt 24
<210>174
<211>41
<212>DNA
<213>Artificial
<220>
<223>OK1S(HuVK1B-SAL)
<400>174
tgagcacaca ggtcgacgga catccagwtg acccagtctc c 41
<210>175
<211>41
<212>DNA
<213>Artificial
<220>
<223>OK2S (HuVK2-SAL)
<400>175
tgagcacaca ggtcgacgga tgttgtgatg actcagtctc c 41
<210>176
<211>41
<212>DNA
<213>Artificial
<220>
<223>OK3S (HuVK2B2-SAL)
<400>176
tgagcacaca ggtcgacgga tattgtgatg acccagactc c 41
<210>177
<211>41
<212>DNA
<213>Artificial
<220>
<223>OK4S (HuVK3B-SAL)
<400>177
tgagcacaca ggtcgacgga aattgtgwtg acrcagtctc c 41
<210>178
<211>41
<212>DNA
<213>Artificial
<220>
<223>OK5S(HuVK5-SAL)
<400>178
tgagcacaca ggtcgacgga aacgacactc acgcagtctc c 41
<210>179
<211>41
<212>DNA
<213>Artificial
<220>
<223>OK6S(HuVK6-SAL)
<400>179
tgagcacaca ggtcgacgga aattgtgctg actcagtctc c 41
<210>180
<211>48
<212>DNA
<213>Artificial
<220>
<223>OJK1(HuJK1-NOT)
<400>180
gagtcattct cgacttgcgg ccgcacgttt gatttccacc ttggtccc 48
<210>181
<211>48
<212>DNA
<213>Artificial
<220>
<223>OJK2(HuJK2-NOT)
<400>181
gagtcattct cgacttgcgg ccgcacgttt gatctccagc ttggtccc 48
<210>182
<211>48
<212>DNA
<213>Artificial
<220>
<223>0JK3(HuJK3-NOT)
<400>182
gagtcattct cgacttgcgg ccgcacgttt gatatccact ttggtccc 48
<210>183
<211>48
<212>DNA
<213>Artificial
<220>
<223>0JK4(HuJK4-NOT)
<400>183
gagtcattct cgacttgcgg ccgcacgttt gatctccacc ttggtccc 48
<210>184
<211>48
<212>DNA
<213>Artificial
<220>
<223>OJK5(HuJK5-NOT)
<400>184
gagtcattct cgacttgcgg ccgcacgttt aatctccagt cgtgtccc 48
<210>185
<211>41
<212>DNA
<213>Artificial
<220>
<223>OL1S(HuVL1A-SAL)
<400>185
tgagcacaca ggtcgacgca gtctgtgctg actcagccac c 41
<210>186
<211>41
<212>DNA
<213>Artificial
<220>
<223>OL1S(HuVL1B-SAL)
<400>186
tgagcacaca ggtcgacgca gtctgtgytg acgcagccgc c 41
<210>187
<211>41
<212>DNA
<213>Artificial
<220>
<223>OL1S(HuVL1C-SAL)
<400>187
tgagcacaca ggtcgacgca gtctgtcgtg acgcagccgc c 41
<210>188
<211>38
<212>DNA
<213>Artificial
<220>
<223>OL2S(HuVL2B-SAL)
<400>188
tgagcacaca ggtcgacgca gtctgccctg actcagcc 38
<210>189
<211>41
<212>DNA
<213>Artificial
<220>
<223>OL3S(HuVL3A-SAL)
<400>189
tgagcacaca ggtcgacgtc ctatgwgctg actcagccac c 41
<210>190
<211>41
<212>DNA
<213>Artificial
<220>
<223>OL4S(HuVL3B-SAL)
<400>190
tgagcacaca ggtcgacgtc ttctgagctg actcaggacc c 41
<210>191
<211>38
<212>DNA
<213>Artificial
<220>
<223>OL5S(HuVL4B-SAL)
<400>191
tgagcacaca ggtcgacgca gcytgtgctg actcaatc 38
<210>192
<211>41
<212>DNA
<213>Artificial
<220>
<223>OL6S(HuVL5-SAL)
<400>192
tgagcacaca ggtcgacgca ggctgtgctg actcagccgt c 41
<210>193
<211>41
<212>DNA
<213>Artificial
<220>
<223>OL7S(HuVL6-SAL)
<400>193
tgagcacaca ggtcgacgaa ttttatgctg actcagcccc a 41
<210>194
<211>41
<212>DNA
<213>Artificial
<220>
<223>OLSS(HuVL7/8-SAL)
<400>194
tgagcacaca ggtcgacgca grctgtggtg acycaggagc c 41
<210>195
<211>41
<212>DNA
<213>Artificial
<220>
<223>OL9S(HuVL9-SAL)
<400>195
tgagcacaca ggtcgacgcw gcctgtgctg actcagccmc c 41
<210>196
<211>36
<212>DNA
<213>Artificial
<220>
<223>OL9S (HuVL10-SAL)
<400>196
tgagcacaca ggtcgacgca ggcagggctg actcag 36
<210>197
<211>48
<212>DNA
<213>Artificial
<220>
<223>OJL1(HuJL1-NOT)
<400>197
gagtcattct cgacttgcgg ccgcacctag gacggtgacc ttggtccc 48
<210>198
<211>48
<212>DNA
<213>Artificial
<220>
<223>OJL2(HuJL2/3-NOT)
<400>198
gagtcattct cgacttgcgg ccgcacctag gacggtcagc ttggtccc 48
<210>199
<211>48
<212>DNA
<213>Artificial
<220>
<223>OJL3(HuJL7-NOT)
<400>199
gagtcattct cgacttgcgg ccgcaccgag gacggtcagc tgggtgcc 48
<210>200
<211>56
<212>DNA
<213>Artificial
<220>
<223>OH1S (HuVH1B-SFI)
<400>200
gtcctcgcaa ctgcggccca gccggccatg gcccagrtgc agctggtgca rtctgg 56
<210>201
<211>56
<212>DNA
<213>Artificial
<220>
<223>OH1S (HuVH1C-SFI)
<400>201
gtcctcgcaa ctgcggccca gccggccatg gccsaggtcc agctggtrca gtctgg 56
<210>202
<211>56
<212>DNA
<213>Artificial
<220>
<223>OH2S (HuVH2B-SFI)
<400>202
gtcctcgcaa ctgcggccca gccggccatg gcccagrtca ccttgaagga gtctgg 56
<210>203
<211>51
<212>DNA
<213>Artificial
<220>
<223>OH3S (HuVH3A-SFI)
<400>203
gtcctcgcaa ctgcggccca gccggccatg gccgaggtgc agctggtgga g 51
<210>204
<211>56
<212>DNA
<213>Artificial
<220>
<223>OH4S (HuVH3C-SFI)
<400>204
gtcctcgcaa ctgcggccca gccggccatg gccgaggtgc agctggtgga gwcygg 56
<210>205
<211>56
<212>DNA
<213>Artificial
<220>
<223>OH5S (HuVH4B-SFI)
<400>205
gtcctcgcaa ctgcggccca gccggccatg gcccaggtgc agctacagca gtgggg 56
<210>206
<211>56
<212>DNA
<213>Artificial
<220>
<223>OH6S (HuVH4C-SFI)
<400>206
gtcctcgcaa ctgcggccca gccggccatg gcccagstgcagctgcagga gtcsgg 56
<210>207
<211>56
<212>DNA
<213>Artificial
<220>
<223>OH7S (HuVH6A-SFI)
<400>207
gtcctcgcaa ctgcggccca gccggccatg gcccaggtac agctgcagca gtcagg 56
<210>208
<211>36
<212>DNA
<213>Artificial
<220>
<223>OJH1(HuLH1/2-XHO)
<400>208
gagtcattct cgactcgaga crgtgaccag ggtgcc 36
<210>209
<211>36
<212>DNA
<213>Artificial
<220>
<223>OJH2(HuJH3-XHO)
<400>209
gagtcattct cgactcgaga cggtgaccat tgtccc 36
<210>210
<211>36
<212>DNA
<213>Artificial
<220>
<223>OJH3(HuJH4/5-XHO)
<400>210
gagtcattct cgactcgaga cggtgaccag ggttcc 36
<210>211
<211>36
<212>DNA
<213>Artificial
<220>
<223>OJH4(HuJH6-XHO)
<400>211
gagtcattct cgactcgaga cggtgaccgt ggtccc 36
<210>212
<211>735
<212>DNA
<213>Artificial
<220>
<223>SC06-141
<220>
<221>CDS
<222>(1)..(735)
<400>212
gag gtc cag ctg gtg cag tct ggg gct gag gtg aag aag cct ggg gcc 48
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
1 5 10 15
tca gtg aag gtc tcc tgc aag gct tct ggg tac acc ttc acc ggc tac 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
20 25 30
tat gtg tac tgg gtg cga cag gcc cct gga caa ggg ctt gag tgg atg 144
Tyr Val Tyr Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
30 40 45
gga tgg atc agc gct tac aat ggt aac aca aac tat gca cag aag ttc 192
Gly Trp Ile Ser Ala Tyr Asn Gly Asn Thr Asn Tyr Ala Gln Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac aaa tcc acg agc aca gcc tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
atg gag ctg agc agc ctg aga tct gaa gac acg gct gtg tat tac tgt 288
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
gcg aga agt aga tcc ctg gac gtc tgg ggc caa ggg acc acg gtc acc 336
Ala Arg Ser Arg Ser Leu Asp Val Trp Gly Glp Gly Thr Thr Val Thr
100 105 110
gtc tcg agc ggt acg ggc ggt tca ggc gga acc ggc agc ggc act ggc 384
Val Ser Ser Gly Thr Gly Gly Ser Gly Gly Thr Gly Ser Gly Thr Gly
115 120 125
ggg tcg acg gat gtt gtg atg act cag tct cca gac tcc ctg gct gtg 432
Gly Ser Thr Asp Val Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val
130 135 140
tct ctg ggc gag agg gcc acc atc aac tgc aag tcc agc cag agt gtt 480
Ser Leu Gly Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val
145 150 155 160
tta tac agc tcc aac aat aag aac tac tta gct tgg tac cag cag aaa 528
Leu Tyr Ser Ser Asn Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys
165 170 175
cca gga cag cct cct aag ctg ctc att tac tgg gca tct acc cgg gaa 576
Pro Gly Gln Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu
180 185 190
tcc ggg gtc cct gac cga ttc agt ggc agc ggg tct ggg aca gat ttc 624
Ser Gly Val Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe
195 200 205
act ctc acc atc agc agc ctg cag gct gaa gat gtg gca gtt tat tac 672
Thr Leu Thr Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr
210 215 220
tgt cag caa tat tat agt act cct ctc act ttc ggc gga ggg acc aaa 720
Cys Gln Gln Tyr Tyr Ser Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys
225 230 235 240
gtg gat atc aaa cgt 735
Val Asp Ile Lys Arg
245
<210>213
<211>245
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>213
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
20 25 30
Tyr Val Tyr Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Trp Ile Ser Ala Tyr Asn Gly Asn Thr Asn Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ser Arg Ser Leu Asp Val Trp Gly Gln Gly Thr Thr Val Thr
100 105 110
Val Ser Ser Gly Thr Gly Gly Ser Gly Gly Thr Gly Ser Gly Thr Gly
115 120 125
Gly Ser Thr Asp Val Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val
130 135 140
Ser Leu Gly Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val
145 150 155 160
Leu Tyr Ser Ser Asn Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys
165 170 175
Pro Gly Gln Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu
180 185 190
Ser Gly Val Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe
195 200 205
Thr Leu Thr Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr
210 215 220
Cys Gln Gln Tyr Tyr Ser Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys
225 230 235 240
Val Asp Ile Lys Arg
245
<210>214
<211>741
<212>DNA
<213>Artificial
<220>
<223>SC06-272
<220>
<221>CDS
<222>(1)..(741)
<400>214
cag atg cag ctg gtg cag tct ggg gct gag gtg aag aag cct ggg tcc 48
Gln Met Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aag gtc tcc tgc aag gct tct gga ggc acc ttc tcc agt tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr
20 25 30
gct atc acc tgg gtg cga cag gcc cct gga caa ggg ctt gag tgg atg 144
Ala Ile Thr Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga ggg atc atc ggt atg ttt ggt tca aca aac tac gca cag aac ttc 192
Gly Gly Ile Ile Gly Met Phe Gly Ser Thr Asn Tyr Ala Gln Asn Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac gaa tcc acg agc aca gcc tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr
65 70 75 80
atg gag ctg agc agc ctc aga tct gag gac acg gcc gtg tat tac tgt 288
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
gcg aga agt act ggt tat tac cct gca tac ctc cac cac tgg ggc cag 336
Ala Arg Ser Thr Gly Tyr Tyr Pro Ala Tyr Leu His His Trp Gly Gln
100 105 110
ggc acc ctg gtc acc gtc tcg agc ggt acg ggc ggt tca ggc gga acc 384
Gly Thr Leu Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly Thr
115 120 125
ggc agc ggc act ggc ggg tcg acg cag tct gcc ctg act cag cct cgc 432
Gly Ser Gly Thr Gly Gly Ser Thr Gln Ser Ala Leu Thr Gln Pro Arg
130 135 140
tca gtg tcc ggg tct cct gga cag tca gtc acc atc tcc tgc act gga 480
Ser Val Ser Gly Ser Pro Gly Gln Ser Val Thr Ile Ser Cys Thr Gly
145 150 155 160
acc agc agt gat gtt ggt ggt tat aac tat gtc tcc tgg tac caa cag 528
Thr Ser Ser Asp Val Gly Gly Tyr Asn Tyr Val Ser Trp Tyr Gln Gln
165 170 175
cac cca ggc aaa gcc ccc aaa ctc atg att tat gat gtc agt aag cgg 576
His Pro Gly Lys Ala Pro Lys Leu Met Ile Tyr Asp Val Ser Lys Arg
180 185 190
ccc tca ggg gtc cct gat cgc ttc tct ggc tcc aag tct ggc aac acg 624
Pro Ser Gly Val Pro Asp Arg Phe Ser Gly Ser Lys Ser Gly Asn Thr
195 200 205
gcc tcc ctg acc atc tct ggg ctc cag gct gag gat gag gct gat tat 672
Ala Ser Leu Thr Ile Ser Gly Leu Gln Ala Glu Asp Glu Ala Asp Tyr
210 215 220
tac tgc agc tca tat aca agc agc agc act cat gtc ttc gga act ggg 720
Tyr Cys Ser Ser Tyr Thr Ser Ser Ser Thr Gis Val Phe Gly Thr Gly
225 230 235 240
acc aag gtc acc gtc cta ggt 741
Thr Lys Val Thr Val Leu Gly
245
<210>215
<211>247
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>215
Gln Met Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr
20 25 30
Ala Ile Thr Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Gly Ile Ile Gly Met Phe Gly Ser Thr Asn Tyr Ala Gln Asn Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ser Thr Gly Tyr Tyr Pro Ala Tyr Leu Gis His Trp Gly Gln
100 105 110
Gly Thr Leu Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly Thr
115 120 125
Gly Ser Gly Thr Gly Gly Ser Thr Gln Ser Ala Leu Thr Gln Pro Arg
130 135 140
Ser Val Ser Gly Ser Pro Gly Gln Ser Val Thr Ile Ser Cys Thr Gly
145 150 155 160
Thr Ser Ser Asp Val Gly Gly Tyr Asn Tyr Val Ser Trp Tyr Gln Gln
165 170 175
His Pro Gly Lys Ala Pro Lys Leu Met Ile Tyr Asp Val Ser Lys Arg
180 185 190
Pro Ser Gly Val Pro Asp Arg Phe Ser Gly Ser Lys Ser Gly Asn Thr
195 200 205
Ala Ser Leu Thr Ile Ser Gly Leu Gln Ala Glu Asp Glu Ala Asp Tyr
210 215 220
Tyr Cys Ser Ser Tyr Thr Ser Ser Ser Thr His Val Phe Gly Thr Gly
225 230 235 240
Thr Lys Val Thr Val Leu Gly
245
<210>216
<211>738
<212>DNA
<213>Artificial
<220>
<223>SC06-296
<220>
<221>CDS
<222>(1)..(738)
<400>216
gag gtg cag ctg gtg gag acc ggg gct gag gtg aag aag cct ggg gcc 48
Glu Val Gln Leu Val Glu Thr Gly Ala Glu Val Lys Lys Pro Gly Ala
1 5 10 15
tca gtg aag gtt tcc tgc aag gca tct gga tac acc ttc acc agc tac 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr
20 25 30
tat atg cac tgg gtg cga cag gcc cct gga caa ggg ctt gag tgg atg 144
Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga tgg atc aac cct aac agt ggt ggc aca aac tat gca cag aag ttt 192
Gly Trp Ile Asn Pro Asn Ser Gly Gly Thr Asn Tyr Ala Gln Lys Phe
50 55 60
cag ggc agg gtc acc atg acc agg gac acg tcc ate agc aca gcc tac 240
Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser lle Ser Thr Ala Tyr
65 70 75 80
atg gag ctg agc agg ctg aga tct gac gac acg gcc gtg tat tac tgt 288
Met Glu Leu Ser Arg Leu Arg Set Asp Asp Thr Ala Val Tyr Tyr Cys
85 90 95
gcg aga gag ggg aaa tgg gga cct caa gcg gct ttt gat atc tgg ggc 336
Ala Arg Glu Gly Lys Trp Gly Pro Gln Ala Ala Phe Asp lle Trp Gly
100 105 110
caa ggg aca atg gtc acc gtc tcg agc ggt acg ggc ggt tca ggc gga 384
Gln Gly Thr Met Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly
115 120 125
acc ggc agc ggc act ggc ggg tcg acg gaa att gtg atg acg cag tct 432
Thr Gly Ser Gly Thr Gly Gly Ser Thr Glu Ile Val Met Thr Gln Ser
130 135 140
cca ggc acc ctg tct ttg tct cca ggg gaa aga gcc acc ctc tcc tgc 480
Pro Gly Thr Leu Ser Leu Ser Pro Gly Glu Arg Ala Thr Leu Ser Cys
145 150 155 160
agg gcc agt cag agt gtt agc agc agc tac tta gcc tgg tac cag cag 528
Arg Ala Ser Gln Ser Val Ser Ser Ser Tyr Leu Ala Trp Tyr Gln Gln
165 170 175
aaa cct ggc cag gct ccc agg ctc ctc atc tat gat gca tcc agc agg 576
Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile Tyr Asp Ala Ser Ser Arg
180 185 190
gcc act gac atc cca gac agg ttc agt ggc agt ggg tct ggg aca gac 624
Ala Thr Asp Ile Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp
195 200 205
ttc act ctc acc atc agc aga ctg gag cct gaa gat ttt gca gtg tat 672
Phe Thr Leu Thr Ile Ser Arg Leu Glu Pro Glu Asp Phe Ala Val Tyr
210 215 220
tac tgt cag cag tat ggt agc tca ctt tgg acg ttc ggc caa ggg acc 720
Tyr Cys Gln Gln Tyr Gly Ser Ser Leu Trp Thr Phe Gly Gln Gly Thr
225 230 235 240
aag gtg gag atc aaa cgt 738
Lys Val Glu Ile Lys Arg
245
<210>217
<211>246
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>217
Glu Val Gln Leu Val Glu Thr Gly Ala Glu Val Lys Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr
20 25 30
Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Trp Ile Asn Pro Asn Ser Gly Gly Thr Ash Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Glu Gly Lys Trp Gly Pro Gln Ala Ala Phe Asp Ile Trp Gly
100 105 110
Gln Gly Thr Met Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly
115 120 125
Thr Gly Ser Gly Thr Gly Gly Ser Thr Glu Ile Val Met Thr Gln Ser
130 135 140
Pro Gly Thr Leu Ser Leu Ser Pro Gly Glu Arg Ala Thr Leu Ser Cys
145 150 155 160
Arg Ala Ser Gln Ser Val Ser Ser Ser Tyr Leu Ala Trp Tyr Gln Gln
165 170 175
Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile Tyr Asp Ala Ser Ser Arg
180 185 190
Ala Thr Asp Ile Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp
195 200 205
Phe Thr Leu Thr Ile Ser Arg Leu Glu Pro Glu Asp Phe Ala Val Tyr
210 215 220
Tyr Cys Gln Gln Tyr Gly Ser Ser Leu Trp Thr Phe Gly Gln Gly Thr
225 230 235 240
Lys Val Glu Ile Lys Arg
245
<210>218
<211>738
<212>DNA
<213>Artificial
<220>
<223>SC06-301
<220>
<22l>CDS
<222>(1)..(738)
<400>218
gag gtg cag ctg gta gag tct ggg gga ggc ttg gta cag cct ggg ggg 48
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
tcc ctg aga ctc tcc tgt gca gcc tct gga ttc acc ttt agc atc tat 96
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ile Tyr
20 25 30
gcc atg agc tgg gtc cgc cag gca cca ggg aag ggg ctg gag tgg gtc 144
Ala Met Ser Trn Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
tca gct att agt agt agt ggt gat agc aca tac tac gca gac tcc gtg 192
Ser Ala Ile Ser Ser Ser GIy Asp Ser Thr Tyr Tyr Ala Asp Ser Val
50 55 60
aag ggc cgg ttc acc atc tcc aga gac aac gcc agg aac acg ctg tat 240
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Arg Asn Thr Leu Tyr
65 70 75 80
ctg caa atg aac agt ctg aga gcc gag gac acg gct gtg tat tac tgt 288
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
gcg aga gcg tat ggc tac acg ttc gac ccc tgg ggc cag gga acc ctg 336
Ala Arg Ala Tyr Gly Tyr Thr Phe Asp Pro Trp Gly Gln Gly Thr Leu
100 105 110
gtc acc gtc tcg agc ggt acg ggc ggt tca ggc gga acc ggc agc ggc 384
Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly Thr Gly Ser Gly
115 120 125
act ggc ggg tcg acg gaa att gtg ctg act cag tct cca ctc tcc ctg 432
Thr Gly Gly Ser Thr Glu Ile Val Leu Thr Gln Ser Pro Leu Ser Leu
130 135 140
ccc gtc acc cct gga gag ccg gcc tcc atc tcc tgc agg tct agt cag 480
Pro Val Thr Pro Gly Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln
145 150 155 160
agc ctc ctg cat agt aat gga tac aac tat ttg gat tgg tac ctg cag 528
Ser Leu Leu Gis Ser Asn Gly Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln
165 170 175
aag cca ggg cag tct cca cag ctc ctg atc tat ttg ggt tct aat cgg 576
Lys Pro Gly Gln Ser Pro Gln Leu Leu Ile Tyr Leu Gly Ser Asn Arg
180 185 190
gcc tcc ggg gtc cct gac agg ttc agt ggc agt gga tca ggc aca gat 624
Ala Ser Gly Val Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp
195 200 205
ttt aca ctg aaa atc agc aga gtg gag gct gag gat gtt ggg gtt tat 672
Phe Thr Leu Lys Ile Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr
210 215 220
tac tgc atg caa gct cta caa act ccc ctc act ttc ggc gga ggg acc 720
Tyr Cys Met Gln Ala Leu Gln Thr Pro Leu Thr Phe Gly Gly Gly Thr
225 230 235 240
aag gtg gag atc aaa cgt 738
Lys yal Glu Ile Lys Arg
245
<210>219
<211>246
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>219
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ile Tyr
20 25 30
Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ser Ala Ile Ser Ser Ser Gly Asp Ser Thr Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Arg Asn Thr Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ala Tyr Gly Tyr Thr Phe Asp Pro Trp Gly Gln Gly Thr Leu
100 105 110
Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly Thr Gly Ser Gly
115 120 125
Thr Gly Gly Ser Thr Glu Ile Val Leu Thr Gln Ser Pro Leu Ser Leu
130 135 140
Pro Val Thr Pro Gly Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln
145 150 155 160
Ser Leu Leu Gis Ser Asn Gly Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln
165 170 175
Lys Pro Gly Gln Ser Pro Gln Leu Leu Ile Tyr Leu Gly Ser Asn Arg
180 185 190
Ala Ser Gly Val Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp
195 200 205
Phe Thr Leu Lys Ile Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr
210 215 220
Tyr Cys Met Gln Ala Leu Gln Thr Pro Leu Thr Phe Gly Gly Gly Thr
225 230 235 240
Lys Val Glu Ile Lys Arg
245
<210>220
<211>738
<212>DNA
<213>Artificial
<220>
<223>SC06-327
<220>
<221>CDS
<222>(1)..(738)
<400>220
gag gtg cag ctg gtg gag acc ggg gct gag gtg aag agg cct ggg tcc 48
Glu Val Gln Leu Val Glu Thr Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 13
tcg gtg aag gtc tcc tgc aag gcc tct gga ggc acc ttc agg acc cat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Arg Thr Gis
20 25 30
gct atc agt tgg gtg cga cag gcc cct gga caa ggg ctt gag tgg atg 144
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga ggg atc atc gct atc ttc gga aca gca aac tac gca cag aag ttc 192
Gly Gly Ile Ile Ala Ile Phe Gly Thr Ala Asn Tyr Ala Gln Lys Phe
50 55 60
cag ggc aga atc acg att acc gcg gac gaa tcc acg agt aca gcc tac 240
Gln Gly Arg Ile Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr
65 70 75 80
atg gag ctg agc agc ctg aga tct gag gac acg gcc gtg tat ttc tgt 288
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Phe Cys
85 90 95
gcg aga ggc agt ggt tat cat ata tcg aca ccc ttt gac aac tgg ggc 336
Ala Arg Gly Ser Gly Tyr His Ile Ser Thr Pro Phe Asp Asn Trp Gly
100 105 110
cag gga acc ctg gtc acc gtc tcg agc ggt acg ggc ggt tca ggc gga 384
Gln Gly Thr Leu Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly
115 120 125
acc ggc agc ggc act ggc ggg tcg acg tcc tat gtg ctg act cag cca 432
Vhr Gly Ser Gly Thr Gly Gly Ser Thr Ser Tyr Val Leu Thr Gln Pro
130 135 140
ccc tcg gtg tca gtg gcc cca gga cag acg gcc agg att acc tgt ggg 480
Pro Ser Val Ser Val Ala Pro Gly Gln Thr Ala Arg Ile Thr Cys Gly
145 150 155 160
gga aac aac att gga agt aaa ggt gtg cac tgg tac cag cag aag cct 528
Gly Asn Asn Ile Gly Ser Lys Gly Val Gis Trp Tyr Gln Gln Lys Pro
165 170 175
ggc cag gcc cct gtg ctg gtc gtc tat gat gat agc gac cgg ccc tca 576
Gly Gln Ala Pro Val Leu Val Val Tyr Asp Asp Ser Asp Arg Pro Ser
180 185 190
ggg atc cct gag cga ttc tct ggc tcc aac tct ggg aac acg gcc acc 624
Gly Ile Pro Glu Arg Phe Ser Gly Ser Asn Ser Gly Asn Thr Ala Thr
195 200 205
ctg acc atc agc agg gtc gaa gcc ggg gat gag gcc gac tat tac tgt 672
Leu Thr Ile Ser Arg Val Glu Ala Gly Asp Glu Ala Asp lyr Tyr Cys
210 215 220
cag gtg tgg gat agt agt agt gat cat gtg gta ttc ggc gga ggg acc 720
Gln Val Trp Asp Ser Ser Ser Asp Gis Val Val Phe Gly Gly Gly Thr
225 230 235 240
aag ctg acc gtc cta ggt 738
Lys Leu Thr Val Leu Gly
245
<210>221
<211>246
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>221
Glu Val Gln Leu Val Glu Thr Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Arg Thr His
20 25 30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Gly Ile Ile Ala Ile Phe Gly Thr Ala Asn Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Ile Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Phe Cys
85 90 95
Ala Arg Gly Ser Gly Tyr His Ile Ser Thr Pro Phe Asp Asn Trp Gly
100 105 110
Gln Gly Thr Leu Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly
115 120 125
Thr Gly Ser Gly Thr Gly Gly Ser Thr Ser Tyr Val Leu Thr Gln Pro
130 135 140
Pro Ser Val Ser Val Ala Pro Gly Gln Thr Ala Arg Ile Thr Cys Gly
145 150 155 160
Gly Asn Asn Ile Gly Ser Lys Gly Val His Trp Tyr Gln Gln Lys Pro
165 170 175
Gly Gln Ala Pro Val Leu Val Val Tyr Asp Asp Ser Asp Arg Pro Ser
180 185 190
Gly Ile Pro Glu Arg Phe Ser Gly Ser Asn Ser Gly Asn Thr Ala Thr
195 200 205
Leu Thr Ile Ser Arg Val Glu Ala Gly Asp Glu Ala Asp Tyr Tyr Cys
210 215 220
Gln Val Trp Asp Ser Ser Ser Asp His Val Val Phe Gly Gly Gly Thr
225 230 235 240
Lys Leu Thr Val Leu Gly
245
<210>222
<211>756
<212>DNA
<213>Artificial
<220>
<223>SC06-328
<220>
<221>CDS
<222>(1)..(756)
<400>222
gag grg cag ctg gtg gag tct ggg gct gag gtg aag aag cct ggg tcc 48
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aag gtc tcc tgc aag gct tct gga cae atc ttc agc ggc tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly His Ile Phe Ser Gly Tyr
20 25 30
gca atc agt tgg gtg cga cag gcc cct gga caa ggg ctt gag tgg atg 144
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga ggg atc atc cct atc ttt ggt aca aca aac tac gca cag aag ttc 192
Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Ash Tyr Ala Gln Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac caa tcc acg agc aca gcc tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Gln Ser Thr Ser Thr Ala Tyr
65 70 75 80
atg gac ctg agc aac ttg aga tct gag gac acg gcc gtc tat tac tgt 288
Met Asp Leu Ser Asn Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
gcg aga gtg aaa gat gga tat tgt act ctt acc agc tgc cct gtc ggc 336
Ala Arg Val Lys Asp Gly Tyr Cys Thr Leu Thr Ser Cys Pro Val Gly
100 105 110
tgg tac ttc gat ctc tgg ggc cgt ggc acc ctg gtc act gtc tcg agc 384
Trp Tyr Phe Asp Leu Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser
115 120 125
ggt acg ggc ggt tca ggc gga acc ggc agc ggc act ggc ggg tcg acg 432
Gly Thr Gly Gly Ser Gly Gly Thr Gly Ser Gly Thr Gly Gly Ser Thr
130 135 140
gaa att gtg atg acg cag tct cca ggc acc ctg tct ttg tct cca ggg 480
Glu Ile Val Met Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly
145 150 155 160
gaa aga gcc acc ctc tcg tgc agg gcc agt cag agt gtt agc agc agc 528
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser
165 170 175
tac tta gcc tgg tac cag cag aaa cct ggc cag gct ccc agg ctc ctc 576
Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu
180 185 190
atc ttt ggt gcc tcc agc agg gcc act ggc atc cca gac agg ttc agt 624
Ile Phe Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser
195 200 205
ggc agt ggg tct ggg aca gac ttc act ctc acc atc agc aga ctg gag 672
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu
210 215 220
cct gaa gat ttt gca gtg tat tac tgt cag cag tat ggt agc tca ctc 720
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Leu
225 230 235 240
act ttc ggc gga ggg acc aag ctg gag atc aaa cgt 756
Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys Arg
245 250
<210>223
<211>252
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>223
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly His Ile Phe Ser Gly Tyr
20 25 30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Asn Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Gln Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Asp Leu Ser Asn Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Val Lys Asp Gly Tyr Cys Thr Leu Thr Ser Cys Pro Val Gly
100 105 110
Trp Tyr Phe Asp Leu Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser
115 120 125
Gly Thr Gly Gly Ser Gly Gly Thr Gly Ser Gly Thr Gly Gly Ser Thr
130 135 140
Glu Ile Val Met Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly
145 150 155 160
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser
165 170 175
Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu
180 185 190
Ile Phe Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser
195 200 205
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu
210 215 220
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Leu
225 230 235 240
Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys Arg
245 250
<210>224
<211>738
<212>DNA
<213>Artificial
<220>
<223>SC06-329
<220>
<221>CDS
<222>(1)..(738)
<400>224
gag gtc cag ctg gta cag tct ggg gct gag gtt aag aag cct ggg tcc 48
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aag gtc tcc tgc aag gct tct gga ggc atc ttc aga agc aat 96
Ser yal Lys Val Ser Cys Lys Ala Ser Gly Gly Ile Pne Arg Ser Asn
20 25 30
tct atc agt tgg gtg cga cag gcc cct ggg caa ggg ctt gag tgg atg 144
Ser Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga ggg atc ttc gct ctt ttc gga aca aca gac tac gcg cag aag ttc 192
Gly Gly Ile Phe Ala Leu Phe Gly Thr Thr Asp Tyr Ala Gln Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac gaa tct tcg acc aca gtc tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Ser Thr Thr Val Tyr
65 70 75 80
ctg gag ctg agt agc ctg aca tct gag gac acg gcc gtt tat tac tgt 288
Leu Glu Leu Ser Ser Leu Thr Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
gcg aga ggc agt ggc tac acc aca cgc aac tac ttt gac tac tgg ggc 336
Ala Arg Gly Ser Gly Tyr Thr Thr Arg Asn Tyr Phe Asp Tyr Trp Gly
100 105 110
cag ggc acc ctg gtc acc gtc tcg agc ggt acg ggc ggt tca ggc gga 384
Gln Gly Thr Leu Val Tnr Val Ser Ser Gly Tnr Gly Gly Ser Gly Gly
115 120 125
acc ggc agc ggc act ggc ggg tcg acg gaa att gtg ctg act cag tct 432
Thr Gly Ser Gly Thr Gly Gly Ser Thr Glu Ile Val Leu Thr Gln Ser
130 135 140
cca ggc acc ctg tct ttg tct cca ggg gaa aga gcc aca ctc tcc tgc 480
Pro Gly Thr Leu Ser Leu Ser Pro Gly Glu Arg Ala Thr Leu Ser Cys
145 150 155 160
agg gcc agt cag agt gtt agc agc aac tac tta ggc tgg tac cag cag 528
Arg Ala Ser Gln Ser Val Ser Ser Asn Tyr Leu Gly Trp Tyr Gln Gln
165 170 175
aaa cct ggc cag gct ccc agg ctc ctg atc tat ggt gca tcc agc agg 576
Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile Tyr Gly Ala Ser Ser Arg
180 185 190
gcc agt ggc arc cca gac agg ttc agt ggc ggt ggg tct ggg aca gac 624
Ala Ser Gly Ile Pro Asp Arg Phe Ser Gly Gly Gly Ser Gly Thr Asp
195 200 205
ttc act ctc acc arc agc aga ctg gag cct gaa gat ttt gca gtg tat 672
Phe Thr Leu Thr Ile Ser Arg Leu Glu Pro Glu Asp Phe Ala Val Tyr
210 215 220
tac tgt cag cag tat ggt agc tca ccc ctc act ttc ggc gga ggg acc 720
Tyr Cys Gln Gln Tyr Gly Ser Ser Pro Leu Thr Phe Gly Gly Gly Thr
225 230 235 240
aag gtg gag arc aaa cgt 738
Lys Val Glu Ile Lys Arg
245
<210>225
<211>246
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>225
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Ile Phe Arg Ser Asn
20 25 30
Ser Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Gly Ile Phe Ala Leu Phe Gly Thr Thr Asp Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Ser Thr Thr Val Tyr
65 70 75 80
Leu Glu Leu Ser Ser Leu Thr Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Ser Gly Tyr Thr Thr Arg Asn Tyr Phe Asp Tyr Trp Gly
100 105 110
Gln Gly Thr Leu Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly
115 120 125
Thr Gly Ser Gly Thr Gly Gly Ser Thr Glu Ile Val Leu Thr Gln Ser
130 135 140
Pro Gly Thr Leu Ser Leu Ser Pro Gly Glu Arg Ala Thr Leu Ser Cys
145 150 155 160
Arg Ala Ser Gln Ser Val Ser Ser Asn Tyr Leu Gly Trp Tyr Gln Gln
165 170 175
Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile Tyr Gly Ala Ser Ser Arg
180 185 190
Ala Ser Gly Ile Pro Asp Arg Phe Ser Gly Gly Gly Ser Gly Thr Asn
195 200 205
Phe Thr Leu Thr Ile Ser Arg Leu Glu Pro Glu Asp Phe Ala Val Tyr
210 215 220
Tyr Cys Gln Gln Tyr Gly Ser Ser Pro Leu Thr Phe Gly Gly Gly Thr
225 230 235 240
Lys Val Glu Ile Lys Arg
245
<210>226
<211>729
<212>DNA
<213>Artificial
<220>
<223>SC06-332
<220>
<221>CDS
<222>(1)..(729)
<400>226
cag gtg cag ctg gtg cag tct ggg gct gag gtg aag aag cct ggg tcc 48
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gta aag gtc tcc tgc aag gct tct gga ggc ccc ttc cgc aat ttt 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Arg Asn Phe
20 25 30
gct atc aac tgg gtg cga cag gcc cct gga caa ggg ctt gag tgg atg 144
Ala Ile Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga ggg atc atc gct gtc ttt ggg acg aca aag tac gca cat aag ttc 192
Gly Gly Ile Ile Ala Val Phe Gly Thr Thr Lys Tyr Ala His Lys Phe
50 55 60
cag ggc aga gtc acc atc acc gcg gac gac tcc aca aat aca gct tac 240
Gln Gly Arg Val Thr Ile T hr Ala Asp Asp Ser Thr Asn Thr Ala Tyr
65 70 75 80
atg gag ctg ggc agc ctg aaa tct gag gac acg gcc gtg tat tac tgt 288
Met Glu Leu Gly Ser Leu Lys Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
gcg aga ggt ccc cac tac tac tcc tcc tac atg gac gtc tgg ggc gaa 336
Ala Arg Gly Pro Gis Tyr Tyr Ser Ser Tyr Met Asp Val Trp Gly Glu
100 105 110
ggg acc acg gtc acc gtc tcg agc ggt acg ggc ggt tca ggc gga acc 384
Gly Thr Thr Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly Thr
1l5 120 125
ggc agc ggc act ggc ggg tcg acg gac atc cag ttg acc cag tct cca 432
Gly Ser Gly Thr Gly Gly Ser Thr Asp Ile Gln Leu Thr Gln Ser Pro
130 135 140
tcc tcc ctg tct gca tct gta gga gac aga gtc acc atc act tgc cgg 480
Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg
145 150 155 160
gcg agt cag ggc att agc act tat tta gcc tgg tat cag cag aaa ccc 528
Ala Ser Gln Gly Ile Ser Thr Tyr Leu Ala Trp Tyr Gln Gln Lys Pro
165 170 175
ggg aaa gtt cct aaa ctc ctg atc tat gct gca tcc act ttg caa tca 576
Gly Lys Val Pro Lys Leu Leu Ile Tyr Ala Ala Ser Thr Leu Gln Ser
180 185 190
ggg gtc cca tct cgg ttc agt ggc agt gga tct ggg aca gat ttc act 624
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr
195 200 205
ctc acc atc agc agc ctg cag cct gaa gat gtt gca act tat tac tgt 672
Leu Thr Ile Ser Ser Leu Glnn Pro Glu Asp ValAla Thr Tyr Tyr Cys
210 215 220
caa aag tat aac agt gcc cct tct ttc ggc cct ggg acc aaa gtg gat 720
Gln Lys Tyr Asn Ser Ala Pro Ser Phe Gly Pro Gly Thr Lys Val Asp
225 230 235 240
atc aaa cgt 729
Ile Lys Arg
<210>227
<211>243
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>227
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Arg Ash Phe
20 25 30
Ala Ile Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Gly Ile Ile Ala Val Phe Gly Thr Thr Lys Tyr Ala His Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Asp Ser Thr Asn Thr Ala Tyr
65 70 75 80
Met Glu Leu Gly Ser Leu Lys Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Pro His Tyr Tyr Ser Ser Tyr Met Asp Val Trp Gly Glu
100 105 110
Gly Thr Thr Val Thr Val Ser Ser Gly Thr Gly GIy Ser GIy Gly Thr
115 120 125
Gly Ser Gly Thr Gly Gly Ser Thr Asp Ile Gln Leu Thr Gln Ser Pro
130 135 140
Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg
145 150 155 160
Ala Ser Gln Gly Ile Ser Thr Tyr Leu Ala Trp Tyr Gln Gln Lys Pro
165 170 175
Gly Lys Val Pro Lys Leu Leu Ile Tyr Ala Ala Ser Thr Leu Gln Ser
180 185 190
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr
195 200 205
Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Val Ala Thr Tyr Tyr Cys
210 215 220
Gln Lys Tyr Asn Ser Ala Pro Ser Phe Gly Pro Gly Thr Lys Val Asp
225 230 235 240
Ile Lys Arg
<210>228
<211>735
<212>DNA
<213>Artificial
<220>
<223>SC06-334
<220>
<221>CDS
<222>(1)..(735)
<400>228
gag gtg cag ctg gtg gag act ggg gct gag gtg aag aag cct ggg tcc 48
Glu Val Gln Leu Val Glu Thr Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aag gtc ccc tgc aaa tct tct gga agc ccc ttc agg agt aat 96
Ser Val Lys Val Pro Cys Lys Ser Ser Gly Ser Pro Phe Arg Ser Asn
20 25 30
gct gtc agc tgg gtg cga cag gcc ccc gga caa ggg ctt gag tgg gtg 144
Ala Val Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Val
35 40 45
gga gga atc ctc ggt gtc ttt ggt tca cca agc tac gca cag aag ttc 192
Gly Gly Ile LeuGly Val Phe Gly Ser Pro Ser Tyr Ala Gln Lys PGe
50 55 60
cag ggc aga gtc acg att acc gcg gac gaa tcc acc aac aca gtc cac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Asn Thr Val His
65 70 75 80
atg gag ctg aga ggt ttg aga tct gag gac acg gcc gtg tat tat tgt 288
Met Glu Leu Arg Gly Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
gcg aga ggt cct acc tac tac tac tcc tac atg gac gtc tgg ggc aaa 336
Ala Arg Gly Pro Thr Tyr Tyr Tyr Ser Tyr Met Asp Val Trp Gly Lys
100 105 110
ggg acc acg gtc acc gtc tcg agc ggt acg ggc ggt tca ggc gga acc 384
Gly Tnr Thr Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly Thr
115 120 125
ggc agc ggc act ggc ggg tcg acg tcc tat gtg ctg act cag cca ccc 432
Gly Ser Gly Tnr Gly Gly Ser Tnr Ser Tyr Val Leu Tnr Gln Pro Pro
130 135 140
tcg gag tca gtg gcc cca gga cag acg gcc agg att acc tgt ggg gga 480
Ser Glu Ser Val Ala Pro Gly Gln Thr Ala Arg Ile Thr Cys Gly Gly
145 150 155 160
aat aac att gga aga aat agt gtg cac tgg tat cag cag aag cca ggc 528
Ash Asn Ile Gly Arg Asn Ser Val His Trp Tyr Gln Gln Lys Pro Gly
165 170 175
cag gcc cct gtg ctg gtc gtg tat gat gat agc gac cgg ccc tca ggg 576
Gln Ala Pro Val Leu Val Val Tyr Asp Asp Ser Asp Arg Pro Ser Gly
180 185 190
atc cct gag cga ttt tct ggc tcc aag tct ggg aac acg gcc acc ctg 624
Ile Pro Glu Arg Phe Ser Gly Ser Lys Ser Gly Asn Thr Ala Thr Leu
195 200 205
att atc agc agg gtc gaa gtc ggg gat gag gcc gac tac tac tgt cag 672
Ile Ile Ser Arg Val Glu Val Gly Asp Glu Ala Asp Tyr Tyr Cys Gln
210 215 220
gtg tgg cat agt agt agt gat cat tat gtc ttc gga act ggg acc aag 720
Val Trp Gis Ser Ser Ser Asp His Tyr Val Phe Gly Thr Gly Thr Lys
225 230 235 240
gtc acc gtc cta ggt 735
Val Thr Val Leu Gly
245
<210>229
<211>245
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>229
Glu Val Gln Leu Val Glu Thr Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Pro Cys Lys Ser Ser Gly Ser Pro Phe Arg Ser Asn
20 25 30
Ala Val Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Val
35 40 45
Gly Gly Ile Leu Gly Val Phe Gly Ser Pro Ser Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Asn Thr Val His
65 70 75 80
Met Glu Leu Arg Gly Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Pro Thr Tyr Tyr Tyr Ser Tyr Met Asp Val Trp Gly Lys
100 105 110
Gly Thr Thr Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly Thr
115 120 125
Gly Ser Gly Thr Gly Gly Ser Thr Ser Tyr Val Leu Thr Gln Pro Pro
130 135 140
Ser Glu Ser Val Ala Pro Gly Gln Thr Ala Arg Ile Thr Cys Gly Gly
145 150 155 160
Asn Asn Ile Gly Arg Asn Ser Val His Trp Tyr Gln Gln Lys Pro Gly
165 170 175
Gln Ala Pro Val Leu Val Val Tyr Asp Asp Ser Asp Arg Pro Ser Gly
180 185 190
Ile Pro Glu Arg Phe Ser Gly Ser Lys Ser Gly Asn Thr Ala Thr Leu
195 200 205
Ile Ile Ser Arg Val Glu Val Gly Asp Glu Ala Asp Tyr Tyr Cys Gln
210 215 220
Val Trp His Ser Ser Ser Asp His Tyr Val Phe Gly Thr Gly Thr Lys
225 230 235 240
Val Thr Val Leu Gly
245
<210>230
<211>735
<212>DNA
<213>Artificial
<220>
<223>SC06-336
<220>
<221>CDS
<222>(1)..(735)
<400>230
cag atg cag ctg gta caa tct gga gct gag gtg aag aag cct ggg tcc 48
Gln Met Gln Leu Val Gln Ser Gly Ala Gln Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aag gtc tcc tgc aag gct tct gga ggc acc ttc agc agc tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr
20 25 30
gct atc agc tgg gtg cga cag gcc cct gga caa ggg ctt gag tgg atg 144
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga ggg atc ttc ggt atg ttt ggg aca gca aac tac gcg cag aag ttc 192
Gly Gly Ile Phe Gly Met Phe Gly Thr Ala Asn Tyr Ala Gln Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac gaa ttc acg agc gcg gcc tac 240
Gln Gly Argg Val Thr Ile Thr Ala Asp Glu Phe Thr Ser Ala Ala Tyr
65 70 75 80
atg gag ctg agc agc ctg gga tct gag gac acg gcc atg tat tac tgt 288
Met Glu Leu Ser Ser Leu Gly Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
gcg agg tct agt ggt tat tac ccc caa tac ttc cag gac tgg ggc cag 336
Ala Arg Ser Ser Gly Tyr Tyr Pro Gln Tyr Phe Gln Asp Trp Gly Gln
100 105 110
ggc acc ctg gtc acc gtc tcg agc ggt acg ggc ggt tca ggc gga acc 384
Gly Thr Leu Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly Thr
115 120 125
ggc agc ggc act ggc ggg tcg acg gaa att gtg atg aca cag tct cca 432
Gly Ser Gly Thr Gly Gly Ser Thr Glu Ile Val Met Thr Gln Ser Pro
130 135 140
ggc acc ctg tct ttg tct cca ggg caa aga gcc acc ctc tcc tgc agg 480
Gly Thr Leu Ser Leu Ser Pro Gly Gln Arg Ala Thr Leu Ser Cys Arg
145 150 155 160
gcc agt cag agt gtt agc agc agc tac tta gcc tgg tac cag cag aaa 528
Ala Ser Gln Ser Val Ser Ser Ser Tyr Leu Ala Trp Tyr Gln Gln Lys
165 170 175
cct ggc cag gct ccc aga ctc ctc atg tat ggt gca tcc agc agg gcc 576
Pro Gly Gln Ala Pro Arg Leu Leu Met Tyr Gly Ala Ser Ser Arg Ala
180 185 190
act ggc atc cca gac agg ttc agt ggc agt ggg tct ggg aca gac ttc 624
Thr Gly Ile Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe
195 200 205
act ctc acc atc agc aga ctg gag cct gaa gat ttt gca gtg tat tac 672
Thr Leu Thr Ile Ser Arg Leu Glu Pro Glu Asp Phe Ala Val Tvr Tvr
210 215 220
tgt cag cag tat ggt agc tca tcg ctc act ttc ggc gga ggg acc aag 720
Cys Gln Gln Tyr Gly Ser Ser Ser Leu Thr Phe Gly Gly Gly Thr Lys
225 230 235 240
ctg gag atc aaa cgt 735
Leu Glu Ile Lys Arg
245
<210>231
<211>245
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>231
Gln Met Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr
20 25 30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Gly Ile Phe Gly Met Phe Gly Thr Ala Asn Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Phe Thr Ser Ala Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Gly Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Arg Ser Ser Gly Tyr Tyr Pro Gln Tyr Phe Gln Asp Trp Gly Gln
100 105 110
Gly Thr Leu Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly Thr
115 120 125
Gly Ser Gly Thr Gly Gly Ser Thr Glu Ile Val Met Thr Gln Ser Pro
130 135 140
Gly Thr Leu Ser Leu Ser Pro Gly Gln Arg Ala Thr Leu Ser Cys Arg
145 150 155 160
Ala Ser Gln Ser Val Ser Ser Ser Tyr Leu Ala Trn Tyr Gln Gln Lys
165 170 175
Pro Gly Gln Ala Pro Arg Leu Leu Met Tyr Gly Ala Ser Ser Arg Ala
180 185 190
Thr Gly Ile Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe
195 200 205
Thr Leu Thr Ile Ser Arg Leu Glu Pro Glu Asp Phe Ala Val Tyr Tyr
210 215 220
Cys Gln Gln Tyr Gly Ser Ser Ser Leu Thr Phe Gly Gly Gly Thr Lys
225 230 235 240
Leu Glu Ile Lys Arg
245
<210>232
<211>738
<212>DNA
<213>Artificial
<220>
<223>SC06-339
<220>
<221>CDS
<222>(1)..(738)
<400>232
gag gtg cag ctg gtg gag tcc ggg gct gag gtg aag aag cct ggg tcc 48
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aag gtc tcc tgc aag gct tct gga ggc atc ttc aac agt tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Ile Phe Asn Ser Tyr
20 25 30
gct atc agc tgg gtg cga cag gcc cct gga caa ggg ctt gag tgg atg 144
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga ggc atc atc gct atc ttt cat aca cca aag tac gca cag aag ttc 192
Gly Gly Ile Ile Ala Ile Phe His Thr Pro Lys Tyr Ala Gln Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac gaa tcc acg aac aca gcc tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Asn Thr Ala Tyr
65 70 75 80
atg gaa ctg aga agc ctg aaa tct gag gac acg gcc ctg tat tac tgt 288
Met Glu Leu Arg Ser Leu Lys Ser Glu Asp Thr Ala Leu Tyr Tyr Cys
85 90 95
gcg aga ggg tcc act tac gat ttt tcg agt ggc ctt gac tac tgg ggc 336
Ala Arg Gly Ser Thr Tyr Asp Phe Ser Ser Gly Leu Asp Tyr Trp Gly
100 105 110
cag gga acc ctg gtc acc gtc tcg agc ggt acg ggc ggt tca ggc gga 384
Gln Gly Thr Leu Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly
115 120 125
acc ggc agc ggc act ggc ggg tcg acg cag gca ggg ctg act cag cca 432
Thr Gly Ser Gly Thr Gly Gly Ser Thr Gln Ala Gly Leu Thr Gln Pro
130 135 140
ccc tcg gtg tca gtg gcc cca gga cag acg gcc agg att acc tgt ggg 480
Pro Ser Val Ser Val Ala Pro Gly Gln Thr Ala Arg Ile Thr Cys Gly
145 150 155 160
gga aac aac att gga agt aaa agt gtg cac tgg tac cag cag aag cca 528
Gly Asn Asn Ile Gly Ser Lys Ser Val His Trp Tyr Gln Gln Lys Pro
165 170 175
ggc cag gcc cct gtc cta gtc gtc tat gat gat agc gac cgg ccc tca 576
Gly Gln Ala Pro Val Leu Val Val Tyr Asp Asp Ser Asp Arg Pro Ser
180 185 190
ggg atc cct gag cga ttc tct ggc tcc aac tct ggg aac acg gcc acc 624
Gly Ile Pro Glu Arg Phe Ser Gly Ser Asn Ser Gly Asn Thr Ala Thr
195 200 205
ctg acc atc agc agg gtc gaa gcc ggg gat gag gcc gac tat tac tgt 672
Leu Thr Ile Ser Arg Val Glu Ala Gly Asp Glu Ala Asp Tyr Tyr Cys
210 215 220
cag gtg tgg gat agt agt agt gat cat gtg gta ttc ggc gga ggg acc 720
Gln Val Trp Asp Ser Ser Ser Asp Gis Val Val Phe Gly Gly Gly Thr
225 230 235 240
aag ctg acc gtc cta ggt 738
Lys Leu Thr Val Leu Gly
245
<210>233
<211>246
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>233
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Ile Phe Asn Ser Tyr
20 25 30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Gly Ile Ile Ala Ile Phe Gis Thr Pro Lys Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Asn Thr Ala Tyr
65 70 75 80
Met Glu Leu Arg Ser Leu Lys Ser Glu Asp Thr Ala Leu Tyr Tyr Cys
85 90 95
Ala Arg Gly Ser Thr Tyr Asp Phe Ser Ser Gly Leu Asp Tyr Trp Gly
100 105 110
Gln Gly Thr Leu Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly
115 120 125
Thr Gly Ser Gly Thr Gly Gly Ser Thr Gln Ala Gly Leu Thr Gln Pro
130 135 140
Pro Ser Val Ser Val Ala Pro Gly Gln Thr Ala Arg Ile Thr Cys Gly
145 150 155 160
Gly Ash Asn Ile Gly Ser Lys Ser Val His Trp Tyr Gln Gln Lys Pro
165 170 175
Gly Gln Ala Pro Val Leu Val Val Tyr Asp Asp Ser Asp Arg Pro Ser
180 185 190
Gly Ile Pro Glu Arg Phe Ser Gly Ser Asn Ser Gly Asn Thr Ala Thr
195 200 205
Leu Thr Ile Ser Arg Val Glu Ala Gly Asp Glu Ala Asp Tyr Tyr Cys
210 215 220
Gln Val Trp Asp Ser Ser Ser Asp Gis Val Val Phe Gly Gly Gly Thr
225 230 235 240
Lys Leu Thr Val Leu Gly
245
<210>234
<211>768
<212>DNA
<213>Artificial
<220>
<223>SC06-342
<220>
<221>CDS
<222>(1)..(768)
<400>234
cag gtc cag ctg gtg cag tct ggg gct gag gtg aag aag cct ggg tcc 48
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aag gtc tcc tgc aag gct tct gga ggc ttc ttc agc agc tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Phe Phe Ser Ser Tyr
20 25 30
gct atc agc tgg gtg cgc cag gcc cct gga caa gga ctt gag tgg atg 144
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
ggg ggg gtc atc cct atc ttt cgt aca gca aac tac gca cag aac ttc 192
Gly Gly Val Ile Pro Ile Phe Arg Thr Ala Asn Tyr Ala Gln Asn Phe
50 55 60
cag ggc aga gtc acc att acc gcg gac gaa ttc aca tcg tat atg gag 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Phe Thr Ser Tyr Met Glu
65 70 75 80
ctg agc agc ctg aga tct gac gac acg gcc gtg tat tac tgt gcg agg 288
Leu Ser Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys Ala Arg
85 90 95
ttg aat tac cat gat tcg ggg act tat tat aac gcc ccc cgg ggc tgg 336
Leu Asn Tyr Gis Asp Ser Gly Thr Tyr Tyr Asn Ala Pro Arg Gly Trp
100 105 110
ttc gac ccc tgg ggc cag gga acc ctg gtc acc gtc tcg agc ggt acg 384
Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Thr
115 120 125
ggc ggt tca ggc gga acc ggc agc ggc act ggc ggg tcg acg gac atc 432
Gly Gly Ser Gly Gly Thr Gly Ser Gly Thr Gly Gly Ser Thr Asp Ile
130 135 140
cag atg acc cag tct cca gac tcc ctg gct gtg tct ctg ggc gag aag 480
Gln Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly Glu Lys
145 150 155 160
gcc acc atc aac tgc aag tcc agc cag agt att tta aac agc tcc aac 528
Ala Thr lle Asn Cys Lys Ser Ser Gln Ser Ile Leu Asn Ser Ser Asn
165 170 175
aat aag aac tac tta gct tgg tac cag cag aaa cca gga cag cct cct 576
Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Pro Pro
180 185 190
aag ctg ctc att tac tgg gca tct acc cgg gaa tcc ggg gtc cct gac 624
Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val Pro Asp
195 200 205
cga ttc agt ggc agc ggg tct ggg aca gat ttc act ctc acc atc agc 672
Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser
210 215 220
agc ctg cag gct gaa gat gtg gca gtt tat tac tgt cag caa tat tat 720
Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln Tyr Tyr
225 230 235 240
agt agt ccg ccg acg ttc ggc caa ggg acc aag gtg gaa atc aaa cgt 768
Ser Ser Pro Pro Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg
245 250 255
<210>235
<211>256
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>235
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Phe Phe Ser Ser Tyr
20 25 30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Gly Val Ile Pro Ile Phe Arg Thr Ala Asn Tyr Ala Gln Asn Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Phe Thr Ser Tyr Met Glu
65 70 75 80
Leu Ser Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys Ala Arg
85 90 95
Leu Asn Tyr His Asp Ser Gly Thr Tyr Tyr Asn Ala Pro Arg Gly Trp
100 105 110
Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Gly Thr
115 120 125
Gly Gly Ser Gly Gly Thr Gly Ser Gly Thr Gly Gly Ser Thr Asp Ile
130 135 140
Gln Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly Glu Lys
145 150 155 160
Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Ile Leu Asn Ser Ser Asn
165 170 175
Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Pro Pro
180 185 190
Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val Pro Asp
195 200 205
Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser
210 215 220
Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln Tyr Tyr
225 230 235 240
Ser Ser Pro Pro Thr Phe Gly Gln Gly Thr Lys ValGlu Ile Lys Arg
245 250 255
<210>236
<211>735
<212>DNA
<213>Artificial
<220>
<223>SC06-343
<220>
<221>CDS
<222>(1)..(735)
<400>236
cag gtc cag ctg gtg cag tct gga gct gag gtg aag aag cct ggg tcc 48
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aag gtc tcc tgc aag gct tct gga gtc acc ttc agt tac tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Val Thr Phe Ser Tyr Tyr
20 25 30
gct atg agc tgg gtg cga cag gcc cct gga caa ggg ctt gag tgg atg 144
Ala Met Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga gga atc agc cct atg ttt ggg aca aca acc tac gca cag aag ttc 192
Gly Gly Ile Ser Pro Met Phe Gly Thr Thr Thr Tyr Ala Gln Lys Phe
50 55 60
cag ggc aga gtc acg att act gcg gac gac tcc acg agt aca gcc tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Asp Ser Thr Ser Thr Ala Tyr
65 70 75 80
atg gag gtg agg agc ctg aga tct gag gac acg gcc gtg tat tac tgt 288
Met Glu Val Arg Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
gcg aga tct tcg aat tac tat gat agt gta tat gac tac tgg ggc cag 336
Ala Arg Ser Ser Asn Tyr Tyr Asp Ser Val Tyr Asp Tyr Trp Gly Gln
100 105 110
gga acc ctg gtc acc gtc tcg agc ggt acg ggc ggt tca ggc gga acc 384
Gly Thr Leu Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly Thr
115 120 125
ggc agc ggc act ggc ggg tcg acg cag tct gtc gtg acg cag ccg ccc 432
Gly Ser Gly Thr Gly Gly Ser Thr Gln Ser Val Val Thr Gln Pro Pro
130 135 140
tcg gag tca gtg gcc cca gga cag acg gcc agg att acc tgt ggg gga 480
Ser Glu Ser Val Ala Pro Gly Gln Thr Ala Arg Ile Thr Cys Gly Gly
145 150 155 160
cat aac att gga agt aat agt gtg cac tgg tac cag cag aag cca ggc 528
Gis Asn Ile Gly Ser Asn Ser Val His Trp Tyr Gln Gln Lys Pro Gly
165 170 175
cag gcc cct gtg ctg gtc gtg tat gat aat agc gac cgg ccc tca ggg 576
Gln Ala Pro Val Leu Val Val Tyr Asp Asn Ser Asp Arg Pro Ser Gly
180 185 190
atc cct gag cga ttc tct ggc tcc aac tct ggg aac acg gcc acc ctg 624
Ile Pro Glu Arg Phe Ser Gly Ser Asn Ser Gly Asn Thr Ala Thr Leu
195 200 205
acc atc agc agg gtc gaa gcc ggg gat gag gcc gac tat tac tgt cag 672
Thr Ile Ser Arg Val Glu Ala Gly Asp Glu Ala Asp Tyr Tyr Cys Gln
210 215 220
gtg tgg ggt agt agt agt gac cat tat gtc ttc gga act ggg acc aag 720
Val Trp Gly Ser Ser Ser Asp His Tyr Val Phe Gly Thr Gly Thr Lys
225 230 235 240
gtc acc gtc cta ggt 735
Val Thr Val Leu Gly
245
<210>237
<211>245
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>237
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Val Thr Phe Ser Tyr Tyr
20 25 30
Ala Met Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Gly Ile Ser Pro Met Phe Gly Thr Thr Thr Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Asp Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Val Arg Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ser Ser Asn Tyr Tyr Asp Ser Val Tyr Asp Tyr Trp Gly Gln
100 105 110
Gly Thr Leu Val Thr Val Ser Ser Gly Thr Gly Gly Ser Gly Gly Thr
115 120 125
Gly Ser Gly Thr Gly Gly Ser Thr Gln Ser Val Val Thr Gln Pro Pro
130 135 140
Ser Glu Ser Val Ala Pro Gly Gln Thr Ala Arg Ile Thr Cys Gly Gly
145 150 155 160
His Asn Ile Gly Ser Asn Ser Val His Trp Tyr Gln Gln Lys Pro Gly
165 170 175
Gln Ala Pro Val Leu Val Val Tyr Asp Asn Ser Asp Arg Pro Ser Gly
180 185 190
Ile Pro Glu Arg Phe Ser Gly Ser Asn Ser Gly Asn Thr Ala Thr Leu
195 200 205
Thr Ile Ser Arg Val Glu Ala Gly Asp Glu Ala Asp Tyr Tyr Cys Gln
210 215 220
Val Trp Gly Ser Ser Ser Asp His Tyr Val Phe Gly Thr Gly Thr Lys
225 230 235 240
Val Thr Val Leu Gly
245
<210>238
<211>5
<212>PRT
<213>Homo sapiens
<400>238
Gly Tyr Tyr Val Tyr
1 5
<210>239
<211>17
<212>PRT
<213>Homo sapiens
<400>239
Trp Ile Ser Ala Tyr Asn Gly Asn Thr Asn Tyr Ala Gln Lys Phe Gln
1 5 10 15
Gly
<210>240
<211>6
<212>PRT
<213>Homo sapiens
<400>240
Ser Arg Ser Leu Asp Val
1 5
<210>241
<211>17
<212>PRT
<213>Homo sapiens
<400>241
Lys Ser Ser Gln Ser Val Leu Tyr Ser Ser Asn Asn Lys Asn Tyr Leu
1 5 10 15
Ala
<210>242
<211>7
<212>PRT
<213>Homo sapiens
<400>242
Trp Ala Ser Thr Arg Glu Ser
1 5
<210>243
<211>9
<212>PRT
<213>Homo sapiens
<400>243
Gln Gln Tyr Tyr Ser Thr Pro Leu Thr
1 5
<210>244
<211>5
<212>PRT
<213>Homo sapiens
<400>244
Ser Tyr Ala Ile Thr
1 5
<210>245
<211>17
<212>PRT
<213>Homo sapiens
<400>245
Gly Ile Ile Gly Met Phe Gly Ser Thr Asn Tyr Ala Gln Asn Phe Gln
1 5 10 15
Gly
<210>246
<211>11
<212>PRT
<213>Homo sapiens
<400>246
Ser Thr Gly Tyr Tyr Pro Ala Tyr Leu His His
1 5 10
<210>247
<211>14
<212>PRT
<213>Homo sapiens
<400>247
Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr Asn Tyr Val Ser
1 5 10
<210>248
<211>7
<212>PRT
<213>Homo sapiens
<400>248
Asp Val Ser Lys Arg Pro Ser
1 5
<210>249
<211>10
<212>PRT
<213>Homo sapiens
<400>249
Ser Ser Tyr Thr Ser Ser Ser Thr His Val
1 5 10
<210>250
<211>5
<212>PRT
<213>Homo sapiens
<400>250
Ser Tyr Tyr Met His
1 5
<210>251
<211>17
<212>PRT
<213>Gomo sapiens
<400>251
Trp Ile Asn Pro Asn Ser Gly Gly Thr Asn Tyr Ala Gln Lys Phe Gln
1 5 10 15
Gly
<210>252
<211>12
<212>PRT
<213>Homo sapiens
<400>252
Glu Gly Lys Trp Gly Pro Gln Ala Ala Phe Asp Ile
1 5 10
<210>253
<211>12
<212>PRT
<213>Homo sapiens
<400>253
Arg Ala Ser Gln Ser Val Ser Ser Ser Tyr Leu Ala
1 5 10
<210>254
<211>7
<212>PRT
<213>Homo sapiens
<400>254
Asp Ala Ser Ser Arg Ala Thr
1 5
<210>255
<211>8
<212>PRT
<213>Homo sapiens
<400>255
Hln Gln Tyr Gly Ser Ser Leu Trp
1 5
<210>256
<211>5
<212>PRT
<213>Homo sapiens
<400>256
Ile Tyr Ala Met Ser
1 5
<210>257
<211>17
<212>PRT
<213>Homo sapiens
<400>257
Ala Ile Ser Ser Ser Gly Asp Ser Thr Tyr Tyr Ala Asp Ser Val Lys
1 5 10 15
Gly
<210>258
<211>8
<212>PRT
<213>Homo sapiens
<400>258
Ala Tyr Gly Tyr Thr Phe Asp Pro
1 5
<210>259
<211>16
<212>PRT
<213>Homo sapiens
<400>259
Arg Ser Ser Gln Ser Leu Leu His Ser Asn Gly Tyr Asn Tyr Leu Asp
1 5 10 15
<210>260
<211>7
<212>PRT
<213>Homo sapiens
<400>260
Leu Gly Ser Asn Arg Ala Ser
1 5
<210>261
<211>8
<212>PRT
<213>Homo sapiens
<400>261
Met Gln Ala Leu Gln Thr Pro Leu
1 5
<210>262
<211>5
<212>PRT
<213>Homo sapiens
<400>262
Thr His Ala Ile Ser
1 5
<210>263
<211>17
<212>PRT
<213>Homo sapiens
<400>263
Gly Ile Ile Ala Ile Phe Gly Thr Ala Asn Tyr Ala Gln Lys Phe Gln
1 5 10 15
Gly
<210>264
<211>12
<212>PRT
<213>Homo sapiens
<400>264
Gly Ser Gly Tyr His Ile Ser Thr Pro Phe Asp Asn
1 5 10
<210>265
<211>11
<212>PRT
<213>Homo sapiens
<400>265
Gly Gly Asn Asn Ile Gly Ser Lys Gly Val His
1 5 10
<210>266
<211>7
<212>PRT
<213>Homo sapiens
<400>266
Asp Asp Ser Asp Arg Pro Ser
1 5
<210>267
<211>11
<212>PRT
<213>Homo sapiens
<400>267
Gln Val Trp Asp Ser Ser Ser Asp His Val Val
1 5 10
<210>268
<211>5
<212>PRT
<213>Homo sapiens
<400>268
Gly Tyr Ala Ile Ser
1 5
<210>269
<211>17
<212>PRT
<213>Homo sapiens
<400>269
Gly Ile Ile Pro Ile Phe Gly Thr Thr Asn Tyr Ala Gln Lys Phe Gln
1 5 10 15
Gly
<210>270
<211>19
<212>PRT
<213>Homo sapiens
<400>270
Val Lys Asp Gly Tyr Cys Thr Leu Thr Ser Cys Pro Val Gly Trp Tyr
1 5 10 15
Phe Asp Leu
<210>271
<211>12
<212>PRT
<213>Homo sapiens
<400>271
Arg Ala Ser Gln Ser Val Ser Ser Ser Tyr Leu Ala
1 5 10
<210>272
<211>7
<212>PRT
<213>Homo sapiens
<400>272
Gly Ala Ser Ser Arg Ala Thr
1 5
<210>273
<211>8
<212>PRT
<213>Homo sapiens
<400>273
Gln Gln Tyr Gly Ser Ser Leu Thr
1 5
<210>274
<211>5
<212>PRT
<213>Homo sapiens
<400>274
Ser Asn Ser Ile Ser
1 5
<210>275
<211>17
<212>PRT
<213>Homo sapiens
<400>275
GIy Ile Phe Ala Leu Phe GIy Thr Thr Asp Tyr Ala Gln Lys Phe Gln
1 5 10 15
Gly
<210>276
<211>12
<212>PRT
<213>Homo sapiens
<400>276
Gly Ser Gly Tyr Thr Thr Arg Asn Tyr Phe Asp Tyr
1 5 10
<210>277
<211>12
<212>PRT
<213>Homo sapiens
<400>277
Arg Ala Ser Gln Ser Val Ser Ser Asn Tyr Leu Gly
1 5 l0
<210>278
<211>7
<212>PRT
<213>Homo sapiens
<400>278
Gly Ala Ser Ser Arg Ala Ser
1 5
<210>279
<211>9
<212>PRT
<213>Homo sapiens
<400>279
Gln Gln Tyr Gly Ser Ser Pro Leu Thr
1 5
<210>280
<211>5
<212>PRT
<213>Homo sapiens
<400>280
Asn Phe Ala Ile Asn
1 5
<210>281
<211>17
<212>PRT
<213>Homo sapiens
<400>281
Gly Ile Ile Ala Val Phe Gly Thr Thr Lys Tyr Ala His Lys Phe Gln
1 5 10 15
Gly
<210>282
<211>11
<212>PRT
<213>Homo sapiens
<400>282
GIy Pro His Tyr Tyr Ser Ser Tyr Met Asp Val
1 5 10
<210>283
<211>11
<212>PRT
<213>Homo sapiens
<400>283
Arg Ala Ser Gln Gly Ile Ser Thr Tyr Leu Ala
1 5 10
<210>284
<211>7
<212>PRT
<213>Homo sapiens
<400>284
Ala Ala Ser Thr Leu Gln Ser
1 5
<210>285
<211>8
<212>PRT
<213>Homo sapiens
<400>285
Gln Lys Tyr Asn Ser Ala Pro Ser
1 5
<210>286
<211>5
<212>PRT
<213>Homo sapiens
<400>286
Ser Asn Ala Val Ser
1 5
<210>287
<211>17
<212>PRT
<213>Homo sapiens
<400>287
Gly Ile Leu Gly Val Phe Gly Ser Pro Ser Tyr Ala Gln Lys Phe Gln
1 5 10 15
Gly
<210>288
<211>11
<212>PRT
<213>Homo sapiens
<400>288
Gly Pro Thr Tyr Tyr Tyr Ser Tyr Met Asp Val
1 5 10
<210>289
<211>11
<212>PRT
<213>Homo sapiens
<400>289
Gly Gly Asn Asn Ile Gly Arg Asn Ser Val His
1 5 10
<210>290
<211>7
<212>PRT
<213>Homo sapiens
<400>290
Asp Asp Ser Asp Arg Pro Ser
1 5
<210>291
<211>11
<212>PRT
<213>Homo sapiens
<400>291
Gln Val Trp His Ser Ser Ser Asp His Tyr Val
1 5 10
<210>292
<211>5
<212>PRT
<213>Homo sapiens
<400>292
Ser Tyr Ala Ile Ser
1 5
<210>293
<211>17
<212>PRT
<213>Homo sapiens
<400>293
Gly Ile Phe Gly Met Phe Gly Thr Ala Asn Tyr Ala Gln Lys Phe Gln
1 5 10 15
Gly
<210>294
<211>11
<212>PRT
<213>Homo sapiens
<400>294
Ser Ser Gly Tyr Tyr Pro Gln Tyr Phe Gln Asp
1 5 10
<210>295
<211>12
<212>PRT
<213>Homo sapiens
<400>295
Arg Ala Ser Gln Ser Val Ser Ser Ser Tyr Leu Ala
1 5 10
<210>296
<211>7
<212>PRT
<213>Homo sapiens
<400>296
Gly Ala Ser Ser Arg Ala Thr
1 5
<210>297
<211>9
<212>PRT
<213>Homo sapiens
<400>297
Gln Gln Tyr Gly Ser Ser Ser Leu Thr
1 5
<210>298
<211>5
<212>PRT
<213>Homo sapiens
<400>298
Ser Tyr Ala Ile Ser
1 5
<210>299
<211>17
<212>PRT
<213>Homo sapiens
<400>299
Gly Ile Ile Ala Ile Phe His Thr Pro Lys Tyr Ala Gln Lys Phe Gln
1 5 10 15
Gly
<210>300
<211>12
<212>PRT
<213>Homo sapiens
<400>300
Gly Ser Thr Tyr Asp Phe Ser Ser Gly Leu Asp Tyr
1 5 10
<210>301
<211>11
<212>PRT
<213>Homo sapiens
<400>301
Gly Gly Asn Asn Ile Gly Ser Lys Ser Val His
1 5 10
<210>302
<211>7
<212>PRT
<213>Homo sapiens
<400>302
Asp Asp Ser Asp Arg Pro Ser
1 5
<210>303
<211>11
<212>PRT
<213>Homo sapiens
<400>303
Gln Val Trp Asp Ser Ser Ser Asp His Val Val
1 5 10
<210>304
<211>5
<212>PRT
<213>Homo sapiens
<400>304
Ser Tyr Ala Ile Ser
1 5
<210>305
<211>17
<212>PRT
<213>Homo sapiens
<400>305
Gly Val Ile Pro Ile Phe Arg Thr Ala Asn Tyr Ala Gln Asn Phe Gln
1 5 10 15
Gly
<210>306
<211>19
<212>PRT
<213>Homo sapiens
<400>306
Leu Asn Tyr His Asp Ser Gly Thr Tyr Tyr Asn Ala Pro Arg Gly Trp
1 5 10 15
Phe Asp Pro
<210>307
<211>17
<212>PRT
<213>Homo sapiens
<400>307
Lys Ser Ser Gln Ser Ile Leu Asn Ser Ser Asn Asn Lys Asn Tyr Leu
1 5 10 15
Ala
<210>308
<211>7
<212>PRT
<213>Homo sapiens
<400>308
Trp Ala Ser Thr Arg Glu Ser
1 5
<210>309
<211>9
<212>PRT
<213>Homo sapiens
<400>309
Gln Gln Tyr Tyr Ser Ser Pro Pro Thr
1 5
<210>310
<211>5
<212>PRT
<213>Homo sapiens
<400>310
Tyr Tyr Ala Met Ser
1 5
<210>311
<211>17
<212>PRT
<213>Homo sapiens
<400>311
Gly Ile Ser Pro Met Phe Gly Thr Thr Thr Tyr Ala Gln Lys Phe Gln
1 5 10 15
Gly
<210>312
<211>11
<212>PRT
<213>Homo sapiens
<400>312
Ser Ser Asn Tyr Tyr Asp Ser Val Tyr Asp Tyr
1 5 10
<210>313
<211>11
<212>PRT
<213>Homo sapiens
<400>313
Gly Gly His Asn Ile Gly Ser Asn Ser Val His
1 5 10
<210>314
<211>7
<212>PRT
<213>Homo sapiens
<400>314
Asp Asn Ser Asp Arg Pro Ser
1 5
<210>315
<211>11
<212>PRT
<213>Homo sapiens
<400>315
Gln Val Trp Gly Ser Ser Ser Asp His Tyr Val
1 5 10
<210>316
<211>1335
<212>DNA
<213>Artificial
<220>
<223>CR6141Heavy chain
<220>
<221>CDS
<222>(1)..(1335)
<400>316
gag gtc cag ctg gtg cag tct ggg gct gag gtg aag aag cct ggg gcc 48
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
1 5 10 15
tca gtg aag gtc tcc tgc aag gct tct ggg tac acc ttc acc ggc tac 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
20 25 30
tat gtg tac tgg gtg cga cag gcc cct gga caa ggg ctt gag tgg atg 144
Tyr Val Tyr Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga tgg atc agc gct tac aat ggt aac aca aac tat gca cag aag ttc 192
Gly Trp Ile Ser Ala Tyr Asn Gly Asn Thr Asn Tyr Ala Gln Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac aaa tcc acg agc aca gcc tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
atg gag ctg agc agc ctg aga tct gaa gac acg gct gtg tat tac tgt 288
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
gcg aga agt aga tcc ctg gac gtc tgg ggc caa ggg acc acg gtc acc 336
Ala Arg Ser Arg Ser Leu Asp Val Trp Gly Gln Gly Thr Thr Val Thr
100 105 110
gtc tcg agt gct agc acc aag ggc ccc agc gtg ttc ccc ctg gcc ccc 384
Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro
115 120 125
agc agc aag agc acc agc ggc ggc aca gcc gcc ctg ggc tgc ctg gtg 432
Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala AlaLeu Gly Cys Leu Val
130 135 140
aag gac tacttc ccc gag ccc gtgg acc gtg agc tgg aac agc ggc gcc 480
Lys Asp Tyr Pne Pro Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala
145 150 155 160
ttg acc agc ggc gtg cac acc ttc ccc gcc gtg ctg cag agc agc ggc 528
Leu Tnr Ser Gly Val Hls Tnr Pne Pro Ala Val Leu Gln Ser Ser Gly
165 170 175
ctg tac agc ctg agc agc gtg gtg acc gtg ccc agc agc agc ctg ggc 576
Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly
180 185 190
acc cag acc tac atc tgc aac gtg aac cac aag ccc agc aac acc aag 624
Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro Ser Asn Thr Lys
195 200 205
gtg gac aaa cgc gtg gag ccc aag agc tgc gac aag acc cac acc tgc 672
Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp Lys Thr His Thr Cys
210 215 220
ccc ccc tgc cct gcc ccc gag ctg ctg ggc gga ccc tcc gtg ttc ctg 720
Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly Pro Ser Val Phe Leu
225 230 235 240
ttc ccc ccc aag ccc aag gac acc ctc atg atc agc cgg acc ccc gag 768
Phe Pro Pro Lyg Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu
245 250 255
gtg acc tgc gtg gtg gtg gac gtg agc cac gag gac ccc gag gtg aag 816
Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys
260 265 270
ttc aac tgg tac gtg gac ggc gtg gag gtg cac aac gcc aag acc aag 864
Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys
275 280 285
ccc cgg gag gag cag tac aac agc acc tac cgg gtg gtg agc gtg ctc 912
Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu
290 295 300
acc gtg ctg cac cag gac tgg ctg aac ggc aag gag tac aag tgc aag 960
Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys
305 310 315 320
gtg agc aac aag gcc ctg cct gcc ccc atc gag aag acc atc agc aag 1008
Val Ser Asn Lys Ala Leu Pro AlaPro Ile Glu Lys Thr Ile Ser Lys
325 330 335
gcc aag ggc cag ccc cgg gag ccc cag gtg tac acc ctg ccc ccc agc 1056
Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser
340 345 350
cgg gag gag atg acc aag aac cag gtg tcc ctc acc tgt ctg gtg aag 1104
Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys
355 360 365
ggc ttc tac ccc agc gac atc gcc gtg gag tgg gag agc aac ggc cag 1152
Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln
370 375 380
ccc gag aac aac tac aag acc acc ccc cct gtg ctg gac agc gac ggc 1200
Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly
385 390 395 400
agc ttc ttc ctg tac agc aag ctc acc gtg gac aag agc cgg tgg cag 1248
Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln
405 410 415
cag ggc aac gtg ttc agc tgc agc gtg atg cac gag gcc ctg cac aac 1296
Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn
420 425 430
cac tac acc cag aag agc ctg agc ctg agc ccc ggc aag 1335
His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys
435 440 445
<210>317
<211>445
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>317
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr
20 25 30
Tyr Val Tyr Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Trp Ile Ser Ala Tyr Asn Gly Asn Thr Asn Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ser Arg Ser Leu Asp Val Trp Gly Gln Gly Thr Thr Val Thr
100 105 110
Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro
115 120 125
ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly Cys Leu Val
130 135 140
Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala
145 150 155 160
Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly
165 170 175
Leu Tyr Ser Leu Ser Ser Val ValThr Val Pro Ser Ser Ser Leu Gly
180 185 190
Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro Ser Asn Thr Lys
195 200 205
Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp Lys Thr His Thr Cys
210 215 220
Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly Pro Ser Val Phe Leu
225 230 235 240
Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu
245 250 255
Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys
260 265 270
Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys
275 280 285
Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu
290 295 300
Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys
305 310 315 320
Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys
325 330 335
Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser
340 345 350
Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys
355 360 365
Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln
370 375 380
Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly
385 390 395 400
Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln
405 410 415
Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn
420 425 430
His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys
435 440 445
<210>318
<211>657
<212>DNA
<213>Artificial
<220>
<223>CR6141Light chain
<220>
<221>CDS
<222>(1)..(657)
<400>318
gat gtt gtg atg act cag tct cca gac tcc ctg gct gtg tct ctg ggc 48
Asp Val Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly
1 5 10 15
gag agg gcc acc atc aac tgc aag tcc agc cag agt gtt tta tac agc 96
Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu Tyr Ser
20 25 30
tcc aac aat aag aac tac tta gct tgg tac cag cag aaa cca gga cag 144
Ser Asn Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln
35 40 45
cct cct aag ctg ctc att tac tgg gca tct acc cgg gaa tcc ggg gtc 192
Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val
50 55 60
cct gac cga ttc agt ggc agc ggg tct ggg aca gat ttc act ctc acc 240
Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr
65 70 75 80
atc agc agc ctg cag gct gaa gat gtg gca gtt tat tac tgt cag caa 288
Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln
85 90 95
tat tat agt act cot ctc act ttc ggc gga ggg acc aaa gtg gat atc 336
Tyr Tyr Ser Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Asp Ile
100 105 110
aaa cgt gcg gcc gca ccc agc gtg ttc atc ttc ccc ccc tcc gac gag 384
Lys Arg Ala Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu
115 120 125
cag ctg aag agc ggc acc gcc agc gtg gtg tgc ctg ctg aac aac ttc 432
Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe
130 135 140
tac ccc cgg agg gcc aag gtg cag tgg aag gtg gac aac gcc ctg cag 480
Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln
145 150 155 160
agc ggc aac agc cag gag agc gtg acc gag cag gac agc aag gac tcc 528
Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser
165 170 175
acc tac agc ctg agc agc acc ctc acc ctg agc aag gcc gac tac gag 576
Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu
180 185 190
aag cac aag gtg tac gcc tgc gag gtg acc cac cag ggc ctg agc agc 624
Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser
195 200 205
ccc gtg acc aag agc ttc aac cgg ggc gag tgt 657
Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215
<210>319
<211>219
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>319
Asp Val Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly
1 5 10 15
Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu Tyr Ser
20 25 30
Ser Asn Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln
35 40 45
Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val
50 55 60
Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr
65 70 75 80
Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln
85 90 95
Tyr Tyr Ser Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Asp Ile
100 105 110
Lys Arg Ala Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu
115 120 125
Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe
130 135 140
Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln
145 150 155 160
Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser
165 170 175
Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asn Tyr Glu
180 185 190
Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser
195 200 205
Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215
<210>320
<211>1350
<212>DNA
<213>Artificial
<220>
<223>CR6272Heavy chain
<220>
<221>CDS
<222>(1)..(1350)
<400>320
cag atg cag ctg gtg cag tct ggg gct gag gtg aag aag cct ggg tcc 48
Gln Met Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aag gtc tcc tgc aag gct tct gga ggc acc ttc tcc agt tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr
20 25 30
gct atc acc tgg gtg cga cag gcc cct gga caa ggg ctt gag tgg atg 144
Ala Ile Thr Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga ggg atc atc ggt atg ttt ggt tca aca aac tac gca cag aac ttc 192
Gly Gly Ile Ile Gly Met Phe Gly Ser Thr Asn Tyr Ala Gln Asn Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac gaa tcc acg agc aca gcc tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr
65 70 75 80
atg gag ctg agc agc ctc aga tct gag gac acg gcc gtg tat tac tgt 288
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
gcg aga agt act ggt tat tac cct gca tac ctc cac cac tgg ggc cag 336
Ala Arg Ser Thr Gly Tyr Tyr Pro Ala Tyr Leu His His Trp Gly Gln
100 105 110
ggc acc ctg gtc acc gtc tcg agt gct agc acc aag ggc ccc agc gtg 384
Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val
115 120 125
ttc ccc ctg gcc ccc agc agc aag agc acc agc ggc ggc aca gcc gcc 432
Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala
130 135 140
ctg ggc tgc ctg gtg aag gac tac ttc ccc gag ccc gtg acc gtg agc 480
Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser
145 150 155 160
tgg aac agc ggc gcc ttg acc agc ggc gtg cac acc ttc ccc gcc gtg 528
Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val
165 170 175
ctg cag agc agc ggc ctg tac agc ctg agc agc gtg gtg acc gtg ccc 576
Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro
180 185 190
agc agc agc ctg ggc acc cag acc tac atc tgc aac gtg aac cac aag 624
Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys
195 200 205
ccc agc aac acc aag gtg gac aaa cgc gtg gag ccc aag agc tgc gac 672
Pro Ser Asn Thr Lys Val Asn Lys Arg Val Glu Pro Lys Ser Cys Asp
210 215 220
aag acc cac acc tgc ccc ccc tgc cct gcc ccc gag ctg ctg ggc gga 720
Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly
225 230 235 240
ccc tcc gtg ttc ctg ttc ccc ccc aag ccc aag gac acc crc atg atc 768
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Lle
245 250 255
agc cgg acc ccc gag gtg acc tgc gtg gtg gtg gac gtg agc cac gag 816
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu
260 265 270
gac ccc gag gtg aag ttc aac tgg tac gtg gac ggc gtg gag gtg cac 864
Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
aac gcc aag acc aag ccc cgg gag gag cag tac aac agc acc tac cgg 912
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg
290 295 300
gtg gtg agc gtg ctc acc gtg ctg cac cag gac tgg ctg aac ggc aag 960
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
gag tac aag tgc aag gtg agc aac aag gcc ctg cct gcc ccc atc gag 1008
Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu
325 330 335
aag acc atc agc aag gcc aag ggc cag ccc cgg gag ccc cag gtg tac 1056
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
acc ctg ccc ccc agc cgg gag gag atg acc aag aac cag gtg tcc ctc 1104
Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
acc tgt ctg gtg aag ggc ttc tac ccc agc gac atc gcc gtg gag tgg 1152
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
gag agc aac ggc cag ccc gag aac aac tac aag acc acc ccc cct gtg 1200
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
ctg gac agc gac ggc agc ttc ttc ctg tac agc aag ctc acc gtg gac 1248
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp
405 410 415
aag agc cgg tgg cag cag ggc aac gtg ttc agc tgc agc gtg atg cac 1296
Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
gag gcc ctg cac aac cac tac acc cag aag agc ctg agc ctg agc ccc 1344
Glu Ala Leu His Ash His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro
435 440 445
ggc aag 1350
Gly Lys
450
<210>321
<211>450
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>321
Gln Met Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr
20 25 30
Ala Ile Thr Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Gly Ile Ile Gly Met Phe Gly Ser Thr Asn Tyr Ala Gln Asn Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ser Thr Gly Tyr Tyr Pro Ala Tyr Leu His His Trp Gly Gln
100 105 110
Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val
115 120 125
Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala
130 135 140
Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser
145 150 155 160
Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val
165 170 175
Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro
180 185 190
Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys
195 200 205
Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp
210 215 220
Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly
225 230 235 240
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu
260 265 270
Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg
290 295 300
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
Glu Tyr Lys Cys Lys ValSer Asn Lys Ala Leu Pro Ala Pro Ile Glu
325 330 335
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp
405 410 415
Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro
435 440 445
Gly Lys
450
<210>322
<211>660
<212>DNA
<213>Artificial
<220>
<223>CR6272Light chain
<220>
<221>CDS
<222>(1)..(660)
<400>322
cag tct gcc ctg act cag cct cgc tca gtg tcc ggg tct cct gga cag 48
Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln
1 5 10 15
tca gtc acc atc tcc tgc act gga acc agc agt gat gtt ggt ggt tat 96
Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr
20 25 30
aac tat gtc tcc tgg tac caa cag cac cca ggc aaa gcc ccc aaa ctc 144
Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
35 40 45
atg att tat gat gtc agt aag cgg ccc tca ggg gtc cct gat cgc ttc 192
Met Ile Tyr Asp Val Ser Lys Arg Pro Ser Gly Val Pro Asp Arg Phe
50 55 60
tct ggc tcc aag tct ggc aac acg gcc tcc ctg acc atc tct ggg ctc 240
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu
65 70 75 80
cag gct gag gat gag gct gat tat tac tgc agc tca tat aca agc agc 288
Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser
85 90 95
agc act cat gtc ttc gga act ggg acc aag gtc acc gtc cta ggt gcg 336
Ser Thr His Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu Gly Ala
100 105 110
gcc gca ggc cag ccc aag gcc gct ccc agc gtg acc ctg ttc ccc ccc 384
Ala Ala Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro
115 120 125
tcc tcc gag gag ctg cag gcc aac aag gcc acc ctg gtg tgc ctc atc 432
Ser Ser Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile
130 135 140
agc gac ttc tac cct ggc gcc gtg acc gtg gcc tgg aag gcc gac agc 480
Ser Asp Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser
145 150 155 160
agc ccc gtg aag gcc ggc gtg gag acc acc acc ccc agc aag cag agc 528
Ser Pro Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser
165 170 175
aac aac aag tac gcc gcc agc agc tac ctg agc ctc acc ccc gag cag 576
Ash Asn Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln
180 185 190
tgg aag agc cac cgg agc tac agc tgc cag gtg acc cac gag ggc agc 624
Trp Lys Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser
195 200 205
acc gtg gag aag acc gtg gcc ccc acc gag tgc agc 660
Thr Val Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215 220
<210>323
<211>220
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>323
Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln
1 5 10 15
Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr
20 25 30
Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
35 40 45
Met Ile Tyr Asp Val Ser Lys Arg Pro Ser Gly Val Pro Asp Arg Phe
50 55 60
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu
65 70 75 80
Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser
85 90 95
Ser Thr His Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu Gly Ala
100 105 110
Ala Ala Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro
115 120 125
Ser Ser Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile
130 135 140
Ser Asp Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser
145 150 155 160
Ser Pro Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser
165 170 175
Ash Asn Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln
180 185 190
Trp Lys Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser
195 200 205
Thr Val Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215 220
<210>324
<211>1353
<212>DNA
<213>Artificial
<220>
<223>CR6296Heayy chain
<220>
<221>CDS
<222>(1)..(1353)
<400>324
gag gtg cag ctg gtg gag acc ggg gct gag gtg aag aag cct ggg gcc 48
Glu Val Gln Leu Val Glu Thr Gly Ala Glu Val Lys Lys Pro Gly Ala
1 5 10 15
tca gtg aag gtt tcc tgc aag gca tct gga tac acc ttc acc agc tac 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr
20 25 30
tat atg cac tgg gtg cga cag gcc cct gga caa ggg ctt gag tgg atg 144
Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga tgg atc aac cct aac agt ggt ggc aca aac tat gca cag aag ttt 192
Gly Trp Ile Asn Pro Asn Ser Gly Gly Thr Ash Tyr Ala Gln Lys Phe
50 55 60
cag ggc agg gtc acc atg acc agg gac acg tcc atc agc aca gcc tac 240
Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr
65 70 75 80
atg gag ctg agc agg ctg aga tct gac gac acg gcc gtg tat tac tgt 288
Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
85 90 95
gcg aga gag ggg aaa tgg gga cct caa gcg gct ttt gat atc tgg ggc 336
Ala Arg Glu Gly Lys Trp Gly Pro Gln Ala Ala Phe Asp Ile Trp Gly
100 105 110
caa ggg aca atg gtc acc gtc tcg agt gct agc acc aag ggc ccc agc 384
Gln Gly Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser
115 120 125
gtg ttc ccc ctg gcc ccc agc agc aag agc acc agc ggc ggc aca gcc 432
Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala
130 135 140
gcc ctg ggc tgc ctg gtg aag gac tac ttc ccc gag ccc gtg acc gtg 480
Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val
145 150 155 160
agc tgg aac agc ggc gcc ttg acc agc ggc gtg cac acc ttc ccc gcc 528
Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala
165 170 175
gtg ctg cag agc agc ggc ctg tac agc ctg agc agc gtg gtg acc gtg 576
Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val
180 185 190
ccc agc agc agc ctg ggc acc cag acc tac atc tgc aac gtg aac cac 624
Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His
195 200 205
aag ccc agc aac acc aag gtg gac aaa cgc gtg gag ccc aag agc tgc 672
Lys Pro Ser Asp Thr Lys ValAsp Lys Arg Val Glu Pro Lys Ser Cys
210 215 220
gac aag acc cac acc tgc ccc ccc tgc cct gcc ccc gag ctg ctg ggc 720
Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly
225 230 235 240
gga ccc tcc gtg ttc ctg ttc ccc ccc aag ccc aag gac acc ctc atg 768
Gly pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met
245 250 255
atc agc cgg acc ccc gag gtg acc tgc gtg gtg gtg gac gtg agc cac 816
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His
260 265 270
gag gac ccc gag gtg aag ttc aac tgg tac gtg gac ggc gtg gag gtg 864
Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val
275 280 285
cac aac gcc aag acc aag ccc cgg gag gag cag tac aac agc acc tac 912
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr
290 295 300
cgg gtg gtg agc gtg ctc acc gtg ctg cac cag gac tgg ctg aac ggc 960
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly
305 310 315 320
aag gag tac aag tgc aag gtg agc aac aag gcc ctg cct gcc ccc atc 1008
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile
325 330 335
gag aag acc atc agc aag gcc aag ggc cag ccc cgg gag ccc cag gtg 1056
Glu Lys Thr Ile Ser Lys Alg Lys Gly Gln Pro Arg Glu Pro Gln Val
340 345 350
tac acc ctg ccc ccc agc cgg gag gag atg acc aag aac cag gtg tcc 1104
Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser
355 360 365
ctc acc tgt ctg gtg aag ggc ttc tac ccc agc gac atc gcc gtg gag 1152
Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu
370 375 380
tgg gag agc aac ggc cag ccc gag aac aac tac aag acc acc ccc cct 1200
Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro
385 390 395 400
gtg ctg gac agc gac ggc agc ttc ttc ctg tac agc aag ctc acc gtg 1248
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val
405 410 415
gac aag agc cgg tgg cag cag ggc aac gtg ttc agc tgc agc gtg atg 1296
Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met
420 425 430
cac gag gcc ctg cac aac cac tac acc cag aag agc ctg agc ctg agc 1344
His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser
435 440 445
ccc ggc aag 1353
Pro Gly Lys
450
<210>325
<211>451
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>325
Glu Val Gln Leu Val Glu Thr Gly Ala Glu Val Lys Lys Pro Gly Ala
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr
20 25 30
Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Trp Ile Ash Pro Ash Ser Gly Gly Thr Asn Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Glu Gly Lys Trp Gly Pro Gln Ala Ala Phe Asp Ile Trp Gly
100 105 110
Gln Gly Thr Met Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser
115 120 125
Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala
130 135 140
Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val
145 150 155 160
Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala
165 170 175
Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val
180 185 190
Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His
195 200 205
Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys
210 215 220
Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly
225 230 235 240
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met
245 250 255
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His
260 265 270
Glu Asp Pro Glu Val Lys Phe Ash Trp Tyr Val Asp Gly Val Glu Val
275 280 285
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr hsn Ser Thr Tyr
290 295 300
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly
305 310 315 320
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile
325 330 335
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val
340 345 350
Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser
355 360 365
Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu
370 375 380
Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro
385 390 395 400
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val
405 410 4l5
Asp Lys Ser Arg Trp Gln Gln Gly Ash Val Phe Ser Cys Ser Val Met
420 425 430
His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser
435 440 445
Pro Gly Lys
450
<210>326
<211>642
<212>DNA
<213>Artificial
<220>
<223>CR6296Light chain
<220>
<221>CDS
<222>(1)..(642)
<400>326
gaa att gtg atg acg cag tct cca ggc acc ctg tct ttg tct cca ggg 48
Glu Ile Val Met Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly
1 5 10 15
gaa aga gcc acc ctc tcc tgc agg gcc agt cag agt gtt agc agc agc 96
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser
20 25 30
tac tta gcc tgg tac cag cag aaa cct ggc cag gct ccc agg ctc ctc 144
Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu
35 40 45
atc tat gat gca tcc agc agg gcc act gac atc cca gac agg ttc agt 192
Ile Tyr Asp Ala Ser Ser Arg Ala Thr Asp Ile Pro Asp Arg Phe Ser
50 55 60
ggc agt ggg tct ggg aca gac ttc act ctc acc atc agc aga ctg gag 240
Gly Ser Gly Ser Gly Thr AsP Phe Thr Leu Thr Ile Ser Arg Leu Glu
65 70 75 80
cct gaa gat ttt gca gtg tat tac tgt cag cag tat ggt agc tca ctt 288
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Leu
85 90 95
tgg acg ttc ggc caa ggg acc aag gtg gag atc aaa cgt gcg gcc gca 336
Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Ala Ala Ala
100 105 110
ccc agc gtg ttc atc ttc ccc ccc tcc gac gag cag ctg aag agc ggc 384
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
acc gcc agc gtg gtg tgc ctg ctg aac aac ttc tac ccc cgg gag gcc 432
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
aag gtg cag tgg aag gtg gac aac gcc ctg cag agc ggc aac agc cag 480
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
gag agc gtg acc gag cag gac agc aag gac tcc acc tac agc ctg agc 528
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Sar Thr Tyr Ser Leu Ser
165 170 175
agc acc ctc acc ctg agc aag gcc gac tac gag aag cac aag gtg tac 576
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
gcc tgc gag gtg acc cac cag ggc ctg agc agc ccc gtg acc aag agc 624
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
ttc aac cgg ggc gag tgt 642
Phe Asn Arg Gly Glu Cys
210
<210>327
<211>214
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>327
Glu Ile Val Met Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly
1 5 10 15
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser
20 25 30
Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu
35 40 45
Ile Tyr Asp Ala Ser Ser Arg Ala Thr Asp Ile Pro Asp Arg Phe Ser
50 55 60
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu
65 70 75 80
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Leu
85 90 95
Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Ala Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cvs Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210>328
<211>1341
<212>DNA
<213>Artificial
<220>
<223>CR6301Heavy chain
<220>
<221>CDS
<222>(1)..(1341)
<400>328
gag gtg cag ctg gta gag tct ggg gga ggc ttg gta cag cct ggg ggg 48
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
tcc ctg aga ctc tcc tgt gca gcc tct gga ttc acc ttt agc atc tat 96
Ser Leu Arg Leu Sar Cys Ala Ala Ser Gly Phe Thr Phe Ser Ile Tyr
20 25 30
gcc atg agc tgg gtc cgc cag gca cca ggg aag ggg ctg gag tgg gtc 144
Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
tca gct att agt agt agt ggt gat agc aca tac tac gca gac tcc gtg 192
Ser Ala Ile Ser Ser Ser Gly Asp Ser Thr Tyr Tyr Ala Asp Ser Val
50 55 60
aag ggc cgg ttc acc atc tcc aga gac aac gcc agg aac acg ctg tat 240
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Arg Asn Thr Leu Tyr
65 70 75 80
ctg caa atg aac agt ctg aga gcc gag gac acg gct gtg tat tac tgt 288
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Tnr Ala Val Tyr Tyr Cys
85 90 95
gcg aga gcg tat ggc tac acg ttc gac ccc tgg ggc cag gga acc ctg 336
Ala Arg Ala Tyr Gly Tyr Thr Phe Asp Pro Trp Gly Gln Gly Thr Leu
100 105 110
gtc acc gtc tcg agt gct agc acc aag ggc ccc agc gtg ttc ccc ctg 384
Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu
115 120 125
gcc ccc agc agc aag agc acc agc ggc ggc aca gcc gcc ctg ggc tgc 432
Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly Cys
130 135 140
ctg gtg aag gac tac ttc ccc gag ccc gtg acc gtg agc tgg aac agc 480
Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser
145 150 155 160
ggc gcc ttg acc agc ggc gtg cac acc ttc ccc gcc gtg ctg cag agc 528
Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu Gln Ser
165 170 175
agc ggc ctg tac agc ctg agc agc gtg gtg acc gtg ccc agc agc agc 576
Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser Ser Ser
180 185 190
ctg ggc acc cag acc tac atc tgc aac gtg aac cac aag ccc agc aac 624
Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro Ser Asn
195 200 205
acc aag gtg gac aaa cgc gtg gag ccc aag agc tgc gac aag acc cac 672
Tnr Lys yal Asp Lys Arg yal Glu Pro Lys Ser Cys Asp Lys Tnr His
210 215 220
acc tgc ccc ccc tgc cct gcc ccc gag ctg ctg ggc gga ccc tcc gtg 720
Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly Pro Ser Val
225 230 235 240
ttc ctg ttc ccc ccc aag ccc aag gac acc ctc atg atc agc cgg acc 768
Phe Lec Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
245 250 255
ccc gag gtg acc tgc gtg gtg gtg gac gtg agc cac gag gac ccc gag 816
Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Asp Pro Glu
260 265 270
gtg aag ttc aac tgg tac gtg gac ggc gtg gag gtg cac aac gcc aag 864
Val Lys Phe Asn Trp Tyr Val Asp Gly ValGlu Val His Asn Ala Lys
275 280 285
acc aag ccc cgg gag gag cag tac aac agc acc tac cgg gtg gtg agc 912
Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser
290 295 300
gtg ctc acc gtg ctg cac cag gac tgg ctg aac ggc aag gag tac aag 960
Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys
305 310 315 320
tgc aag gtg agc aac aag gcc ctg cct gcc ccc atc gag aag acc atc 1008
Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile
325 330 335
agc aag gcc aag ggc cag ccc cgg gag ccc cag gtg tac acc ctg ccc 1056
Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro
340 345 350
ccc agc cgg gag gag atg acc aag aac cag gtg tcc ctc acc tgt ctg 1104
Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr Cys Leu
355 360 365
gtg aag ggc ttc tac ccc agc gac atc gcc gtg gag tgg gag agc aac 1152
Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn
370 375 380
ggc cag ccc gag aac aac tac aag acc acc ccc cct gtg ctg gac agc 1200
Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser
385 390 395 400
gac ggc agc ttc ttc ctg tac agc aag ctc acc gtg gac aag agc cgg 1248
Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg
405 410 415
tgg cag cag ggc aac gtg ttc agc tgc agc gtg atg cac gag gcc ctg 1296
Trp Glp Glp Gly Asp Val Phe Ser Cys Ser Vel Met His Glu Ala Leu
420 425 430
cac aac cac tac acc cag aag agc ctg agc ctg agc ccc ggc aag 1341
His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys
435 440 445
<210>329
<211>447
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>329
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly
1 5 10 15
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ile Tyr
20 25 30
Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
35 40 45
Ser Ala Ile Ser Ser Ser Gly Asp Ser Thr Tyr Tyr Ala Asp Ser Val
50 55 60
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Arg Asn Thr Leu Tyr
65 70 75 80
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ala Tyr Gly Tyr Thr Phe Asp Pro Trp Gly Gln Gly Thr Leu
100 105 110
Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu
115 120 125
AIa Pro Ser Ser Lys Ser Thr Ser Gly GIy Thr Ala Ala Leu Gly Cys
130 135 140
Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser
145 150 155 160
Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val Leu Gln Ser
165 170 175
Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro Ser Ser Ser
180 185 190
Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys Pro Ser Asn
195 200 205
Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp Lys Thr His
210 215 220
Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly Pro Ser Val
225 230 235 240
Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr
245 250 255
Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu Aso Pro Glu
260 265 270
Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His Asn Ala Lys
275 280 285
Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser
290 295 300
Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys
305 310 315 320
Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile
325 330 335
Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro
340 345 350
Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu Thr Cys Leu
355 360 365
Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn
370 375 380
Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser
385 390 395 400
Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg
405 410 415
Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His Glu Ala Leu
420 425 430
His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys
435 440 445
<210>330
<211>654
<212>DNA
<213>Artificial
<220>
<223>CR6301Light chain
<220>
<221>CDS
<222>(1)..(654)
<400>330
gaa att gtg ctg act cag tct cca ctc tcc ctg ccc gtc acc cct gga 48
Glu Ile Val Leu Thr Gln Ser Pro Leu Ser Leu Pro Val Tnr Pro Gly
1 5 10 15
gag ccg gcc tcc atc tcc tgc agg tct agt cag agc ctc ctg cat agt 96
Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser
20 25 30
aat gga tac aac tat ttg gat tgg tac ctg cag aag cca ggg cag tct 144
Asn Gly Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser
35 40 45
cca cag ctc ctg atc tat ttg ggt tct aat cgg gcc tcc ggg gtc cct 192
Pro Gln Leu Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro
50 55 60
gac agg ttc agt ggc agt gga tca ggc aca gat ttt aca ctg aaa atc 240
Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile
65 70 75 80
agc aga gtg gag gct gag gat gtt ggg gtt tat tac tgc atg caa gct 288
Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala
85 90 95
cta caa act ccc ctc act ttc ggc gga ggg acc aag gtg gag atc aaa 336
Leu Gln Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys
100 105 110
cgt gcg gcc gca ccc agc gtg ttc atc ttc ccc ccc tcc gac gag cag 384
Arg Ala Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln
115 120 125
ctg aag agc ggc acc gcc agc gtg gtg tgc ctg ctg aac aac ttc tac 432
Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr
130 135 140
ccc cgg gag gcc aag gtg cag tgg aag gtg gac aac gcc ctg cag agc 480
Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser
145 150 155 160
ggc aac agc cag gag agc gtg acc gag cag gac agc aag gac tcc acc 528
Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr
165 170 175
tac agc ctg agc agc acc ctc acc ctg agc aag gcc gac tac gag aag 576
Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys
180 185 190
cac aag gtg tac gcc tgc gag gtg acc cac cag ggc ctg agc agc ccc 624
His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro
195 200 205
gtg acc aag agc ttc aac cgg ggc gag tgt 654
Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215
<210>331
<211>218
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>331
Glu Ile Val Leu Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly
1 5 10 15
Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser
20 25 30
Asn Gly Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser
35 40 45
Pro Gln Leu Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro
50 55 60
Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile
65 70 75 80
Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala
85 90 95
Leu Gln Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys
100 105 110
Arg Ala Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln
115 120 125
Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr
130 135 140
Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser
145 150 155 160
Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr
165 170 175
Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys
180 185 190
His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro
195 200 205
Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215
<210>332
<211>1353
<212>DNA
<213>Artificial
<220>
<223>CR6327Heayy chain
<220>
<221>CDS
<222>(1)..(1353)
<400>332
gag gtg cag ctg gtg gag acc ggg gct gag gtg aag aag cct ggg tcc 48
Glu Val Gln Leu Val Glu Thr Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aag gtc tcc tgc aag gcc tct gga ggc acc ttc agg acc cat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Arg Thr His
20 25 30
gct atc agt tgg gtg cga cag gcc cct gga caa ggg ctt gag tgg atg 144
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga ggg atc atc gct atc ttc gga aca gca aac tac gca cag aag ttc 192
Gly Gly Ile Ile Ala Ile Phe Gly Tnr Ala Asn Tyr Ala Gln Lys Phe
50 55 60
cag ggc aga atc acg att acc gcg gac gaa tcc acg agt aca gcc tac 240
Gln Gly Arg Ile Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr
65 70 75 80
atg gag ctg agc agc ctg aga tct gag gac acg gcc gtg tat ttc tgt 288
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Phe Cys
85 90 95
gcg aga ggc agt ggt tat cat ata tcg aca ccc ttt gac aac tgg ggc 336
Ala Arg Gly Ser Gly Tyr His Ile Ser Thr Pro Phe Asp Asn Trp Gly
100 105 110
cag gga acc ctg gtc acc gtc tcg agt gct agc acc aag ggc ccc agc 384
Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser
115 120 125
gtg ttc ccc ctg gcc ccc agc agc aag agc acc agc ggc ggc aca gcc 432
Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala
130 135 140
gcc ctg ggc tgc ctg gtg aag gac tac ttc ccc gag ccc gtg acc gtg 480
Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val
145 150 155 160
agc tgg aac agc ggc gcc ttg acc agc ggc gtg cac acc ttc ccc gcc 528
Ser Trn Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala
165 170 175
gtg ctg cag agc agc ggc ctg tac agc ctg agc agc gtg gtg acc gtg 576
Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val
180 185 190
ccc agc agc agc ctg ggc acc cag acc tac atc tgc aac gtg aac cac 624
Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Ash Val Asn His
195 200 205
aag ccc agc aac acc aag gtg gac aaa cgc gtg gag ccc aag agc tgc 672
Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys
210 215 220
gac aag acc cac acc tgc ccc ccc tgc cct gcc ccc gag ctg ctg ggc 720
Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly
225 230 235 240
gga ccc tcc gtg ttc ctg ttc ccc ccc aag ccc aag gac acc ctc atg 768
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met
245 250 255
atc agc cgg acc ccc gag gtg acc tgc gtg gtg gtg gac gtg agc cac 816
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His
260 265 270
gag gac ccc gag gtg aag ttc aac tgg tac gtg gac ggc gtg gag gtg 864
Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val
275 280 285
cac aac gcc aag acc aag ccc cgg gag gag cag tac aac agc acc tac 912
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr
290 295 300
cgg gtg gtg agcgtg ctc acc gtg ctg cac cag gac tgg ctg aac ggc 960
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly
305 310 315 320
aag gag tac aag tgc aag gtg agc aac aag gcc ctg cct gcc ccc atc 1008
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile
325 330 335
gag aag acc atc agc aag gcc aag ggc cag ccc cgg gag ccc cag gtg 1056
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val
340 345 350
tac acc ctg ccc ccc agc cgg gag gag atg acc aag aac cag gtg tcc 1104
Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser
355 360 365
ctc acc tgt ctg gtg aag ggc ttc tac ccc agc gac atc gcc gtg gag 1152
Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu
370 375 380
tgg gag agc aac ggc cag ccc gag aac aac tac aag acc acc ccc cct 1200
Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro
385 390 395 400
gtg ctg gac agc gac ggc agc ttc ttc ctg tac agc aag ctc acc gtg 1248
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val
405 410 415
gac aag agc cgg tgg cag cag ggc aac gtg ttc agc tgc agc gtg atg 1296
Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met
420 425 430
cac gag gcc ctg cac aac cac tac acc cag aag agc ctg agc ctg agc 1344
His Glu Ala Leu His Asn Gis Tyr Thr Gln Lys Ser Leu Ser Leu Ser
435 440 445
ccc ggc aag 1353
Pro Gly Lys
450
<210>333
<211>451
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>333
Glu Val Gln Leu Val Glu Thr Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Arg Thr His
20 25 30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Gly Ile Ile Ala Ile Phe Gly Thr Ala Asn Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Ile Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Phe Cys
85 90 95
Ala Arg Gly Ser Gly Tyr His Ile Ser Thr Pro Phe Asp Asn Trp Gly
100 105 110
Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser
115 120 125
Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala
130 135 140
Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val
145 150 155 160
Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala
165 170 175
Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val
180 185 190
Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His
195 200 205
Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys
210 215 220
Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly
225 230 235 240
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met
245 250 255
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His
260 265 270
Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val
275 280 285
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr
290 295 300
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly
305 310 315 320
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile
325 330 335
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val
340 345 350
Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser
355 360 365
Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu
370 375 380
Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro
385 390 395 400
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val
405 410 415
Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met
420 425 430
His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser
435 440 445
Pro Gly Lys
450
<210>334
<211>654
<212>DNA
<213>Artificial
<220>
<223>CR6327Light chain
<220>
<221>CDS
<222>(1)..(654)
<400>334
tcc tat gtg ctg act cag cca ccc tcg gtg tca gtg gcc cca gga cag 48
Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Gln
1 5 10 15
acg gcc agg att acc tgt ggg gga aac aac att gga agt aaa ggt gtg 96
Thr Ala Arg Ile Thr Cys Gly GIy Asn Asn Ile Gly Ser Lys Gly Val
20 25 30
cac tgg tac cag cag aag cct ggc cag gcc cct gtg ctg gtc gtc tat 144
His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr
35 40 45
gat gat agc gac cgg ccc tca ggg atc cct gag cga ttc tct ggc tcc 192
Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser
50 55 60
aac tct ggg aac acg gcc acc ctg acc atc agc agg gtc gaa gcc ggg 240
Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly
65 70 75 80
gat gag gcc gac tat tac tgt cag gtg tgg gat agt agt agt gat cat 288
Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His
85 90 95
gtg gta ttc ggc gga ggg acc aag ctg acc gtc cta ggt gcg gcc gca 336
Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu Gly Ala Ala Ala
100 105 110
ggc cag ccc aag gcc gct ccc agc gtg acc ctg ttc ccc ccc tcc tcc 384
Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro Ser Ser
115 120 125
gag gag ctg cag gcc aac aag gcc acc ctg gtg tgc ctc atc agc gac 432
Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile Ser Asp
130 135 140
ttc tac cct ggc gcc gtg acc gtg gcc tgg aag gcc gac agc agc ccc 480
Phe Tyr Pro Gly Ala Val Thr Val Ala Trn Lys Ala Asn Ser Ser Pro
145 150 155 160
gtg aag gcc ggc gtg gag acc acc acc ccc agc aag cag agc aac aac 528
Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser Asn Asn
165 170 175
aag tac gcc gcc agc agc tac ctg agc ctc acc ccc gag cag tgg aag 576
Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln Trp Lys
180 185 190
agc cac cgg agc tac agc tgc cag gtg acc cac gag ggc agc acc gtg 624
Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser Thr Val
195 200 205
gag aag acc gtg gcc ccc acc gag tgc agc 654
Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215
<210>335
<211>218
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>335
Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser ValAla Pro Gly Gln
1 5 10 15
Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Gly Val
20 25 30
His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr
35 40 45
Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser
50 55 60
Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly
65 70 75 80
Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His
85 90 95
Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu Gly Ala Ala Ala
100 105 110
Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro Ser Ser
115 120 125
Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile Ser Asp
130 135 140
Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser Ser Pro
145 150 155 160
Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser Asn Asn
165 170 175
Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln Trp Lys
180 185 190
Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser Thr Val
195 200 205
Glu Lys Thr ValAla Pro Thr Glu Cys Ser
210 215
<210>336
<211>1374
<212>DNA
<213>Artificial
<220>
<223>CR6328Heayy chain
<220>
<221>CDS
<222>(1)..(1374)
<400>336
gag gtg cag ctg gtg gag tct ggg gct gag gtg aag aag cct ggg tcc 48
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aag gtc tcc tgc aag gct tct gga cac atc ttc agc ggc tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly His Ile Phe Ser Gly Tyr
20 25 30
gca atc agt tgg gtg cga cag gcc cct gga caa ggg ctt gag tgg atg 144
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga ggg atc atc cct atc ttt ggt aca aca aac tac gca cag aag ttc 192
Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Asn Tyr Ala Gln Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac caa tcc acg agc aca gcc tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Gln Ser Thr Ser Thr Ala Tyr
65 70 75 80
atg gac ctg agc aac ttg aga tct gag gac acg gcc gtc tat tac tgt 288
Met Asp Leu Ser Asn Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
gcg aga gtg aaa gat gga tat tgt act ctt acc agc tgc cct gtc ggc 336
Ala Arg Val Lys Asp Gly Tyr Cys Thr Leu Thr Ser Cys Pro Val Gly
100 105 110
tgg tac ttc gat ctc tgg ggc cgt ggc acc ctg gtc act gtc tcg agt 384
Trp Tyr Phe Asp Leu Trp Gly Arg Gly Thr Leu yal Thr yal Ser Ser
115 120 125
gct agc acc aag ggc ccc agc gtg ttc ccc ctg gcc ccc agc agc aag 432
Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys
130 135 140
agc acc agc ggc ggc aca gcc gcc ctg ggc tgc ctg gtg aag gac tac 480
Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr
145 150 155 160
ttc ccc gag ccc gtg acc gtg agc tgg aac agc ggc gcc ttg acc agc 528
Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser
165 170 175
ggc gtg cac acc ttc ccc gcc gtg ctg cag agc agc ggc ctg tac agc 576
Gly Val His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser
180 185 190
ctg agc agc gtg gtg acc gtg ccc agc agc agc ctg ggc acc cag acc 624
Leu Ser Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr
195 200 205
tac atc tgc aac gtg aac cac aag ccc agc aac acc aag gtg gac aaa 672
Tyr Ile Cys Asn Val Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys
210 215 220
cgc gtg gag ccc aag agc tgc gac aag acc cac acc tgc ccc ccc tgc 720
Arg Val Glu Pro Lys Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys
225 230 235 240
cct gcc ccc gag ctg ctg ggc gga ccc tcc gtg ttc ctg ttc ccc ccc 768
Pro Ala Pro Glu Leu Leu Gly Gly Pro Ser ValPhe Leu Phe Pro Pro
245 250 255
aag ccc aag gac acc ctc atg atc agc cgg acc ccc gag gtg acc tgc 816
Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys
260 265 270
gtg gtg gtg gac gtg agc cac gag gac ccc gag gtg aag ttc aac tgg 864
Val Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trn
275 280 285
tac gtg gac ggc gtg gag gtg cac aac gcc aag acc aag ccc cgg gag 912
Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu
290 295 300
gag cag tac aac agc acc tac cgg gtg gtg agc gtg ctc acc gtg ctg 960
Glu Gln Tyr Asn Ser Thr Tyr Arg ValVal Ser Val Leu Thr Val Leu
305 310 315 320
cac cag gac tgg ctg aac ggc aag gag tac aag tgc aag gtg agc aac 1008
His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn
325 330 335
aag gcc ctg cct gcc ccc atc gag aag acc atc agc aag gcc aag ggc 1056
Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly
340 345 350
cag ccc cgg gag ccc cag gtg tac acc ctg ccc ccc agc cgg gag gag 1104
Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu
355 360 365
atg acc aag aac cag gtg tcc ctc acc tgt ctg gtg aag ggc ttc tac 1152
Met Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr
370 375 380
ccc agc gac atc gcc gtg gag tgg gag agc aac ggc cag ccc gag aac 1200
Pro Ser Asp Ile Ala Val Glu Trp Glu Set Asn Gly Gln Pro Glu Asn
385 390 395 400
aac tac aag acc acc ccc cct gtg ctg gac agc gac ggc agc ttc ttc 1248
Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe
405 410 415
ctg tac agc aag ctc acc gtg gac aag agc cgg tgg cag cag ggc aac 1296
Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn
420 425 430
gtg ttc agc tgc agc gtg atg cac gag gcc ctg cac aac cac tac acc 1344
yal Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr
435 440 445
cag aag agc ctg agc ctg agc ccc ggc aag 1374
Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys
450 455
<210>337
<211>458
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>337
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly His Tle Phe Ser Gly Tyr
20 25 30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Asn Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Gln Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Asp Leu Ser Asn Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Val Lys Asp Gly Tyr Cys Thr Leu Thr Ser Cys Pro Val Gly
100 105 110
Trp Tyr Phe Asp Leu Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser
115 120 125
Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys
130 135 140
Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr
145 150 155 160
Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser
165 170 175
Gly Val His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser
180 185 190
Leu Ser Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr
195 200 205
Tyr Ile Cys Asn Val Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys
210 215 220
Arg Val Glu Pro Lys Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys
225 230 235 240
Pro Ala Pro Glu Leu Leu Gly Gly Pro Ser Val Phe Leu Phe Pro Pro
245 250 255
Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys
260 265 270
Val Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp
275 280 285
Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu
290 295 300
Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu
305 310 315 320
His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn
325 330 335
Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly
340 345 350
Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu
355 360 365
Met Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr
370 375 380
Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn
385 390 395 400
Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe
405 410 415
Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn
420 425 430
Val Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr
435 440 445
Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys
450 455
<210>338
<211>639
<212>DNA
<213>Artificial
<220>
<223>CR6328Light chain
<220>
<221>CDS
<222>(1)..(639)
<400>338
gaa att gtg atg acg cag tct cca ggc acc ctg tct ttg tct cca ggg 48
Glu Ile Val Met Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly
1 5 10 15
gaa aga gcc acc ctc tcg tgc agg gcc agt cag agt gtt agc agc agc 96
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser
20 25 30
tac tta gcc tgg tac cag cag aaa cct ggc cag gct ccc agg ctc ctc 144
Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu
35 40 45
atc ttt ggt gcc tcc agc agg gcc act ggc atc cca gac agg ttc agt 192
Ile Phe Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser
50 55 60
ggc agt ggg tct ggg aca gac ttc act ctc acc atc agc aga ctg gag 240
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu
65 70 75 80
cct gaa gat ttt gca gtg tat tac tgt cag cag tat ggt agc tca ctc 288
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Leu
85 90 95
act ttc ggc gga ggg acc aag ctg gag atc aaa cgt gcg gcc gca ccc 336
Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys Arg Ala Ala Ala Pro
100 105 110
agc gtg ttc atc ttc ccc ccc tcc gac gag cag ctg aag agc ggc acc 384
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
gcc agc gtg gtg tgc ctg ctg aac aac ttc tac ccc cgg gag gcc aag 432
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
gtg cag tgg aag gtg gac aac gcc ctg cag agc ggc aac agc cag gag 480
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
agc gtg acc gag cag gac agc aag gac tcc acc tac agc ctg agc agc 528
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
acc ctc acc ctg agc aag gcc gac tac gag aag cac aag gtg tac gcc 576
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
tgc gag gtg acc cac cag ggc ctg agc agc ccc gtg acc aag agc ttc 624
Cys Glu Val Thr His Gin Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
aac cgg ggc gag tgt 639
Asn Arg Gly Glu Cys
210
<210>339
<211>213
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>339
Glu Ile Val Met Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly
1 5 10 15
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser
20 25 30
Tyr Leu Ala Trn Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu
35 40 45
Ile Phe Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser
50 55 60
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu
65 70 75 80
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Leu
85 90 95
Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys Arg Ala Ala Ala Pro
100 105 110
Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr
115 120 125
Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys
130 135 140
Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu
145 150 155 160
Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser
165 170 175
Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala
180 185 190
Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe
195 200 205
Asn Arg Gly Glu Cys
210
<210>340
<211>1353
<212>DNA
<213>Artificial
<220>
<223>CR6329Heavy chain
<220>
<221>CDS
<222>(1)..(1353)
<400>340
gag gtc cag ctg gta cag tct ggg gct gag gtt aag aag cct ggg tcc 48
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aag gtc tcc tgc aag gct tct gga ggc atc ttc aga agc aat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Ile Phe Arg Ser Asn
20 25 30
tct atc agt tgg gtg cga cag gcc cct ggg caa ggg ctt gag tgg atg 144
Ser Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga ggg atc ttc gct ctt ttc gga aca aca gac tac gcg cag aag ttc 192
Gly Gly Ile Phe Ala Leu Phe Gly Thr Thr Asp Tyr Ala Gln Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac gaa tct tcg acc aca gtc tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Ser Thr Thr Val Tyr
65 70 75 80
ctg gag ctg agt agc ctg aca tct gag gac acg gcc gtt tat tac tgt 288
Leu Glu Leu Ser Ser Leu Thr Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
gcg aga ggc agt ggc tac acc aca cgc aac tac ttt gac tac tgg ggc 336
Ala Arg Gly Ser Gly Tyr Thr Thr Arg Asn Tyr Phe Asp Tyr Trp Gly
100 105 110
cag ggc acc ctg gtc acc gtc tcg agt gct agc acc aag ggc ccc agc 384
Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser
115 120 125
gtg ttc ccc ctg gcc ccc agc agc aag agc acc agc ggc ggc aca gcc 432
Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala
130 135 140
gcc ctg ggc tgc ctg gtg aag gac tac ttc ccc gag ccc gtg acc gtg 480
Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val
145 150 155 160
agc tgg aac agc ggc gcc ttg acc agc ggc gtg cac acc ttc ccc gcc 528
Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala
165 170 175
gtg ctg cag agc agc ggc ctg tac agc ctg agc agc gtg gtg acc gtg 576
Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val
180 185 190
ccc agc agc agc ctg ggc acc cag acc tac atc tgc aac gtg aac cac 624
Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His
195 200 205
aag ccc agc aac acc aag gtg gac aaa cgc gtg gag ccc aag agc tgc 672
Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys
210 215 220
gac aag acc cac acc tgc ccc ccc tgc cct gcc ccc gag ctg ctg ggc 720
Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly
225 230 235 240
gga ccc tcc gtg ttc ctg ttc ccc ccc aag ccc aag gac acc ctc atg 768
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met
245 250 255
atc agc cgg acc ccc gag gtg acc tgc gtg gtg gtg gac gtg agc cac 816
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His
260 265 270
gag gac ccc gag gtg aag ttc aac tgg tac gtg gac ggc gtg gag gtg 864
Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val
275 280 285
cac aac gcc aag acc aag ccc cgg gag gag cag tac aac agc acc tac 912
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr
290 295 300
cgg gtg gtg agc gtg ctc acc gtg ctg cac cag gac tgg ctg aac ggc 960
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly
305 310 315 320
aag gag tac aag tgc aag gtg agc aac aag gcc ctg cct gcc ccc atc 1008
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile
325 330 335
gag aag acc atc agc aag gcc aag ggc cag ccc cgg gag ccc cag gtg 1056
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val
340 345 350
tac acc ctg ccc ccc agc cgg gag gag atg acc aag aac cag gtg tcc 1104
Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser
355 360 365
ctc acc tgt ctg gtg aag ggc ttc tac ccc agc gac atc gcc gtg gag 1152
Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala ValGlu
370 375 380
tgg gag agc aac ggc cag ccc gag aac aac tac aag acc acc ccc cct 1200
Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro
385 390 395 400
gtg ctg gac agc gac ggc agc ttc ttc ctg tac agc aag ctc acc gtg 1248
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val
405 410 415
gac aag agc cgg tgg cag cag ggc aac gtg ttc agc tgc agc gtg atg 1296
Asp Lys Ser Arg Trp Gln Gln Gly Ash Val Phe Ser Cys Ser Val Met
420 425 430
cac gag gcc ctg cac aac cac tac acc cag aag agc ctg agc ctg agc 1344
His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser
435 440 445
ccc ggc aag 1353
Pro Gly Lys
450
<210>341
<211>451
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>341
Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Ile Phe Arg Ser Asn
20 25 30
Ser Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Gly Ile Phe Ala Leu Phe Gly Thr Thr Asp Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Ser Thr Thr Val Tyr
65 70 75 80
Leu Glu Leu Ser Ser Leu Thr Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Ser Gly Tyr Thr Thr Arg Asn Tyr Phe Asp Tyr Trp Gly
100 105 110
Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser
115 120 125
Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala
130 135 140
Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val
145 150 155 160
Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala
165 170 175
Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val
180 185 190
Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His
195 200 205
Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys
210 215 220
Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly
225 230 235 240
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met
245 250 255
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His
260 265 270
Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val
275 280 285
Gis Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr
290 295 300
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly
305 310 315 320
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile
325 330 335
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val
340 345 350
Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser
355 360 365
Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu
370 375 380
Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro
385 390 395 400
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val
405 410 415
Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met
420 425 430
His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser
435 440 445
Pro Gly Lys
450
<210>342
<211>654
<212>DNA
<213>Artificial
<220>
<223>CR6329Light chain
<220>
<221>CDS
<222>(1)..(654)
<400>342
gaa att gtg ctg act cag tct cca ggc acc ctg tct ttg tct cca ggg 48
Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly
1 5 10 15
gaa aga gcc aca ctc tcc tgc agg gcc agt cag agt gtt agc agc aac 96
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn
20 25 30
tac tta ggc tgg tac cag cag aaa cct ggc cag gct ccc agg ctc ctg 144
Tyr Leu Gly Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro ArgLeu Leu
35 40 45
atc tat ggt gca tcc agc agg gcc agt ggc atc cca gac agg ttc agt 192
Ile Tyr Gly Ala Ser Ser Arg Ala Ser Gly Ile Pro Asp Arg Phe Ser
50 55 60
ggc ggt ggg tct ggg aca gac ttc act ctc acc atc agc aga ctg gag 240
Gly Gly Gly Ser Gly Tnr Asp Phe Tnr Leu Thr Ile Ser Arg Leu Glu
65 70 75 80
cct gaa gat ttt gca gtg tat tac tgt cag cag tat ggt agc tca ccc 288
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro
85 90 95
ctc act ttc ggc gga ggg acc aag gtg gag atc aaa cgt gcg gcc gca 336
Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Ala Ala Ala
100 105 110
ggc cag ccc aag gcc gct ccc agc gtg acc ctg ttc ccc ccc tcc tcc 384
Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro Ser Ser
115 120 125
gag gag ctg cag gcc aac aag gcc acc ctg gtg tgc ctc atc agc gac 432
Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile Ser Asp
130 135 140
ttc tac cct ggc gcc gtg acc gtg gcc tgg aag gcc gac agc agc ccc 480
Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser Ser Pro
145 150 155 160
gtg aag gcc ggc gtg gag acc acc acc ccc agc aag cag agc aac aac 528
Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser Asn Asn
165 170 175
aag tac gcc gcc agc agc tac ctg agc ctc acc ccc gag cag tgg aag 576
Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln Trp Lys
180 185 190
agc cac cgg agc tac agc tgc cag gtg acc cac gag ggc agc acc gtg 624
Ser His Arg Ser Tyr Ser Cys Gln yal Thr His Glu Gly Ser Thr Val
195 200 205
gag aag acc gtg gcc ccc acc gag tgc agc 654
Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215
<210>343
<211>218
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>343
Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly
1 5 10 15
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn
20 25 30
Tyr Leu Gly Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu
35 40 45
Ile Tyr Gly Ala Ser Ser Arg Ala Ser Gly Ile Pro Asp Arg Phe Ser
50 55 60
Gly Gly Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu
65 70 75 80
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro
85 90 95
Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Ala Ala Ala
100 105 110
Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro Ser Ser
115 120 125
Glu Glu Leu Gln Ala Ash Lys Ala Thr Leu Val Cys Leu Ile Ser Asp
130 135 140
Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser Ser Pro
145 150 155 160
Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser Asn Asn
165 170 175
Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln Trp Lys
180 185 190
Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser Thr Val
195 200 205
Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215
<210>344
<211>1350
<212>DNA
<213>Artificial
<220>
<223>CR6332Heavy chain
<220>
<221>CDS
<222>(1)..(1350)
<400>344
cag gtg cag ctg gtg cag tct ggg gct gag gtg aag aag cct ggg tcc 48
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gta aag gtc tcc tgc aag gct tct gga ggc ccc ttc cgc aat ttt 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Arg Asn Phe
20 25 30
gct atc aac tgg gtg cga cag gcc cct gga caa ggg ctt gag tgg atg 144
Ala Ile Asn Tro Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga ggg atc atc gct gtc ttt ggg acg aca aag tac gca cat aag ttc 192
Gly Gly Ile Ile Ala Val Phe Gly Thr Thr Lys Tyr Ala His Lys Phe
50 55 60
cag ggc aga gtc acc atc acc gcg gac gac tcc aca aat aca gct tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Asp Ser Thr Asn Thr Ala Tyr
65 70 75 80
atg gag ctg ggc agc ctg aaa tct gag gac acg gcc gtg tat tac tgt 288
Met Glu Leu Gly Ser Leu Lys Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
gcg aga ggt ccc cac tac tac tcc tcc tac atg gac gtc tgg ggc gaa 336
Ala Arg Gly Pro his Tyr Tyr Ser Ser Tyr Met Asp Val Trp Gly Glu
100 105 110
ggg acc acg gtc acc gtc tcg agt gct agc acc aag ggc ccc agc gtg 384
Gly Thr Thr Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val
115 120 125
ttc ccc ctg gcc ccc agc agc aag agc acc agc ggc ggc aca gcc gcc 432
Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala
130 135 140
ctg ggc tgc ctg gtg aag gac tac ttc ccc gag ccc gtg acc gtg agc 480
Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser
145 150 155 160
tgg aac agc ggc gcc ttg acc agc ggc gtg cac acc ttc ccc gcc gtg 528
Trp Asn Ser Gly Ala Leu Tnr Ser Gly Val His Tnr Pne Pro Ala Val
165 170 175
ctg cag agc agc ggc ctg tac agc ctg agc age gtg gtg acc gtg ccc 576
Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro
180 185 190
agc agc agc ctg ggc acc cag acc tac atc tgc aac gtg aac cac aag 624
Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Ash Val Ash His Lys
195 200 205
ccc agc aac acc aag gtg gac aaa cgc gtg gag ccc aag agc tgc gac 672
Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp
210 215 220
aag acc cac acc tgc ccc ccc tgc cct gcc ccc gag ctg ctg ggc gga 720
Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly
225 230 235 240
ccc tcc gtg ttc ctg ttc ccc ccc aag ccc aag gac acc ctc atg atc 768
Pro Ser Val Pne Leu Pne Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
agc cgg acc ccc gag gtg acc tgc gtg gtg gtg gac gtg agc cac gag 816
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu
260 265 270
gac ccc gag gtg aag ttc aac tgg tac gtg gac ggc gtg gag gtg cac 864
Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
aac gcc aag acc aag ccc cgg gag gag cag tac aac agc acc tac cgg 912
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg
290 295 300
gtg gtg agc gtg ctc acc gtg ctg cac cag gac tgg ctg aac ggc aag 960
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
gag tac aag tgc aag gtg agc aac aag gcc ctg cct gcc ccc atc gag 1008
Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu
325 330 335
aag acc atc agc aag gcc aag ggc cag ccc cgg gag ccc cag gtg tac 1056
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
acc ctg ccc ccc agc cgg gag gag atg acc aag aac cag gtg tcc ctc 1104
Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lsy Asn Gln Val Ser Leu
355 360 365
acc tgt ctg gtg aag ggc ttc tac ccc agc gac atc gcc gtg gag tgg 1152
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
gag agc aac ggc cag ccc gag aac aac tac aag acc acc ccc cct gtg 1200
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
ctg gac agc gac ggc agc ttc ttc ctg tac agc aag ctc acc gtg gac 1248
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp
405 410 415
aag agc cgg tgg cag cag ggc aac gtg ttc agc tgc agc gtg atg cac 1296
Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
gag gcc ctg cac aac cac tac acc cag aag agc ctg agc ctg agc ccc 1344
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro
435 440 445
ggc aag 1350
Gly Lys
450
<210>345
<211>450
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>345
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Pro Phe Arg Asn Phe
20 25 30
Ala Ile Asn Trp ValArg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Gly Ile Ile Ala Val Phe Gly Thr Thr Lys Tyr Ala His Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Asp Ser Thr Asn Thr Ala Tyr
65 70 75 80
Met Glu Leu Gly Ser Leu Lys Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Pro His Tyr Tyr Ser Ser Tyr Met Asp Val Trp Gly Glu
100 105 110
Gly Thr Thr Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val
115 120 125
Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala
130 135 140
Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser
145 150 155 160
Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val
165 170 175
Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro
180 185 190
Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys
195 200 205
Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp
210 215 220
Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly
225 230 235 240
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu
260 265 270
Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg
290 295 300
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu
325 330 335
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp
405 410 415
Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro
435 440 445
Gly Lys
450
<210>346
<211>636
<212>DNA
<213>Artificial
<220>
<223>CR6332Light chain
<220>
<221>CDS
<222>(1)..(636)
<400>346
gac atc cag ttg acc cag tct cca tcc tcc ctg tct gca tct gta gga 48
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
gac aga gtc acc atc act tgc cgg gcg agt cag ggc att agc act tat 96
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Thr Tyr
20 25 30
tta gcc tgg tat cag cag aaa ccc ggg aaa gtt cct aaa ctc ctg atc 144
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Val Pro Lys Leu Leu Ile
35 40 45
tat gct gca tcc act ttg caa tca ggg gtc cca tct cgg ttc agt ggc 192
Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
agt gga tct ggg aca gat ttc act ctc acc atc agc agc ctg cag cct 240
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
gaa gat gtt gca act tat tac tgt caa aag tat aac agt gcc cct tct 288
Glu Asp Val Ala Thr Tyr Tyr Cys Gln Lys Tyr Asn Ser Ala Pro Ser
85 90 95
ttc ggc cct ggg acc aaa gtg gat atc aaa cgt gcg gcc gca ccc agc 336
Phe Gly Pro Gly Thr Lys Val Asp Ile Lys Arg Ala Ala Ala Pro Ser
100 105 110
gtg ttc atc ttc ccc ccc tcc gac gag cag ctg aag agc ggc acc gcc 384
Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr Ala
115 120 125
agc gtg gtg tgc ctg ctg aac aac ttc tac ccc cgg gag gcc aag gtg 432
Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys Val
130 135 140
cag tgg aag gtg gac aac gcc ctg cag agc ggc aac agc cag gag agc 480
Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn Ser Gln Glu Ser
145 150 155 160
gtg acc gag cag gac agc aag gac tcc acc tac agc ctg agc agc acc 528
Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser Thr
165 170 175
ctc acc ctg agc aag gcc gac tac gag aag cac aag gtg tac gcc tgc 576
Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys Gis Lys Val Tyr Ala Cys
180 185 190
gag gtg acc cac cag ggc ctg agc agc ccc gtg acc aag agc ttc aac 624
Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe Asn
195 200 205
cgg ggc gag tgt 636
Arg Gly Glu Cys
210
<210>347
<211>212
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>347
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
1 5 10 15
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Thr Tyr
20 25 30
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Val Pro Lys Leu Leu Ile
35 40 45
Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
50 55 60
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65 70 75 80
Glu Asp Val Ala Thr Tyr Tyr Cys Gln Lys Tyr Asn Ser Ala Pro Ser
85 90 95
Phe Gly Pro Gly Thr Lys Val Asp Ile Lys Arg Ala Ala Ala Pro Ser
100 105 110
Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly Thr Ala
115 120 125
Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala Lys Val
130 135 140
Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Ash Ser Gln Glu Ser
145 150 155 160
Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser Ser Thr
165 170 175
Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr Ala Cys
180 185 190
Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr Lys Ser Phe Asn
195 200 205
Arg Gly Glu Cys
210
<210>348
<211>1350
<212>DNA
<213>Artificial
<220>
<223>CR6334Heavy chain
<220>
<221>CDS
<222>(1)..(1350)
<400>348
gag gtg cag ctg gtg gag act ggg gct gag gtg aag aag cct ggg tcc 48
Glu Val Gln Leu Val Glu Thr Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aag gtc ccc tgc aaa tct tct gga agc ccc ttc agg agt aat 96
Ser Val Lys Val Pro Cys Lys Ser Ser Gly Ser Pro Phe Arg Ser Asn
20 25 30
gct gtc agc tgg gtg cga cag gcc ccc gga caa ggg ctt gag tgg gtg 144
Ala Val Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Val
35 40 45
gga gga atc ctc ggt gtc ttt ggt tca cca agc tac gca cag aag ttc 192
Gly Gly Ile Leu Gly ValPhe Gly Ser Pro Ser Tyr Ala Gln Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac gaa tcc acc aac aca gtc cac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Asn Thr Val His
65 70 75 80
atg gag ctg aga ggt ttg aga tct gag gac acg gcc gtg tat tat tgt 288
Met Glu Leu Arg Gly Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
gcg aga ggt cct acc tac tac tac tcc tac atg gac gtc tgg ggc aaa 336
Ala Arg Gly Pro Thr Tyr Tyr Tyr Ser Tyr Met Asp Val Trp Gly Lys
100 105 110
ggg acc acg gtc acc gtc tcg agt gct agc acc aag ggc ccc agc gtg 384
Gly Thr Thr Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val
115 120 125
ttc ccc ctg gcc ccc agc agc aag agc acc agc ggc ggc aca gcc gcc 432
Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala
130 135 140
ctg ggc tgc ctg gtg aag gac tac ttc ccc gag ccc gtg acc gtg agc 480
Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser
145 150 155 160
tgg aac agc ggc gcc ttg acc agc ggc gtg cac acc ttc ccc gcc gtg 528
Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val
165 170 175
ctg cag agc agc ggc ctg tac agc ctg agc agc gtg gtg acc gtg ccc 576
Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro
180 185 190
agc agc agc ctg ggc acc cag acc tac atc tgc aac gtg aac cac aag 624
Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Ash His Lys
195 200 205
ccc agc aac acc aag gtg gac aaa cgc gtg gag ccc aag agc tgc gac 672
Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp
210 215 220
aag acc cac acc tgc ccc ccc tgc cct gcc ccc gag ctg ctg ggc gga 720
Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly
225 230 235 240
ccc tcc gtg ttc ctg ttc ccc ccc aag ccc aag gac acc ctc atg atc 768
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
agc cgg acc ccc gag gtg acc tgc gtg gtg gtg gac gtg agc cac gag 816
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu
260 265 270
gac ccc gag gtg aag ttc aac tgg tac gtg gac ggc gtg gag gtg cac 864
Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly ValGlu Val His
275 280 285
aac gcc aag acc aag ccc cgg gag gag cag tac aac agc acc tac cgg 912
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg
290 295 300
gtg gtg agc gtg ctc acc gtg ctg cac cag gac tgg ctg aac ggc aag 960
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
gag tac aag tgc aag gtg agc aac aag gcc ctg cct gcc ccc atc gag 1008
Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu
325 330 335
aag acc atc agc aag gcc aag ggc cag ccc cgg gag ccc cag gtg tac 1056
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
acc ctg ccc ccc agc cgg gag gag atg acc aag aac cag gtg tcc ctc 1104
Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
acc tgt ctg gtg aag ggc ttc tac ccc agc gac atc gcc gtg gag tgg 1152
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
gag agc aac ggc cag ccc gag aac aac tac aag acc acc ccc cct gtg 1200
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
ctg gac agc gac ggc agc ttc ttc ctg tac agc aag ctc acc gtg gac 1248
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp
405 410 415
aag agc cgg tgg cag cag ggc aac gtg ttc agc tgc agc gtg atg cac 1296
Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
gag gcc ctg cac aac cac tac acc cag aag agc ctg agc ctg agc ccc 1344
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro
435 440 445
ggc aag 1350
Gly Lys
450
<210>349
<211>450
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>349
Glu Val Gln Leu Val Glu Thr Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser ValLys Val Pro Cys Lys Ser Ser Gly Ser Pro Phe Arg Ser Asn
20 25 30
Ala Val Ser Trp Val Arg Gln Ala Pro GIy Gln Gly Leu Glu Trp Val
35 40 45
Gly Gly Ile Leu Gly Val Phe Gly Ser Pro Ser Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Asn Thr Val His
65 70 75 80
Met Glu Leu Arg Gly Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Gly Pro Thr Tyr Tyr Tyr Ser Tyr Met Asp Val Trp Gly Lys
100 105 110
Gly Thr Thr Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val
115 120 125
Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala
130 135 140
Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser
145 150 155 160
Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val
165 170 175
Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro
180 185 190
Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn Gis Lys
195 200 205
Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp
210 215 220
Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly
225 230 235 240
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu
260 265 270
Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg
290 295 300
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu
325 330 335
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp
405 410 415
Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro
435 440 445
Gly Lys
450
<210>350
<211>654
<212>DNA
<213>Artificial
<220>
<223>CR6334Light chain
<220>
<221>CDS
<222>(1)..(654)
<400>350
tcc tat gtg ctg act cag cca ccc tcg gag tca gtg gcc cca gga cag 48
Ser Tyr Val Leu Thr Gln Pro Pro Ser Glu Ser Val Ala Pro Gly Gln
1 5 10 15
acg gcc agg att acc tgt ggg gga aat aac att gga aga aat agt gtg 96
Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Arg Asn Ser Val
20 25 30
cac tgg tat cag cag aag cca ggc cag gcc cct gtg ctg gtc gtg tat 144
His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr
35 40 45
gat gat agc gac cgg ccc tca ggg atc cct gag cga ttt tct ggc tcc 192
Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser
50 55 60
aag tct ggg aac acg gcc acc ctg att atc agc agg gtc gaa gtc ggg 240
Lys Ser Gly Asn Thr Ala Thr Leu Ile Ile Ser Arg Val Glu Val Gly
65 70 75 80
gat gag gcc gac tac tac tgt cag gtg tgg cat agt agt agt gat cat 288
Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp His Ser Ser Ser Asp His
85 90 95
tat gtc ttc gga act ggg acc aag gtc acc gtc cta ggt gcg gcc gca 336
Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu Gly Ala Ala Ala
100 105 110
ggc cag ccc aag gcc gct ccc agc gtg acc ctg ttc ccc ccc tcc tcc 384
Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro Ser Ser
115 120 125
gag gag ctg cag gcc aac aag gcc acc ctg gtg tgc ctc atc agc gac 432
Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile Ser Asp
130 135 140
ttc tac cct ggc gcc gtg acc gtg gcc tgg aag gcc gac agc agc ccc 480
Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser Ser Pro
145 150 155 160
gtg aag gcc ggc gtg gag acc acc acc ccc agc aag cag agc aac aac 528
Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser Asn Ash
165 170 175
aag tac gcc gcc agc agc tac ctg agc ctc acc ccc gag cag tgg aag 576
Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln Trp Lys
180 185 190
agc cac cgg agc tac agc tgc cag gtg acc cac gag ggc agc acc gtg 624
Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser Thr Val
195 200 205
gag aag acc gtg gcc ccc acc gag tgc agc 654
Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215
<210>351
<211>218
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>351
Ser Tyr Val Leu Thr Gln Pro Pro Ser Glu Ser Val Ala Pro Gly Gln
1 5 10 15
Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Arg Asn Ser Val
20 25 30
His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr
35 40 45
Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser
50 55 60
Lys Ser Gly Asn Thr Ala Thr Leu Ile Ile Ser Arg Val Glu Val Gly
65 70 75 80
Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp His Ser Ser Ser Asp His
85 90 95
Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu Gly Ala Ala Ala
100 105 110
Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro Ser Ser
115 120 125
Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile Ser Asp
130 135 140
Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser Ser Pro
145 150 155 160
Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser Asn Asn
165 170 175
Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln Trp Lys
180 185 190
Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser Thr Val
195 200 205
Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215
<210>352
<211>1350
<212>DNA
<213>Artificial
<220>
<223>CR6336Heavy chain
<220>
<221>CDS
<222>(1)..(1350)
<400>352
cag atg cag ctg gta caa tct gga gct gag gtg aag aag cct ggg tcc 48
Gln Met Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aag gtc tcc tgc aag gct tct gga ggc acc ttc agc agc tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr
20 25 30
gct atc agc tgg gtg cga cag gcc cct gga caa ggg ctt gag tgg atg 144
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga ggg atc ttc ggt atg ttt ggg aca gca aac tac gcg cag aag ttc 192
Gly Gly Ile Phe Gly Met Phe Gly Thr Ala Asn Tyr Ala Gln Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac gaa ttc acg agc gcg gcc tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Phe Thr Ser Ala Ala Tyr
65 70 75 80
atg gag ctg agc agc ctg gga tct gag gac acg gcc atg tat tac tgt 288
Met Glu Leu Ser Ser Leu Gly Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
gcg agg tct agt ggt tat tac ccc caa tac ttc cag gac tgg ggc cag 336
Ala Arg Ser Ser Gly Tyr Tyr Pro Gln Tyr Phe Gln Asp Trp Gly Gln
100 105 110
ggc acc ctg gtc acc gtc tcg agt gct agc acc aag ggc ccc agc gtg 384
Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val
115 120 125
ttc ccc ctg gcc ccc agc agc aag agc acc agc ggc ggc aca gcc gcc 432
Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala
130 135 140
ctg ggc tgc ctg gtg aag gac tac ttc ccc gag ccc gtg acc gtg agc 480
Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser
145 150 155 160
tgg aac agc ggc gcc ttg acc agc ggc gtg cac acc ttc ccc gcc gtg 528
Trp Asp Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val
165 170 175
ctg cag agc agc ggc ctg tac agc ctg agc agc gtg gtg acc gtg ccc 576
Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro
180 185 190
agc agc agc ctg ggc acc cag acc tac atc tgc aac gtg aac cac aag 624
Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Ash His Lys
195 200 205
ccc agc aac acc aag gtg gac aaa cgc gtg gag ccc aag agc tgc gac 672
Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp
210 215 220
aag acc cac acc tgc ccc ccc tgc cct gcc ccc gag ctg ctg ggc gga 720
lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly
225 230 235 240
ccc tcc gtg ttc ctg ttc ccc ccc aag ccc aag gac acc ctc atg atc 768
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
agc cgg acc ccc gag gtg acc tgc gtg gtg gtg gac gtg agc cac gag 816
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu
260 265 270
gac ccc gag gtg aag ttc aac tgg tac gtg gac ggc gtg gag gtg cac 864
Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
aac gcc aag acc aag ccc cgg gag gag cag tac aac agc acc tac cgg 912
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg
290 295 300
gtg gtg agc gtg ctc acc gtg ctg cac cag gac tgg ctg aac ggc aag 960
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
gag tac aag tgc aag gtg agc aac aag gcc ctg cct gcc ccc atc gag 1008
Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu
325 330 335
aag acc atc agc aag gcc aag ggc cag ccc cgg gag ccc cag gtg tac 1056
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
acc ctg ccc ccc agc cgg gag gag atg acc aag aac cag gtg tcc ctc 1104
Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
acc tgt ctg gtg aag ggc ttc tac ccc agc gac atc gcc gtg gag tgg 1152
Thr Cys Leu Val Lys Gly Pne Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
gag agc aac ggc cag ccc gag aac aac tac aag acc acc ccc cct gtg 1200
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Tnr Pro Pro Val
385 390 395 400
ctg gac agc gac ggc agc ttc ttc ctg tac agc aag ctc acc gtg gac 1248
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp
405 410 415
aag agc cgg tgg cag cag ggc aac gtg ttc agc tgc agc gtg atg cac 1296
Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
gag gcc ctg cac aac cac tac acc cag aag agc ctg agc ctg agc ccc 1344
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro
435 440 445
ggc aag 1350
Gly Lys
450
<210>353
<211>450
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>353
Gln Met Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
l 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr
20 25 30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Gly Ile Phe Gly Met Phe Gly Thr Ala Ash Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Phe Thr Ser Ala Ala Tyr
65 70 75 80
Met Glu Leu Ser Ser Leu Gly Ser Glu Asp Thr Ala Met Tyr Tyr Cys
85 90 95
Ala Arg Ser Ser Gly Tyr Tyr Pro Gln Tyr Phe Gln Asp Trp Gly Gln
100 105 110
Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val
115 120 125
Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala
130 135 140
Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser
145 150 155 160
Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val
165 170 175
Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro
180 185 190
Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asp Val Asn Gis Lys
195 200 205
Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp
210 215 220
Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly
225 230 235 240
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu
260 265 270
Asp Pro Glu Val Lys Phe Asp Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg
290 295 300
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Ash Gly Lys
305 310 315 320
Glu Tyr Lys Cys Lys Val Ser Ash Lys Ala Leu Pro Ala Pro Ile Glu
325 330 335
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
Glu Ser Asn Gly Gln Pro Glu Asn Ash Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp
405 410 415
Lys Ser Arg Trp Gln Gln Gly Ash Val Phe Ser Cys Ser Val Met His
420 425 430
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro
435 440 445
Gly Lys
450
<210>354
<211>642
<212>DNA
<213>Artificial
<220>
<223>CR6336Light chain
<220>
<221>CDS
<222>(1)..(642)
<400>354
gaa att gtg atg aca cag tct cca ggc acc ctg tct ttg tct cca ggg 48
Glu Ile Val Met Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly
1 5 10 15
caa aga gcc acc ctc tcc tgc agg gcc agt cag agt gtt agc agc agc 96
Gln Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser
20 25 30
tac tta gcc tgg tac cag cag aaa cct ggc cag gct ccc aga ctc ctc 144
Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu
35 40 45
atg tat ggt gca tcc agc agg gcc act ggc atc cca gac agg ttc agt 192
Met Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser
50 55 60
ggc agt ggg tct ggg aca gac ttc act ctc acc atc agc aga ctg gag 240
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu
65 70 75 80
cct gaa gat ttt gca gtg tat tac tgt cag cag tat ggt agc tca tcg 288
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Ser
85 90 95
ctc act ttc ggc gga ggg acc aag ctg gag ate aaa cgt gcg gcc gca 336
Leu Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys Arg Ala Ala Ala
100 105 110
ccc agc gtg ttc atc ttc ccc ccc tcc gac gag cag ctg aag agc ggc 384
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
acc gcc agc gtg gtg tgc ctg ctg aac aac ttc tac ccc cgg gag gcc 432
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
aag gtg cag tgg aag gtg gac aac gcc ctg cag agc ggc aac agc cag 480
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Ash Ser Gln
145 150 155 160
gag agc gtg acc gag cag gac agc aag gac tcc acc tac agc ctg agc 528
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
agc acc ctc acc ctg agc aag gcc gac tac gag aag cac aag gtg tac 576
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
gcc tgc gag gtg acc cac cag ggc ctg agc agc ccc gtg acc aag agc 624
Ala Cys Glu Val Thr Gis Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
ttc aac cgg ggc gag tgt 642
Phe Asn Arg Gly Glu Cys
210
<210>355
<211>214
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>355
Glu Ile Val Met Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly
1 5 10 15
Gln Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser
20 25 30
Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu
35 40 45
Met Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser
50 55 60
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu
65 70 75 80
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Ser
85 90 95
Leu Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys Arg Ala Ala Ala
100 105 110
Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys Ser Gly
115 120 125
Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg Glu Ala
130 135 140
Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Ash Ser Gln
145 150 155 160
Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser Leu Ser
165 170 175
Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys Val Tyr
180 185 190
Ala Cys Glu Val Thr Gis Gln Gly Leu Ser Ser Pro Val Thr Lys Ser
195 200 205
Phe Asn Arg Gly Glu Cys
210
<210>356
<211>1353
<212>DNA
<213>Artificial
<220>
<223>CR6339Heavy chain
<220>
<221>CDS
<222>(1)..(1353)
<400>356
gag gtg cag ctg gtg gag tcc ggg gct gag gtg aag aag cct ggg tcc 48
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aag gtc tcc tgc aag gct tct gga ggc atc ttc aac agt tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Ile Phe Asn Ser Tyr
20 25 30
gct atc agc tgg gtg cga cag gcc cct gga caa ggg ctt gag tgg atg 144
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga ggc atc atc gct atc ttt cat aca cca aag tac gca cag aag ttc 192
Gly Gly Ile Ile Ala Ile Phe His Thr Pro Lys Tyr Ala Gln Lys Phe
50 55 60
cag ggc aga gtc acg att acc gcg gac gaa tcc acg aac aca gcc tac 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Asn Thr Ala Tyr
65 70 75 80
atg gaa ctg aga agc ctg aaa tct gag gac acg gcc ctg tat tac tgt 288
Met Glu Leu Arg Ser Leu Lys Ser Glu Asp Thr Ala Leu Tyr Tyr Cys
85 90 95
gcg aga ggg tcc act tac gat ttt tcg agt ggc ctt gac tac tgg ggc 336
Ala Arg Gly Ser Thr Tyr Asp Phe Ser Ser Gly Leu Asp Tyr Trp Gly
100 105 110
cag gga acc ctg gtc acc gtc tcg agt gct agc acc aag ggc ccc agc 384
Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser
115 120 125
gtg ttc ccc ctg gcc ccc agc agc aag agc acc agc ggc ggc aca gcc 432
Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala
130 135 140
gcc ctg ggc tgc ctg gtg aag gac tac ttc ccc gag ccc gtg acc gtg 480
Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val
145 150 155 160
agc tgg aac agc ggc gcc ttg acc agc ggc gtg cac acc ttc ccc gcc 528
Ser Trp Asp Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala
165 170 175
gtg ctg cag agc agc ggc ctg tac agc ctg agc agc gtg gtg acc gtg 576
Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val
180 185 190
ccc agc agc agc ctg ggc acc cag acc tac atc tgc aac gtg aac cac 624
Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn Gis
195 200 205
aag ccc agc aac acc aag gtg gac aaa cgc gtg gag ccc aag agc tgc 672
Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys
210 215 220
gac aag acc cac acc tgc ccc ccc tgc cct gcc ccc gag ctg ctg ggc 720
Asp Lys Thr Gis Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly
225 230 235 240
gga ccc tcc gtg ttc ctg ttc ccc ccc aag ccc aag gac acc ctc atg 768
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met
245 250 255
atc agc cgg acc ccc gag gtg acc tgc gtg gtg gtg gac gtg agc cac 816
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His
260 265 270
gag gac ccc gag gtg aag ttc aac tgg tac gtg gac ggc gtg gag gtg 864
Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val
275 280 285
cac aac gcc aag acc aag ccc cgg gag gag cag tac aac agc acc tac 912
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr
290 295 300
cgg gtg gtg agc gtg ctc acc gtg ctg cac cag gac tgg ctg aac ggc 960
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly
305 310 315 320
aag gag tac aag tgc aag gtg agc aac aag gcc ctg cct gcc ccc atc 1008
Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile
325 330 335
gag aag acc atc agc aag gcc aag ggc cag ccc cgg gag ccc cag gtg 1056
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val
340 345 350
tac acc ctg ccc ccc agc cgg gag gag atg acc aag aac cag gtg tcc 1104
Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser
355 360 365
ctc acc tgt ctg gtg aag ggc ttc tac ccc agc gac atc gcc gtg gag 1152
Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu
370 375 380
tgg gag agc aac ggc cag ccc gag aac aac tac aag acc ecc ccc cct 1200
Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro
385 390 395 400
gtg ctg gac agc gac ggc agc ttc ttc ctg tac agc aag ctc acc gtg 1248
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val
405 410 415
gac aag agc cgg tgg cag cag ggc aac gtg ttc agc tgc agc gtg atg 1296
Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met
420 425 430
cac gag gcc ctg cac aac cac tac acc cag aag agc ctg agc ctg agc 1344
Gis Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser
435 440 445
ccc ggc aag 1353
Pro Gly Lys
450
<210>357
<211>451
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>357
Glu Val Gln Leu Val Glu Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Ile Phe Asn Ser Tyr
20 25 30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Gly Ile Ile Ala Ile Phe His Thr Pro Lys Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Asn Thr Ala Tyr
65 70 75 80
Met Glu Leu Arg Ser Leu Lys Ser Glu Asp Thr Ala Leu Tyr Tyr Cys
85 90 95
Ala Arg Gly Ser Thr Tyr Asp Phe Ser Ser Gly Leu Asp Tyr Trp Gly
100 105 110
Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser
115 120 125
Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala
130 135 140
Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val
145 150 155 160
Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala
165 170 175
Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val
180 185 190
Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His
195 200 205
Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys
210 215 220
Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly
225 230 235 240
Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met
245 250 255
Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His
260 265 270
Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val
275 280 285
His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr
290 295 300
Arg Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly
305 310 315 320
Lys Glu Tyr Lys Cys Lys Val Ser Ash Lys Ala Leu Pro Ala Pro Ile
325 330 335
Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val
340 345 350
Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser
355 360 365
Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu
370 375 380
Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro
385 390 395 400
Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val
405 410 415
Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met
420 425 430
His Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu SerLeu Ser
435 440 445
Pro Gly Lys
450
<210>358
<211>654
<212>DNA
<213>Artificial
<220>
<223>CR6339Light chain
<220>
<221>CDS
<222>(1)..(654)
<400>358
cag gca ggg ctg act cag cca ccc tcg gtg tca gtg gcc cca gga cag 48
Gln Ala Gly Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Gln
1 5 10 15
acg gcc agg att acc tgt ggg gga aac aac att gga agt aaa agt gtg 96
Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Ser Val
20 25 30
cac tgg tac cag cag aag cca ggc cag gcc cct gtc cta gtc gtc tat 144
His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val ValTyr
35 40 45
gat gat agc gac cgg ccc tca ggg atc cct gag cga ttc tct ggc tcc 192
Asp Asp Ser Asp Arg Pro Ser Gly lle Pro Glu Arg Phe Ser Gly Ser
50 55 60
aac tct ggg aac acg gcc acc ctg acc atc agc agg gtc gaa gcc ggg 240
Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly
65 70 75 80
gat gag gcc gac tat tac tgt cag gtg tgg gat agt agt agt gat cat 288
Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His
85 90 95
gtg gta ttc ggc gga ggg acc aag ctg acc gtc cta ggt gcg gcc gca 336
Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu Gly Ala Ala Ala
100 105 110
ggc cag ccc aag gcc gct ccc agc gtg acc ctg ttc ccc ccc tcc tcc 384
Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro Ser Ser
115 120 125
gag gag ctg cag gcc aac aag gcc acc ctg gtg tgc ctc atc agc gac 432
Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile Ser Asp
130 135 140
ttc tac cct ggc gcc gtg acc gtg gcc tgg aag gcc gac agc agc ccc 480
Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser Ser Pro
145 150 155 160
gtg aag gcc ggc gtg gag acc acc acc ccc agc aag cag agc aac aac 528
Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser Asn Asn
165 170 175
aag tac gcc gcc agc agc tac ctg agc ctc acc ccc gag cag tgg aag 576
Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln Trp Lys
180 185 190
agc cac cgg agc tac agc tgc cag gtg acc cac gag ggc agc acc gtg 624
Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser Thr Val
195 200 205
gag aag acc gtg gcc ccc acc gag tgc agc 654
Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215
<210>359
<211>218
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>359
Gln Ala Gly Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Gln
1 5 10 15
Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Ser Lys Ser Val
20 25 30
His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr
35 40 45
Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser
50 55 60
Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly
65 70 75 80
Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His
85 90 95
Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu Gly Ala Ala Ala
100 105 110
Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro Ser Ser
115 120 125
Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile Ser Asp
130 135 140
Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser Ser Pro
145 150 155 160
Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser Asn Asn
165 170 175
Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln Trp Lys
180 185 190
Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser Thr Val
195 200 205
Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215
<210>360
<211>1368
<212>DNA
<213>Artificial
<220>
<223>CR6342Heavy chain
<220>
<221>CDS
<222>(1)..(1368)
<400>360
cag gtc cag ctg gtg cag tct ggg gct gag gtg aag aag cct ggg tcc 48
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aag gtc tcc tgc aag gct tct gga ggc ttc ttc agc agc tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Phe Phe Ser Ser Tyr
20 25 30
gct atc agc tgg gtg cgc cag gcc cct gga caa gga ctt gag tgg atg 144
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
ggg ggg gtc atc cct atc ttt cgt aca gca aac tac gca cag aac ttc 192
Gly Gly Val Ile Pro Ile Phe Arg Thr Ala Asn Tyr Ala Gln Ash Phe
50 55 60
cag ggc aga gtc acc att acc gcg gac gaa ttc aca tcg tat atg gag 240
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Phe Thr Ser Tyr Met Glu
65 70 75 80
ctg agc agc ctg aga tct gac gac acg gcc gtg tat tac tgt gcg agg 288
Leu Ser Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys Ala Arg
85 90 95
ttg aat tac cat gat tcg ggg act tat tat aac gcc ccc cgg ggc tgg 336
Leu Asn Tyr His Asp Ser Gly Thr Tyr Tyr Asn Ala Pro Arg Gly Trp
100 105 110
ttc gac ccc tgg ggc cag gga acc ctg gtc acc gtc tcg agt gct agc 384
Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser
115 120 125
acc aag ggc ccc agc gtg ttc ccc ctg gcc ccc agc agc aag agc acc 432
Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr
130 135 140
agc ggc ggc aca gcc gcc ctg ggc tgc ctg gtg aag gac tac ttc ccc 480
Ser Gly Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro
145 150 155 160
gag ccc gtg acc gtg agc tgg aac agc ggc gcc ttg acc agc ggc gtg 528
Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val
165 170 175
cac acc ttc ccc gcc gtg ctg cag agc agc ggc ctg tac agc ctg agc 576
His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser
180 185 190
agc gtg gtg acc gtg ccc agc agc agc ctg ggc acc cag acc tac atc 624
Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile
195 200 205
tgc aac gtg aac cac aag ccc agc aac acc aag gtg gac aaa cgc gtg 672
Cys Asn Val Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys Arg Val
210 215 220
gag ccc aag agc tgc gac aag acc cac acc tgc ccc ccc tgc cct gcc 720
Glu Pro Lys Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala
225 230 235 240
ccc gag ctg ctg ggc gga ccc tcc gtg ttc ctg ttc ccc ccc aag ccc 768
Pro Glu Leu Leu Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro
245 250 255
aag gac acc ctc atg atc agc cgg acc ccc gag gtg acc tgc gtg gtg 816
Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val
260 265 270
gtg gac gtg agc cac gag gac ccc gag gtg aag ttc aac tgg tac gtg 864
Val Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val
275 280 285
gac ggc gtg gag gtg cac aac gcc aag acc aag ccc cgg gag gag cag 912
Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln
290 295 300
tac aac agc acc tac cgg gtg gtg agc gtg ctc acc gtg ctg cac cag 960
Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln
305 310 315 320
gac tgg ctg aac ggc aag gag tac aag tgc aag gtg agc aac aag gcc 1008
Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala
325 330 335
ctg cct gcc ccc atc gag aag acc atc agc aag gcc aag ggc cag ccc 1056
Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro
340 345 350
cgg gag ccc cag gtg tac acc ctg ccc ccc agc cgg gag gag atg acc 1104
Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr
355 360 365
aag aac cag gtg tcc ctc acc tgt ctg gtg aag ggc ttc tac ccc agc 1152
Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser
370 375 380
gac atc gcc gtg gag tgg gag agc aac ggc cag ccc gag aac aac tac 1200
AsP Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr
385 390 395 400
aag acc acc ccc cct gtg ctg gac agc gac ggc agc ttc ttc ctg tac 1248
Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr
405 410 415
agc aag ctc acc gtg gac aag agc cgg tgg cag cag ggc aac gtg ttc 1296
Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Pne
420 425 430
agc tgc agc gtg atg cac gag gcc ctg cac aac cac tac acc cag aag 1344
Ser Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys
435 440 445
agc ctg agc ctg agc ccc ggc aag 1368
Ser Leu Ser Leu Ser Pro Gly Lys
450 455
<210>361
<211>456
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>361
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Phe Phe Ser Ser Tyr
20 25 30
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Gly Val Ile Pro Ile Phe Arg Thr Ala Asn Tyr Ala Gln Asn Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Phe Thr Ser Tyr Met Glu
65 70 75 80
Leu Ser Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys Ala Arg
85 90 95
Leu Asn Tyr His Asp Ser Gly Thr Tyr Tyr Asn Ala Pro Arg Gly Trp
100 105 110
Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser Ala Ser
115 120 125
Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr
130 135 140
Ser Gly Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro
145 150 155 160
Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser Gly Val
165 170 175
His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser
180 185 190
Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile
195 200 205
Cys Asn Val Asn His Lys Pro Ser Ash Thr Lys Val Asp Lys Arg Val
210 215 220
Glu Pro Lys Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro Ala
225 230 235 240
Pro Glu Leu Leu Gly Gly Pro Ser Val Phe Leu Phe Pro Pro Lys Pro
245 250 255
Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys Val Val
260 265 270
Val Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp Tyr Val
275 280 285
Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln
290 295 300
Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu His Gln
305 310 315 320
Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala
325 330 335
Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro
340 345 350
Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Glu Glu Met Thr
355 360 365
Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser
370 375 380
Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr
385 390 395 400
Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr
405 410 415
Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn Val Phe
420 425 430
Ser Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr Gln Lys
435 440 445
Ser Leu Ser Leu Ser Pro Gly Lys
450 455
<210>362
<211>657
<212>DNA
<213>Artificial
<220>
<223>CR6342Light chain
<220>
<221>CDS
<222>(1)..(657)
<400>362
gac atc cag atg acc cag tct cca gac tcc ctg gct gtg tct ctg ggc 48
Asp Ile Gln Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly
1 5 10 15
gag aag gcc acc atc aac tgc aag tcc agc cag agt att tta aac agc 96
Glu Lys Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Ile Leu Asn Ser
20 25 30
tcc aac aat aag aac tac tta gct tgg tac cag cag aaa cca gga cag 144
Ser Asn Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln
35 40 45
cct cct aag ctg ctc att tac tgg gca tct acc cgg gaa tcc ggg gtc 192
Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val
50 55 60
cct gac cga ttc agt agc agc ggg tct ggg aca gat ttc act ctc acc 240
Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr
65 70 75 80
atc agc agc ctg cag gct gaa gat gtg gca gtt tat tac tgt cag caa 288
Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln
85 90 95
tat tat agt agt ccg ccg acg ttc ggc caa ggg acc aag gtg gaa atc 336
Tyr Tyr Ser Ser Pro Pro Thr Phe Gly Gln Gly Thr Lys Val Glu Ile
100 105 110
aaa cgt gcg gcc gca ccc agc gtg ttc atc ttc ccc ccc tcc gac gag 384
Lys Arg Ala Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu
115 120 125
cag ctg aag agc ggc acc gcc agc gtg gtg tgc ctg ctg aac aac ttc 432
Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe
130 135 140
tac ccc cgg gag gcc aag gtg cag tgg aag gtg gac aac gcc ctg cag 480
Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln
145 150 155 160
agc ggc aac agc cag gag agc gtg acc gag cag gac agc aag gac tcc 528
Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser
165 170 175
acc tac agc ctg agc agc acc ctc acc ctg agc aag gcc gac tac gag 576
Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu
180 185 190
aag cac aag gtg tac gcc tgc gag gtg acc cac cag ggc ctg agc agc 624
Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser
195 200 205
ccc gtg acc aag agc ttc aac cgg ggc gag tgt 657
Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215
<210>363
<211>219
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>363
Asp Ile Gln Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly
1 5 10 15
Glu Lys Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Ile Leu Asn Ser
20 25 30
Ser Asn Asn Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln
35 40 45
Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val
50 55 60
Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr
65 70 75 80
Ile Ser Ser Leu Gln Ala Glu Asn Val Ala Val Tyr Tyr Cys Gln Gln
85 90 95
Tyr Tyr Ser Ser Pro Pro Thr Phe Gly Gln Gly Thr Lys Val Glu Ile
100 105 110
Lys Arg Ala Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu
115 120 125
Gln Leu Lys Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe
130 135 140
Tyr Pro Arg Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Glp
145 150 155 160
Ser Gly Asn Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lsy Asp Ser
165 170 175
Thr Tyr Ser Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu
180 185 190
Lys His Lys Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser
195 200 205
Pro Val Thr Lys Ser Phe Asn Arg Gly Glu Cys
210 215
<210>364
<211>1350
<212>DNA
<213>Artificial
<220>
<223>CR6343Heavy chain
<220>
<221>CDS
<222>(1)..(1350)
<400>364
cag gtc cag ctg gtg cag tct gga gct gag gtg aag aag cct ggg tcc 48
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
tcg gtg aag gtc tcc tgc aag gct tct gga gtc acc ttc agt tac tat 96
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Val Thr Phe Ser Tyr Tyr
20 25 30
gct atg agc tgg gtg cga cag gcc cct gga caa ggg ctt gag tgg gtg 144
Ala Met Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
gga gga atc agc cct atg ttt ggg aca aca acc tac gca cag aag ttc 192
Gly Gly Ile Ser Pro Met Phe Gly Thr Thr Thr Tyr Ala Gln Lys Phe
50 55 60
cag ggc aga gtc acg att act gcg gac gac tcc acg agt aca gcc tac 240
Gln Gly Arg yal Tnr lle lnr Ala Asp ASp Ser Thr Ser Thr Ala Tyr
65 70 75 80
atg gag gtg agg agc ctg aga tct gag gac acg gcc gtg tat tac tgt 288
Met Glu Val Arg Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
gcg aga tct tcg aat tac tat gat agt gta tat gac tac tgg ggc cag 336
Ala Arg Ser Ser Asn Tyr Tyr Asp Ser Val Tyr Asp Tyr Trp Gly Gln
100 105 110
gga acc ctg gtc acc gtc tcg agt gct agc acc aag ggc ccc agc gtg 384
Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val
115 120 125
ttc ccc ctg gcc ccc agc agc aag agc acc agc ggc ggc aca gcc gcc 432
Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala
130 135 140
ctg ggc tgc ctg gtg aag gac tac ttc ccc gag ccc gtg acc gtg agc 480
Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser
145 150 155 160
tgg aac agc ggc gcc ttg acc agc ggc gtg cac acc ttc ccc gcc gtg 528
Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val
165 170 175
ctg cag agc agc ggc ctg tac agc ctg agc agc gtg gtg acc gtg ccc 576
Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro
180 185 190
agc agc agc ctg ggc acc cag acc tac atc tgc aac gtg aac cac aag 624
Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys
195 200 205
ccc agc aac acc aag gtg gac aaa cgc gtg gag ccc aag agc tgc gac 672
Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp
210 215 220
aag acc cac acc tgc ccc ccc tgc cct gcc ccc gag ctg ctg ggc gga 720
Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly
225 230 235 240
ccc tcc gtg ttc ctg ttc ccc ccc aag ccc aag gac acc ctc atg atc 768
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
agc cgg acc ccc gag gtg acc tgc gtg gtg gtg gac gtg agc cac gag 816
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu
260 265 270
gac ccc gag gtg aag ttc aac tgg tac gtg gac ggc gtg gag gtg cac 864
Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
aac gcc aag acc aag ccc cgg gag gag cag tac aac agc acc tac cgg 912
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg
290 295 300
gtg gtg agc gtg ctc acc gtg ctg cac cag gac tgg ctg aac ggc aag 960
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
gag tac aag tgc aag gtg agc aac aag gcc ctg cct gcc ccc atc gag 1008
Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu
325 330 335
aag acc atc agc aag gcc aag ggc cag ccc cgg gag ccc cag gtg tac 1056
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
acc ctg ccc ccc agc cgg gag gag atg acc aag aac cag gtg tcc ctc 1104
Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
acc tgt ctg gtg aag ggc ttc tac ccc agc gac atc gcc gtg gag tgg 1152
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
gag agc aac ggc cag ccc gag aac aac tac aag acc acc ccc cct gtg 1200
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
ctg gac agc gac ggc agc ttc ttc ctg tac agc aag ctc acc gtg gac 1248
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp
405 410 415
aag agc cgg tgg cag cag ggc aac gtg ttc agc tgc agc gtg atg cac 1296
Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
gag gcc ctg cac aac cac tac acc cag aag agc ctg agc ctg agc ccc 1344
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro
435 440 445
ggc aag 1350
Gly Lys
450
<210>365
<211>450
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>365
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser
1 5 10 15
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Val Thr Phe Ser Tyr Tyr
20 25 30
Ala Met Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
35 40 45
Gly Gly Ile Ser Pro Met Phe Gly Thr Thr Thr Tyr Ala Gln Lys Phe
50 55 60
Gln Gly Arg Val Thr Ile Thr Ala Asp Asp Ser Thr Ser Thr Ala Tyr
65 70 75 80
Met Glu Val Arg Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys
85 90 95
Ala Arg Ser Ser Asn Tyr Tyr Asp Ser Val Tyr Asp Tyr Trp Gly Gln
100 105 110
Gly Thr Leu Val Thr Val Ser Ser Ala Ser Thr Lys Gly Pro Ser Val
115 120 125
Phe Pro Leu Ala Pro Ser Ser Lys Ser Thr Ser Gly Gly Thr Ala Ala
130 135 140
Leu Gly Cys Leu Val Lys Asp Tyr Phe Pro Glu Pro Val Thr Val Ser
145 150 155 160
Trp Asn Ser Gly Ala Leu Thr Ser Gly Val His Thr Phe Pro Ala Val
165 170 175
Leu Gln Ser Ser Gly Leu Tyr Ser Leu Ser Ser Val Val Thr Val Pro
180 185 190
Ser Ser Ser Leu Gly Thr Gln Thr Tyr Ile Cys Asn Val Asn His Lys
195 200 205
Pro Ser Asn Thr Lys Val Asp Lys Arg Val Glu Pro Lys Ser Cys Asp
210 215 220
Lys Thr His Thr Cys Pro Pro Cys Pro Ala Pro Glu Leu Leu Gly Gly
225 230 235 240
Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys Asp Thr Leu Met Ile
245 250 255
Ser Arg Thr Pro Glu Val Thr Cys Val Val Val Asp Val Ser His Glu
260 265 270
Asp Pro Glu Val Lys Phe Asn Trp Tyr Val Asp Gly Val Glu Val His
275 280 285
Asn Ala Lys Thr Lys Pro Arg Glu Glu Gln Tyr Asn Ser Thr Tyr Arg
290 295 300
Val Val Ser Val Leu Thr Val Leu His Gln Asp Trp Leu Asn Gly Lys
305 310 315 320
Glu Tyr Lys Cys Lys Val Ser Asn Lys Ala Leu Pro Ala Pro Ile Glu
325 330 335
Lys Thr Ile Ser Lys Ala Lys Gly Gln Pro Arg Glu Pro Gln Val Tyr
340 345 350
Thr Leu Pro Pro Ser Arg Glu Glu Met Thr Lys Asn Gln Val Ser Leu
355 360 365
Thr Cys Leu Val Lys Gly Phe Tyr Pro Ser Asp Ile Ala Val Glu Trp
370 375 380
Glu Ser Asn Gly Gln Pro Glu Asn Asn Tyr Lys Thr Thr Pro Pro Val
385 390 395 400
Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser Lys Leu Thr Val Asp
405 410 415
Lys Ser Arg Trp Gln Gln Gly Asn Val Phe Ser Cys Ser Val Met His
420 425 430
Glu Ala Leu His Asn His Tyr Thr Gln Lys Ser Leu Ser Leu Ser Pro
435 440 445
Gly Lys
450
<210>366
<211>654
<212>DNA
<213>Artificial
<220>
<223>CR6343Light chain
<220>
<221>CDS
<222>(1)..(654)
<400>366
cag tct gtc gtg acg cag ccg ccc tcg gag tca gtg gcc cca gga cag 48
Gln Ser Val Val Thr Gln Pro Pro Ser Glu Ser Val Ala Pro Gly Gln
1 5 10 15
acg gcc agg att acc tgt ggg gga cat aac att gga agt aat agt gtg 96
Thr Ala Arg Ile Thr Cys Gly Gly His Asn Ile Gly Ser Asn Ser Val
20 25 30
cac tgg tac cag cag aag cca ggc cag gcc cct gtg ctg gtc gtg tat 144
His Trn Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr
35 40 45
gat aat agc gac cgg ccc tca ggg atc cct gag cga ttc tct ggc tcc 192
Asp Asn Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser
50 55 60
aac tct ggg aac acg gcc acc ctg acc atc agc agg gtc gaa gcc ggg 240
Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly
65 70 75 80
gat gag gcc gac tat tac tgt cag gtg tgg ggt agt agt agt gac cat 288
Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Gly Ser Ser Ser Asp Gis
85 90 95
tat gtc ttc gga act ggg acc aag gtc acc gtc cta ggt gcg gcc gca 336
Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu Gly Ala Ala Ala
100 105 110
ggc cag ccc aag gcc gct ccc agc gtg acc ctg ttc ccc ccc tcc tcc 384
Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro Ser Ser
115 120 125
gag gag ctg cag gcc aac aag gcc acc ctg gtg tgc ctc atc agc gac 432
Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Gys Leu Ile Ser Asp
130 135 140
ttc tac cct ggc gcc gtg acc gtg gcc tgg aag gcc gac agc agc ccc 480
Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser Ser Pro
145 150 155 160
gtg aag gcc ggc gtg gag acc acc acc ccc agc aag cag agc aac aac 528
Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser Asn Asn
165 170 175
aag tac gcc gcc agc agc tac ctg agc ctc acc ccc gag cag tgg aag 576
Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln Trp Lys
180 185 190
agc cac cgg agc tac agc tgc cag gtg acc cac gag ggc agc acc gtg 624
Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser Thr Val
195 200 205
gag gag acc gtg gcc ccc acc gag tgc agc 654
Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215
<210>367
<211>218
<212>PRT
<213>Artificial
<220>
<223>Synthetic Construct
<400>367
Gln Set Val Val Thr Gln Pro Pro Set Glu Set Val Ala Pro Gly Gln
1 5 10 15
Thr Ala Arg Ile Thr Cys Gly Gly His Asn Ile Gly Set Asn Ser Val
20 25 30
His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr
35 40 45
Asp Asn Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser
50 55 60
Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly
65 70 75 80
Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Gly Ser Ser Ser Asp His
85 90 95
Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu Gly Ala Ala Ala
100 105 110
Gly Gln Pro Lys Ala Ala Pro Ser Val Thr Leu Phe Pro Pro Ser Ser
115 120 125
Glu Glu Leu Gln Ala Asn Lys Ala Thr Leu Val Cys Leu Ile Ser Asp
130 135 140
Phe Tyr Pro Gly Ala Val Thr Val Ala Trp Lys Ala Asp Ser Ser Pro
145 150 155 160
Val Lys Ala Gly Val Glu Thr Thr Thr Pro Ser Lys Gln Ser Asn Asn
165 170 175
Lys Tyr Ala Ala Ser Ser Tyr Leu Ser Leu Thr Pro Glu Gln Trp Lys
180 185 190
Ser His Arg Ser Tyr Ser Cys Gln Val Thr His Glu Gly Ser Thr Val
195 200 205
Glu Lys Thr Val Ala Pro Thr Glu Cys Ser
210 215
<210>368
<211>12
<212>PRT
<213>Influenza A virus
<400>368
Gly Val Thr Asn Lys Val Asn Ser Ile Ile Asp Lys
1 5 10
<210>269
<211>12
<212>PRT
<213>Influenza A yirus
<400>369
Gly Val Thr Asn Lys Val Asn Ser Ile Ile Asn Lys
1 5 10
<210>370
<211>12
<212>PRT
<213>Influenza A yirus
<400>370
Gly Val Thr Asn Lys Glu Asn Ser Ile Ile Asp Lys
1 5 10
<210>371
<211>12
<212>PRT
<213>Influenza A virus
<400>371
Gly Val Thr Asn Lys Val Asn Arg Ile Ile Asp Lys
1 5 10
<210>372
<211>12
<212>PRT
<213>Influenza A virus
<400>372
G1y Ile Thr Asn Lys Val Asn Ser Val Ile Glu Lys
1 5 10
<210>373
<211>12
<212>PRT
<213>Influenza A yirus
<400>373
Gly Ile Thr Asn Lys Glu Asn Ser Val Ile Glu Lys
1 5 10
<210>374
<211>12
<212>PRT
<213>Influenza A virus
<400>374
Gly Ile Thr Asn Lys Val Asn Ser Ile Ile Asp Lys
1 5 10
<210>375
<211>12
<212>PRT
<213>Influenza A yirus
<400>375
Lys Ile Thr Ser Lys Val Asn Asn Ile Val Asp Lys
1 5 10
<210>376
<211>12
<212>PRT
<213>Influenza A yirus
<400>376
Gln Ile Asn Gly Lys Leu Asn Arg Val Ile Glu Lys
1 5 10
<210>377
<211>12
<212>PRT
<213>Influenza A yirus
<400>377
Gln Ile Asn Gly Lys Leu Asn Arg Leu Ile Glu Lys
1 5 10
Claims (11)
1.一种分离的人结合分子,其能识别并结合流感血凝素蛋白(HA)的HA2亚基中的表位,特征在于所述结合分子具有对于包含H5亚型的HA的流感病毒的中和活性,其中所述结合分子包含SEQ ID NO:1所示重链CDR1区、SEQ ID NO:2所示重链CDR2区、SEQ ID NO:3所示重链CDR3区、SEQ ID NO:13所示轻链CDR1区、SEQ ID NO:14所示轻链CDR2区以及SEQ ID NO:15所示轻链CDR3区。
2.权利要求1的结合分子,其中所述结合分子还具有对于包含H1亚型的HA的流感病毒的中和活性。
3.权利要求2的结合分子,其中所述结合分子还具有对于包含H2、H6和/或H9亚型的HA的流感病毒的中和活性。
4.权利要求1、2或3的结合分子,其中所述结合分子包含重链可变区,所述重链可变区包含SEQ ID NO:65的氨基酸1-121。
5.权利要求1、2或3的结合分子,其中所述结合分子包含重链可变区和轻链可变区,所述重链可变区包含SEQ ID NO:65的氨基酸1-121,所述轻链可变区包含SEQ ID NO:91的氨基酸1-112。
6.权利要求1-5任一项的结合分子,其中所述结合分子是人单克隆抗体。
7.编码权利要求1-6任一项的结合分子的核酸分子。
8.一种药物组合物,其包含权利要求1-6任一项的结合分子以及药物可接受的赋形剂。
9.权利要求1-6任一项的结合分子在制备用于诊断、预防和/或治疗流感病毒感染的药物中的应用。
10.权利要求9的应用,其中所述流感感染是由于流感病毒所致,所述流感病毒与流行性爆发相关,或者具有流行性爆发相关的潜力。
11.权利要求10的应用,其中所述与流行性爆发相关的流感病毒毒株选自如下一组:H1N1、H5N1、H5N2、H5N8、H5N9、基于H2的毒株以及H9N2。
Applications Claiming Priority (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84293006P | 2006-09-07 | 2006-09-07 | |
US60/842,930 | 2006-09-07 | ||
EP06120316.2 | 2006-09-07 | ||
EP06120316 | 2006-09-07 | ||
EP06120644 | 2006-09-14 | ||
EP06120644.7 | 2006-09-14 | ||
EP06125107 | 2006-11-30 | ||
EP06125107.0 | 2006-11-30 | ||
EP07111235 | 2007-06-28 | ||
EP07111235.3 | 2007-06-28 | ||
PCT/EP2007/059356 WO2008028946A2 (en) | 2006-09-07 | 2007-09-06 | Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101541832A CN101541832A (zh) | 2009-09-23 |
CN101541832B true CN101541832B (zh) | 2014-11-12 |
Family
ID=37720792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200780041285.1A Active CN101541832B (zh) | 2006-09-07 | 2007-09-06 | 能中和流感病毒h5n1的人结合分子及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101541832B (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102046654A (zh) * | 2007-03-13 | 2011-05-04 | 胡马斯有限公司 | 针对甲型流感病毒h5n1株系的抗体 |
EA201400855A1 (ru) * | 2010-03-08 | 2014-11-28 | Селлтрион, Инк. | Моноклональные антитела человека, полученные из в-клеток человека и обладающие нейтрализующей активностью против вирусов гриппа а |
CN102219853B (zh) * | 2010-04-15 | 2013-10-30 | 上海人类基因组研究中心 | 抗h5n1型禽流感病毒的小羊驼vhh重链抗体及其制备方法和用途 |
ES2562818T3 (es) * | 2010-05-03 | 2016-03-08 | Glaxosmithkline Biologicals S.A. | Procedimiento de inactivación del virus de la gripe |
CN102279266A (zh) * | 2010-06-09 | 2011-12-14 | 中国科学院动物研究所 | 用于检测h5亚型禽流感病毒的生物芯片及其制备方法和用途 |
CN102041265B (zh) * | 2010-09-30 | 2012-10-17 | 中国科学院武汉病毒研究所 | 检测甲型h1n1病毒抗原的免疫检测试剂 |
ES2732552T3 (es) * | 2011-07-18 | 2019-11-25 | Inst Res Biomedicine | Anticuerpos neutralizantes del virus de la influenza A y usos de los mismos |
EP3052192B1 (en) * | 2013-10-02 | 2020-07-01 | Medlmmune, LLC | Neutralizing anti-influenza a antibodies and uses thereof |
EP3105246B1 (en) * | 2014-02-10 | 2021-03-31 | Merck Patent GmbH | Targeted tgf beta inhibition |
SG11201809783RA (en) * | 2016-05-05 | 2018-12-28 | Univ Pennsylvania | Dna monoclonal antibodies targeting influenza virus |
CN111440228B (zh) * | 2020-03-09 | 2021-08-24 | 扬州大学 | 多种亚型流感病毒ha2蛋白共同抗原表位、抗体、鉴定方法和应用 |
CN113121680B (zh) * | 2021-04-12 | 2022-03-29 | 华南农业大学 | 一种抗h5亚型禽流感纳米抗体蛋白及其编码基因与应用 |
CN113433328B (zh) * | 2021-08-30 | 2021-11-02 | 南京立顶医疗科技有限公司 | 病毒中和抗体与非中和抗体联合检测方法、检测卡及应用 |
-
2007
- 2007-09-06 CN CN200780041285.1A patent/CN101541832B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN101541832A (zh) | 2009-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101485197B1 (ko) | 인플루엔자 바이러스 h5n1을 중화시킬 수 있는 인간 결합분자 및 그것의 용도 | |
KR101941724B1 (ko) | 계통발생군 1과 계통발생군 2의 인플루엔자 a형 바이러스 및 인플루엔자 b형 바이러스를 중화시킬 수 있는 인간 결합분자 | |
AU2010247530B2 (en) | Human binding molecules capable of neutralizing influenza virus H3N2 and uses thereof | |
CN101541832B (zh) | 能中和流感病毒h5n1的人结合分子及其应用 | |
AU2006290736A1 (en) | Method for preparing immunoglobulin libraries | |
KR20220031126A (ko) | 장내구균에 대한 사멸활성을 갖는 인간결합분자 및 그것의 용도 | |
KR20170042376A (ko) | 장내구균에 대한 사멸활성을 갖는 인간결합분자 및 그것의 용도 | |
DK2455399T3 (da) | Humane bindingsmolekyler, der er i stand til at neutralisere influenzavirus h5n1, og anvendelser deraf | |
NZ618530B2 (en) | Human binding molecules capable of neutralizing influenza a viruses of phylogenetic group 1 and phylogenetic group 2 and influenza b viruses | |
KR20140095558A (ko) | 장내구균에 대한 사멸활성을 갖는 인간결합분자 및 그것의 용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |